Gene_Id,Gene_Symbol,Gene_Description,Disease_Id,DiseaseName,PsychiatricDisorder,diseaseId,name,type,diseaseClassMSH,diseaseClassNameMSH,hpoClassId,hpoClassName,doClassId,doClassName,umlsSemanticTypeId,umlsSemanticTypeName,Approved symbol,HGNC ID,Approved name,NCBI gene ID,Ensembl gene ID,GENE,TARGET_NAME,TARGET_CLASS,SWISSPROT,ACT_VALUE,ACT_TYPE,ACT_SOURCE
1312,COMT,catechol-O-methyltransferase,C0001723,"affective disorders, psychotic",Depressive disorders,C0001723,"Affective Disorders, Psychotic",group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
267012,DAOA,D-amino acid oxidase activator,C0001723,"affective disorders, psychotic",Depressive disorders,C0001723,"Affective Disorders, Psychotic",group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3240,HP,haptoglobin,C0001723,"affective disorders, psychotic",Depressive disorders,C0001723,"Affective Disorders, Psychotic",group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP,HGNC:5141,haptoglobin,3240,ENSG00000257017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3557,IL1RN,interleukin 1 receptor antagonist,C0001723,"affective disorders, psychotic",Depressive disorders,C0001723,"Affective Disorders, Psychotic",group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1RN,HGNC:6000,interleukin 1 receptor antagonist,3557,ENSG00000136689,IL1RN,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,11.21467018,Kd,DRUG LABEL
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0001723,"affective disorders, psychotic",Depressive disorders,C0001723,"Affective Disorders, Psychotic",group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0001723,"affective disorders, psychotic",Depressive disorders,C0001723,"Affective Disorders, Psychotic",group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
127,ADH4,"alcohol dehydrogenase 4 (class II), pi polypeptide",C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH4,HGNC:252,"alcohol dehydrogenase 4 (class II), pi polypeptide",127,ENSG00000198099,ADH4,Alcohol dehydrogenase 4,Enzyme,ADH4_HUMAN,5.523,Ki,WOMBAT-PK
9531,BAG3,BCL2-associated athanogene 3,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BAG3,HGNC:939,BAG cochaperone 3,9531,ENSG00000151929,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2067,ERCC1,excision repair cross-complementation group 1,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERCC1,HGNC:3433,"ERCC excision repair 1, endonuclease non-catalytic subunit",2067,ENSG00000012061,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
4174,MCM5,minichromosome maintenance complex component 5,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCM5,HGNC:6948,minichromosome maintenance complex component 5,4174,ENSG00000100297,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406938,MIR146A,microRNA 146a,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR146A,HGNC:31533,microRNA 146a,406938,ENSG00000283733,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5496,PPM1G,"protein phosphatase, Mg2+/Mn2+ dependent, 1G",C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPM1G,HGNC:9278,"protein phosphatase, Mg2+/Mn2+ dependent 1G",5496,ENSG00000115241,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
9705,ST18,"suppression of tumorigenicity 18, zinc finger",C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST18,HGNC:18695,ST18 C2H2C-type zinc finger transcription factor,9705,ENSG00000147488,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50838,TAS2R13,"taste receptor, type 2, member 13",C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAS2R13,HGNC:14919,taste 2 receptor member 13,50838,ENSG00000212128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
121278,TPH2,tryptophan hydroxylase 2,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7450,VWF,von Willebrand factor,C0001956,alcohol use disorder,Alcohol use disorders,C0001956,Alcohol Use Disorder,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VWF,HGNC:12726,von Willebrand factor,7450,ENSG00000110799,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0001957,alcohol withdrawal delirium,Alcohol use disorders,C0001957,Alcohol Withdrawal Delirium,disease,C10;F03;C25,Nervous System Diseases; Mental Disorders; Substance-Related Disorders,0,0,0,0,T047,Disease or Syndrome,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2918,GRM8,"glutamate receptor, metabotropic 8",C0001957,alcohol withdrawal delirium,Alcohol use disorders,C0001957,Alcohol Withdrawal Delirium,disease,C10;F03;C25,Nervous System Diseases; Mental Disorders; Substance-Related Disorders,0,0,0,0,T047,Disease or Syndrome,GRM8,HGNC:4600,glutamate metabotropic receptor 8,2918,ENSG00000179603,GRM8,Metabotropic glutamate receptor 8,GPCR,GRM8_HUMAN,5.349999905,IC50,IUPHAR
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,ADH1B,HGNC:250,"alcohol dehydrogenase 1B (class I), beta polypeptide",125,ENSG00000196616,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,ADH1C,HGNC:251,"alcohol dehydrogenase 1C (class I), gamma polypeptide",126,ENSG00000248144,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10327,AKR1A1,"aldo-keto reductase family 1, member A1 (aldehyde reductase)",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,AKR1A1,HGNC:380,aldo-keto reductase family 1 member A1,10327,ENSG00000117448,AKR1A1,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_HUMAN,5.59,IC50,CHEMBL
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,ALDH1A1,HGNC:402,aldehyde dehydrogenase 1 family member A1,216,ENSG00000165092,ALDH1A1,Retinal dehydrogenase 1,Enzyme,AL1A1_HUMAN,0,0,WOMBAT-PK
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
590,BCHE,butyrylcholinesterase,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,BCHE,HGNC:983,butyrylcholinesterase,590,ENSG00000114200,BCHE,Cholinesterase,Enzyme,CHLE_HUMAN,8.5,IC50,IUPHAR
627,BDNF,brain-derived neurotrophic factor,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
930,CD19,CD19 molecule,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,CD19,HGNC:1633,CD19 molecule,930,ENSG00000177455,CD19,B-lymphocyte antigen CD19,Surface antigen,CD19_HUMAN,0,0,DRUG LABEL
1103,CHAT,choline O-acetyltransferase,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,CHAT,HGNC:1912,choline O-acetyltransferase,1103,ENSG00000070748,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1351,COX8A,cytochrome c oxidase subunit VIIIA (ubiquitous),C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,COX8A,HGNC:2294,cytochrome c oxidase subunit 8A,1351,ENSG00000176340,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
1815,DRD4,dopamine receptor D4,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
1974,EIF4A2,eukaryotic translation initiation factor 4A2,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,EIF4A2,HGNC:3284,eukaryotic translation initiation factor 4A2,1974,ENSG00000156976,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,FYN,HGNC:4037,"FYN proto-oncogene, Src family tyrosine kinase",2534,ENSG00000010810,FYN,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,6.087777943,IC50,DRUG MATRIX
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,GABRA1,HGNC:4075,gamma-aminobutyric acid type A receptor subunit alpha1,2554,ENSG00000022355,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,7.300000191,Ki,CHEMBL
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
3308,HSPA4,heat shock 70kDa protein 4,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3479,IGF1,insulin-like growth factor 1 (somatomedin C),C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,IGF1,HGNC:5464,insulin like growth factor 1,3479,ENSG00000017427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3606,IL18,interleukin 18,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,IL18,HGNC:5986,interleukin 18,3606,ENSG00000150782,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3929,LBP,lipopolysaccharide binding protein,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,LBP,HGNC:6517,lipopolysaccharide binding protein,3929,ENSG00000129988,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4353,MPO,myeloperoxidase,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MPO,HGNC:7218,myeloperoxidase,4353,ENSG00000005381,MPO,Myeloperoxidase,Enzyme,PERM_HUMAN,5.301,IC50,WOMBAT-PK
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MTR,HGNC:7468,5-methyltetrahydrofolate-homocysteine methyltransferase,4548,ENSG00000116984,MTR,Methionine synthase,Enzyme,METH_HUMAN,0,0,WOMBAT-PK
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
5444,PON1,paraoxonase 1,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,PON1,HGNC:9204,paraoxonase 1,5444,ENSG00000005421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,RELA,HGNC:9955,"RELA proto-oncogene, NF-kB subunit",5970,ENSG00000173039,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5972,REN,renin,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,REN,HGNC:9958,renin,5972,ENSG00000143839,REN,Renin,Enzyme,RENI_HUMAN,9.22,IC50,WOMBAT-PK
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
6648,SOD2,"superoxide dismutase 2, mitochondrial",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,SOD2,HGNC:11180,superoxide dismutase 2,6648,ENSG00000112096,SOD2,"Superoxide dismutase [Mn], mitochondrial",Enzyme,SODM_HUMAN,0,0,WOMBAT-PK
6480,ST6GAL1,"ST6 beta-galactosamide alpha-2,6-sialyltranferase 1",C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,ST6GAL1,HGNC:10860,"ST6 beta-galactoside alpha-2,6-sialyltransferase 1",6480,ENSG00000073849,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7157,TP53,tumor protein p53,C0001969,alcoholic intoxication,Alcohol use disorders,C0001969,Alcoholic Intoxication,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,TP53,HGNC:11998,tumor protein p53,7157,ENSG00000141510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABO,HGNC:79,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",28,ENSG00000175164,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
57001,ACN9,ACN9 homolog (S. cerevisiae),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
111,ADCY5,adenylate cyclase 5,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY5,HGNC:236,adenylate cyclase 5,111,ENSG00000173175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
113,ADCY7,adenylate cyclase 7,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY7,HGNC:238,adenylate cyclase 7,113,ENSG00000121281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
124,ADH1A,"alcohol dehydrogenase 1A (class I), alpha polypeptide",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH1A,HGNC:249,"alcohol dehydrogenase 1A (class I), alpha polypeptide",124,ENSG00000187758,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH1B,HGNC:250,"alcohol dehydrogenase 1B (class I), beta polypeptide",125,ENSG00000196616,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH1C,HGNC:251,"alcohol dehydrogenase 1C (class I), gamma polypeptide",126,ENSG00000248144,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
127,ADH4,"alcohol dehydrogenase 4 (class II), pi polypeptide",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH4,HGNC:252,"alcohol dehydrogenase 4 (class II), pi polypeptide",127,ENSG00000198099,ADH4,Alcohol dehydrogenase 4,Enzyme,ADH4_HUMAN,5.523,Ki,WOMBAT-PK
128,ADH5,"alcohol dehydrogenase 5 (class III), chi polypeptide",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH5,HGNC:253,"alcohol dehydrogenase 5 (class III), chi polypeptide",128,ENSG00000197894,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
130,ADH6,alcohol dehydrogenase 6 (class V),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH6,HGNC:255,alcohol dehydrogenase 6 (class V),130,ENSG00000172955,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
131,ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH7,HGNC:256,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",131,ENSG00000196344,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
150,ADRA2A,adrenoceptor alpha 2A,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2A,HGNC:281,adrenoceptor alpha 2A,150,ENSG00000150594,ADRA2A,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,6.3,IC50,WOMBAT-PK
26523,AGO1,argonaute RISC catalytic component 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGO1,HGNC:3262,argonaute RISC component 1,26523,ENSG00000092847,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27161,AGO2,argonaute RISC catalytic component 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGO2,HGNC:3263,argonaute RISC catalytic component 2,27161,ENSG00000123908,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10327,AKR1A1,"aldo-keto reductase family 1, member A1 (aldehyde reductase)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1A1,HGNC:380,aldo-keto reductase family 1 member A1,10327,ENSG00000117448,AKR1A1,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_HUMAN,5.59,IC50,CHEMBL
8644,AKR1C3,"aldo-keto reductase family 1, member C3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1C3,HGNC:386,aldo-keto reductase family 1 member C3,8644,ENSG00000196139,AKR1C3,Aldo-keto reductase family 1 member C3,Enzyme,AK1C3_HUMAN,5.59,IC50,CHEMBL
1109,AKR1C4,"aldo-keto reductase family 1, member C4",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1C4,HGNC:387,aldo-keto reductase family 1 member C4,1109,ENSG00000198610,AKR1C4,Aldo-keto reductase family 1 member C4,Enzyme,AK1C4_HUMAN,4.27,IC50,CHEMBL
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH1A1,HGNC:402,aldehyde dehydrogenase 1 family member A1,216,ENSG00000165092,ALDH1A1,Retinal dehydrogenase 1,Enzyme,AL1A1_HUMAN,0,0,WOMBAT-PK
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
222,ALDH3B2,"aldehyde dehydrogenase 3 family, member B2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH3B2,HGNC:411,aldehyde dehydrogenase 3 family member B2,222,ENSG00000132746,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
238,ALK,anaplastic lymphoma receptor tyrosine kinase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALK,HGNC:427,ALK receptor tyrosine kinase,238,ENSG00000171094,ALK,ALK tyrosine kinase receptor,Kinase,ALK_HUMAN,5.92,Kd,CHEMBL
64682,ANAPC1,anaphase promoting complex subunit 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANAPC1,HGNC:19988,anaphase promoting complex subunit 1,64682,ENSG00000153107,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
56311,ANKRD7,ankyrin repeat domain 7,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKRD7,HGNC:18588,ankyrin repeat domain 7,56311,ENSG00000106013,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
348,APOE,apolipoprotein E,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOE,HGNC:613,apolipoprotein E,348,ENSG00000130203,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
367,AR,androgen receptor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
23237,ARC,activity-regulated cytoskeleton-associated protein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARC,HGNC:648,activity regulated cytoskeleton associated protein,23237,ENSG00000198576,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
410,ARSA,arylsulfatase A,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARSA,HGNC:713,arylsulfatase A,410,ENSG00000100299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
460,ASTN1,astrotactin 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASTN1,HGNC:773,astrotactin 1,460,ENSG00000152092,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9531,BAG3,BCL2-associated athanogene 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BAG3,HGNC:939,BAG cochaperone 3,9531,ENSG00000151929,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
627,BDNF,brain-derived neurotrophic factor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
635,BHMT,betaine--homocysteine S-methyltransferase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BHMT,HGNC:1047,betaine--homocysteine S-methyltransferase,635,ENSG00000145692,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
400359,C15orf53,chromosome 15 open reading frame 53,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10438,C1D,C1D nuclear receptor corepressor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C1D,HGNC:29911,C1D nuclear receptor corepressor,10438,ENSG00000197223,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
796,CALCA,calcitonin-related polypeptide alpha,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALCA,HGNC:1437,calcitonin related polypeptide alpha,796,ENSG00000110680,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK2A,HGNC:1460,calcium/calmodulin dependent protein kinase II alpha,815,ENSG00000070808,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,7.1,Kd,CHEMBL
814,CAMK4,calcium/calmodulin-dependent protein kinase IV,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK4,HGNC:1464,calcium/calmodulin dependent protein kinase IV,814,ENSG00000152495,CAMK4,Calcium/calmodulin-dependent protein kinase type IV,Kinase,KCC4_HUMAN,6.05,Kd,CHEMBL
833,CARS,cysteinyl-tRNA synthetase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9607,CARTPT,CART prepropeptide,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
113201,CASC4,cancer susceptibility candidate 4,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
847,CAT,catalase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAT,HGNC:1516,catalase,847,ENSG00000121691,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
885,CCK,cholecystokinin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCK,HGNC:1569,cholecystokinin,885,ENSG00000187094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
886,CCKAR,cholecystokinin A receptor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
1008,CDH10,"cadherin 10, type 2 (T2-cadherin)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH10,HGNC:1749,cadherin 10,1008,ENSG00000040731,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1009,CDH11,"cadherin 11, type 2, OB-cadherin (osteoblast)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH11,HGNC:1750,cadherin 11,1009,ENSG00000140937,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1010,CDH12,"cadherin 12, type 2 (N-cadherin 2)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH12,HGNC:1751,cadherin 12,1010,ENSG00000154162,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1012,CDH13,cadherin 13,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH13,HGNC:1753,cadherin 13,1012,ENSG00000140945,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1013,CDH15,"cadherin 15, type 1, M-cadherin (myotubule)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH15,HGNC:1754,cadherin 15,1013,ENSG00000129910,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1016,CDH18,"cadherin 18, type 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH18,HGNC:1757,cadherin 18,1016,ENSG00000145526,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1003,CDH5,"cadherin 5, type 2 (vascular endothelium)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH5,HGNC:1764,cadherin 5,1003,ENSG00000179776,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1006,CDH8,"cadherin 8, type 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH8,HGNC:1767,cadherin 8,1006,ENSG00000150394,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1007,CDH9,"cadherin 9, type 2 (T1-cadherin)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH9,HGNC:1768,cadherin 9,1007,ENSG00000113100,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CFTR,HGNC:1884,CF transmembrane conductance regulator,1080,ENSG00000001626,CFTR,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,8.4,Ki,IUPHAR
1129,CHRM2,"cholinergic receptor, muscarinic 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM2,HGNC:1951,cholinergic receptor muscarinic 2,1129,ENSG00000181072,CHRM2,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,5.900000095,Ki,IUPHAR
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA3,HGNC:1957,cholinergic receptor nicotinic alpha 3 subunit,1136,ENSG00000080644,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_HUMAN,4.17,Ki,CHEMBL
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA4,HGNC:1958,cholinergic receptor nicotinic alpha 4 subunit,1137,ENSG00000101204,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,4.039999962,IC50,IUPHAR
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA5,HGNC:1959,cholinergic receptor nicotinic alpha 5 subunit,1138,ENSG00000169684,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB3,HGNC:1963,cholinergic receptor nicotinic beta 3 subunit,1142,ENSG00000147432,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1143,CHRNB4,"cholinergic receptor, nicotinic, beta 4 (neuronal)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB4,HGNC:1964,cholinergic receptor nicotinic beta 4 subunit,1143,ENSG00000117971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
1269,CNR2,cannabinoid receptor 2 (macrophage),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
152330,CNTN4,contactin 4,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTN4,HGNC:2174,contactin 4,152330,ENSG00000144619,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27255,CNTN6,contactin 6,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTN6,HGNC:2176,contactin 6,27255,ENSG00000134115,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26047,CNTNAP2,contactin associated protein-like 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTNAP2,HGNC:13830,contactin associated protein 2,26047,ENSG00000174469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
130749,CPO,carboxypeptidase O,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CPO,HGNC:21011,carboxypeptidase O,130749,ENSG00000144410,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1385,CREB1,cAMP responsive element binding protein 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1496,CTNNA2,"catenin (cadherin-associated protein), alpha 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNNA2,HGNC:2510,catenin alpha 2,1496,ENSG00000066032,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
1553,CYP2A13,"cytochrome P450, family 2, subfamily A, polypeptide 13",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2A13,HGNC:2608,cytochrome P450 family 2 subfamily A member 13,1553,ENSG00000197838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2B6,HGNC:2615,cytochrome P450 family 2 subfamily B member 6,1555,ENSG00000197408,CYP2B6,Cytochrome P450 2B6,Enzyme,CP2B6_HUMAN,6.3,Ki,WOMBAT-PK
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2E1,HGNC:2631,cytochrome P450 family 2 subfamily E member 1,1571,ENSG00000130649,CYP2E1,Cytochrome P450 2E1,Enzyme,CP2E1_HUMAN,4.958607315,IC50,DRUG MATRIX
54360,CYTL1,cytokine-like 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYTL1,HGNC:24435,cytokine like 1,54360,ENSG00000170891,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
27123,DKK2,dickkopf WNT signaling pathway inhibitor 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DKK2,HGNC:2892,dickkopf WNT signaling pathway inhibitor 2,27123,ENSG00000155011,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1808,DPYSL2,dihydropyrimidinase-like 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPYSL2,HGNC:3014,dihydropyrimidinase like 2,1808,ENSG00000092964,DPYSL2,Dihydropyrimidinase-related protein 2,Unclassified,DPYL2_HUMAN,0,0,WOMBAT-PK
1812,DRD1,dopamine receptor D1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD1,HGNC:3020,dopamine receptor D1,1812,ENSG00000184845,DRD1,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,5.339988779,Ki,DRUG MATRIX
1813,DRD2,dopamine receptor D2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
57453,DSCAML1,Down syndrome cell adhesion molecule like 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DSCAML1,HGNC:14656,DS cell adhesion molecule like 1,57453,ENSG00000177103,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84062,DTNBP1,dystrobrevin binding protein 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1850,DUSP8,dual specificity phosphatase 8,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP8,HGNC:3074,dual specificity phosphatase 8,1850,ENSG00000184545,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1892,ECHS1,"enoyl CoA hydratase, short chain, 1, mitochondrial",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ECHS1,HGNC:3151,"enoyl-CoA hydratase, short chain 1",1892,ENSG00000127884,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1950,EGF,epidermal growth factor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGF,HGNC:3229,epidermal growth factor,1950,ENSG00000138798,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1956,EGFR,epidermal growth factor receptor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGFR,HGNC:3236,epidermal growth factor receptor,1956,ENSG00000146648,EGFR,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,5.217742426,IC50,DRUG MATRIX
2033,EP300,E1A binding protein p300,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EP300,HGNC:3373,E1A binding protein p300,2033,ENSG00000100393,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2046,EPHA8,EPH receptor A8,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EPHA8,HGNC:3391,EPH receptor A8,2046,ENSG00000070886,EPHA8,Ephrin type-A receptor 8,Kinase,EPHA8_HUMAN,9.62,Kd,CHEMBL
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EPHX1,HGNC:3401,epoxide hydrolase 1,2052,ENSG00000143819,EPHX1,Epoxide hydrolase 1,Unclassified,HYEP_HUMAN,6.92,IC50,CHEMBL
2169,FABP2,"fatty acid binding protein 2, intestinal",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FABP2,HGNC:3556,fatty acid binding protein 2,2169,ENSG00000145384,FABP2,"Fatty acid-binding protein, intestinal",Cytosolic other,FABPI_HUMAN,4.48,Ki,CHEMBL
2289,FKBP5,FK506 binding protein 5,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2348,FOLR1,folate receptor 1 (adult),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOLR1,HGNC:3791,folate receptor alpha,2348,ENSG00000110195,FOLR1,Folate receptor alpha,Membrane receptor,FOLR1_HUMAN,6.940000057,IC50,CHEMBL
79068,FTO,fat mass and obesity associated,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FTO,HGNC:24678,FTO alpha-ketoglutarate dependent dioxygenase,79068,ENSG00000140718,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FYN,HGNC:4037,"FYN proto-oncogene, Src family tyrosine kinase",2534,ENSG00000010810,FYN,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,6.087777943,IC50,DRUG MATRIX
2550,GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABBR1,HGNC:4070,gamma-aminobutyric acid type B receptor subunit 1,2550,ENSG00000204681,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA1,HGNC:4075,gamma-aminobutyric acid type A receptor subunit alpha1,2554,ENSG00000022355,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,7.300000191,Ki,CHEMBL
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA2,HGNC:4076,gamma-aminobutyric acid type A receptor subunit alpha2,2555,ENSG00000151834,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,6.94,Ki,CHEMBL
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA5,HGNC:4079,gamma-aminobutyric acid type A receptor subunit alpha5,2558,ENSG00000186297,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_HUMAN,7.639999866,Kd,CHEMBL
2559,GABRA6,"gamma-aminobutyric acid (GABA) A receptor, alpha 6",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA6,HGNC:4080,gamma-aminobutyric acid type A receptor subunit alpha6,2559,ENSG00000145863,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,GBRA6_HUMAN,6.29,IC50,WOMBAT-PK
2560,GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB1,HGNC:4081,gamma-aminobutyric acid type A receptor subunit beta1,2560,ENSG00000163288,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2561,GABRB2,"gamma-aminobutyric acid (GABA) A receptor, beta 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB2,HGNC:4082,gamma-aminobutyric acid type A receptor subunit beta2,2561,ENSG00000145864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB3,HGNC:4083,gamma-aminobutyric acid type A receptor subunit beta3,2562,ENSG00000166206,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,9.05,IC50,CHEMBL
2565,GABRG1,"gamma-aminobutyric acid (GABA) A receptor, gamma 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRG1,HGNC:4086,gamma-aminobutyric acid type A receptor subunit gamma1,2565,ENSG00000163285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRG2,HGNC:4087,gamma-aminobutyric acid type A receptor subunit gamma2,2566,ENSG00000113327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2567,GABRG3,"gamma-aminobutyric acid (GABA) A receptor, gamma 3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRG3,HGNC:4088,gamma-aminobutyric acid type A receptor subunit gamma3,2567,ENSG00000182256,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2569,GABRR1,"gamma-aminobutyric acid (GABA) A receptor, rho 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRR1,HGNC:4090,gamma-aminobutyric acid type A receptor subunit rho1,2569,ENSG00000146276,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,Ion channel,GBRR1_HUMAN,6.570000172,EC50,CHEMBL
2570,GABRR2,"gamma-aminobutyric acid (GABA) A receptor, rho 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRR2,HGNC:4091,gamma-aminobutyric acid type A receptor subunit rho2,2570,ENSG00000111886,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,Ion channel,GBRR2_HUMAN,0,0,WOMBAT-PK
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD2,HGNC:4093,glutamate decarboxylase 2,2572,ENSG00000136750,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51083,GAL,galanin/GMAP prepropeptide,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2587,GALR1,galanin receptor 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR1,HGNC:4132,galanin receptor 1,2587,ENSG00000166573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8811,GALR2,galanin receptor 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR2,HGNC:4133,galanin receptor 2,8811,ENSG00000182687,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8484,GALR3,galanin receptor 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR3,HGNC:4134,galanin receptor 3,8484,ENSG00000128310,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2596,GAP43,growth associated protein 43,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAPDH,HGNC:4141,glyceraldehyde-3-phosphate dehydrogenase,2597,ENSG00000111640,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase liver,Enzyme,G3P_HUMAN,4.46,IC50,CHEMBL
50628,GEMIN4,gem (nuclear organelle) associated protein 4,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GEMIN4,HGNC:15717,gem nuclear organelle associated protein 4,50628,ENSG00000179409,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8836,GGH,"gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GGH,HGNC:4248,gamma-glutamyl hydrolase,8836,ENSG00000137563,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2688,GH1,growth hormone 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GH1,HGNC:4261,growth hormone 1,2688,ENSG00000259384,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7971,GHS,Goldenhar syndrome,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2736,GLI2,GLI family zinc finger 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLI2,HGNC:4318,GLI family zinc finger 2,2736,ENSG00000074047,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2752,GLUL,glutamate-ammonia ligase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
10399,GNB2L1,"guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
2902,GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN1,HGNC:4584,glutamate ionotropic receptor NMDA type subunit 1,2902,ENSG00000176884,GRIN1,"Glutamate receptor ionotropic, NMDA 1",Ion channel,NMDZ1_HUMAN,5.26,IC50,WOMBAT-PK
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2A,HGNC:4585,glutamate ionotropic receptor NMDA type subunit 2A,2903,ENSG00000183454,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,5.64,IC50,WOMBAT-PK
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2B,HGNC:4586,glutamate ionotropic receptor NMDA type subunit 2B,2904,ENSG00000273079,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,5.64,IC50,WOMBAT-PK
2911,GRM1,"glutamate receptor, metabotropic 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM1,HGNC:4593,glutamate metabotropic receptor 1,2911,ENSG00000152822,GRM1,Metabotropic glutamate receptor 1,GPCR,GRM1_HUMAN,6.05,Ki,WOMBAT-PK
2912,GRM2,"glutamate receptor, metabotropic 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM2,HGNC:4594,glutamate metabotropic receptor 2,2912,ENSG00000164082,GRM2,Metabotropic glutamate receptor 2,GPCR,GRM2_HUMAN,6.539999962,EC50,CHEMBL
2913,GRM3,"glutamate receptor, metabotropic 3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM3,HGNC:4595,glutamate metabotropic receptor 3,2913,ENSG00000198822,GRM3,Metabotropic glutamate receptor 3,GPCR,GRM3_HUMAN,6.900000095,Ki,IUPHAR
2914,GRM4,"glutamate receptor, metabotropic 4",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM4,HGNC:4596,glutamate metabotropic receptor 4,2914,ENSG00000124493,GRM4,Metabotropic glutamate receptor 4,GPCR,GRM4_HUMAN,5.849999905,Ki,CHEMBL
2917,GRM7,"glutamate receptor, metabotropic 7",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
2918,GRM8,"glutamate receptor, metabotropic 8",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM8,HGNC:4600,glutamate metabotropic receptor 8,2918,ENSG00000179603,GRM8,Metabotropic glutamate receptor 8,GPCR,GRM8_HUMAN,5.349999905,IC50,IUPHAR
2944,GSTM1,glutathione S-transferase mu 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTM1,HGNC:4632,glutathione S-transferase mu 1,2944,ENSG00000134184,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57817,HAMP,hepcidin antimicrobial peptide,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HAMP,HGNC:15598,hepcidin antimicrobial peptide,57817,ENSG00000105697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3066,HDAC2,histone deacetylase 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC2,HGNC:4853,histone deacetylase 2,3066,ENSG00000196591,HDAC2,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,4.19,IC50,CHEMBL
9709,HERPUD1,"homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HERPUD1,HGNC:13744,homocysteine inducible ER protein with ubiquitin like domain 1,9709,ENSG00000051108,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3122,HLA-DRA,"major histocompatibility complex, class II, DR alpha",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DRA,HGNC:4947,"major histocompatibility complex, class II, DR alpha",3122,ENSG00000204287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3146,HMGB1,high mobility group box 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HMGB1,HGNC:4983,high mobility group box 1,3146,ENSG00000189403,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3176,HNMT,histamine N-methyltransferase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HNMT,HGNC:5028,histamine N-methyltransferase,3176,ENSG00000150540,HNMT,Histamine N-methyltransferase,Enzyme,HNMT_HUMAN,7.72,Ki,CHEMBL
9456,HOMER1,homer homolog 1 (Drosophila),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR7,HGNC:5302,5-hydroxytryptamine receptor 7,3363,ENSG00000148680,HTR7,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,7.93930216,Ki,PDSP
3490,IGFBP7,insulin-like growth factor binding protein 7,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGFBP7,HGNC:5476,insulin like growth factor binding protein 7,3490,ENSG00000163453,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3586,IL10,interleukin 10,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL10,HGNC:5962,interleukin 10,3586,ENSG00000136634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3605,IL17A,interleukin 17A,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL17A,HGNC:5981,interleukin 17A,3605,ENSG00000112115,IL17A,Interleukin-17A,Cytokine,IL17_HUMAN,0,0,SCIENTIFIC LITERATURE
3552,IL1A,"interleukin 1, alpha",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1A,HGNC:5991,interleukin 1 alpha,3552,ENSG00000115008,IL1A,Interleukin-1 alpha,Cytokine,IL1A_HUMAN,11.8538723,Kd,DRUG LABEL
3553,IL1B,"interleukin 1, beta",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
3554,IL1R1,"interleukin 1 receptor, type I",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1R1,HGNC:5993,interleukin 1 receptor type 1,3554,ENSG00000115594,IL1R1,Interleukin-1 receptor type 1,Membrane receptor,IL1R1_HUMAN,6.52,IC50,WOMBAT-PK
3557,IL1RN,interleukin 1 receptor antagonist,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1RN,HGNC:6000,interleukin 1 receptor antagonist,3557,ENSG00000136689,IL1RN,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,11.21467018,Kd,DRUG LABEL
3569,IL6,interleukin 6,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
51194,IPO11,importin 11,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IPO11,HGNC:20628,importin 11,51194,ENSG00000086200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23189,KANK1,KN motif and ankyrin repeat domains 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KANK1,HGNC:19309,KN motif and ankyrin repeat domains 1,23189,ENSG00000107104,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3763,KCNJ6,"potassium channel, inwardly rectifying subfamily J, member 6",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNJ6,HGNC:6267,potassium inwardly rectifying channel subfamily J member 6,3763,ENSG00000157542,KCNJ6,G protein-activated inward rectifier potassium channel 2,Ion channel,KCNJ6_HUMAN,4.2823,IC50,WOMBAT-PK
9674,KIAA0040,KIAA0040,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KIAA0040,HGNC:28950,KIAA0040,9674,ENSG00000235750,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8462,KLF11,Kruppel-like factor 11,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KLF11,HGNC:11811,Kruppel like factor 11,8462,ENSG00000172059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3839,KPNA3,karyopherin alpha 3 (importin alpha 4),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KPNA3,HGNC:6396,karyopherin subunit alpha 3,3839,ENSG00000102753,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3952,LEP,leptin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11024,LILRA1,"leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LILRA1,HGNC:6602,leukocyte immunoglobulin like receptor A1,11024,ENSG00000104974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7804,LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP8,HGNC:6700,LDL receptor related protein 8,7804,ENSG00000157193,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
4155,MBP,myelin basic protein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MBP,HGNC:6925,myelin basic protein,4155,ENSG00000197971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11343,MGLL,monoglyceride lipase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MGLL,HGNC:17038,monoglyceride lipase,11343,ENSG00000074416,MGLL,Monoglyceride lipase,Enzyme,MGLL_HUMAN,5.9,IC50,CHEMBL
494331,MIR382,microRNA 382,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR382,HGNC:31875,microRNA 382,494331,ENSG00000283170,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP2,HGNC:7166,matrix metallopeptidase 2,4313,ENSG00000087245,MMP2,72 kDa type IV collagenase,Enzyme,MMP2_HUMAN,5,IC50,CHEMBL
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP9,HGNC:7176,matrix metallopeptidase 9,4318,ENSG00000100985,MMP9,Matrix metalloproteinase-9,Enzyme,MMP9_HUMAN,4,IC50,CHEMBL
4336,MOBP,myelin-associated oligodendrocyte basic protein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MOBP,HGNC:7189,myelin associated oligodendrocyte basic protein,4336,ENSG00000168314,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4340,MOG,myelin oligodendrocyte glycoprotein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MOG,HGNC:7197,myelin oligodendrocyte glycoprotein,4340,ENSG00000204655,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8777,MPDZ,multiple PDZ domain protein,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MPDZ,HGNC:7208,multiple PDZ domain crumbs cell polarity complex component,8777,ENSG00000107186,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4676,NAP1L4,nucleosome assembly protein 1-like 4,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NAP1L4,HGNC:7640,nucleosome assembly protein 1 like 4,4676,ENSG00000205531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NAT1,HGNC:7645,N-acetyltransferase 1,9,ENSG00000171428,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4684,NCAM1,neural cell adhesion molecule 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4761,NEUROD2,neuronal differentiation 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEUROD2,HGNC:7763,neuronal differentiation 2,4761,ENSG00000171532,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NFKB1,HGNC:7794,nuclear factor kappa B subunit 1,4790,ENSG00000109320,NFKB1,Nuclear factor NF-kappa-B p105 subunit,Cytosolic other,NFKB1_HUMAN,5.6,IC50,CHEMBL
79570,NKAIN1,Na+/K+ transporting ATPase interacting 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NKAIN1,HGNC:25743,sodium/potassium transporting ATPase interacting 1,79570,ENSG00000084628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
154215,NKAIN2,Na+/K+ transporting ATPase interacting 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NKAIN2,HGNC:16443,sodium/potassium transporting ATPase interacting 2,154215,ENSG00000188580,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57502,NLGN4X,"neuroligin 4, X-linked",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NLGN4X,HGNC:14287,neuroligin 4 X-linked,57502,ENSG00000146938,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56923,NMUR2,neuromedin U receptor 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NMUR2,HGNC:16454,neuromedin U receptor 2,56923,ENSG00000132911,NMUR2,Neuromedin-U receptor 2,GPCR,NMUR2_HUMAN,5.920000076,EC50,CHEMBL
594857,NPS,neuropeptide S,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPS,HGNC:33940,neuropeptide S,594857,ENSG00000214285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
387129,NPSR1,neuropeptide S receptor 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPSR1,HGNC:23631,neuropeptide S receptor 1,387129,ENSG00000187258,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4887,NPY2R,neuropeptide Y receptor Y2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY2R,HGNC:7957,neuropeptide Y receptor Y2,4887,ENSG00000185149,NPY2R,Neuropeptide Y receptor type 2,GPCR,NPY2R_HUMAN,4.959081349,Ki,DRUG MATRIX
4889,NPY5R,neuropeptide Y receptor Y5,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY5R,HGNC:7958,neuropeptide Y receptor Y5,4889,ENSG00000164129,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO1,HGNC:2874,NAD(P)H quinone dehydrogenase 1,1728,ENSG00000181019,NQO1,NAD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_HUMAN,4.6,IC50,CHEMBL
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO2,HGNC:7856,N-ribosyldihydronicotinamide:quinone reductase 2,4835,ENSG00000124588,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,NQO2_HUMAN,0,0,WOMBAT-PK
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR4A2,HGNC:7981,nuclear receptor subfamily 4 group A member 2,4929,ENSG00000153234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4898,NRD1,nardilysin (N-arginine dibasic convertase),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9369,NRXN3,neurexin 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN3,HGNC:8010,neurexin 3,9369,ENSG00000021645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4922,NTS,neurotensin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTS,HGNC:8038,neurotensin,4922,ENSG00000133636,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4923,NTSR1,neurotensin receptor 1 (high affinity),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTSR1,HGNC:8039,neurotensin receptor 1,4923,ENSG00000101188,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4985,OPRD1,"opioid receptor, delta 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRD1,HGNC:8153,opioid receptor delta 1,4985,ENSG00000116329,OPRD1,Delta-type opioid receptor,GPCR,OPRD_HUMAN,7.92,Ki,CHEMBL
4986,OPRK1,"opioid receptor, kappa 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
4987,OPRL1,opiate receptor-like 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRL1,HGNC:8155,opioid related nociceptin receptor 1,4987,ENSG00000125510,OPRL1,Nociceptin receptor,GPCR,OPRX_HUMAN,7.11,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
114879,OSBPL5,oxysterol binding protein-like 5,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OSBPL5,HGNC:16392,oxysterol binding protein like 5,114879,ENSG00000021762,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5020,OXT,oxytocin/neurophysin I prepropeptide,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
57575,PCDH10,protocadherin 10,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCDH10,HGNC:13404,protocadherin 10,57575,ENSG00000138650,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51294,PCDH12,protocadherin 12,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCDH12,HGNC:8657,protocadherin 12,51294,ENSG00000113555,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10846,PDE10A,phosphodiesterase 10A,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE10A,HGNC:8772,phosphodiesterase 10A,10846,ENSG00000112541,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_HUMAN,6,Ki,CHEMBL
5173,PDYN,prodynorphin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5179,PENK,proenkephalin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PENK,HGNC:8831,proenkephalin,5179,ENSG00000181195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8863,PER3,period circadian clock 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER3,HGNC:8847,period circadian regulator 3,8863,ENSG00000049246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23469,PHF3,PHD finger protein 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PHF3,HGNC:8921,PHD finger protein 3,23469,ENSG00000118482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7262,PHLDA2,"pleckstrin homology-like domain, family A, member 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PHLDA2,HGNC:12385,pleckstrin homology like domain family A member 2,7262,ENSG00000181649,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIK3R1,HGNC:8979,phosphoinositide-3-kinase regulatory subunit 1,5295,ENSG00000145675,PIK3R1,Phosphatidylinositol 3-kinase regulatory subunit alpha,Kinase,P85A_HUMAN,5.42,IC50,CHEMBL
63876,PKNOX2,PBX/knotted 1 homeobox 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PKNOX2,HGNC:16714,PBX/knotted 1 homeobox 2,63876,ENSG00000165495,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5443,POMC,proopiomelanocortin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POMC,HGNC:9201,proopiomelanocortin,5443,ENSG00000115138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP1R1B,HGNC:9287,protein phosphatase 1 regulatory inhibitor subunit 1B,84152,ENSG00000131771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2185,PTK2B,protein tyrosine kinase 2 beta,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTK2B,HGNC:9612,protein tyrosine kinase 2 beta,2185,ENSG00000120899,PTK2B,Protein-tyrosine kinase 2-beta,Kinase,FAK2_HUMAN,7.09,Kd,CHEMBL
7803,PTP4A1,"protein tyrosine phosphatase type IVA, member 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTP4A1,HGNC:9634,protein tyrosine phosphatase 4A1,7803,ENSG00000112245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5924,RASGRF2,Ras protein-specific guanine nucleotide-releasing factor 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RASGRF2,HGNC:9876,Ras protein specific guanine nucleotide releasing factor 2,5924,ENSG00000113319,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5972,REN,renin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REN,HGNC:9958,renin,5972,ENSG00000143839,REN,Renin,Enzyme,RENI_HUMAN,9.22,IC50,WOMBAT-PK
5981,RFC1,"replication factor C (activator 1) 1, 145kDa",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RFC1,HGNC:9969,replication factor C subunit 1,5981,ENSG00000035928,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5992,RFX4,"regulatory factor X, 4 (influences HLA class II expression)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RFX4,HGNC:9985,regulatory factor X4,5992,ENSG00000111783,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5999,RGS4,regulator of G-protein signaling 4,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS4,HGNC:10000,regulator of G protein signaling 4,5999,ENSG00000117152,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
9037,SEMA5A,"sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEMA5A,HGNC:10736,semaphorin 5A,9037,ENSG00000112902,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
347735,SERINC2,serine incorporator 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERINC2,HGNC:23231,serine incorporator 2,347735,ENSG00000168528,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8910,SGCE,"sarcoglycan, epsilon",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SGCE,HGNC:10808,sarcoglycan epsilon,8910,ENSG00000127990,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84251,SGIP1,SH3-domain GRB2-like (endophilin) interacting protein 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SGIP1,HGNC:25412,SH3GL interacting endocytic adaptor 1,84251,ENSG00000118473,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6462,SHBG,sex hormone-binding globulin,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHBG,HGNC:10839,sex hormone binding globulin,6462,ENSG00000129214,SHBG,Sex hormone-binding globulin,Secreted,SHBG_HUMAN,5.32,Kd,CHEMBL
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIGMAR1,HGNC:8157,sigma non-opioid intracellular receptor 1,10280,ENSG00000147955,SIGMAR1,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_HUMAN,7.69,Ki,CHEMBL
26503,SLC17A5,"solute carrier family 17 (acidic sugar transporter), member 5",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A5,HGNC:10933,solute carrier family 17 member 5,26503,ENSG00000119899,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A2,HGNC:10940,solute carrier family 1 member 2,6506,ENSG00000110436,SLC1A2,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,4.210000038,Ki,CHEMBL
5002,SLC22A18,"solute carrier family 22, member 18",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC22A18,HGNC:10964,solute carrier family 22 member 18,5002,ENSG00000110628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2030,SLC29A1,"solute carrier family 29 (equilibrative nucleoside transporter), member 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC29A1,HGNC:11003,solute carrier family 29 member 1 (Augustine blood group),2030,ENSG00000112759,SLC29A1,Equilibrative nucleoside transporter 1,Transporter,S29A1_HUMAN,9,Ki,CHEMBL
113235,SLC46A1,"solute carrier family 46 (folate transporter), member 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC46A1,HGNC:30521,solute carrier family 46 member 1,113235,ENSG00000076351,SLC46A1,Proton-coupled folate transporter,Transporter,PCFT_HUMAN,6.920000076,IC50,CHEMBL
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A1,HGNC:11042,solute carrier family 6 member 1,6529,ENSG00000157103,SLC6A1,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_HUMAN,0,0,WOMBAT-PK
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
9152,SLC6A5,"solute carrier family 6 (neurotransmitter transporter), member 5",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A5,HGNC:11051,solute carrier family 6 member 5,9152,ENSG00000165970,SLC6A5,Sodium- and chloride-dependent glycine transporter 2,Transporter,SC6A5_HUMAN,4.0362,IC50,WOMBAT-PK
6536,SLC6A9,"solute carrier family 6 (neurotransmitter transporter, glycine), member 9",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A9,HGNC:11056,solute carrier family 6 member 9,6536,ENSG00000196517,SLC6A9,Sodium- and chloride-dependent glycine transporter 1,Transporter,SC6A9_HUMAN,4.5,IC50,CHEMBL
28232,SLCO3A1,"solute carrier organic anion transporter family, member 3A1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLCO3A1,HGNC:10952,solute carrier organic anion transporter family member 3A1,28232,ENSG00000176463,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNCA,HGNC:11138,synuclein alpha,6622,ENSG00000145335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
677833,SNORA54,"small nucleolar RNA, H/ACA box 54",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNORA54,HGNC:32647,"small nucleolar RNA, H/ACA box 54",677833,ENSG00000207008,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6625,SNRNP70,small nuclear ribonucleoprotein 70kDa (U1),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNRNP70,HGNC:11150,small nuclear ribonucleoprotein U1 subunit 70,6625,ENSG00000104852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51324,SPG21,"spastic paraplegia 21 (autosomal recessive, Mast syndrome)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SPG21,HGNC:20373,"SPG21 abhydrolase domain containing, maspardin",51324,ENSG00000090487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A1,HGNC:11284,steroid 5 alpha-reductase 1,6715,ENSG00000145545,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,8.49,IC50,WOMBAT-PK
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A2,HGNC:11285,steroid 5 alpha-reductase 2,6716,ENSG00000277893,SRD5A2,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,S5A2_HUMAN,0,0,WOMBAT-PK
9705,ST18,"suppression of tumorigenicity 18, zinc finger",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST18,HGNC:18695,ST18 C2H2C-type zinc finger transcription factor,9705,ENSG00000147488,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
85439,STON2,stonin 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STON2,HGNC:30652,stonin 2,85439,ENSG00000140022,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6863,TAC1,"tachykinin, precursor 1",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAC1,HGNC:11517,tachykinin precursor 1,6863,ENSG00000006128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6869,TACR1,tachykinin receptor 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR1,HGNC:11526,tachykinin receptor 1,6869,ENSG00000115353,TACR1,Substance-P receptor,GPCR,NK1R_HUMAN,10.7,Ki,CHEMBL
6870,TACR3,tachykinin receptor 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR3,HGNC:11528,tachykinin receptor 3,6870,ENSG00000169836,TACR3,Neuromedin-K receptor,GPCR,NK3R_HUMAN,6.34,Ki,CHEMBL
29114,TAGLN3,transgelin 3,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAGLN3,HGNC:29868,transgelin 3,29114,ENSG00000144834,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5726,TAS2R38,"taste receptor, type 2, member 38",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAS2R38,HGNC:9584,taste 2 receptor member 38,5726,ENSG00000257138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10420,TESK2,testis-specific kinase 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TESK2,HGNC:11732,testis associated actin remodelling kinase 2,10420,ENSG00000070759,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7021,TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TFAP2B,HGNC:11743,transcription factor AP-2 beta,7021,ENSG00000008196,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
387357,THEMIS,thymocyte selection associated,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,THEMIS,HGNC:21569,thymocyte selection associated,387357,ENSG00000172673,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80731,THSD7B,"thrombospondin, type I, domain containing 7B",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,THSD7B,HGNC:29348,thrombospondin type 1 domain containing 7B,80731,ENSG00000144229,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
25976,TIPARP,TCDD-inducible poly(ADP-ribose) polymerase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TIPARP,HGNC:23696,TCDD inducible poly(ADP-ribose) polymerase,25976,ENSG00000163659,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7086,TKT,transketolase,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TKT,HGNC:11834,transketolase,7086,ENSG00000163931,TKT,Transketolase,Enzyme,TKT_HUMAN,0,0,WOMBAT-PK
7157,TP53,tumor protein p53,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TP53,HGNC:11998,tumor protein p53,7157,ENSG00000141510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
7200,TRH,thyrotropin-releasing hormone,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRH,HGNC:12298,thyrotropin releasing hormone,7200,ENSG00000170893,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54970,TTC12,tetratricopeptide repeat domain 12,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TTC12,HGNC:23700,tetratricopeptide repeat domain 12,54970,ENSG00000149292,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55833,UBAP2,ubiquitin associated protein 2,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UBAP2,HGNC:14185,ubiquitin associated protein 2,55833,ENSG00000137073,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7450,VWF,von Willebrand factor,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VWF,HGNC:12726,von Willebrand factor,7450,ENSG00000110799,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7520,XRCC5,X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining),C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,XRCC5,HGNC:12833,X-ray repair cross complementing 5,7520,ENSG00000079246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23174,ZCCHC14,"zinc finger, CCHC domain containing 14",C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZCCHC14,HGNC:24134,zinc finger CCHC-type containing 14,23174,ENSG00000140948,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
374879,ZNF699,zinc finger protein 699,C0001973,"alcoholic intoxication, chronic",Alcohol use disorders,C0001973,"Alcoholic Intoxication, Chronic",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZNF699,HGNC:24750,zinc finger protein 699,374879,ENSG00000196110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
154664,ABCA13,"ATP-binding cassette, sub-family A (ABC1), member 13",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCA13,HGNC:14638,ATP binding cassette subfamily A member 13,154664,ENSG00000179869,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB4,HGNC:45,ATP binding cassette subfamily B member 4,5244,ENSG00000005471,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
35,ACADS,"acyl-CoA dehydrogenase, C-2 to C-3 short chain",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACADS,HGNC:90,acyl-CoA dehydrogenase short chain,35,ENSG00000122971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
60,ACTB,"actin, beta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACTB,HGNC:132,actin beta,60,ENSG00000075624,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
104,ADARB1,"adenosine deaminase, RNA-specific, B1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADARB1,HGNC:226,adenosine deaminase RNA specific B1,104,ENSG00000197381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
108,ADCY2,adenylate cyclase 2 (brain),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY2,HGNC:233,adenylate cyclase 2,108,ENSG00000078295,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
109,ADCY3,adenylate cyclase 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY3,HGNC:234,adenylate cyclase 3,109,ENSG00000138031,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114,ADCY8,adenylate cyclase 8 (brain),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY8,HGNC:239,adenylate cyclase 8,114,ENSG00000155897,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1,HGNC:241,adenylate cyclase activating polypeptide 1,116,ENSG00000141433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
133,ADM,adrenomedullin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADM,HGNC:259,adrenomedullin,133,ENSG00000148926,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
148,ADRA1A,adrenoceptor alpha 1A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
152,ADRA2C,adrenoceptor alpha 2C,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2C,HGNC:283,adrenoceptor alpha 2C,152,ENSG00000184160,ADRA2C,Alpha-2C adrenergic receptor,GPCR,ADA2C_HUMAN,7,Ki,WOMBAT-PK
154,ADRB2,"adrenoceptor beta 2, surface",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB2,HGNC:286,adrenoceptor beta 2,154,ENSG00000169252,ADRB2,Beta-2 adrenergic receptor,GPCR,ADRB2_HUMAN,6.4,Ki,WOMBAT-PK
156,ADRBK1,"adrenergic, beta, receptor kinase 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
157,ADRBK2,"adrenergic, beta, receptor kinase 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGT,HGNC:333,angiotensinogen,183,ENSG00000135744,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54806,AHI1,Abelson helper integration site 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AHI1,HGNC:21575,Abelson helper integration site 1,54806,ENSG00000135541,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11216,AKAP10,A kinase (PRKA) anchor protein 10,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKAP10,HGNC:368,A-kinase anchoring protein 10,11216,ENSG00000108599,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8644,AKR1C3,"aldo-keto reductase family 1, member C3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1C3,HGNC:386,aldo-keto reductase family 1 member C3,8644,ENSG00000196139,AKR1C3,Aldo-keto reductase family 1 member C3,Enzyme,AK1C3_HUMAN,5.59,IC50,CHEMBL
1109,AKR1C4,"aldo-keto reductase family 1, member C4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1C4,HGNC:387,aldo-keto reductase family 1 member C4,1109,ENSG00000198610,AKR1C4,Aldo-keto reductase family 1 member C4,Enzyme,AK1C4_HUMAN,4.27,IC50,CHEMBL
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKT1,HGNC:391,AKT serine/threonine kinase 1,207,ENSG00000142208,AKT1,RAC-alpha serine/threonine-protein kinase,Kinase,AKT1_HUMAN,5.02,IC50,CHEMBL
208,AKT2,v-akt murine thymoma viral oncogene homolog 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKT2,HGNC:392,AKT serine/threonine kinase 2,208,ENSG00000105221,AKT2,RAC-beta serine/threonine-protein kinase,Kinase,AKT2_HUMAN,5.57,Kd,CHEMBL
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
239,ALOX12,arachidonate 12-lipoxygenase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALOX12,HGNC:429,"arachidonate 12-lipoxygenase, 12S type",239,ENSG00000108839,ALOX12,"Arachidonate 12-lipoxygenase, 12S-type",Enzyme,LOX12_HUMAN,5.72,IC50,CHEMBL
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANK3,HGNC:494,ankyrin 3,288,ENSG00000151150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
347,APOD,apolipoprotein D,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOD,HGNC:612,apolipoprotein D,347,ENSG00000189058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
348,APOE,apolipoprotein E,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOE,HGNC:613,apolipoprotein E,348,ENSG00000130203,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
351,APP,amyloid beta (A4) precursor protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APP,HGNC:620,amyloid beta precursor protein,351,ENSG00000142192,APP,Amyloid beta A4 protein,Unclassified,A4_HUMAN,4.52,IC50,CHEMBL
9639,ARHGEF10,Rho guanine nucleotide exchange factor (GEF) 10,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGEF10,HGNC:14103,Rho guanine nucleotide exchange factor 10,9639,ENSG00000104728,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL,HGNC:701,aryl hydrocarbon receptor nuclear translocator like,406,ENSG00000133794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56938,ARNTL2,aryl hydrocarbon receptor nuclear translocator-like 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL2,HGNC:18984,aryl hydrocarbon receptor nuclear translocator like 2,56938,ENSG00000029153,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
409,ARRB2,"arrestin, beta 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB2,HGNC:712,arrestin beta 2,409,ENSG00000141480,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9048,ARTN,artemin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARTN,HGNC:727,artemin,9048,ENSG00000117407,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
438,ASMT,acetylserotonin O-methyltransferase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASMT,HGNC:750,acetylserotonin O-methyltransferase,438,ENSG00000196433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23245,ASTN2,astrotactin 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASTN2,HGNC:17021,astrotactin 2,23245,ENSG00000148219,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
468,ATF4,activating transcription factor 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF4,HGNC:786,activating transcription factor 4,468,ENSG00000128272,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
22809,ATF5,activating transcription factor 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF5,HGNC:790,activating transcription factor 5,22809,ENSG00000169136,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
476,ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP1A1,HGNC:799,ATPase Na+/K+ transporting subunit alpha 1,476,ENSG00000163399,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,AT1A1_HUMAN,7.52,Kd,WOMBAT-PK
477,ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP1A2,HGNC:800,ATPase Na+/K+ transporting subunit alpha 2,477,ENSG00000018625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP1A3,HGNC:801,ATPase Na+/K+ transporting subunit alpha 3,478,ENSG00000105409,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP2A2,HGNC:812,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,488,ENSG00000174437,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
551,AVP,arginine vasopressin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
553,AVPR1B,arginine vasopressin receptor 1B,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVPR1B,HGNC:896,arginine vasopressin receptor 1B,553,ENSG00000198049,AVPR1B,Vasopressin V1b receptor,GPCR,V1BR_HUMAN,9.43,Ki,CHEMBL
573,BAG1,BCL2-associated athanogene,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BAG1,HGNC:937,BAG cochaperone 1,573,ENSG00000107262,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
590,BCHE,butyrylcholinesterase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCHE,HGNC:983,butyrylcholinesterase,590,ENSG00000114200,BCHE,Cholinesterase,Enzyme,CHLE_HUMAN,8.5,IC50,IUPHAR
596,BCL2,B-cell CLL/lymphoma 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL2,HGNC:990,BCL2 apoptosis regulator,596,ENSG00000171791,BCL2,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,4.22,Kd,CHEMBL
607,BCL9,B-cell CLL/lymphoma 9,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL9,HGNC:1008,BCL9 transcription coactivator,607,ENSG00000116128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
613,BCR,breakpoint cluster region,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCR,HGNC:1014,BCR activator of RhoGEF and GTPase,613,ENSG00000186716,BCR,Breakpoint cluster region protein,Kinase,BCR_HUMAN,0,0,WOMBAT-PK
624,BDKRB2,bradykinin receptor B2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDKRB2,HGNC:1030,bradykinin receptor B2,624,ENSG00000168398,BDKRB2,B2 bradykinin receptor,GPCR,BKRB2_HUMAN,5.114978205,Ki,DRUG MATRIX
627,BDNF,brain-derived neurotrophic factor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8553,BHLHE40,"basic helix-loop-helix family, member e40",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BHLHE40,HGNC:1046,basic helix-loop-helix family member e40,8553,ENSG00000134107,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79365,BHLHE41,"basic helix-loop-helix family, member e41",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BHLHE41,HGNC:16617,basic helix-loop-helix family member e41,79365,ENSG00000123095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
637,BID,BH3 interacting domain death agonist,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BID,HGNC:1050,BH3 interacting domain death agonist,637,ENSG00000015475,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
675,BRCA2,"breast cancer 2, early onset",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRCA2,HGNC:1101,BRCA2 DNA repair associated,675,ENSG00000139618,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23774,BRD1,bromodomain containing 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRD1,HGNC:1102,bromodomain containing 1,23774,ENSG00000100425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
122525,C14orf28,chromosome 14 open reading frame 28,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C14orf28,HGNC:19834,chromosome 14 open reading frame 28,122525,ENSG00000179476,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
400359,C15orf53,chromosome 15 open reading frame 53,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
203228,C9orf72,chromosome 9 open reading frame 72,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C9orf72,HGNC:28337,C9orf72-SMCR8 complex subunit,203228,ENSG00000147894,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1A,HGNC:1388,calcium voltage-gated channel subunit alpha1 A,773,ENSG00000141837,CACNA1A,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,CAC1A_HUMAN,6.6,Ki,WOMBAT-PK
774,CACNA1B,"calcium channel, voltage-dependent, N type, alpha 1B subunit",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1B,HGNC:1389,calcium voltage-gated channel subunit alpha1 B,774,ENSG00000148408,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,CAC1B_HUMAN,5.78,IC50,CHEMBL
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
783,CACNB2,"calcium channel, voltage-dependent, beta 2 subunit",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNB2,HGNC:1402,calcium voltage-gated channel auxiliary subunit beta 2,783,ENSG00000165995,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27091,CACNG5,"calcium channel, voltage-dependent, gamma subunit 5",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNG5,HGNC:1409,calcium voltage-gated channel auxiliary subunit gamma 5,27091,ENSG00000075429,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
793,CALB1,"calbindin 1, 28kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALB1,HGNC:1434,calbindin 1,793,ENSG00000104327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
796,CALCA,calcitonin-related polypeptide alpha,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALCA,HGNC:1437,calcitonin related polypeptide alpha,796,ENSG00000110680,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALM2,HGNC:1445,calmodulin 2,805,ENSG00000143933,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
811,CALR,calreticulin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK2A,HGNC:1460,calcium/calmodulin dependent protein kinase II alpha,815,ENSG00000070808,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,7.1,Kd,CHEMBL
9607,CARTPT,CART prepropeptide,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CASP8,HGNC:1509,caspase 8,841,ENSG00000064012,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
875,CBS,cystathionine-beta-synthase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CBS,HGNC:1550,cystathionine beta-synthase,875,ENSG00000160200,CBS,Cystathionine beta-synthase,Enzyme,CBS_HUMAN,0,0,WOMBAT-PK
886,CCKAR,cholecystokinin A receptor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
6347,CCL2,chemokine (C-C motif) ligand 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL2,HGNC:10618,C-C motif chemokine ligand 2,6347,ENSG00000108691,CCL2,C-C motif chemokine 2,Cytokine,CCL2_HUMAN,5.16,IC50,CHEMBL
1015,CDH17,"cadherin 17, LI cadherin (liver-intestine)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH17,HGNC:1756,cadherin 17,1015,ENSG00000079112,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1005,CDH7,"cadherin 7, type 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH7,HGNC:1766,cadherin 7,1005,ENSG00000081138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57132,CHMP1B,charged multivesicular body protein 1B,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHMP1B,HGNC:24287,charged multivesicular body protein 1B,57132,ENSG00000255112,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
89832,CHRFAM7A,"CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRFAM7A,HGNC:15781,CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion,89832,ENSG00000166664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1129,CHRM2,"cholinergic receptor, muscarinic 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM2,HGNC:1951,cholinergic receptor muscarinic 2,1129,ENSG00000181072,CHRM2,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,5.900000095,Ki,IUPHAR
1131,CHRM3,"cholinergic receptor, muscarinic 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM3,HGNC:1952,cholinergic receptor muscarinic 3,1131,ENSG00000133019,CHRM3,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,6.66,EC50,CHEMBL
1135,CHRNA2,"cholinergic receptor, nicotinic, alpha 2 (neuronal)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA2,HGNC:1956,cholinergic receptor nicotinic alpha 2 subunit,1135,ENSG00000120903,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,ACHA2_HUMAN,4.7212,Ki,WOMBAT-PK
8973,CHRNA6,"cholinergic receptor, nicotinic, alpha 6 (neuronal)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA6,HGNC:15963,cholinergic receptor nicotinic alpha 6 subunit,8973,ENSG00000147434,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,ACHA6_HUMAN,4.039999962,IC50,IUPHAR
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA7,HGNC:1960,cholinergic receptor nicotinic alpha 7 subunit,1139,ENSG00000175344,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_HUMAN,5.1,Ki,CHEMBL
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB3,HGNC:1963,cholinergic receptor nicotinic beta 3 subunit,1142,ENSG00000147432,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10462,CLEC10A,"C-type lectin domain family 10, member A",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLEC10A,HGNC:16916,C-type lectin domain containing 10A,10462,ENSG00000132514,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
1269,CNR2,cannabinoid receptor 2 (macrophage),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
152330,CNTN4,contactin 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTN4,HGNC:2174,contactin 4,152330,ENSG00000144619,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27255,CNTN6,contactin 6,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTN6,HGNC:2176,contactin 6,27255,ENSG00000134115,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26047,CNTNAP2,contactin associated protein-like 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTNAP2,HGNC:13830,contactin associated protein 2,26047,ENSG00000174469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1385,CREB1,cAMP responsive element binding protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1387,CREBBP,CREB binding protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREBBP,HGNC:2348,CREB binding protein,1387,ENSG00000005339,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1390,CREM,cAMP responsive element modulator,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREM,HGNC:2352,cAMP responsive element modulator,1390,ENSG00000095794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1395,CRHR2,corticotropin releasing hormone receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR2,HGNC:2358,corticotropin releasing hormone receptor 2,1395,ENSG00000106113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1407,CRY1,cryptochrome circadian clock 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY1,HGNC:2384,cryptochrome circadian regulator 1,1407,ENSG00000008405,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1408,CRY2,cryptochrome circadian clock 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY2,HGNC:2385,cryptochrome circadian regulator 2,1408,ENSG00000121671,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64478,CSMD1,CUB and Sushi multiple domains 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSMD1,HGNC:14026,CUB and Sushi multiple domains 1,64478,ENSG00000183117,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1453,CSNK1D,"casein kinase 1, delta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1D,HGNC:2452,casein kinase 1 delta,1453,ENSG00000141551,CSNK1D,Casein kinase I isoform delta,Kinase,KC1D_HUMAN,5.46,Kd,CHEMBL
1454,CSNK1E,"casein kinase 1, epsilon",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1E,HGNC:2453,casein kinase 1 epsilon,1454,ENSG00000213923,CSNK1E,Casein kinase I isoform epsilon,Kinase,KC1E_HUMAN,5.82,Kd,CHEMBL
1465,CSRP1,cysteine and glycine-rich protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSRP1,HGNC:2469,cysteine and glycine rich protein 1,1465,ENSG00000159176,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTLA4,HGNC:2505,cytotoxic T-lymphocyte associated protein 4,1493,ENSG00000163599,CTLA4,Cytotoxic T-lymphocyte protein 4,Surface antigen,CTLA4_HUMAN,0,0,DRUG LABEL
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNND2,HGNC:2516,catenin delta 2,1501,ENSG00000169862,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23316,CUX2,cut-like homeobox 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CUX2,HGNC:19347,cut like homeobox 2,23316,ENSG00000111249,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
1610,DAO,D-amino-acid oxidase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAO,HGNC:2671,D-amino acid oxidase,1610,ENSG00000110887,DAO,D-amino-acid oxidase,Enzyme,OXDA_HUMAN,5,IC50,CHEMBL
267012,DAOA,D-amino acid oxidase activator,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
282706,DAOA-AS1,DAOA antisense RNA 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA-AS1,HGNC:30243,DAOA antisense RNA 1,282706,ENSG00000232307,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26528,DAZAP1,DAZ associated protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAZAP1,HGNC:2683,DAZ associated protein 1,26528,ENSG00000071626,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
1627,DBN1,drebrin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBN1,HGNC:2695,drebrin 1,1627,ENSG00000113758,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
28988,DBNL,drebrin-like,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBNL,HGNC:2696,drebrin like,28988,ENSG00000136279,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9201,DCLK1,doublecortin-like kinase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCLK1,HGNC:2700,doublecortin like kinase 1,9201,ENSG00000133083,DCLK1,Serine/threonine-protein kinase DCLK1,Kinase,DCLK1_HUMAN,6.43,Kd,CHEMBL
84516,DCTN5,dynactin 5 (p25),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCTN5,HGNC:24594,dynactin subunit 5,84516,ENSG00000166847,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
25861,DFNB31,"deafness, autosomal recessive 31",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1607,DGKB,"diacylglycerol kinase, beta 90kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGKB,HGNC:2850,diacylglycerol kinase beta,1607,ENSG00000136267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
160851,DGKH,"diacylglycerol kinase, eta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGKH,HGNC:2854,diacylglycerol kinase eta,160851,ENSG00000102780,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1734,DIO2,"deiodinase, iodothyronine, type II",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DIO2,HGNC:2884,iodothyronine deiodinase 2,1734,ENSG00000211448,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27185,DISC1,disrupted in schizophrenia 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27121,DKK4,dickkopf WNT signaling pathway inhibitor 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DKK4,HGNC:2894,dickkopf WNT signaling pathway inhibitor 4,27121,ENSG00000104371,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1740,DLG2,"discs, large homolog 2 (Drosophila)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG2,HGNC:2901,discs large MAGUK scaffold protein 2,1740,ENSG00000150672,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1741,DLG3,"discs, large homolog 3 (Drosophila)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG3,HGNC:2902,discs large MAGUK scaffold protein 3,1741,ENSG00000082458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1745,DLX1,distal-less homeobox 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLX1,HGNC:2914,distal-less homeobox 1,1745,ENSG00000144355,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1769,DNAH8,"dynein, axonemal, heavy chain 8",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNAH8,HGNC:2952,dynein axonemal heavy chain 8,1769,ENSG00000124721,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3337,DNAJB1,"DnaJ (Hsp40) homolog, subfamily B, member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNAJB1,HGNC:5270,DnaJ heat shock protein family (Hsp40) member B1,3337,ENSG00000132002,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNMT1,HGNC:2976,DNA methyltransferase 1,1786,ENSG00000130816,DNMT1,DNA (cytosine-5)-methyltransferase 1,Enzyme,DNMT1_HUMAN,0,0,DRUGBANK
23348,DOCK9,dedicator of cytokinesis 9,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DOCK9,HGNC:14132,dedicator of cytokinesis 9,23348,ENSG00000088387,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55816,DOK5,docking protein 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DOK5,HGNC:16173,docking protein 5,55816,ENSG00000101134,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1808,DPYSL2,dihydropyrimidinase-like 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPYSL2,HGNC:3014,dihydropyrimidinase like 2,1808,ENSG00000092964,DPYSL2,Dihydropyrimidinase-related protein 2,Unclassified,DPYL2_HUMAN,0,0,WOMBAT-PK
1812,DRD1,dopamine receptor D1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD1,HGNC:3020,dopamine receptor D1,1812,ENSG00000184845,DRD1,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,5.339988779,Ki,DRUG MATRIX
1813,DRD2,dopamine receptor D2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
1816,DRD5,dopamine receptor D5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD5,HGNC:3026,dopamine receptor D5,1816,ENSG00000169676,DRD5,D(1B) dopamine receptor,GPCR,DRD5_HUMAN,6.7696,Ki,WOMBAT-PK
1826,DSCAM,Down syndrome cell adhesion molecule,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DSCAM,HGNC:3039,DS cell adhesion molecule,1826,ENSG00000171587,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84062,DTNBP1,dystrobrevin binding protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1848,DUSP6,dual specificity phosphatase 6,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP6,HGNC:3072,dual specificity phosphatase 6,1848,ENSG00000139318,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1959,EGR2,early growth response 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR2,HGNC:3239,early growth response 2,1959,ENSG00000122877,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1960,EGR3,early growth response 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR3,HGNC:3240,early growth response 3,1960,ENSG00000179388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1962,EHHADH,"enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EHHADH,HGNC:3247,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase,1962,ENSG00000113790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB3,HGNC:3431,erb-b2 receptor tyrosine kinase 3,2065,ENSG00000065361,ERBB3,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,7.74,Kd,CHEMBL
2066,ERBB4,erb-b2 receptor tyrosine kinase 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB4,HGNC:3432,erb-b2 receptor tyrosine kinase 4,2066,ENSG00000178568,ERBB4,Receptor tyrosine-protein kinase erbB-4,Kinase,ERBB4_HUMAN,7.26,Kd,CHEMBL
9030,ERDA1,"expanded repeat domain, CAG/CTG 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERDA1,HGNC:3442,"expanded repeat domain, CAG/CTG 1",9030,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
30816,ERVW-1,"endogenous retrovirus group W, member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERVW-1,HGNC:13525,"endogenous retrovirus group W member 1, envelope",30816,ENSG00000242950,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2099,ESR1,estrogen receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
2158,F9,coagulation factor IX,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,F9,HGNC:3551,coagulation factor IX,2158,ENSG00000101981,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2173,FABP7,"fatty acid binding protein 7, brain",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FABP7,HGNC:3562,fatty acid binding protein 7,2173,ENSG00000164434,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9415,FADS2,fatty acid desaturase 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FADS2,HGNC:3575,fatty acid desaturase 2,9415,ENSG00000134824,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
144717,FAM109A,"family with sequence similarity 109, member A",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26224,FBXL3,F-box and leucine-rich repeat protein 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FBXL3,HGNC:13599,F-box and leucine rich repeat protein 3,26224,ENSG00000005812,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9638,FEZ1,fasciculation and elongation protein zeta 1 (zygin I),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEZ1,HGNC:3659,fasciculation and elongation protein zeta 1,9638,ENSG00000149557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8822,FGF17,fibroblast growth factor 17,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF17,HGNC:3673,fibroblast growth factor 17,8822,ENSG00000158815,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26281,FGF20,fibroblast growth factor 20,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF20,HGNC:3677,fibroblast growth factor 20,26281,ENSG00000078579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2260,FGFR1,fibroblast growth factor receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR1,HGNC:3688,fibroblast growth factor receptor 1,2260,ENSG00000077782,FGFR1,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,5.43,Kd,CHEMBL
2263,FGFR2,fibroblast growth factor receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR2,HGNC:3689,fibroblast growth factor receptor 2,2263,ENSG00000066468,FGFR2,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,5.85,Kd,CHEMBL
2280,FKBP1A,"FK506 binding protein 1A, 12kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP1A,HGNC:3711,FKBP prolyl isomerase 1A,2280,ENSG00000088832,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,FKB1A_HUMAN,7.7959,IC50,WOMBAT-PK
2289,FKBP5,FK506 binding protein 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2332,FMR1,fragile X mental retardation 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2309,FOXO3,forkhead box O3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXO3,HGNC:3821,forkhead box O3,2309,ENSG00000118689,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
93986,FOXP2,forkhead box P2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXP2,HGNC:13875,forkhead box P2,93986,ENSG00000128573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50943,FOXP3,forkhead box P3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXP3,HGNC:6106,forkhead box P3,50943,ENSG00000049768,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FYN,HGNC:4037,"FYN proto-oncogene, Src family tyrosine kinase",2534,ENSG00000010810,FYN,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,6.087777943,IC50,DRUG MATRIX
8322,FZD4,frizzled class receptor 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FZD4,HGNC:4042,frizzled class receptor 4,8322,ENSG00000174804,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2539,G6PD,glucose-6-phosphate dehydrogenase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,G6PD,HGNC:4057,glucose-6-phosphate dehydrogenase,2539,ENSG00000160211,G6PD,Glucose-6-phosphate 1-dehydrogenase,Enzyme,G6PD_HUMAN,0,0,WOMBAT-PK
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA1,HGNC:4075,gamma-aminobutyric acid type A receptor subunit alpha1,2554,ENSG00000022355,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,7.300000191,Ki,CHEMBL
2556,GABRA3,"gamma-aminobutyric acid (GABA) A receptor, alpha 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA3,HGNC:4077,gamma-aminobutyric acid type A receptor subunit alpha3,2556,ENSG00000011677,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,GBRA3_HUMAN,6.789999962,Ki,CHEMBL
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA5,HGNC:4079,gamma-aminobutyric acid type A receptor subunit alpha5,2558,ENSG00000186297,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_HUMAN,7.639999866,Kd,CHEMBL
2560,GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB1,HGNC:4081,gamma-aminobutyric acid type A receptor subunit beta1,2560,ENSG00000163288,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2561,GABRB2,"gamma-aminobutyric acid (GABA) A receptor, beta 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB2,HGNC:4082,gamma-aminobutyric acid type A receptor subunit beta2,2561,ENSG00000145864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB3,HGNC:4083,gamma-aminobutyric acid type A receptor subunit beta3,2562,ENSG00000166206,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,9.05,IC50,CHEMBL
2565,GABRG1,"gamma-aminobutyric acid (GABA) A receptor, gamma 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRG1,HGNC:4086,gamma-aminobutyric acid type A receptor subunit gamma1,2565,ENSG00000163285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2569,GABRR1,"gamma-aminobutyric acid (GABA) A receptor, rho 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRR1,HGNC:4090,gamma-aminobutyric acid type A receptor subunit rho1,2569,ENSG00000146276,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,Ion channel,GBRR1_HUMAN,6.570000172,EC50,CHEMBL
2570,GABRR2,"gamma-aminobutyric acid (GABA) A receptor, rho 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRR2,HGNC:4091,gamma-aminobutyric acid type A receptor subunit rho2,2570,ENSG00000111886,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,Ion channel,GBRR2_HUMAN,0,0,WOMBAT-PK
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51083,GAL,galanin/GMAP prepropeptide,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2596,GAP43,growth associated protein 43,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2668,GDNF,glial cell derived neurotrophic factor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2691,GHRH,growth hormone releasing hormone,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GHRH,HGNC:4265,growth hormone releasing hormone,2691,ENSG00000118702,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2694,GIF,gastric intrinsic factor (vitamin B synthesis),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2739,GLO1,glyoxalase I,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLO1,HGNC:4323,glyoxalase I,2739,ENSG00000124767,GLO1,Lactoylglutathione lyase,Enzyme,LGUL_HUMAN,4.89,Ki,CHEMBL
10249,GLYAT,glycine-N-acyltransferase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLYAT,HGNC:13734,glycine-N-acyltransferase,10249,ENSG00000149124,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2774,GNAL,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNAL,HGNC:4388,G protein subunit alpha L,2774,ENSG00000141404,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54584,GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB1L,HGNC:4397,G protein subunit beta 1 like,54584,ENSG00000185838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10399,GNB2L1,"guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9248,GPR50,G protein-coupled receptor 50,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR50,HGNC:4506,G protein-coupled receptor 50,9248,ENSG00000102195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27201,GPR78,G protein-coupled receptor 78,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR78,HGNC:4528,G protein-coupled receptor 78,27201,ENSG00000155269,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55507,GPRC5D,"G protein-coupled receptor, class C, group 5, member D",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPRC5D,HGNC:13310,G protein-coupled receptor class C group 5 member D,55507,ENSG00000111291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9721,GPRIN2,G protein regulated inducer of neurite outgrowth 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPRIN2,HGNC:23730,G protein regulated inducer of neurite outgrowth 2,9721,ENSG00000204175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA1,HGNC:4571,glutamate ionotropic receptor AMPA type subunit 1,2890,ENSG00000155511,GRIA1,Glutamate receptor 1,Ion channel,GRIA1_HUMAN,5.7,EC50,CHEMBL
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA2,HGNC:4572,glutamate ionotropic receptor AMPA type subunit 2,2891,ENSG00000120251,GRIA2,Glutamate receptor 2,Ion channel,GRIA2_HUMAN,5.65,EC50,CHEMBL
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA3,HGNC:4573,glutamate ionotropic receptor AMPA type subunit 3,2892,ENSG00000125675,GRIA3,Glutamate receptor 3,Ion channel,GRIA3_HUMAN,4.860000134,EC50,IUPHAR
2893,GRIA4,"glutamate receptor, ionotropic, AMPA 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA4,HGNC:4574,glutamate ionotropic receptor AMPA type subunit 4,2893,ENSG00000152578,GRIA4,Glutamate receptor 4,Ion channel,GRIA4_HUMAN,5.409999847,EC50,IUPHAR
2894,GRID1,"glutamate receptor, ionotropic, delta 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRID1,HGNC:4575,glutamate ionotropic receptor delta type subunit 1,2894,ENSG00000182771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK2,HGNC:4580,glutamate ionotropic receptor kainate type subunit 2,2898,ENSG00000164418,GRIK2,"Glutamate receptor ionotropic, kainate 2",Ion channel,GRIK2_HUMAN,5.960000038,Ki,CHEMBL
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
2901,GRIK5,"glutamate receptor, ionotropic, kainate 5",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK5,HGNC:4583,glutamate ionotropic receptor kainate type subunit 5,2901,ENSG00000105737,GRIK5,"Glutamate receptor ionotropic, kainate 5",Ion channel,GRIK5_HUMAN,6.150000095,Ki,CHEMBL
2902,GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN1,HGNC:4584,glutamate ionotropic receptor NMDA type subunit 1,2902,ENSG00000176884,GRIN1,"Glutamate receptor ionotropic, NMDA 1",Ion channel,NMDZ1_HUMAN,5.26,IC50,WOMBAT-PK
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2A,HGNC:4585,glutamate ionotropic receptor NMDA type subunit 2A,2903,ENSG00000183454,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,5.64,IC50,WOMBAT-PK
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2B,HGNC:4586,glutamate ionotropic receptor NMDA type subunit 2B,2904,ENSG00000273079,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,5.64,IC50,WOMBAT-PK
116443,GRIN3A,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3A",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN3A,HGNC:16767,glutamate ionotropic receptor NMDA type subunit 3A,116443,ENSG00000198785,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,NMD3A_HUMAN,5.64,IC50,WOMBAT-PK
2913,GRM3,"glutamate receptor, metabotropic 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM3,HGNC:4595,glutamate metabotropic receptor 3,2913,ENSG00000198822,GRM3,Metabotropic glutamate receptor 3,GPCR,GRM3_HUMAN,6.900000095,Ki,IUPHAR
2914,GRM4,"glutamate receptor, metabotropic 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM4,HGNC:4596,glutamate metabotropic receptor 4,2914,ENSG00000124493,GRM4,Metabotropic glutamate receptor 4,GPCR,GRM4_HUMAN,5.849999905,Ki,CHEMBL
2915,GRM5,"glutamate receptor, metabotropic 5",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM5,HGNC:4597,glutamate metabotropic receptor 5,2915,ENSG00000168959,GRM5,Metabotropic glutamate receptor 5,GPCR,GRM5_HUMAN,5.41,Ki,WOMBAT-PK
2917,GRM7,"glutamate receptor, metabotropic 7",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
2896,GRN,granulin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRN,HGNC:4601,granulin precursor,2896,ENSG00000030582,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2932,GSK3B,glycogen synthase kinase 3 beta,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSK3B,HGNC:4617,glycogen synthase kinase 3 beta,2932,ENSG00000082701,GSK3B,Glycogen synthase kinase-3 beta,Kinase,GSK3B_HUMAN,4.57,IC50,CHEMBL
2944,GSTM1,glutathione S-transferase mu 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTM1,HGNC:4632,glutathione S-transferase mu 1,2944,ENSG00000134184,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2952,GSTT1,glutathione S-transferase theta 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTT1,HGNC:4641,glutathione S-transferase theta 1,2952,ENSG00000277656,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2954,GSTZ1,glutathione S-transferase zeta 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTZ1,HGNC:4643,glutathione S-transferase zeta 1,2954,ENSG00000100577,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
338442,HCAR2,hydroxycarboxylic acid receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCAR2,HGNC:24827,hydroxycarboxylic acid receptor 2,338442,ENSG00000182782,HCAR2,Hydroxycarboxylic acid receptor 2,GPCR,HCAR2_HUMAN,5.4,EC50,IUPHAR
8843,HCAR3,hydroxycarboxylic acid receptor 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCAR3,HGNC:16824,hydroxycarboxylic acid receptor 3,8843,ENSG00000255398,HCAR3,Hydroxycarboxylic acid receptor 3,GPCR,HCAR3_HUMAN,6.53,IC50,WOMBAT-PK
10255,HCG9,HLA complex group 9 (non-protein coding),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCG9,HGNC:21243,HLA complex group 9,10255,ENSG00000204625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HIF1A,HGNC:4910,hypoxia inducible factor 1 subunit alpha,3091,ENSG00000100644,HIF1A,Hypoxia-inducible factor 1-alpha,Transcription factor,HIF1A_HUMAN,4.75,EC50,CHEMBL
3094,HINT1,histidine triad nucleotide binding protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HINT1,HGNC:4912,histidine triad nucleotide binding protein 1,3094,ENSG00000169567,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9026,HIP1R,huntingtin interacting protein 1 related,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HIP1R,HGNC:18415,huntingtin interacting protein 1 related,9026,ENSG00000130787,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DRB1,HGNC:4948,"major histocompatibility complex, class II, DR beta 1",3123,ENSG00000196126,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3126,HLA-DRB4,"major histocompatibility complex, class II, DR beta 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DRB4,HGNC:4952,"major histocompatibility complex, class II, DR beta 4",3126,ENSG00000227357,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3133,HLA-E,"major histocompatibility complex, class I, E",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-E,HGNC:4962,"major histocompatibility complex, class I, E",3133,ENSG00000204592,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3135,HLA-G,"major histocompatibility complex, class I, G",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-G,HGNC:4964,"major histocompatibility complex, class I, G",3135,ENSG00000204632,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10042,HMGXB4,HMG box domain containing 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HMGXB4,HGNC:5003,HMG-box containing 4,10042,ENSG00000100281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27306,HPGDS,hematopoietic prostaglandin D synthase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPGDS,HGNC:17890,hematopoietic prostaglandin D synthase,27306,ENSG00000163106,HPGDS,Hematopoietic prostaglandin D synthase,Enzyme,HPGDS_HUMAN,4.57,IC50,CHEMBL
7184,HSP90B1,"heat shock protein 90kDa beta (Grp94), member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSP90B1,HGNC:12028,heat shock protein 90 beta family member 1,7184,ENSG00000166598,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3308,HSPA4,heat shock 70kDa protein 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA5,HGNC:5238,heat shock protein family A (Hsp70) member 5,3309,ENSG00000044574,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
3361,HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR5A,HGNC:5300,5-hydroxytryptamine receptor 5A,3361,ENSG00000157219,HTR5A,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,5.906403065,Ki,PDSP
23706,IBGC1,idiopathic basal ganglia calcification 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IBGC1,HGNC:5336,idiopathic basal ganglia calcification 1,0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3439,IFNA1,"interferon, alpha 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNA1,HGNC:5417,interferon alpha 1,3439,ENSG00000197919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
11020,IFT27,intraflagellar transport 27,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFT27,HGNC:18626,intraflagellar transport 27,11020,ENSG00000100360,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3479,IGF1,insulin-like growth factor 1 (somatomedin C),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF1,HGNC:5464,insulin like growth factor 1,3479,ENSG00000017427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3485,IGFBP2,"insulin-like growth factor binding protein 2, 36kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGFBP2,HGNC:5471,insulin like growth factor binding protein 2,3485,ENSG00000115457,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3553,IL1B,"interleukin 1, beta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
3557,IL1RN,interleukin 1 receptor antagonist,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1RN,HGNC:6000,interleukin 1 receptor antagonist,3557,ENSG00000136689,IL1RN,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,11.21467018,Kd,DRUG LABEL
3560,IL2RB,"interleukin 2 receptor, beta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL2RB,HGNC:6009,interleukin 2 receptor subunit beta,3560,ENSG00000100385,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3569,IL6,interleukin 6,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
3612,IMPA1,inositol(myo)-1(or 4)-monophosphatase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPA1,HGNC:6050,inositol monophosphatase 1,3612,ENSG00000133731,IMPA1,Inositol-1(or 4)-monophosphatase 1,Enzyme,IMPA1_HUMAN,0,0,CHEMBL
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPA2,HGNC:6051,inositol monophosphatase 2,3613,ENSG00000141401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55364,IMPACT,impact RWD domain protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPACT,HGNC:20387,impact RWD domain protein,55364,ENSG00000154059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3628,INPP1,inositol polyphosphate-1-phosphatase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,INPP1,HGNC:6071,inositol polyphosphate-1-phosphatase,3628,ENSG00000151689,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3630,INS,insulin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,INS,HGNC:6081,insulin,3630,ENSG00000254647,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3670,ISL1,ISL LIM homeobox 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ISL1,HGNC:6132,ISL LIM homeobox 1,3670,ENSG00000016082,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3680,ITGA9,"integrin, alpha 9",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITGA9,HGNC:6145,integrin subunit alpha 9,3680,ENSG00000144668,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITGAM,HGNC:6149,integrin subunit alpha M,3684,ENSG00000169896,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3697,ITIH1,inter-alpha-trypsin inhibitor heavy chain 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH1,HGNC:6166,inter-alpha-trypsin inhibitor heavy chain 1,3697,ENSG00000055957,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3699,ITIH3,inter-alpha-trypsin inhibitor heavy chain 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH3,HGNC:6168,inter-alpha-trypsin inhibitor heavy chain 3,3699,ENSG00000162267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3700,ITIH4,"inter-alpha-trypsin inhibitor heavy chain family, member 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH4,HGNC:6169,inter-alpha-trypsin inhibitor heavy chain 4,3700,ENSG00000055955,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3708,ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITPR1,HGNC:6180,"inositol 1,4,5-trisphosphate receptor type 1",3708,ENSG00000150995,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3782,KCNN3,"potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNN3,HGNC:6292,potassium calcium-activated channel subfamily N member 3,3782,ENSG00000143603,KCNN3,Small conductance calcium-activated potassium channel protein 3,Ion channel,KCNN3_HUMAN,0,0,IUPHAR
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNQ2,HGNC:6296,potassium voltage-gated channel subfamily Q member 2,3785,ENSG00000075043,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,KCNQ2_HUMAN,5,EC50,IUPHAR
3786,KCNQ3,"potassium channel, voltage gated KQT-like subfamily Q, member 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNQ3,HGNC:6297,potassium voltage-gated channel subfamily Q member 3,3786,ENSG00000184156,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,KCNQ3_HUMAN,0,0,WOMBAT-PK
115207,KCTD12,potassium channel tetramerization domain containing 12,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCTD12,HGNC:14678,potassium channel tetramerization domain containing 12,115207,ENSG00000178695,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11202,KLK8,kallikrein-related peptidase 8,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KLK8,HGNC:6369,kallikrein related peptidase 8,11202,ENSG00000129455,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
246269,LACE1,lactation elevated 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23395,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LARS2,HGNC:17095,"leucyl-tRNA synthetase 2, mitochondrial",23395,ENSG00000011376,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10660,LBX1,ladybird homeobox 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LBX1,HGNC:16960,ladybird homeobox 1,10660,ENSG00000138136,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3939,LDHA,lactate dehydrogenase A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LDHA,HGNC:6535,lactate dehydrogenase A,3939,ENSG00000134333,LDHA,L-lactate dehydrogenase A chain,Enzyme,LDHA_HUMAN,3.19,Kd,CHEMBL
64211,LHX5,LIM homeobox 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LHX5,HGNC:14216,LIM homeobox 5,64211,ENSG00000089116,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
81562,LMAN2L,"lectin, mannose-binding 2-like",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LMAN2L,HGNC:19263,"lectin, mannose binding 2 like",81562,ENSG00000114988,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9223,MAGI1,"membrane associated guanylate kinase, WW and PDZ domain containing 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAGI1,HGNC:946,"membrane associated guanylate kinase, WW and PDZ domain containing 1",9223,ENSG00000151276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9863,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAGI2,HGNC:18957,"membrane associated guanylate kinase, WW and PDZ domain containing 2",9863,ENSG00000187391,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
4133,MAP2,microtubule-associated protein 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2,HGNC:6839,microtubule associated protein 2,4133,ENSG00000078018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5594,MAPK1,mitogen-activated protein kinase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK1,HGNC:6871,mitogen-activated protein kinase 1,5594,ENSG00000100030,MAPK1,Mitogen-activated protein kinase 1,Kinase,MK01_HUMAN,5.227165073,IC50,DRUG MATRIX
4137,MAPT,microtubule-associated protein tau,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPT,HGNC:6893,microtubule associated protein tau,4137,ENSG00000186868,MAPT,Microtubule-associated protein tau,Structural,TAU_HUMAN,8.6,Ki,CHEMBL
55777,MBD5,methyl-CpG binding domain protein 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MBD5,HGNC:20444,methyl-CpG binding domain protein 5,55777,ENSG00000204406,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MBL2,HGNC:6922,mannose binding lectin 2,4153,ENSG00000165471,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4158,MC2R,melanocortin 2 receptor (adrenocorticotropic hormone),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC2R,HGNC:6930,melanocortin 2 receptor,4158,ENSG00000185231,MC2R,Adrenocorticotropic hormone receptor,GPCR,ACTHR_HUMAN,8.267605782,Ki,SCIENTIFIC LITERATURE
4161,MC5R,melanocortin 5 receptor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC5R,HGNC:6933,melanocortin 5 receptor,4161,ENSG00000176136,MC5R,Melanocortin receptor 5,GPCR,MC5R_HUMAN,5.050171041,Ki,DRUG MATRIX
2847,MCHR1,melanin-concentrating hormone receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR1,HGNC:4479,melanin concentrating hormone receptor 1,2847,ENSG00000128285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84539,MCHR2,melanin-concentrating hormone receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR2,HGNC:20867,melanin concentrating hormone receptor 2,84539,ENSG00000152034,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266727,MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDGA1,HGNC:19267,MAM domain containing glycosylphosphatidylinositol anchor 1,266727,ENSG00000112139,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ME2,HGNC:6984,malic enzyme 2,4200,ENSG00000082212,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4240,MFGE8,milk fat globule-EGF factor 8 protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MFGE8,HGNC:7036,milk fat globule EGF and factor V/VIII domain containing,4240,ENSG00000140545,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406928,MIR137,microRNA 137,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR137,HGNC:31523,microRNA 137,406928,ENSG00000284202,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406989,MIR206,microRNA 206,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR206,HGNC:31584,microRNA 206,406989,ENSG00000207604,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406994,MIR212,microRNA 212,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR212,HGNC:31589,microRNA 212,406994,ENSG00000267195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100616452,MIR2682,microRNA 2682,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR2682,HGNC:41688,microRNA 2682,100616452,ENSG00000284247,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MLC1,HGNC:17082,modulator of VRAC current 1,23209,ENSG00000100427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4300,MLLT3,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MLLT3,HGNC:7136,MLLT3 super elongation complex subunit,4300,ENSG00000171843,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4319,MMP10,matrix metallopeptidase 10 (stromelysin 2),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP10,HGNC:7156,matrix metallopeptidase 10,4319,ENSG00000166670,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP3,HGNC:7173,matrix metallopeptidase 3,4314,ENSG00000149968,MMP3,Stromelysin-1,Enzyme,MMP3_HUMAN,4.6,IC50,CHEMBL
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP9,HGNC:7176,matrix metallopeptidase 9,4318,ENSG00000100985,MMP9,Matrix metalloproteinase-9,Enzyme,MMP9_HUMAN,4,IC50,CHEMBL
65258,MPPE1,metallophosphoesterase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MPPE1,HGNC:15988,metallophosphoesterase 1,65258,ENSG00000154889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4391,MRX27,"mental retardation, X-linked 27",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MRX27,HGNC:7257,"mental retardation, X-linked 27",0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4522,MTHFD1,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFD1,HGNC:7432,"methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1",4522,ENSG00000100714,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTR,HGNC:7468,5-methyltetrahydrofolate-homocysteine methyltransferase,4548,ENSG00000116984,MTR,Methionine synthase,Enzyme,METH_HUMAN,0,0,WOMBAT-PK
8774,NAPG,"N-ethylmaleimide-sensitive factor attachment protein, gamma",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NAPG,HGNC:7642,NSF attachment protein gamma,8774,ENSG00000134265,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4684,NCAM1,neural cell adhesion molecule 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1463,NCAN,neurocan,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAN,HGNC:2465,neurocan,1463,ENSG00000130287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9612,NCOR2,nuclear receptor corepressor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCOR2,HGNC:7673,nuclear receptor corepressor 2,9612,ENSG00000196498,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23413,NCS1,neuronal calcium sensor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCS1,HGNC:3953,neuronal calcium sensor 1,23413,ENSG00000107130,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9348,NDST3,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDST3,HGNC:7682,N-deacetylase and N-sulfotransferase 3,9348,ENSG00000164100,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV1,HGNC:7716,NADH:ubiquinone oxidoreductase core subunit V1,4723,ENSG00000167792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV2,HGNC:7717,NADH:ubiquinone oxidoreductase core subunit V2,4729,ENSG00000178127,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4731,NDUFV3,"NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV3,HGNC:7719,NADH:ubiquinone oxidoreductase subunit V3,4731,ENSG00000160194,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4734,NEDD4,"neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEDD4,HGNC:7727,NEDD4 E3 ubiquitin protein ligase,4734,ENSG00000069869,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4747,NEFL,"neurofilament, light polypeptide",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFL,HGNC:7739,neurofilament light,4747,ENSG00000277586,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4741,NEFM,"neurofilament, medium polypeptide",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFM,HGNC:7734,neurofilament medium,4741,ENSG00000104722,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6787,NEK4,NIMA-related kinase 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEK4,HGNC:11399,NIMA related kinase 4,6787,ENSG00000114904,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4784,NFIX,nuclear factor I/X (CCAAT-binding transcription factor),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NFIX,HGNC:7788,nuclear factor I X,4784,ENSG00000008441,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
22871,NLGN1,neuroligin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NLGN1,HGNC:14291,neuroligin 1,22871,ENSG00000169760,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4837,NNMT,nicotinamide N-methyltransferase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NNMT,HGNC:7861,nicotinamide N-methyltransferase,4837,ENSG00000166741,NNMT,Nicotinamide N-methyltransferase,Enzyme,NNMT_HUMAN,0,0,WOMBAT-PK
64127,NOD2,nucleotide-binding oligomerization domain containing 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOD2,HGNC:5331,nucleotide binding oligomerization domain containing 2,64127,ENSG00000167207,NOD2,Nucleotide-binding oligomerization domain-containing protein 2,Cytosolic other,NOD2_HUMAN,0,0,DRUG LABEL
4846,NOS3,nitric oxide synthase 3 (endothelial cell),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOS3,HGNC:7876,nitric oxide synthase 3,4846,ENSG00000164867,NOS3,"Nitric oxide synthase, endothelial",Enzyme,NOS3_HUMAN,5.06,IC50,CHEMBL
4855,NOTCH4,notch 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOTCH4,HGNC:7884,notch receptor 4,4855,ENSG00000204301,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4862,NPAS2,neuronal PAS domain protein 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS2,HGNC:7895,neuronal PAS domain protein 2,4862,ENSG00000170485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64067,NPAS3,neuronal PAS domain protein 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS3,HGNC:19311,neuronal PAS domain protein 3,64067,ENSG00000151322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9572,NR1D1,"nuclear receptor subfamily 1, group D, member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR1D1,HGNC:7962,nuclear receptor subfamily 1 group D member 1,9572,ENSG00000126368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7101,NR2E1,"nuclear receptor subfamily 2, group E, member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR2E1,HGNC:7973,nuclear receptor subfamily 2 group E member 1,7101,ENSG00000112333,NR2E1,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,NR2E1_HUMAN,4.560667515,Kd,SCIENTIFIC LITERATURE
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR4A2,HGNC:7981,nuclear receptor subfamily 4 group A member 2,4929,ENSG00000153234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3084,NRG1,neuregulin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG1,HGNC:7997,neuregulin 1,3084,ENSG00000157168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10718,NRG3,neuregulin 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG3,HGNC:7999,neuregulin 3,10718,ENSG00000185737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4900,NRGN,"neurogranin (protein kinase C substrate, RC3)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRGN,HGNC:8000,neurogranin,4900,ENSG00000154146,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4902,NRTN,neurturin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRTN,HGNC:8007,neurturin,4902,ENSG00000171119,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9378,NRXN1,neurexin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN1,HGNC:8008,neurexin 1,9378,ENSG00000179915,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4908,NTF3,neurotrophin 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTF3,HGNC:8023,neurotrophin 3,4908,ENSG00000185652,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4909,NTF4,neurotrophin 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTF4,HGNC:8024,neurotrophin 4,4909,ENSG00000225950,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84628,NTNG2,netrin G2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTNG2,HGNC:14288,netrin G2,84628,ENSG00000196358,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4986,OPRK1,"opioid receptor, kappa 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
5015,OTX2,orthodenticle homeobox 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OTX2,HGNC:8522,orthodenticle homeobox 2,5015,ENSG00000165588,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,P2RX7,HGNC:8537,purinergic receptor P2X 7,5027,ENSG00000089041,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5053,PAH,phenylalanine hydroxylase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAH,HGNC:8582,phenylalanine hydroxylase,5053,ENSG00000171759,PAH,Phenylalanine-4-hydroxylase,Enzyme,PH4H_HUMAN,5.400000095,Ki,IUPHAR
79728,PALB2,partner and localizer of BRCA2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PALB2,HGNC:26144,partner and localizer of BRCA2,79728,ENSG00000083093,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55193,PBRM1,polybromo 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PBRM1,HGNC:30064,polybromo 1,55193,ENSG00000163939,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27445,PCLO,piccolo presynaptic cytomatrix protein,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCLO,HGNC:13406,piccolo presynaptic cytomatrix protein,27445,ENSG00000186472,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5116,PCNT,pericentrin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCNT,HGNC:16068,pericentrin,5116,ENSG00000160299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10846,PDE10A,phosphodiesterase 10A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE10A,HGNC:8772,phosphodiesterase 10A,10846,ENSG00000112541,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_HUMAN,6,Ki,CHEMBL
5141,PDE4A,"phosphodiesterase 4A, cAMP-specific",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4A,HGNC:8780,phosphodiesterase 4A,5141,ENSG00000065989,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,5.976336082,IC50,DRUG MATRIX
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4B,HGNC:8781,phosphodiesterase 4B,5142,ENSG00000184588,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,PDE4B_HUMAN,0,0,WOMBAT-PK
5152,PDE9A,phosphodiesterase 9A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE9A,HGNC:8795,phosphodiesterase 9A,5152,ENSG00000160191,PDE9A,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Enzyme,PDE9A_HUMAN,5.47,IC50,CHEMBL
10611,PDLIM5,PDZ and LIM domain 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDLIM5,HGNC:17468,PDZ and LIM domain 5,10611,ENSG00000163110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8864,PER2,period circadian clock 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8863,PER3,period circadian clock 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER3,HGNC:8847,period circadian regulator 3,8863,ENSG00000049246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKFB3,HGNC:8874,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",5209,ENSG00000170525,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5211,PFKL,"phosphofructokinase, liver",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKL,HGNC:8876,"phosphofructokinase, liver type",5211,ENSG00000141959,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5223,PGAM1,phosphoglycerate mutase 1 (brain),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PGAM1,HGNC:8888,phosphoglycerate mutase 1,5223,ENSG00000171314,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
283871,PGP,phosphoglycolate phosphatase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PGP,HGNC:8909,phosphoglycolate phosphatase,283871,ENSG00000184207,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55300,PI4K2B,phosphatidylinositol 4-kinase type 2 beta,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PI4K2B,HGNC:18215,phosphatidylinositol 4-kinase type 2 beta,55300,ENSG00000038210,PI4K2B,Phosphatidylinositol 4-kinase type 2-beta,Kinase,P4K2B_HUMAN,4.75,IC50,IUPHAR
5289,PIK3C3,"phosphatidylinositol 3-kinase, catalytic subunit type 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIK3C3,HGNC:8974,phosphatidylinositol 3-kinase catalytic subunit type 3,5289,ENSG00000078142,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5305,PIP4K2A,"phosphatidylinositol-5-phosphate 4-kinase, type II, alpha",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIP4K2A,HGNC:8997,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,5305,ENSG00000150867,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79837,PIP4K2C,"phosphatidylinositol-5-phosphate 4-kinase, type II, gamma",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIP4K2C,HGNC:23786,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,79837,ENSG00000166908,PIP4K2C,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,PI42C_HUMAN,6,Kd,CHEMBL
5319,PLA2G1B,"phospholipase A2, group IB (pancreas)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G1B,HGNC:9030,phospholipase A2 group IB,5319,ENSG00000170890,PLA2G1B,Phospholipase A2,Enzyme,PA21B_HUMAN,5.7,IC50,CHEMBL
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G2A,HGNC:9031,phospholipase A2 group IIA,5320,ENSG00000188257,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G4A,HGNC:9035,phospholipase A2 group IVA,5321,ENSG00000116711,PLA2G4A,Cytosolic phospholipase A2,Enzyme,PA24A_HUMAN,0,0,WOMBAT-PK
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G6,HGNC:9039,phospholipase A2 group VI,8398,ENSG00000184381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLCB1,HGNC:15917,phospholipase C beta 1,23236,ENSG00000182621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5335,PLCG1,"phospholipase C, gamma 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLCG1,HGNC:9065,phospholipase C gamma 1,5335,ENSG00000124181,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
345557,PLCXD3,"phosphatidylinositol-specific phospholipase C, X domain containing 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLCXD3,HGNC:31822,phosphatidylinositol specific phospholipase C X domain containing 3,345557,ENSG00000182836,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5367,PMCH,pro-melanin-concentrating hormone,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PMCH,HGNC:9109,pro-melanin concentrating hormone,5367,ENSG00000183395,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5428,POLG,"polymerase (DNA directed), gamma",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POLG,HGNC:9179,"DNA polymerase gamma, catalytic subunit",5428,ENSG00000140521,POLG,DNA polymerase subunit gamma-1,Enzyme,DPOG1_HUMAN,0,0,WOMBAT-PK
5443,POMC,proopiomelanocortin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POMC,HGNC:9201,proopiomelanocortin,5443,ENSG00000115138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5444,PON1,paraoxonase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PON1,HGNC:9204,paraoxonase 1,5444,ENSG00000005421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5454,POU3F2,POU class 3 homeobox 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POU3F2,HGNC:9215,POU class 3 homeobox 2,5454,ENSG00000184486,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5467,PPARD,peroxisome proliferator-activated receptor delta,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPARD,HGNC:9235,peroxisome proliferator activated receptor delta,5467,ENSG00000112033,PPARD,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,PPARD_HUMAN,4.45,EC50,CHEMBL
5481,PPID,peptidylprolyl isomerase D,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPID,HGNC:9257,peptidylprolyl isomerase D,5481,ENSG00000171497,PPID,Peptidyl-prolyl cis-trans isomerase D,Enzyme,PPID_HUMAN,8.15,Ki,CHEMBL
728448,PPIEL,peptidylprolyl isomerase E-like pseudogene,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPIEL,HGNC:33195,peptidylprolyl isomerase E like pseudogene,728448,ENSG00000243970,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP1R1B,HGNC:9287,protein phosphatase 1 regulatory inhibitor subunit 1B,84152,ENSG00000131771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5522,PPP2R2C,"protein phosphatase 2, regulatory subunit B, gamma",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP2R2C,HGNC:9306,protein phosphatase 2 regulatory subunit Bgamma,5522,ENSG00000074211,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5524,PPP2R4,"protein phosphatase 2A activator, regulatory subunit 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5533,PPP3CC,"protein phosphatase 3, catalytic subunit, gamma isozyme",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP3CC,HGNC:9316,protein phosphatase 3 catalytic subunit gamma,5533,ENSG00000120910,PPP3CC,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,0,0,WOMBAT-PK
5550,PREP,prolyl endopeptidase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PREP,HGNC:9358,prolyl endopeptidase,5550,ENSG00000085377,PREP,Prolyl endopeptidase,Enzyme,PPCE_HUMAN,4.89,IC50,CHEMBL
5584,PRKCI,"protein kinase C, iota",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCI,HGNC:9404,protein kinase C iota,5584,ENSG00000163558,PRKCI,Protein kinase C iota type,Kinase,KPCI_HUMAN,5.85,Kd,CHEMBL
5590,PRKCZ,"protein kinase C, zeta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCZ,HGNC:9412,protein kinase C zeta,5590,ENSG00000067606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5625,PRODH,proline dehydrogenase (oxidase) 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRODH,HGNC:9453,proline dehydrogenase 1,5625,ENSG00000100033,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
128674,PROKR2,prokineticin receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROKR2,HGNC:15836,prokineticin receptor 2,128674,ENSG00000101292,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5664,PSEN2,presenilin 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSEN2,HGNC:9509,presenilin 2,5664,ENSG00000143801,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5623,PSPN,persephin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSPN,HGNC:9579,persephin,5623,ENSG00000125650,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5730,PTGDS,prostaglandin D2 synthase 21kDa (brain),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGDS,HGNC:9592,prostaglandin D2 synthase,5730,ENSG00000107317,PTGDS,Prostaglandin-H2 D-isomerase,Enzyme,PTGDS_HUMAN,6.3,IC50,WOMBAT-PK
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPGEF5,HGNC:16862,Rap guanine nucleotide exchange factor 5,9771,ENSG00000136237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5914,RARA,"retinoic acid receptor, alpha",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RARA,HGNC:9864,retinoic acid receptor alpha,5914,ENSG00000131759,RARA,Retinoic acid receptor alpha,Nuclear hormone receptor,RARA_HUMAN,0,0,WOMBAT-PK
5923,RASGRF1,Ras protein-specific guanine nucleotide-releasing factor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RASGRF1,HGNC:9875,Ras protein specific guanine nucleotide releasing factor 1,5923,ENSG00000058335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10125,RASGRP1,RAS guanyl releasing protein 1 (calcium and DAG-regulated),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RASGRP1,HGNC:9878,RAS guanyl releasing protein 1,10125,ENSG00000172575,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5649,RELN,reelin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELN,HGNC:9957,reelin,5649,ENSG00000189056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5972,REN,renin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REN,HGNC:9958,renin,5972,ENSG00000143839,REN,Renin,Enzyme,RENI_HUMAN,9.22,IC50,WOMBAT-PK
5992,RFX4,"regulatory factor X, 4 (influences HLA class II expression)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RFX4,HGNC:9985,regulatory factor X4,5992,ENSG00000111783,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5999,RGS4,regulator of G-protein signaling 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS4,HGNC:10000,regulator of G protein signaling 4,5999,ENSG00000117152,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10193,RNF41,"ring finger protein 41, E3 ubiquitin protein ligase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNF41,HGNC:18401,ring finger protein 41,10193,ENSG00000181852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4919,ROR1,receptor tyrosine kinase-like orphan receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ROR1,HGNC:10256,receptor tyrosine kinase like orphan receptor 1,4919,ENSG00000185483,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6095,RORA,RAR-related orphan receptor A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RORA,HGNC:10258,RAR related orphan receptor A,6095,ENSG00000069667,RORA,Nuclear receptor ROR-alpha,Nuclear hormone receptor,RORA_HUMAN,9,EC50,WOMBAT-PK
57142,RTN4,reticulon 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RTN4,HGNC:14085,reticulon 4,57142,ENSG00000115310,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6281,S100A10,S100 calcium binding protein A10,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
1901,S1PR1,sphingosine-1-phosphate receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S1PR1,HGNC:3165,sphingosine-1-phosphate receptor 1,1901,ENSG00000170989,S1PR1,Sphingosine 1-phosphate receptor 1,GPCR,S1PR1_HUMAN,9.52,EC50,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SCN8A,HGNC:10596,sodium voltage-gated channel alpha subunit 8,6334,ENSG00000196876,SCN8A,Sodium channel protein type 8 subunit alpha,Ion channel,SCN8A_HUMAN,0,0,SCIENTIFIC LITERATURE
9632,SEC24C,SEC24 family member C,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEC24C,HGNC:10705,"SEC24 homolog C, COPII coat complex component",9632,ENSG00000176986,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINA1,HGNC:8941,serpin family A member 1,5265,ENSG00000197249,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23544,SEZ6L,seizure related 6 homolog (mouse)-like,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEZ6L,HGNC:10763,seizure related 6 homolog like,23544,ENSG00000100095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6422,SFRP1,secreted frizzled-related protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SFRP1,HGNC:10776,secreted frizzled related protein 1,6422,ENSG00000104332,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6474,SHOX2,short stature homeobox 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHOX2,HGNC:10854,short stature homeobox 2,6474,ENSG00000168779,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23411,SIRT1,sirtuin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT1,HGNC:14929,sirtuin 1,23411,ENSG00000096717,SIRT1,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,4.3,IC50,CHEMBL
9990,SLC12A6,"solute carrier family 12 (potassium/chloride transporter), member 6",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC12A6,HGNC:10914,solute carrier family 12 member 6,9990,ENSG00000140199,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57084,SLC17A6,"solute carrier family 17 (vesicular glutamate transporter), member 6",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A6,HGNC:16703,solute carrier family 17 member 6,57084,ENSG00000091664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57030,SLC17A7,"solute carrier family 17 (vesicular glutamate transporter), member 7",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A7,HGNC:16704,solute carrier family 17 member 7,57030,ENSG00000104888,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6570,SLC18A1,"solute carrier family 18 (vesicular monoamine transporter), member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A1,HGNC:10934,solute carrier family 18 member A1,6570,ENSG00000036565,SLC18A1,Chromaffin granule amine transporter,Transporter,VMAT1_HUMAN,5.8,Ki,IUPHAR
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A1,HGNC:10939,solute carrier family 1 member 1,6505,ENSG00000106688,SLC1A1,Excitatory amino acid transporter 3,Transporter,EAA3_HUMAN,7.289999962,Ki,CHEMBL
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A2,HGNC:10940,solute carrier family 1 member 2,6506,ENSG00000110436,SLC1A2,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,4.210000038,Ki,CHEMBL
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A3,HGNC:10941,solute carrier family 1 member 3,6507,ENSG00000079215,SLC1A3,Excitatory amino acid transporter 1,Transporter,EAA1_HUMAN,4.460000038,Ki,CHEMBL
6509,SLC1A4,"solute carrier family 1 (glutamate/neutral amino acid transporter), member 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A4,HGNC:10942,solute carrier family 1 member 4,6509,ENSG00000115902,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6511,SLC1A6,"solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A6,HGNC:10944,solute carrier family 1 member 6,6511,ENSG00000105143,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
85413,SLC22A16,"solute carrier family 22 (organic cation/carnitine transporter), member 16",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC22A16,HGNC:20302,solute carrier family 22 member 16,85413,ENSG00000004809,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
291,SLC25A4,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC25A4,HGNC:10990,solute carrier family 25 member 4,291,ENSG00000151729,SLC25A4,ADP/ATP translocase 1,Transporter,ADT1_HUMAN,0,0,WOMBAT-PK
29985,SLC39A3,"solute carrier family 39 (zinc transporter), member 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC39A3,HGNC:17128,solute carrier family 39 member 3,29985,ENSG00000141873,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6540,SLC6A13,"solute carrier family 6 (neurotransmitter transporter), member 13",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A13,HGNC:11046,solute carrier family 6 member 13,6540,ENSG00000010379,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
6611,SMS,spermine synthase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SMS,HGNC:11123,spermine synthase,6611,ENSG00000102172,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6616,SNAP25,"synaptosomal-associated protein, 25kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNAP25,HGNC:11132,synaptosome associated protein 25,6616,ENSG00000132639,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6647,SOD1,"superoxide dismutase 1, soluble",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD1,HGNC:11179,superoxide dismutase 1,6647,ENSG00000142168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6648,SOD2,"superoxide dismutase 2, mitochondrial",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD2,HGNC:11180,superoxide dismutase 2,6648,ENSG00000112096,SOD2,"Superoxide dismutase [Mn], mitochondrial",Enzyme,SODM_HUMAN,0,0,WOMBAT-PK
57537,SORCS2,sortilin-related VPS10 domain containing receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SORCS2,HGNC:16698,sortilin related VPS10 domain containing receptor 2,57537,ENSG00000184985,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6671,SP4,Sp4 transcription factor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP4,HGNC:11209,Sp4 transcription factor,6671,ENSG00000105866,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
221833,SP8,Sp8 transcription factor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP8,HGNC:19196,Sp8 transcription factor,221833,ENSG00000164651,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6697,SPR,"sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SPR,HGNC:11257,sepiapterin reductase,6697,ENSG00000116096,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A1,HGNC:11284,steroid 5 alpha-reductase 1,6715,ENSG00000145545,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,8.49,IC50,WOMBAT-PK
51593,SRRT,"serrate, RNA effector molecule",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRRT,HGNC:24101,"serrate, RNA effector molecule",51593,ENSG00000087087,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6428,SRSF3,serine/arginine-rich splicing factor 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRSF3,HGNC:10785,serine and arginine rich splicing factor 3,6428,ENSG00000112081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6750,SST,somatostatin,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SST,HGNC:11329,somatostatin,6750,ENSG00000157005,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6755,SSTR5,somatostatin receptor 5,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SSTR5,HGNC:11334,somatostatin receptor 5,6755,ENSG00000162009,SSTR5,Somatostatin receptor type 5,GPCR,SSR5_HUMAN,5.39,Ki,CHEMBL
6482,ST3GAL1,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST3GAL1,HGNC:10862,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",6482,ENSG00000008513,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8128,ST8SIA2,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST8SIA2,HGNC:10870,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",8128,ENSG00000140557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23166,STAB1,stabilin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STAB1,HGNC:18628,stabilin 1,23166,ENSG00000010327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6854,SYN2,synapsin II,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYN2,HGNC:11495,synapsin II,6854,ENSG00000157152,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8224,SYN3,synapsin III,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYN3,HGNC:11496,synapsin III,8224,ENSG00000185666,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYNE1,HGNC:17089,spectrin repeat containing nuclear envelope protein 1,23345,ENSG00000131018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9145,SYNGR1,synaptogyrin 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYNGR1,HGNC:11498,synaptogyrin 1,9145,ENSG00000100321,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
319100,TAAR6,trace amine associated receptor 6,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAAR6,HGNC:20978,trace amine associated receptor 6,319100,ENSG00000146383,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6869,TACR1,tachykinin receptor 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR1,HGNC:11526,tachykinin receptor 1,6869,ENSG00000115353,TACR1,Substance-P receptor,GPCR,NK1R_HUMAN,10.7,Ki,CHEMBL
6891,TAP2,"transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAP2,HGNC:44,"transporter 2, ATP binding cassette subfamily B member",6891,ENSG00000204267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6925,TCF4,transcription factor 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF4,HGNC:11634,transcription factor 4,6925,ENSG00000196628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF7L2,HGNC:11641,transcription factor 7 like 2,6934,ENSG00000148737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6999,TDO2,"tryptophan 2,3-dioxygenase",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7052,TGM2,transglutaminase 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGM2,HGNC:11778,transglutaminase 2,7052,ENSG00000198959,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
8914,TIMELESS,timeless circadian clock,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TIMELESS,HGNC:11813,timeless circadian regulator,8914,ENSG00000111602,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7093,TLL2,tolloid-like 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLL2,HGNC:11844,tolloid like 2,7093,ENSG00000095587,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7097,TLR2,toll-like receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR2,HGNC:11848,toll like receptor 2,7097,ENSG00000137462,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7099,TLR4,toll-like receptor 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR4,HGNC:11850,toll like receptor 4,7099,ENSG00000136869,TLR4,Toll-like receptor 4,Membrane receptor,TLR4_HUMAN,0,0,WOMBAT-PK
9168,TMSB10,thymosin beta 10,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TMSB10,HGNC:11879,thymosin beta 10,9168,ENSG00000034510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7124,TNF,tumor necrosis factor,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNF,HGNC:11892,tumor necrosis factor,7124,ENSG00000232810,TNF,Tumor necrosis factor,Cytokine,TNFA_HUMAN,8,IC50,WOMBAT-PK
10043,TOM1,target of myb1 (chicken),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TOM1,HGNC:11982,target of myb1 membrane trafficking protein,10043,ENSG00000100284,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
121278,TPH2,tryptophan hydroxylase 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7173,TPO,thyroid peroxidase,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPO,HGNC:12015,thyroid peroxidase,7173,ENSG00000115705,TPO,Thyroid peroxidase,Enzyme,PERT_HUMAN,0,0,WOMBAT-PK
57113,TRPC7,"transient receptor potential cation channel, subfamily C, member 7",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRPC7,HGNC:20754,transient receptor potential cation channel subfamily C member 7,57113,ENSG00000069018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10194,TSHZ1,teashirt zinc finger homeobox 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSHZ1,HGNC:10669,teashirt zinc finger homeobox 1,10194,ENSG00000179981,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7257,TSNAX,translin-associated factor X,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX,HGNC:12380,translin associated factor X,7257,ENSG00000116918,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100303453,TSNAX-DISC1,TSNAX-DISC1 readthrough (NMD candidate),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX-DISC1,HGNC:49177,TSNAX-DISC1 readthrough (NMD candidate),100303453,ENSG00000270106,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7103,TSPAN8,tetraspanin 8,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSPAN8,HGNC:11855,tetraspanin 8,7103,ENSG00000127324,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
706,TSPO,translocator protein (18kDa),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSPO,HGNC:1158,translocator protein,706,ENSG00000100300,TSPO,Translocator protein,Transporter,TSPO_HUMAN,7.1,IC50,WOMBAT-PK
51807,TUBA8,"tubulin, alpha 8",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TUBA8,HGNC:12410,tubulin alpha 8,51807,ENSG00000183785,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UCP2,HGNC:12518,uncoupling protein 2,7351,ENSG00000175567,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
127933,UHMK1,U2AF homology motif (UHM) kinase 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UHMK1,HGNC:19683,U2AF homology motif kinase 1,127933,ENSG00000152332,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54986,ULK4,unc-51 like kinase 4,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ULK4,HGNC:15784,unc-51 like kinase 4,54986,ENSG00000168038,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64854,USP46,ubiquitin specific peptidase 46,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,USP46,HGNC:20075,ubiquitin specific peptidase 46,64854,ENSG00000109189,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6844,VAMP2,vesicle-associated membrane protein 2 (synaptobrevin 2),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP2,HGNC:12643,vesicle associated membrane protein 2,6844,ENSG00000220205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9341,VAMP3,vesicle-associated membrane protein 3,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP3,HGNC:12644,vesicle associated membrane protein 3,9341,ENSG00000049245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9218,VAPA,"VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAPA,HGNC:12648,VAMP associated protein A,9218,ENSG00000101558,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VDR,HGNC:12679,vitamin D receptor,7421,ENSG00000111424,VDR,Vitamin D3 receptor,Nuclear hormone receptor,VDR_HUMAN,0,0,WOMBAT-PK
7422,VEGFA,vascular endothelial growth factor A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
7425,VGF,VGF nerve growth factor inducible,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VGF,HGNC:12684,VGF nerve growth factor inducible,7425,ENSG00000128564,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7432,VIP,vasoactive intestinal peptide,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7434,VIPR2,vasoactive intestinal peptide receptor 2,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VIPR2,HGNC:12695,vasoactive intestinal peptide receptor 2,7434,ENSG00000106018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7466,WFS1,Wolfram syndrome 1 (wolframin),C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WFS1,HGNC:12762,wolframin ER transmembrane glycoprotein,7466,ENSG00000109501,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7494,XBP1,X-box binding protein 1,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,XBP1,HGNC:12801,X-box binding protein 1,7494,ENSG00000100219,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7531,YWHAE,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAE,HGNC:12851,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,7531,ENSG00000108953,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7533,YWHAH,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAH,HGNC:12853,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta,7533,ENSG00000128245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAZ,HGNC:12855,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,7534,ENSG00000164924,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29801,ZDHHC8,"zinc finger, DHHC-type containing 8",C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZDHHC8,HGNC:18474,zinc finger DHHC-type palmitoyltransferase 8,29801,ENSG00000099904,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
91752,ZNF804A,zinc finger protein 804A,C0005586,bipolar disorder,Bipolar disorders and related disorders,C0005586,Bipolar Disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZNF804A,HGNC:21711,zinc finger protein 804A,91752,ENSG00000170396,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
15,AANAT,aralkylamine N-acetyltransferase,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AANAT,HGNC:19,aralkylamine N-acetyltransferase,15,ENSG00000129673,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
27185,DISC1,disrupted in schizophrenia 1,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
8564,KMO,kynurenine 3-monooxygenase (kynurenine 3-hydroxylase),C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KMO,HGNC:6381,kynurenine 3-monooxygenase,8564,ENSG00000117009,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4684,NCAM1,neural cell adhesion molecule 1,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266743,NPAS4,neuronal PAS domain protein 4,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS4,HGNC:18983,neuronal PAS domain protein 4,266743,ENSG00000174576,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
121278,TPH2,tryptophan hydroxylase 2,C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7466,WFS1,Wolfram syndrome 1 (wolframin),C0005587,"depression, bipolar",Bipolar disorders and related disorders,C0005587,"Depression, Bipolar",disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WFS1,HGNC:12762,wolframin ER transmembrane glycoprotein,7466,ENSG00000109501,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
148,ADRA1A,adrenoceptor alpha 1A,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
1813,DRD2,dopamine receptor D2,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
2166,FAAH,fatty acid amide hydrolase,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA2,HGNC:4076,gamma-aminobutyric acid type A receptor subunit alpha2,2555,ENSG00000151834,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,6.94,Ki,CHEMBL
3060,HCRT,hypocretin (orexin) neuropeptide precursor,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRT,HGNC:4847,hypocretin neuropeptide precursor,3060,ENSG00000161610,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3084,NRG1,neuregulin 1,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG1,HGNC:7997,neuregulin 1,3084,ENSG00000157168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5179,PENK,proenkephalin,C0006870,cannabis dependence,Cannabis use disorders,C0006870,Cannabis Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PENK,HGNC:8831,proenkephalin,5179,ENSG00000181195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
148,ADRA1A,adrenoceptor alpha 1A,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
157,ADRBK2,"adrenergic, beta, receptor kinase 2",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
9607,CARTPT,CART prepropeptide,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA4,HGNC:1958,cholinergic receptor nicotinic alpha 4 subunit,1137,ENSG00000101204,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,4.039999962,IC50,IUPHAR
1666,DECR1,"2,4-dienoyl CoA reductase 1, mitochondrial",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DECR1,HGNC:2753,"2,4-dienoyl-CoA reductase 1",1666,ENSG00000104325,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1813,DRD2,dopamine receptor D2,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR4A2,HGNC:7981,nuclear receptor subfamily 4 group A member 2,4929,ENSG00000153234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4900,NRGN,"neurogranin (protein kinase C substrate, RC3)",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRGN,HGNC:8000,neurogranin,4900,ENSG00000154146,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5309,PITX3,paired-like homeodomain 3,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PITX3,HGNC:9006,paired like homeodomain 3,5309,ENSG00000107859,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5354,PLP1,proteolipid protein 1,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLP1,HGNC:9086,proteolipid protein 1,5354,ENSG00000123560,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8434,RECK,reversion-inducing-cysteine-rich protein with kazal motifs,C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RECK,HGNC:11345,reversion inducing cysteine rich protein with kazal motifs,8434,ENSG00000122707,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0009171,cocaine abuse,Cocaine use disorders,C0009171,Cocaine Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
551,AVP,arginine vasopressin,C0009178,cocaine withdrawal,Cocaine use disorders,C0009178,Cocaine withdrawal,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100128998,C20orf181,chromosome 20 open reading frame 181,C0009178,cocaine withdrawal,Cocaine use disorders,C0009178,Cocaine withdrawal,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,C20orf181,HGNC:16174,chromosome 20 open reading frame 181,100128998,ENSG00000279610,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",C0009178,cocaine withdrawal,Cocaine use disorders,C0009178,Cocaine withdrawal,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HSP90AA1,HGNC:5253,heat shock protein 90 alpha family class A member 1,3320,ENSG00000080824,HSP90AA1,Heat shock protein HSP 90-alpha,Cytosolic other,HS90A_HUMAN,5.3036,IC50,WOMBAT-PK
348,APOE,apolipoprotein E,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOE,HGNC:613,apolipoprotein E,348,ENSG00000130203,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
1813,DRD2,dopamine receptor D2,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
3479,IGF1,insulin-like growth factor 1 (somatomedin C),C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF1,HGNC:5464,insulin like growth factor 1,3479,ENSG00000017427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3557,IL1RN,interleukin 1 receptor antagonist,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1RN,HGNC:6000,interleukin 1 receptor antagonist,3557,ENSG00000136689,IL1RN,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,11.21467018,Kd,DRUG LABEL
3569,IL6,interleukin 6,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
3976,LIF,leukemia inhibitory factor,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LIF,HGNC:6596,LIF interleukin 6 family cytokine,3976,ENSG00000128342,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
7054,TH,tyrosine hydroxylase,C0011206,delirium,Schizophrenia spectrum and other psychotic disorders,C0011206,Delirium,disease,C23;C10;F03;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms",0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
2,A2M,alpha-2-macroglobulin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,A2M,HGNC:7,alpha-2-macroglobulin,2,ENSG00000175899,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
15,AANAT,aralkylamine N-acetyltransferase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AANAT,HGNC:19,aralkylamine N-acetyltransferase,15,ENSG00000129673,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
111,ADCY5,adenylate cyclase 5,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY5,HGNC:236,adenylate cyclase 5,111,ENSG00000173175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
113,ADCY7,adenylate cyclase 7,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY7,HGNC:238,adenylate cyclase 7,113,ENSG00000121281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114,ADCY8,adenylate cyclase 8 (brain),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY8,HGNC:239,adenylate cyclase 8,114,ENSG00000155897,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1,HGNC:241,adenylate cyclase activating polypeptide 1,116,ENSG00000141433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
117,ADCYAP1R1,adenylate cyclase activating polypeptide 1 (pituitary) receptor type I,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1R1,HGNC:242,ADCYAP receptor type I,117,ENSG00000078549,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
150,ADRA2A,adrenoceptor alpha 2A,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2A,HGNC:281,adrenoceptor alpha 2A,150,ENSG00000150594,ADRA2A,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,6.3,IC50,WOMBAT-PK
153,ADRB1,adrenoceptor beta 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB1,HGNC:285,adrenoceptor beta 1,153,ENSG00000043591,ADRB1,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,0,0,DRUGBANK
156,ADRBK1,"adrenergic, beta, receptor kinase 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26523,AGO1,argonaute RISC catalytic component 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGO1,HGNC:3262,argonaute RISC component 1,26523,ENSG00000092847,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGT,HGNC:333,angiotensinogen,183,ENSG00000135744,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKT1,HGNC:391,AKT serine/threonine kinase 1,207,ENSG00000142208,AKT1,RAC-alpha serine/threonine-protein kinase,Kinase,AKT1_HUMAN,5.02,IC50,CHEMBL
238,ALK,anaplastic lymphoma receptor tyrosine kinase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALK,HGNC:427,ALK receptor tyrosine kinase,238,ENSG00000171094,ALK,ALK tyrosine kinase receptor,Kinase,ALK_HUMAN,5.92,Kd,CHEMBL
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
351,APP,amyloid beta (A4) precursor protein,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APP,HGNC:620,amyloid beta precursor protein,351,ENSG00000142192,APP,Amyloid beta A4 protein,Unclassified,A4_HUMAN,4.52,IC50,CHEMBL
353,APRT,adenine phosphoribosyltransferase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APRT,HGNC:626,adenine phosphoribosyltransferase,353,ENSG00000198931,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
361,AQP4,aquaporin 4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AQP4,HGNC:637,aquaporin 4,361,ENSG00000171885,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
367,AR,androgen receptor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
9639,ARHGEF10,Rho guanine nucleotide exchange factor (GEF) 10,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGEF10,HGNC:14103,Rho guanine nucleotide exchange factor 10,9639,ENSG00000104728,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL,HGNC:701,aryl hydrocarbon receptor nuclear translocator like,406,ENSG00000133794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
409,ARRB2,"arrestin, beta 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB2,HGNC:712,arrestin beta 2,409,ENSG00000141480,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9048,ARTN,artemin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARTN,HGNC:727,artemin,9048,ENSG00000117407,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
438,ASMT,acetylserotonin O-methyltransferase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASMT,HGNC:750,acetylserotonin O-methyltransferase,438,ENSG00000196433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
467,ATF3,activating transcription factor 3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF3,HGNC:785,activating transcription factor 3,467,ENSG00000162772,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
468,ATF4,activating transcription factor 4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF4,HGNC:786,activating transcription factor 4,468,ENSG00000128272,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP1A3,HGNC:801,ATPase Na+/K+ transporting subunit alpha 3,478,ENSG00000105409,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP2A2,HGNC:812,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,488,ENSG00000174437,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4287,ATXN3,ataxin 3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATXN3,HGNC:7106,ataxin 3,4287,ENSG00000066427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
573,BAG1,BCL2-associated athanogene,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BAG1,HGNC:937,BAG cochaperone 1,573,ENSG00000107262,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
627,BDNF,brain-derived neurotrophic factor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80114,BICC1,BicC family RNA binding protein 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BICC1,HGNC:19351,BicC family RNA binding protein 1,80114,ENSG00000122870,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
672,BRCA1,"breast cancer 1, early onset",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRCA1,HGNC:1100,BRCA1 DNA repair associated,672,ENSG00000012048,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALM2,HGNC:1445,calmodulin 2,805,ENSG00000143933,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK2A,HGNC:1460,calcium/calmodulin dependent protein kinase II alpha,815,ENSG00000070808,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,7.1,Kd,CHEMBL
9607,CARTPT,CART prepropeptide,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
1012,CDH13,cadherin 13,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH13,HGNC:1753,cadherin 13,1012,ENSG00000140945,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDKN2A,HGNC:1787,cyclin dependent kinase inhibitor 2A,1029,ENSG00000147889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1103,CHAT,choline O-acetyltransferase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHAT,HGNC:1912,choline O-acetyltransferase,1103,ENSG00000070748,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1129,CHRM2,"cholinergic receptor, muscarinic 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM2,HGNC:1951,cholinergic receptor muscarinic 2,1129,ENSG00000181072,CHRM2,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,5.900000095,Ki,IUPHAR
1135,CHRNA2,"cholinergic receptor, nicotinic, alpha 2 (neuronal)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA2,HGNC:1956,cholinergic receptor nicotinic alpha 2 subunit,1135,ENSG00000120903,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,ACHA2_HUMAN,4.7212,Ki,WOMBAT-PK
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA4,HGNC:1958,cholinergic receptor nicotinic alpha 4 subunit,1137,ENSG00000101204,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,4.039999962,IC50,IUPHAR
8973,CHRNA6,"cholinergic receptor, nicotinic, alpha 6 (neuronal)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA6,HGNC:15963,cholinergic receptor nicotinic alpha 6 subunit,8973,ENSG00000147434,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,ACHA6_HUMAN,4.039999962,IC50,IUPHAR
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB3,HGNC:1963,cholinergic receptor nicotinic beta 3 subunit,1142,ENSG00000147432,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1240,CMKLR1,chemokine-like receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CMKLR1,HGNC:2121,chemerin chemokine-like receptor 1,1240,ENSG00000174600,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
1269,CNR2,cannabinoid receptor 2 (macrophage),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1270,CNTF,ciliary neurotrophic factor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTF,HGNC:2169,ciliary neurotrophic factor,1270,ENSG00000242689,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
4513,COX2,cytochrome c oxidase subunit II,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10815,CPLX1,complexin 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CPLX1,HGNC:2309,complexin 1,10815,ENSG00000168993,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10814,CPLX2,complexin 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CPLX2,HGNC:2310,complexin 2,10814,ENSG00000145920,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1385,CREB1,cAMP responsive element binding protein 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1395,CRHR2,corticotropin releasing hormone receptor 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR2,HGNC:2358,corticotropin releasing hormone receptor 2,1395,ENSG00000106113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1407,CRY1,cryptochrome circadian clock 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY1,HGNC:2384,cryptochrome circadian regulator 1,1407,ENSG00000008405,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1408,CRY2,cryptochrome circadian clock 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY2,HGNC:2385,cryptochrome circadian regulator 2,1408,ENSG00000121671,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114784,CSMD2,CUB and Sushi multiple domains 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSMD2,HGNC:19290,CUB and Sushi multiple domains 2,114784,ENSG00000121904,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C19,HGNC:2621,cytochrome P450 family 2 subfamily C member 19,1557,ENSG00000165841,CYP2C19,Cytochrome P450 2C19,Enzyme,CP2CJ_HUMAN,6,IC50,CHEMBL
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
267012,DAOA,D-amino acid oxidase activator,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
282706,DAOA-AS1,DAOA antisense RNA 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA-AS1,HGNC:30243,DAOA antisense RNA 1,282706,ENSG00000232307,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
10522,DEAF1,DEAF1 transcription factor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DEAF1,HGNC:14677,DEAF1 transcription factor,10522,ENSG00000177030,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54487,DGCR8,DGCR8 microprocessor complex subunit,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGCR8,HGNC:2847,DGCR8 microprocessor complex subunit,54487,ENSG00000128191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1607,DGKB,"diacylglycerol kinase, beta 90kDa",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGKB,HGNC:2850,diacylglycerol kinase beta,1607,ENSG00000136267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27185,DISC1,disrupted in schizophrenia 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27121,DKK4,dickkopf WNT signaling pathway inhibitor 4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DKK4,HGNC:2894,dickkopf WNT signaling pathway inhibitor 4,27121,ENSG00000104371,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1803,DPP4,dipeptidyl-peptidase 4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPP4,HGNC:3009,dipeptidyl peptidase 4,1803,ENSG00000197635,DPP4,Dipeptidyl peptidase 4,Enzyme,DPP4_HUMAN,4.54,IC50,CHEMBL
1808,DPYSL2,dihydropyrimidinase-like 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPYSL2,HGNC:3014,dihydropyrimidinase like 2,1808,ENSG00000092964,DPYSL2,Dihydropyrimidinase-related protein 2,Unclassified,DPYL2_HUMAN,0,0,WOMBAT-PK
1812,DRD1,dopamine receptor D1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD1,HGNC:3020,dopamine receptor D1,1812,ENSG00000184845,DRD1,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,5.339988779,Ki,DRUG MATRIX
1813,DRD2,dopamine receptor D2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
84062,DTNBP1,dystrobrevin binding protein 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1843,DUSP1,dual specificity phosphatase 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP1,HGNC:3064,dual specificity phosphatase 1,1843,ENSG00000120129,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1846,DUSP4,dual specificity phosphatase 4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP4,HGNC:3070,dual specificity phosphatase 4,1846,ENSG00000120875,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1848,DUSP6,dual specificity phosphatase 6,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP6,HGNC:3072,dual specificity phosphatase 6,1848,ENSG00000139318,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1960,EGR3,early growth response 3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR3,HGNC:3240,early growth response 3,1960,ENSG00000179388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB3,HGNC:3431,erb-b2 receptor tyrosine kinase 3,2065,ENSG00000065361,ERBB3,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,7.74,Kd,CHEMBL
2099,ESR1,estrogen receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
54738,FEV,FEV (ETS oncogene family),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEV,HGNC:18562,"FEV transcription factor, ETS family member",54738,ENSG00000163497,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8822,FGF17,fibroblast growth factor 17,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF17,HGNC:3673,fibroblast growth factor 17,8822,ENSG00000158815,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26281,FGF20,fibroblast growth factor 20,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF20,HGNC:3677,fibroblast growth factor 20,26281,ENSG00000078579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2260,FGFR1,fibroblast growth factor receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR1,HGNC:3688,fibroblast growth factor receptor 1,2260,ENSG00000077782,FGFR1,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,5.43,Kd,CHEMBL
2263,FGFR2,fibroblast growth factor receptor 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR2,HGNC:3689,fibroblast growth factor receptor 2,2263,ENSG00000066468,FGFR2,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,5.85,Kd,CHEMBL
2289,FKBP5,FK506 binding protein 5,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2346,FOLH1,folate hydrolase (prostate-specific membrane antigen) 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOLH1,HGNC:3788,folate hydrolase 1,2346,ENSG00000086205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOS,HGNC:3796,"Fos proto-oncogene, AP-1 transcription factor subunit",2353,ENSG00000170345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79068,FTO,fat mass and obesity associated,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FTO,HGNC:24678,FTO alpha-ketoglutarate dependent dioxygenase,79068,ENSG00000140718,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2556,GABRA3,"gamma-aminobutyric acid (GABA) A receptor, alpha 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA3,HGNC:4077,gamma-aminobutyric acid type A receptor subunit alpha3,2556,ENSG00000011677,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,GBRA3_HUMAN,6.789999962,Ki,CHEMBL
2559,GABRA6,"gamma-aminobutyric acid (GABA) A receptor, alpha 6",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA6,HGNC:4080,gamma-aminobutyric acid type A receptor subunit alpha6,2559,ENSG00000145863,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,GBRA6_HUMAN,6.29,IC50,WOMBAT-PK
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB3,HGNC:4083,gamma-aminobutyric acid type A receptor subunit beta3,2562,ENSG00000166206,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,9.05,IC50,CHEMBL
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51083,GAL,galanin/GMAP prepropeptide,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2596,GAP43,growth associated protein 43,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2688,GH1,growth hormone 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GH1,HGNC:4261,growth hormone 1,2688,ENSG00000259384,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2739,GLO1,glyoxalase I,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLO1,HGNC:4323,glyoxalase I,2739,ENSG00000124767,GLO1,Lactoylglutathione lyase,Enzyme,LGUL_HUMAN,4.89,Ki,CHEMBL
2752,GLUL,glutamate-ammonia ligase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2876,GPX1,glutathione peroxidase 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPX1,HGNC:4553,glutathione peroxidase 1,2876,ENSG00000233276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA1,HGNC:4571,glutamate ionotropic receptor AMPA type subunit 1,2890,ENSG00000155511,GRIA1,Glutamate receptor 1,Ion channel,GRIA1_HUMAN,5.7,EC50,CHEMBL
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA3,HGNC:4573,glutamate ionotropic receptor AMPA type subunit 3,2892,ENSG00000125675,GRIA3,Glutamate receptor 3,Ion channel,GRIA3_HUMAN,4.860000134,EC50,IUPHAR
2894,GRID1,"glutamate receptor, ionotropic, delta 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRID1,HGNC:4575,glutamate ionotropic receptor delta type subunit 1,2894,ENSG00000182771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2A,HGNC:4585,glutamate ionotropic receptor NMDA type subunit 2A,2903,ENSG00000183454,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,5.64,IC50,WOMBAT-PK
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2B,HGNC:4586,glutamate ionotropic receptor NMDA type subunit 2B,2904,ENSG00000273079,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,5.64,IC50,WOMBAT-PK
2911,GRM1,"glutamate receptor, metabotropic 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM1,HGNC:4593,glutamate metabotropic receptor 1,2911,ENSG00000152822,GRM1,Metabotropic glutamate receptor 1,GPCR,GRM1_HUMAN,6.05,Ki,WOMBAT-PK
2917,GRM7,"glutamate receptor, metabotropic 7",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
2896,GRN,granulin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRN,HGNC:4601,granulin precursor,2896,ENSG00000030582,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2925,GRPR,gastrin-releasing peptide receptor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRPR,HGNC:4609,gastrin releasing peptide receptor,2925,ENSG00000126010,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2932,GSK3B,glycogen synthase kinase 3 beta,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSK3B,HGNC:4617,glycogen synthase kinase 3 beta,2932,ENSG00000082701,GSK3B,Glycogen synthase kinase-3 beta,Kinase,GSK3B_HUMAN,4.57,IC50,CHEMBL
2944,GSTM1,glutathione S-transferase mu 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTM1,HGNC:4632,glutathione S-transferase mu 1,2944,ENSG00000134184,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2952,GSTT1,glutathione S-transferase theta 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTT1,HGNC:4641,glutathione S-transferase theta 1,2952,ENSG00000277656,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2973,GTS,Gilles de la Tourette syndrome,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GTS,HGNC:4671,Gilles de la Tourette syndrome,0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2996,GYPE,glycophorin E (MNS blood group),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GYPE,HGNC:4705,glycophorin E (MNS blood group),2996,ENSG00000197465,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCN1,HGNC:4845,hyperpolarization activated cyclic nucleotide gated potassium channel 1,348980,ENSG00000164588,HCN1,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,HCN1_HUMAN,5.799999714,IC50,IUPHAR
3060,HCRT,hypocretin (orexin) neuropeptide precursor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRT,HGNC:4847,hypocretin neuropeptide precursor,3060,ENSG00000161610,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3061,HCRTR1,hypocretin (orexin) receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRTR1,HGNC:4848,hypocretin receptor 1,3061,ENSG00000121764,HCRTR1,Orexin receptor type 1,GPCR,OX1R_HUMAN,9.259636879,Ki,SCIENTIFIC LITERATURE
3066,HDAC2,histone deacetylase 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC2,HGNC:4853,histone deacetylase 2,3066,ENSG00000196591,HDAC2,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,4.19,IC50,CHEMBL
9759,HDAC4,histone deacetylase 4,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC4,HGNC:14063,histone deacetylase 4,9759,ENSG00000068024,HDAC4,Histone deacetylase 4,Enzyme,HDAC4_HUMAN,6.2924,IC50,WOMBAT-PK
10014,HDAC5,histone deacetylase 5,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC5,HGNC:14068,histone deacetylase 5,10014,ENSG00000108840,HDAC5,Histone deacetylase 5,Enzyme,HDAC5_HUMAN,6.260000229,Ki,IUPHAR
10013,HDAC6,histone deacetylase 6,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC6,HGNC:14064,histone deacetylase 6,10013,ENSG00000094631,HDAC6,Histone deacetylase 6,Enzyme,HDAC6_HUMAN,4.84,IC50,CHEMBL
9734,HDAC9,histone deacetylase 9,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC9,HGNC:14065,histone deacetylase 9,9734,ENSG00000048052,HDAC9,Histone deacetylase 9,Enzyme,HDAC9_HUMAN,5.960000038,Ki,IUPHAR
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HIF1A,HGNC:4910,hypoxia inducible factor 1 subunit alpha,3091,ENSG00000100644,HIF1A,Hypoxia-inducible factor 1-alpha,Transcription factor,HIF1A_HUMAN,4.75,EC50,CHEMBL
9456,HOMER1,homer homolog 1 (Drosophila),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3240,HP,haptoglobin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP,HGNC:5141,haptoglobin,3240,ENSG00000257017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSD11B1,HGNC:5208,hydroxysteroid 11-beta dehydrogenase 1,3290,ENSG00000117594,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,DHI1_HUMAN,6.1,IC50,CHEMBL
3297,HSF1,heat shock transcription factor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSF1,HGNC:5224,heat shock transcription factor 1,3297,ENSG00000185122,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR7,HGNC:5302,5-hydroxytryptamine receptor 7,3363,ENSG00000148680,HTR7,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,7.93930216,Ki,PDSP
3064,HTT,huntingtin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTT,HGNC:4851,huntingtin,3064,ENSG00000197386,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3620,IDO1,"indoleamine 2,3-dioxygenase 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IDO1,HGNC:6059,"indoleamine 2,3-dioxygenase 1",3620,ENSG00000131203,IDO1,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_HUMAN,4.639999866,IC50,CHEMBL
3458,IFNG,"interferon, gamma",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
3479,IGF1,insulin-like growth factor 1 (somatomedin C),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF1,HGNC:5464,insulin like growth factor 1,3479,ENSG00000017427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3606,IL18,interleukin 18,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL18,HGNC:5986,interleukin 18,3606,ENSG00000150782,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3552,IL1A,"interleukin 1, alpha",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1A,HGNC:5991,interleukin 1 alpha,3552,ENSG00000115008,IL1A,Interleukin-1 alpha,Cytokine,IL1A_HUMAN,11.8538723,Kd,DRUG LABEL
3553,IL1B,"interleukin 1, beta",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
3569,IL6,interleukin 6,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
3570,IL6R,interleukin 6 receptor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6R,HGNC:6019,interleukin 6 receptor,3570,ENSG00000160712,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPA2,HGNC:6051,inositol monophosphatase 2,3613,ENSG00000141401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3763,KCNJ6,"potassium channel, inwardly rectifying subfamily J, member 6",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNJ6,HGNC:6267,potassium inwardly rectifying channel subfamily J member 6,3763,ENSG00000157542,KCNJ6,G protein-activated inward rectifier potassium channel 2,Ion channel,KCNJ6_HUMAN,4.2823,IC50,WOMBAT-PK
3776,KCNK2,"potassium channel, two pore domain subfamily K, member 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNK2,HGNC:6277,potassium two pore domain channel subfamily K member 2,3776,ENSG00000082482,KCNK2,Potassium channel subfamily K member 2,Ion channel,KCNK2_HUMAN,6.4,IC50,CHEMBL
3939,LDHA,lactate dehydrogenase A,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LDHA,HGNC:6535,lactate dehydrogenase A,3939,ENSG00000134333,LDHA,L-lactate dehydrogenase A chain,Enzyme,LDHA_HUMAN,3.19,Kd,CHEMBL
3952,LEP,leptin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9211,LGI1,"leucine-rich, glioma inactivated 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LGI1,HGNC:6572,leucine rich glioma inactivated 1,9211,ENSG00000108231,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3976,LIF,leukemia inhibitory factor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LIF,HGNC:6596,LIF interleukin 6 family cytokine,3976,ENSG00000128342,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4048,LTA4H,leukotriene A4 hydrolase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LTA4H,HGNC:6710,leukotriene A4 hydrolase,4048,ENSG00000111144,LTA4H,Leukotriene A-4 hydrolase,Enzyme,LKHA4_HUMAN,7.15,IC50,CHEMBL
4074,M6PR,mannose-6-phosphate receptor (cation dependent),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,M6PR,HGNC:6752,"mannose-6-phosphate receptor, cation dependent",4074,ENSG00000003056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
5595,MAPK3,mitogen-activated protein kinase 3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK3,HGNC:6877,mitogen-activated protein kinase 3,5595,ENSG00000102882,MAPK3,Mitogen-activated protein kinase 3,Kinase,MK03_HUMAN,5.213177621,IC50,DRUG MATRIX
5599,MAPK8,mitogen-activated protein kinase 8,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK8,HGNC:6881,mitogen-activated protein kinase 8,5599,ENSG00000107643,MAPK8,Mitogen-activated protein kinase 8,Kinase,MK08_HUMAN,5.49,Kd,CHEMBL
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC1R,HGNC:6929,melanocortin 1 receptor,4157,ENSG00000258839,MC1R,Melanocyte-stimulating hormone receptor,GPCR,MSHR_HUMAN,10,IC50,IUPHAR
4160,MC4R,melanocortin 4 receptor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC4R,HGNC:6932,melanocortin 4 receptor,4160,ENSG00000166603,MC4R,Melanocortin receptor 4,GPCR,MC4R_HUMAN,4.878571482,Ki,DRUG MATRIX
2847,MCHR1,melanin-concentrating hormone receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR1,HGNC:4479,melanin concentrating hormone receptor 1,2847,ENSG00000128285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTR,HGNC:7468,5-methyltetrahydrofolate-homocysteine methyltransferase,4548,ENSG00000116984,MTR,Methionine synthase,Enzyme,METH_HUMAN,0,0,WOMBAT-PK
4684,NCAM1,neural cell adhesion molecule 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4741,NEFM,"neurofilament, medium polypeptide",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFM,HGNC:7734,neurofilament medium,4741,ENSG00000104722,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4803,NGF,nerve growth factor (beta polypeptide),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NGF,HGNC:7808,nerve growth factor,4803,ENSG00000134259,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4804,NGFR,nerve growth factor receptor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NGFR,HGNC:7809,nerve growth factor receptor,4804,ENSG00000064300,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4843,NOS2,"nitric oxide synthase 2, inducible",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOS2,HGNC:7873,nitric oxide synthase 2,4843,ENSG00000007171,NOS2,"Nitric oxide synthase, inducible",Enzyme,NOS2_HUMAN,4.85,IC50,CHEMBL
4846,NOS3,nitric oxide synthase 3 (endothelial cell),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOS3,HGNC:7876,nitric oxide synthase 3,4846,ENSG00000164867,NOS3,"Nitric oxide synthase, endothelial",Enzyme,NOS3_HUMAN,5.06,IC50,CHEMBL
4862,NPAS2,neuronal PAS domain protein 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS2,HGNC:7895,neuronal PAS domain protein 2,4862,ENSG00000170485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
594857,NPS,neuropeptide S,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPS,HGNC:33940,neuropeptide S,594857,ENSG00000214285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
387129,NPSR1,neuropeptide S receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPSR1,HGNC:23631,neuropeptide S receptor 1,387129,ENSG00000187258,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
3084,NRG1,neuregulin 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG1,HGNC:7997,neuregulin 1,3084,ENSG00000157168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9378,NRXN1,neurexin 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN1,HGNC:8008,neurexin 1,9378,ENSG00000179915,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4922,NTS,neurotensin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTS,HGNC:8038,neurotensin,4922,ENSG00000133636,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4939,OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OAS2,HGNC:8087,2'-5'-oligoadenylate synthetase 2,4939,ENSG00000111335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4986,OPRK1,"opioid receptor, kappa 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
125958,OR7D4,"olfactory receptor, family 7, subfamily D, member 4",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OR7D4,HGNC:8380,olfactory receptor family 7 subfamily D member 4,125958,ENSG00000174667,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5020,OXT,oxytocin/neurophysin I prepropeptide,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
5021,OXTR,oxytocin receptor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXTR,HGNC:8529,oxytocin receptor,5021,ENSG00000180914,OXTR,Oxytocin receptor,GPCR,OXYR_HUMAN,8.148741722,Ki,SCIENTIFIC LITERATURE
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,P2RX7,HGNC:8537,purinergic receptor P2X 7,5027,ENSG00000089041,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27445,PCLO,piccolo presynaptic cytomatrix protein,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCLO,HGNC:13406,piccolo presynaptic cytomatrix protein,27445,ENSG00000186472,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5153,PDE1B,"phosphodiesterase 1B, calmodulin-dependent",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE1B,HGNC:8775,phosphodiesterase 1B,5153,ENSG00000123360,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5141,PDE4A,"phosphodiesterase 4A, cAMP-specific",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4A,HGNC:8780,phosphodiesterase 4A,5141,ENSG00000065989,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,5.976336082,IC50,DRUG MATRIX
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4B,HGNC:8781,phosphodiesterase 4B,5142,ENSG00000184588,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,PDE4B_HUMAN,0,0,WOMBAT-PK
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4D,HGNC:8783,phosphodiesterase 4D,5144,ENSG00000113448,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,PDE4D_HUMAN,6.78,IC50,CHEMBL
5173,PDYN,prodynorphin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5179,PENK,proenkephalin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PENK,HGNC:8831,proenkephalin,5179,ENSG00000181195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8864,PER2,period circadian clock 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8863,PER3,period circadian clock 3,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER3,HGNC:8847,period circadian regulator 3,8863,ENSG00000049246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51555,PEX5L,peroxisomal biogenesis factor 5-like,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEX5L,HGNC:30024,peroxisomal biogenesis factor 5 like,51555,ENSG00000114757,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKFB3,HGNC:8874,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",5209,ENSG00000170525,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5367,PMCH,pro-melanin-concentrating hormone,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PMCH,HGNC:9109,pro-melanin concentrating hormone,5367,ENSG00000183395,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5368,PNOC,prepronociceptin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PNOC,HGNC:9163,prepronociceptin,5368,ENSG00000168081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5443,POMC,proopiomelanocortin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POMC,HGNC:9201,proopiomelanocortin,5443,ENSG00000115138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP1R1B,HGNC:9287,protein phosphatase 1 regulatory inhibitor subunit 1B,84152,ENSG00000131771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5533,PPP3CC,"protein phosphatase 3, catalytic subunit, gamma isozyme",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP3CC,HGNC:9316,protein phosphatase 3 catalytic subunit gamma,5533,ENSG00000120910,PPP3CC,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,0,0,WOMBAT-PK
5584,PRKCI,"protein kinase C, iota",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCI,HGNC:9404,protein kinase C iota,5584,ENSG00000163558,PRKCI,Protein kinase C iota type,Kinase,KPCI_HUMAN,5.85,Kd,CHEMBL
5663,PSEN1,presenilin 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSEN1,HGNC:9508,presenilin 1,5663,ENSG00000080815,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
5697,PYY,peptide YY,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PYY,HGNC:9748,peptide YY,5697,ENSG00000131096,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAC1,HGNC:9801,Rac family small GTPase 1,5879,ENSG00000136238,RAC1,Ras-related C3 botulinum toxin substrate 1,Unclassified,RAC1_HUMAN,0,0,WOMBAT-PK
5649,RELN,reelin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELN,HGNC:9957,reelin,5649,ENSG00000189056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5972,REN,renin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REN,HGNC:9958,renin,5972,ENSG00000143839,REN,Renin,Enzyme,RENI_HUMAN,9.22,IC50,WOMBAT-PK
63891,RNF123,ring finger protein 123,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNF123,HGNC:21148,ring finger protein 123,63891,ENSG00000164068,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6095,RORA,RAR-related orphan receptor A,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RORA,HGNC:10258,RAR related orphan receptor A,6095,ENSG00000069667,RORA,Nuclear receptor ROR-alpha,Nuclear hormone receptor,RORA_HUMAN,9,EC50,WOMBAT-PK
6281,S100A10,S100 calcium binding protein A10,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
866,SERPINA6,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINA6,HGNC:1540,serpin family A member 6,866,ENSG00000170099,SERPINA6,Corticosteroid-binding globulin,Secreted,CBG_HUMAN,6.28,Ki,CHEMBL
6422,SFRP1,secreted frizzled-related protein 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SFRP1,HGNC:10776,secreted frizzled related protein 1,6422,ENSG00000104332,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8910,SGCE,"sarcoglycan, epsilon",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SGCE,HGNC:10808,sarcoglycan epsilon,8910,ENSG00000127990,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6570,SLC18A1,"solute carrier family 18 (vesicular monoamine transporter), member 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A1,HGNC:10934,solute carrier family 18 member A1,6570,ENSG00000036565,SLC18A1,Chromaffin granule amine transporter,Transporter,VMAT1_HUMAN,5.8,Ki,IUPHAR
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A1,HGNC:10939,solute carrier family 1 member 1,6505,ENSG00000106688,SLC1A1,Excitatory amino acid transporter 3,Transporter,EAA3_HUMAN,7.289999962,Ki,CHEMBL
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A2,HGNC:10940,solute carrier family 1 member 2,6506,ENSG00000110436,SLC1A2,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,4.210000038,Ki,CHEMBL
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC29A3,HGNC:23096,solute carrier family 29 member 3,55315,ENSG00000198246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A1,HGNC:11042,solute carrier family 6 member 1,6529,ENSG00000157103,SLC6A1,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_HUMAN,0,0,WOMBAT-PK
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
53919,SLCO1C1,"solute carrier organic anion transporter family, member 1C1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLCO1C1,HGNC:13819,solute carrier organic anion transporter family member 1C1,53919,ENSG00000139155,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6616,SNAP25,"synaptosomal-associated protein, 25kDa",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNAP25,HGNC:11132,synaptosome associated protein 25,6616,ENSG00000132639,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6647,SOD1,"superoxide dismutase 1, soluble",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD1,HGNC:11179,superoxide dismutase 1,6647,ENSG00000142168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6648,SOD2,"superoxide dismutase 2, mitochondrial",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD2,HGNC:11180,superoxide dismutase 2,6648,ENSG00000112096,SOD2,"Superoxide dismutase [Mn], mitochondrial",Enzyme,SODM_HUMAN,0,0,WOMBAT-PK
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A1,HGNC:11284,steroid 5 alpha-reductase 1,6715,ENSG00000145545,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,8.49,IC50,WOMBAT-PK
3925,STMN1,stathmin 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STMN1,HGNC:6510,stathmin 1,3925,ENSG00000117632,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6853,SYN1,synapsin I,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYN1,HGNC:11494,synapsin I,6853,ENSG00000008056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6863,TAC1,"tachykinin, precursor 1",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAC1,HGNC:11517,tachykinin precursor 1,6863,ENSG00000006128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6869,TACR1,tachykinin receptor 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR1,HGNC:11526,tachykinin receptor 1,6869,ENSG00000115353,TACR1,Substance-P receptor,GPCR,NK1R_HUMAN,10.7,Ki,CHEMBL
9095,TBX19,T-box 19,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX19,HGNC:11596,T-box transcription factor 19,9095,ENSG00000143178,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
8914,TIMELESS,timeless circadian clock,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TIMELESS,HGNC:11813,timeless circadian regulator,8914,ENSG00000111602,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7088,TLE1,"transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLE1,HGNC:11837,"TLE family member 1, transcriptional corepressor",7088,ENSG00000196781,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7124,TNF,tumor necrosis factor,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNF,HGNC:11892,tumor necrosis factor,7124,ENSG00000232810,TNF,Tumor necrosis factor,Cytokine,TNFA_HUMAN,8,IC50,WOMBAT-PK
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1A,HGNC:11916,TNF receptor superfamily member 1A,7132,ENSG00000067182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1B,HGNC:11917,TNF receptor superfamily member 1B,7133,ENSG00000028137,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
121278,TPH2,tryptophan hydroxylase 2,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7200,TRH,thyrotropin-releasing hormone,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRH,HGNC:12298,thyrotropin releasing hormone,7200,ENSG00000170893,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7276,TTR,transthyretin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TTR,HGNC:12405,transthyretin,7276,ENSG00000118271,TTR,Transthyretin,Secreted,TTHY_HUMAN,5.92,Kd,CHEMBL
7349,UCN,urocortin,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UCN,HGNC:12516,urocortin,7349,ENSG00000163794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7422,VEGFA,vascular endothelial growth factor A,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
7425,VGF,VGF nerve growth factor inducible,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VGF,HGNC:12684,VGF nerve growth factor inducible,7425,ENSG00000128564,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7466,WFS1,Wolfram syndrome 1 (wolframin),C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WFS1,HGNC:12762,wolframin ER transmembrane glycoprotein,7466,ENSG00000109501,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23286,WWC1,WW and C2 domain containing 1,C0011570,mental depression,Depressive disorders,C0011570,Mental Depression,disease,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WWC1,HGNC:29435,WW and C2 domain containing 1,23286,ENSG00000113645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
351,APP,amyloid beta (A4) precursor protein,C0011573,endogenous depression,Depressive disorders,C0011573,Endogenous depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APP,HGNC:620,amyloid beta precursor protein,351,ENSG00000142192,APP,Amyloid beta A4 protein,Unclassified,A4_HUMAN,4.52,IC50,CHEMBL
1387,CREBBP,CREB binding protein,C0011573,endogenous depression,Depressive disorders,C0011573,Endogenous depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREBBP,HGNC:2348,CREB binding protein,1387,ENSG00000005339,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2778,GNAS,GNAS complex locus,C0011573,endogenous depression,Depressive disorders,C0011573,Endogenous depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNAS,HGNC:4392,GNAS complex locus,2778,ENSG00000087460,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5134,PDCD2,programmed cell death 2,C0011573,endogenous depression,Depressive disorders,C0011573,Endogenous depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDCD2,HGNC:8762,programmed cell death 2,5134,ENSG00000071994,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10016,PDCD6,programmed cell death 6,C0011573,endogenous depression,Depressive disorders,C0011573,Endogenous depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDCD6,HGNC:8765,programmed cell death 6,10016,ENSG00000249915,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2,A2M,alpha-2-macroglobulin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,A2M,HGNC:7,alpha-2-macroglobulin,2,ENSG00000175899,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
15,AANAT,aralkylamine N-acetyltransferase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AANAT,HGNC:19,aralkylamine N-acetyltransferase,15,ENSG00000129673,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
1636,ACE,angiotensin I converting enzyme,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
389036,ACT,actin-like protein (ACT) gene,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
111,ADCY5,adenylate cyclase 5,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY5,HGNC:236,adenylate cyclase 5,111,ENSG00000173175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
113,ADCY7,adenylate cyclase 7,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY7,HGNC:238,adenylate cyclase 7,113,ENSG00000121281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114,ADCY8,adenylate cyclase 8 (brain),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY8,HGNC:239,adenylate cyclase 8,114,ENSG00000155897,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1,HGNC:241,adenylate cyclase activating polypeptide 1,116,ENSG00000141433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
117,ADCYAP1R1,adenylate cyclase activating polypeptide 1 (pituitary) receptor type I,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1R1,HGNC:242,ADCYAP receptor type I,117,ENSG00000078549,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
150,ADRA2A,adrenoceptor alpha 2A,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2A,HGNC:281,adrenoceptor alpha 2A,150,ENSG00000150594,ADRA2A,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,6.3,IC50,WOMBAT-PK
153,ADRB1,adrenoceptor beta 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB1,HGNC:285,adrenoceptor beta 1,153,ENSG00000043591,ADRB1,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,0,0,DRUGBANK
156,ADRBK1,"adrenergic, beta, receptor kinase 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26523,AGO1,argonaute RISC catalytic component 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGO1,HGNC:3262,argonaute RISC component 1,26523,ENSG00000092847,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGT,HGNC:333,angiotensinogen,183,ENSG00000135744,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKT1,HGNC:391,AKT serine/threonine kinase 1,207,ENSG00000142208,AKT1,RAC-alpha serine/threonine-protein kinase,Kinase,AKT1_HUMAN,5.02,IC50,CHEMBL
79053,ALG8,"ALG8, alpha-1,3-glucosyltransferase",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALG8,HGNC:23161,"ALG8 alpha-1,3-glucosyltransferase",79053,ENSG00000159063,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
238,ALK,anaplastic lymphoma receptor tyrosine kinase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALK,HGNC:427,ALK receptor tyrosine kinase,238,ENSG00000171094,ALK,ALK tyrosine kinase receptor,Kinase,ALK_HUMAN,5.92,Kd,CHEMBL
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
351,APP,amyloid beta (A4) precursor protein,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APP,HGNC:620,amyloid beta precursor protein,351,ENSG00000142192,APP,Amyloid beta A4 protein,Unclassified,A4_HUMAN,4.52,IC50,CHEMBL
353,APRT,adenine phosphoribosyltransferase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APRT,HGNC:626,adenine phosphoribosyltransferase,353,ENSG00000198931,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
361,AQP4,aquaporin 4,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AQP4,HGNC:637,aquaporin 4,361,ENSG00000171885,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
367,AR,androgen receptor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
9639,ARHGEF10,Rho guanine nucleotide exchange factor (GEF) 10,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGEF10,HGNC:14103,Rho guanine nucleotide exchange factor 10,9639,ENSG00000104728,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL,HGNC:701,aryl hydrocarbon receptor nuclear translocator like,406,ENSG00000133794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
409,ARRB2,"arrestin, beta 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB2,HGNC:712,arrestin beta 2,409,ENSG00000141480,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9048,ARTN,artemin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARTN,HGNC:727,artemin,9048,ENSG00000117407,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
438,ASMT,acetylserotonin O-methyltransferase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASMT,HGNC:750,acetylserotonin O-methyltransferase,438,ENSG00000196433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
467,ATF3,activating transcription factor 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF3,HGNC:785,activating transcription factor 3,467,ENSG00000162772,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
468,ATF4,activating transcription factor 4,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF4,HGNC:786,activating transcription factor 4,468,ENSG00000128272,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP1A3,HGNC:801,ATPase Na+/K+ transporting subunit alpha 3,478,ENSG00000105409,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP2A2,HGNC:812,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,488,ENSG00000174437,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4287,ATXN3,ataxin 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATXN3,HGNC:7106,ataxin 3,4287,ENSG00000066427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
573,BAG1,BCL2-associated athanogene,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BAG1,HGNC:937,BAG cochaperone 1,573,ENSG00000107262,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
596,BCL2,B-cell CLL/lymphoma 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL2,HGNC:990,BCL2 apoptosis regulator,596,ENSG00000171791,BCL2,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,4.22,Kd,CHEMBL
627,BDNF,brain-derived neurotrophic factor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80114,BICC1,BicC family RNA binding protein 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BICC1,HGNC:19351,BicC family RNA binding protein 1,80114,ENSG00000122870,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
672,BRCA1,"breast cancer 1, early onset",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRCA1,HGNC:1100,BRCA1 DNA repair associated,672,ENSG00000012048,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALM2,HGNC:1445,calmodulin 2,805,ENSG00000143933,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK2A,HGNC:1460,calcium/calmodulin dependent protein kinase II alpha,815,ENSG00000070808,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,7.1,Kd,CHEMBL
9607,CARTPT,CART prepropeptide,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
1012,CDH13,cadherin 13,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH13,HGNC:1753,cadherin 13,1012,ENSG00000140945,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDKN2A,HGNC:1787,cyclin dependent kinase inhibitor 2A,1029,ENSG00000147889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1103,CHAT,choline O-acetyltransferase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHAT,HGNC:1912,choline O-acetyltransferase,1103,ENSG00000070748,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1129,CHRM2,"cholinergic receptor, muscarinic 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM2,HGNC:1951,cholinergic receptor muscarinic 2,1129,ENSG00000181072,CHRM2,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,5.900000095,Ki,IUPHAR
1135,CHRNA2,"cholinergic receptor, nicotinic, alpha 2 (neuronal)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA2,HGNC:1956,cholinergic receptor nicotinic alpha 2 subunit,1135,ENSG00000120903,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,ACHA2_HUMAN,4.7212,Ki,WOMBAT-PK
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA4,HGNC:1958,cholinergic receptor nicotinic alpha 4 subunit,1137,ENSG00000101204,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,4.039999962,IC50,IUPHAR
8973,CHRNA6,"cholinergic receptor, nicotinic, alpha 6 (neuronal)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA6,HGNC:15963,cholinergic receptor nicotinic alpha 6 subunit,8973,ENSG00000147434,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,ACHA6_HUMAN,4.039999962,IC50,IUPHAR
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB3,HGNC:1963,cholinergic receptor nicotinic beta 3 subunit,1142,ENSG00000147432,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1240,CMKLR1,chemokine-like receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CMKLR1,HGNC:2121,chemerin chemokine-like receptor 1,1240,ENSG00000174600,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
1269,CNR2,cannabinoid receptor 2 (macrophage),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1270,CNTF,ciliary neurotrophic factor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTF,HGNC:2169,ciliary neurotrophic factor,1270,ENSG00000242689,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
4513,COX2,cytochrome c oxidase subunit II,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10815,CPLX1,complexin 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CPLX1,HGNC:2309,complexin 1,10815,ENSG00000168993,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10814,CPLX2,complexin 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CPLX2,HGNC:2310,complexin 2,10814,ENSG00000145920,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1385,CREB1,cAMP responsive element binding protein 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1395,CRHR2,corticotropin releasing hormone receptor 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR2,HGNC:2358,corticotropin releasing hormone receptor 2,1395,ENSG00000106113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1407,CRY1,cryptochrome circadian clock 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY1,HGNC:2384,cryptochrome circadian regulator 1,1407,ENSG00000008405,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1408,CRY2,cryptochrome circadian clock 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY2,HGNC:2385,cryptochrome circadian regulator 2,1408,ENSG00000121671,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114784,CSMD2,CUB and Sushi multiple domains 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSMD2,HGNC:19290,CUB and Sushi multiple domains 2,114784,ENSG00000121904,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C19,HGNC:2621,cytochrome P450 family 2 subfamily C member 19,1557,ENSG00000165841,CYP2C19,Cytochrome P450 2C19,Enzyme,CP2CJ_HUMAN,6,IC50,CHEMBL
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
267012,DAOA,D-amino acid oxidase activator,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
282706,DAOA-AS1,DAOA antisense RNA 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA-AS1,HGNC:30243,DAOA antisense RNA 1,282706,ENSG00000232307,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
140947,DCANP1,dendritic cell-associated nuclear protein,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCANP1,HGNC:24459,dendritic cell associated nuclear protein,140947,ENSG00000251380,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10522,DEAF1,DEAF1 transcription factor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DEAF1,HGNC:14677,DEAF1 transcription factor,10522,ENSG00000177030,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54487,DGCR8,DGCR8 microprocessor complex subunit,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGCR8,HGNC:2847,DGCR8 microprocessor complex subunit,54487,ENSG00000128191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1607,DGKB,"diacylglycerol kinase, beta 90kDa",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGKB,HGNC:2850,diacylglycerol kinase beta,1607,ENSG00000136267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27185,DISC1,disrupted in schizophrenia 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27121,DKK4,dickkopf WNT signaling pathway inhibitor 4,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DKK4,HGNC:2894,dickkopf WNT signaling pathway inhibitor 4,27121,ENSG00000104371,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1803,DPP4,dipeptidyl-peptidase 4,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPP4,HGNC:3009,dipeptidyl peptidase 4,1803,ENSG00000197635,DPP4,Dipeptidyl peptidase 4,Enzyme,DPP4_HUMAN,4.54,IC50,CHEMBL
1808,DPYSL2,dihydropyrimidinase-like 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPYSL2,HGNC:3014,dihydropyrimidinase like 2,1808,ENSG00000092964,DPYSL2,Dihydropyrimidinase-related protein 2,Unclassified,DPYL2_HUMAN,0,0,WOMBAT-PK
1812,DRD1,dopamine receptor D1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD1,HGNC:3020,dopamine receptor D1,1812,ENSG00000184845,DRD1,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,5.339988779,Ki,DRUG MATRIX
1813,DRD2,dopamine receptor D2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
84062,DTNBP1,dystrobrevin binding protein 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1843,DUSP1,dual specificity phosphatase 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP1,HGNC:3064,dual specificity phosphatase 1,1843,ENSG00000120129,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1846,DUSP4,dual specificity phosphatase 4,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP4,HGNC:3070,dual specificity phosphatase 4,1846,ENSG00000120875,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1848,DUSP6,dual specificity phosphatase 6,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP6,HGNC:3072,dual specificity phosphatase 6,1848,ENSG00000139318,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1960,EGR3,early growth response 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR3,HGNC:3240,early growth response 3,1960,ENSG00000179388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2099,ESR1,estrogen receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
54738,FEV,FEV (ETS oncogene family),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEV,HGNC:18562,"FEV transcription factor, ETS family member",54738,ENSG00000163497,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8822,FGF17,fibroblast growth factor 17,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF17,HGNC:3673,fibroblast growth factor 17,8822,ENSG00000158815,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26281,FGF20,fibroblast growth factor 20,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF20,HGNC:3677,fibroblast growth factor 20,26281,ENSG00000078579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2260,FGFR1,fibroblast growth factor receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR1,HGNC:3688,fibroblast growth factor receptor 1,2260,ENSG00000077782,FGFR1,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,5.43,Kd,CHEMBL
2263,FGFR2,fibroblast growth factor receptor 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR2,HGNC:3689,fibroblast growth factor receptor 2,2263,ENSG00000066468,FGFR2,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,5.85,Kd,CHEMBL
2289,FKBP5,FK506 binding protein 5,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2346,FOLH1,folate hydrolase (prostate-specific membrane antigen) 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOLH1,HGNC:3788,folate hydrolase 1,2346,ENSG00000086205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOS,HGNC:3796,"Fos proto-oncogene, AP-1 transcription factor subunit",2353,ENSG00000170345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79068,FTO,fat mass and obesity associated,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FTO,HGNC:24678,FTO alpha-ketoglutarate dependent dioxygenase,79068,ENSG00000140718,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2551,GABPA,"GA binding protein transcription factor, alpha subunit 60kDa",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABPA,HGNC:4071,GA binding protein transcription factor subunit alpha,2551,ENSG00000154727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2556,GABRA3,"gamma-aminobutyric acid (GABA) A receptor, alpha 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA3,HGNC:4077,gamma-aminobutyric acid type A receptor subunit alpha3,2556,ENSG00000011677,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,GBRA3_HUMAN,6.789999962,Ki,CHEMBL
2559,GABRA6,"gamma-aminobutyric acid (GABA) A receptor, alpha 6",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA6,HGNC:4080,gamma-aminobutyric acid type A receptor subunit alpha6,2559,ENSG00000145863,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,GBRA6_HUMAN,6.29,IC50,WOMBAT-PK
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB3,HGNC:4083,gamma-aminobutyric acid type A receptor subunit beta3,2562,ENSG00000166206,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,9.05,IC50,CHEMBL
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51083,GAL,galanin/GMAP prepropeptide,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8811,GALR2,galanin receptor 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR2,HGNC:4133,galanin receptor 2,8811,ENSG00000182687,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2596,GAP43,growth associated protein 43,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2688,GH1,growth hormone 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GH1,HGNC:4261,growth hormone 1,2688,ENSG00000259384,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2739,GLO1,glyoxalase I,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLO1,HGNC:4323,glyoxalase I,2739,ENSG00000124767,GLO1,Lactoylglutathione lyase,Enzyme,LGUL_HUMAN,4.89,Ki,CHEMBL
2752,GLUL,glutamate-ammonia ligase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2876,GPX1,glutathione peroxidase 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPX1,HGNC:4553,glutathione peroxidase 1,2876,ENSG00000233276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA1,HGNC:4571,glutamate ionotropic receptor AMPA type subunit 1,2890,ENSG00000155511,GRIA1,Glutamate receptor 1,Ion channel,GRIA1_HUMAN,5.7,EC50,CHEMBL
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA3,HGNC:4573,glutamate ionotropic receptor AMPA type subunit 3,2892,ENSG00000125675,GRIA3,Glutamate receptor 3,Ion channel,GRIA3_HUMAN,4.860000134,EC50,IUPHAR
2894,GRID1,"glutamate receptor, ionotropic, delta 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRID1,HGNC:4575,glutamate ionotropic receptor delta type subunit 1,2894,ENSG00000182771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2A,HGNC:4585,glutamate ionotropic receptor NMDA type subunit 2A,2903,ENSG00000183454,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,5.64,IC50,WOMBAT-PK
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2B,HGNC:4586,glutamate ionotropic receptor NMDA type subunit 2B,2904,ENSG00000273079,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,5.64,IC50,WOMBAT-PK
2911,GRM1,"glutamate receptor, metabotropic 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM1,HGNC:4593,glutamate metabotropic receptor 1,2911,ENSG00000152822,GRM1,Metabotropic glutamate receptor 1,GPCR,GRM1_HUMAN,6.05,Ki,WOMBAT-PK
2917,GRM7,"glutamate receptor, metabotropic 7",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
2896,GRN,granulin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRN,HGNC:4601,granulin precursor,2896,ENSG00000030582,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2925,GRPR,gastrin-releasing peptide receptor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRPR,HGNC:4609,gastrin releasing peptide receptor,2925,ENSG00000126010,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2932,GSK3B,glycogen synthase kinase 3 beta,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSK3B,HGNC:4617,glycogen synthase kinase 3 beta,2932,ENSG00000082701,GSK3B,Glycogen synthase kinase-3 beta,Kinase,GSK3B_HUMAN,4.57,IC50,CHEMBL
2944,GSTM1,glutathione S-transferase mu 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTM1,HGNC:4632,glutathione S-transferase mu 1,2944,ENSG00000134184,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2952,GSTT1,glutathione S-transferase theta 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTT1,HGNC:4641,glutathione S-transferase theta 1,2952,ENSG00000277656,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2973,GTS,Gilles de la Tourette syndrome,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GTS,HGNC:4671,Gilles de la Tourette syndrome,0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2996,GYPE,glycophorin E (MNS blood group),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GYPE,HGNC:4705,glycophorin E (MNS blood group),2996,ENSG00000197465,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCN1,HGNC:4845,hyperpolarization activated cyclic nucleotide gated potassium channel 1,348980,ENSG00000164588,HCN1,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,HCN1_HUMAN,5.799999714,IC50,IUPHAR
3060,HCRT,hypocretin (orexin) neuropeptide precursor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRT,HGNC:4847,hypocretin neuropeptide precursor,3060,ENSG00000161610,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3061,HCRTR1,hypocretin (orexin) receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRTR1,HGNC:4848,hypocretin receptor 1,3061,ENSG00000121764,HCRTR1,Orexin receptor type 1,GPCR,OX1R_HUMAN,9.259636879,Ki,SCIENTIFIC LITERATURE
10014,HDAC5,histone deacetylase 5,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC5,HGNC:14068,histone deacetylase 5,10014,ENSG00000108840,HDAC5,Histone deacetylase 5,Enzyme,HDAC5_HUMAN,6.260000229,Ki,IUPHAR
10013,HDAC6,histone deacetylase 6,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC6,HGNC:14064,histone deacetylase 6,10013,ENSG00000094631,HDAC6,Histone deacetylase 6,Enzyme,HDAC6_HUMAN,4.84,IC50,CHEMBL
9734,HDAC9,histone deacetylase 9,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC9,HGNC:14065,histone deacetylase 9,9734,ENSG00000048052,HDAC9,Histone deacetylase 9,Enzyme,HDAC9_HUMAN,5.960000038,Ki,IUPHAR
9456,HOMER1,homer homolog 1 (Drosophila),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3240,HP,haptoglobin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP,HGNC:5141,haptoglobin,3240,ENSG00000257017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10855,HPSE,heparanase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPSE,HGNC:5164,heparanase,10855,ENSG00000173083,HPSE,Heparanase,Enzyme,HPSE_HUMAN,4.28,Kd,CHEMBL
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSD11B1,HGNC:5208,hydroxysteroid 11-beta dehydrogenase 1,3290,ENSG00000117594,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,DHI1_HUMAN,6.1,IC50,CHEMBL
3297,HSF1,heat shock transcription factor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSF1,HGNC:5224,heat shock transcription factor 1,3297,ENSG00000185122,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8988,HSPB3,heat shock 27kDa protein 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPB3,HGNC:5248,heat shock protein family B (small) member 3,8988,ENSG00000169271,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3352,HTR1D,"5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1D,HGNC:5289,5-hydroxytryptamine receptor 1D,3352,ENSG00000179546,HTR1D,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_HUMAN,7.5,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR7,HGNC:5302,5-hydroxytryptamine receptor 7,3363,ENSG00000148680,HTR7,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,7.93930216,Ki,PDSP
3064,HTT,huntingtin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTT,HGNC:4851,huntingtin,3064,ENSG00000197386,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3620,IDO1,"indoleamine 2,3-dioxygenase 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IDO1,HGNC:6059,"indoleamine 2,3-dioxygenase 1",3620,ENSG00000131203,IDO1,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_HUMAN,4.639999866,IC50,CHEMBL
3479,IGF1,insulin-like growth factor 1 (somatomedin C),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF1,HGNC:5464,insulin like growth factor 1,3479,ENSG00000017427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3606,IL18,interleukin 18,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL18,HGNC:5986,interleukin 18,3606,ENSG00000150782,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3552,IL1A,"interleukin 1, alpha",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1A,HGNC:5991,interleukin 1 alpha,3552,ENSG00000115008,IL1A,Interleukin-1 alpha,Cytokine,IL1A_HUMAN,11.8538723,Kd,DRUG LABEL
3553,IL1B,"interleukin 1, beta",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
3569,IL6,interleukin 6,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
3570,IL6R,interleukin 6 receptor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6R,HGNC:6019,interleukin 6 receptor,3570,ENSG00000160712,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPA2,HGNC:6051,inositol monophosphatase 2,3613,ENSG00000141401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3763,KCNJ6,"potassium channel, inwardly rectifying subfamily J, member 6",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNJ6,HGNC:6267,potassium inwardly rectifying channel subfamily J member 6,3763,ENSG00000157542,KCNJ6,G protein-activated inward rectifier potassium channel 2,Ion channel,KCNJ6_HUMAN,4.2823,IC50,WOMBAT-PK
3776,KCNK2,"potassium channel, two pore domain subfamily K, member 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNK2,HGNC:6277,potassium two pore domain channel subfamily K member 2,3776,ENSG00000082482,KCNK2,Potassium channel subfamily K member 2,Ion channel,KCNK2_HUMAN,6.4,IC50,CHEMBL
3952,LEP,leptin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9211,LGI1,"leucine-rich, glioma inactivated 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LGI1,HGNC:6572,leucine rich glioma inactivated 1,9211,ENSG00000108231,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3976,LIF,leukemia inhibitory factor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LIF,HGNC:6596,LIF interleukin 6 family cytokine,3976,ENSG00000128342,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4048,LTA4H,leukotriene A4 hydrolase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LTA4H,HGNC:6710,leukotriene A4 hydrolase,4048,ENSG00000111144,LTA4H,Leukotriene A-4 hydrolase,Enzyme,LKHA4_HUMAN,7.15,IC50,CHEMBL
4074,M6PR,mannose-6-phosphate receptor (cation dependent),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,M6PR,HGNC:6752,"mannose-6-phosphate receptor, cation dependent",4074,ENSG00000003056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
5607,MAP2K5,mitogen-activated protein kinase kinase 5,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2K5,HGNC:6845,mitogen-activated protein kinase kinase 5,5607,ENSG00000137764,MAP2K5,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,MP2K5_HUMAN,8.48,Kd,CHEMBL
5595,MAPK3,mitogen-activated protein kinase 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK3,HGNC:6877,mitogen-activated protein kinase 3,5595,ENSG00000102882,MAPK3,Mitogen-activated protein kinase 3,Kinase,MK03_HUMAN,5.213177621,IC50,DRUG MATRIX
5599,MAPK8,mitogen-activated protein kinase 8,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK8,HGNC:6881,mitogen-activated protein kinase 8,5599,ENSG00000107643,MAPK8,Mitogen-activated protein kinase 8,Kinase,MK08_HUMAN,5.49,Kd,CHEMBL
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC1R,HGNC:6929,melanocortin 1 receptor,4157,ENSG00000258839,MC1R,Melanocyte-stimulating hormone receptor,GPCR,MSHR_HUMAN,10,IC50,IUPHAR
4160,MC4R,melanocortin 4 receptor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC4R,HGNC:6932,melanocortin 4 receptor,4160,ENSG00000166603,MC4R,Melanocortin receptor 4,GPCR,MC4R_HUMAN,4.878571482,Ki,DRUG MATRIX
2847,MCHR1,melanin-concentrating hormone receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR1,HGNC:4479,melanin concentrating hormone receptor 1,2847,ENSG00000128285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
326625,MMAB,methylmalonic aciduria (cobalamin deficiency) cblB type,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMAB,HGNC:19331,metabolism of cobalamin associated B,326625,ENSG00000139428,MMAB,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",Enzyme,MMAB_HUMAN,0,0,WOMBAT-PK
4397,MS,multiple sclerosis,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MS,HGNC:7314,multiple sclerosis,0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTR,HGNC:7468,5-methyltetrahydrofolate-homocysteine methyltransferase,4548,ENSG00000116984,MTR,Methionine synthase,Enzyme,METH_HUMAN,0,0,WOMBAT-PK
4684,NCAM1,neural cell adhesion molecule 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4741,NEFM,"neurofilament, medium polypeptide",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFM,HGNC:7734,neurofilament medium,4741,ENSG00000104722,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4803,NGF,nerve growth factor (beta polypeptide),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NGF,HGNC:7808,nerve growth factor,4803,ENSG00000134259,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4804,NGFR,nerve growth factor receptor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NGFR,HGNC:7809,nerve growth factor receptor,4804,ENSG00000064300,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4843,NOS2,"nitric oxide synthase 2, inducible",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOS2,HGNC:7873,nitric oxide synthase 2,4843,ENSG00000007171,NOS2,"Nitric oxide synthase, inducible",Enzyme,NOS2_HUMAN,4.85,IC50,CHEMBL
4846,NOS3,nitric oxide synthase 3 (endothelial cell),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOS3,HGNC:7876,nitric oxide synthase 3,4846,ENSG00000164867,NOS3,"Nitric oxide synthase, endothelial",Enzyme,NOS3_HUMAN,5.06,IC50,CHEMBL
4862,NPAS2,neuronal PAS domain protein 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS2,HGNC:7895,neuronal PAS domain protein 2,4862,ENSG00000170485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
594857,NPS,neuropeptide S,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPS,HGNC:33940,neuropeptide S,594857,ENSG00000214285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
387129,NPSR1,neuropeptide S receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPSR1,HGNC:23631,neuropeptide S receptor 1,387129,ENSG00000187258,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9572,NR1D1,"nuclear receptor subfamily 1, group D, member 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR1D1,HGNC:7962,nuclear receptor subfamily 1 group D member 1,9572,ENSG00000126368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
3084,NRG1,neuregulin 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG1,HGNC:7997,neuregulin 1,3084,ENSG00000157168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9378,NRXN1,neurexin 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN1,HGNC:8008,neurexin 1,9378,ENSG00000179915,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4922,NTS,neurotensin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTS,HGNC:8038,neurotensin,4922,ENSG00000133636,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4939,OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OAS2,HGNC:8087,2'-5'-oligoadenylate synthetase 2,4939,ENSG00000111335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4986,OPRK1,"opioid receptor, kappa 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
125958,OR7D4,"olfactory receptor, family 7, subfamily D, member 4",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OR7D4,HGNC:8380,olfactory receptor family 7 subfamily D member 4,125958,ENSG00000174667,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5020,OXT,oxytocin/neurophysin I prepropeptide,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
5021,OXTR,oxytocin receptor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXTR,HGNC:8529,oxytocin receptor,5021,ENSG00000180914,OXTR,Oxytocin receptor,GPCR,OXYR_HUMAN,8.148741722,Ki,SCIENTIFIC LITERATURE
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,P2RX7,HGNC:8537,purinergic receptor P2X 7,5027,ENSG00000089041,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27445,PCLO,piccolo presynaptic cytomatrix protein,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCLO,HGNC:13406,piccolo presynaptic cytomatrix protein,27445,ENSG00000186472,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5153,PDE1B,"phosphodiesterase 1B, calmodulin-dependent",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE1B,HGNC:8775,phosphodiesterase 1B,5153,ENSG00000123360,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5141,PDE4A,"phosphodiesterase 4A, cAMP-specific",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4A,HGNC:8780,phosphodiesterase 4A,5141,ENSG00000065989,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,5.976336082,IC50,DRUG MATRIX
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4B,HGNC:8781,phosphodiesterase 4B,5142,ENSG00000184588,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,PDE4B_HUMAN,0,0,WOMBAT-PK
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4D,HGNC:8783,phosphodiesterase 4D,5144,ENSG00000113448,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,PDE4D_HUMAN,6.78,IC50,CHEMBL
5173,PDYN,prodynorphin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5179,PENK,proenkephalin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PENK,HGNC:8831,proenkephalin,5179,ENSG00000181195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8864,PER2,period circadian clock 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8863,PER3,period circadian clock 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER3,HGNC:8847,period circadian regulator 3,8863,ENSG00000049246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51555,PEX5L,peroxisomal biogenesis factor 5-like,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEX5L,HGNC:30024,peroxisomal biogenesis factor 5 like,51555,ENSG00000114757,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5309,PITX3,paired-like homeodomain 3,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PITX3,HGNC:9006,paired like homeodomain 3,5309,ENSG00000107859,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G2A,HGNC:9031,phospholipase A2 group IIA,5320,ENSG00000188257,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5367,PMCH,pro-melanin-concentrating hormone,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PMCH,HGNC:9109,pro-melanin concentrating hormone,5367,ENSG00000183395,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5368,PNOC,prepronociceptin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PNOC,HGNC:9163,prepronociceptin,5368,ENSG00000168081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5443,POMC,proopiomelanocortin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POMC,HGNC:9201,proopiomelanocortin,5443,ENSG00000115138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP1R1B,HGNC:9287,protein phosphatase 1 regulatory inhibitor subunit 1B,84152,ENSG00000131771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5533,PPP3CC,"protein phosphatase 3, catalytic subunit, gamma isozyme",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP3CC,HGNC:9316,protein phosphatase 3 catalytic subunit gamma,5533,ENSG00000120910,PPP3CC,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,0,0,WOMBAT-PK
5584,PRKCI,"protein kinase C, iota",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCI,HGNC:9404,protein kinase C iota,5584,ENSG00000163558,PRKCI,Protein kinase C iota type,Kinase,KPCI_HUMAN,5.85,Kd,CHEMBL
5621,PRNP,prion protein,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRNP,HGNC:9449,prion protein,5621,ENSG00000171867,PRNP,Major prion protein,Surface antigen,PRIO_HUMAN,5.3,EC50,CHEMBL
5663,PSEN1,presenilin 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSEN1,HGNC:9508,presenilin 1,5663,ENSG00000080815,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
5697,PYY,peptide YY,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PYY,HGNC:9748,peptide YY,5697,ENSG00000131096,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAC1,HGNC:9801,Rac family small GTPase 1,5879,ENSG00000136238,RAC1,Ras-related C3 botulinum toxin substrate 1,Unclassified,RAC1_HUMAN,0,0,WOMBAT-PK
5649,RELN,reelin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELN,HGNC:9957,reelin,5649,ENSG00000189056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5972,REN,renin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REN,HGNC:9958,renin,5972,ENSG00000143839,REN,Renin,Enzyme,RENI_HUMAN,9.22,IC50,WOMBAT-PK
5996,RGS1,regulator of G-protein signaling 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS1,HGNC:9991,regulator of G protein signaling 1,5996,ENSG00000090104,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
63891,RNF123,ring finger protein 123,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNF123,HGNC:21148,ring finger protein 123,63891,ENSG00000164068,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6095,RORA,RAR-related orphan receptor A,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RORA,HGNC:10258,RAR related orphan receptor A,6095,ENSG00000069667,RORA,Nuclear receptor ROR-alpha,Nuclear hormone receptor,RORA_HUMAN,9,EC50,WOMBAT-PK
6281,S100A10,S100 calcium binding protein A10,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
866,SERPINA6,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINA6,HGNC:1540,serpin family A member 6,866,ENSG00000170099,SERPINA6,Corticosteroid-binding globulin,Secreted,CBG_HUMAN,6.28,Ki,CHEMBL
6422,SFRP1,secreted frizzled-related protein 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SFRP1,HGNC:10776,secreted frizzled related protein 1,6422,ENSG00000104332,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8910,SGCE,"sarcoglycan, epsilon",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SGCE,HGNC:10808,sarcoglycan epsilon,8910,ENSG00000127990,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6570,SLC18A1,"solute carrier family 18 (vesicular monoamine transporter), member 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A1,HGNC:10934,solute carrier family 18 member A1,6570,ENSG00000036565,SLC18A1,Chromaffin granule amine transporter,Transporter,VMAT1_HUMAN,5.8,Ki,IUPHAR
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A1,HGNC:10939,solute carrier family 1 member 1,6505,ENSG00000106688,SLC1A1,Excitatory amino acid transporter 3,Transporter,EAA3_HUMAN,7.289999962,Ki,CHEMBL
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A2,HGNC:10940,solute carrier family 1 member 2,6506,ENSG00000110436,SLC1A2,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,4.210000038,Ki,CHEMBL
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC29A3,HGNC:23096,solute carrier family 29 member 3,55315,ENSG00000198246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A1,HGNC:11042,solute carrier family 6 member 1,6529,ENSG00000157103,SLC6A1,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_HUMAN,0,0,WOMBAT-PK
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
53919,SLCO1C1,"solute carrier organic anion transporter family, member 1C1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLCO1C1,HGNC:13819,solute carrier organic anion transporter family member 1C1,53919,ENSG00000139155,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6616,SNAP25,"synaptosomal-associated protein, 25kDa",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNAP25,HGNC:11132,synaptosome associated protein 25,6616,ENSG00000132639,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6647,SOD1,"superoxide dismutase 1, soluble",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD1,HGNC:11179,superoxide dismutase 1,6647,ENSG00000142168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6648,SOD2,"superoxide dismutase 2, mitochondrial",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD2,HGNC:11180,superoxide dismutase 2,6648,ENSG00000112096,SOD2,"Superoxide dismutase [Mn], mitochondrial",Enzyme,SODM_HUMAN,0,0,WOMBAT-PK
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A1,HGNC:11284,steroid 5 alpha-reductase 1,6715,ENSG00000145545,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,8.49,IC50,WOMBAT-PK
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STAT3,HGNC:11364,signal transducer and activator of transcription 3,6774,ENSG00000168610,STAT3,Signal transducer and activator of transcription 3,Transcription factor,STAT3_HUMAN,6.150000095,IC50,CHEMBL
10963,STIP1,stress-induced phosphoprotein 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STIP1,HGNC:11387,stress induced phosphoprotein 1,10963,ENSG00000168439,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3925,STMN1,stathmin 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STMN1,HGNC:6510,stathmin 1,3925,ENSG00000117632,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6853,SYN1,synapsin I,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYN1,HGNC:11494,synapsin I,6853,ENSG00000008056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
319100,TAAR6,trace amine associated receptor 6,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAAR6,HGNC:20978,trace amine associated receptor 6,319100,ENSG00000146383,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6863,TAC1,"tachykinin, precursor 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAC1,HGNC:11517,tachykinin precursor 1,6863,ENSG00000006128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6869,TACR1,tachykinin receptor 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR1,HGNC:11526,tachykinin receptor 1,6869,ENSG00000115353,TACR1,Substance-P receptor,GPCR,NK1R_HUMAN,10.7,Ki,CHEMBL
9095,TBX19,T-box 19,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX19,HGNC:11596,T-box transcription factor 19,9095,ENSG00000143178,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
8914,TIMELESS,timeless circadian clock,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TIMELESS,HGNC:11813,timeless circadian regulator,8914,ENSG00000111602,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7088,TLE1,"transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLE1,HGNC:11837,"TLE family member 1, transcriptional corepressor",7088,ENSG00000196781,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7124,TNF,tumor necrosis factor,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNF,HGNC:11892,tumor necrosis factor,7124,ENSG00000232810,TNF,Tumor necrosis factor,Cytokine,TNFA_HUMAN,8,IC50,WOMBAT-PK
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1A,HGNC:11916,TNF receptor superfamily member 1A,7132,ENSG00000067182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1B,HGNC:11917,TNF receptor superfamily member 1B,7133,ENSG00000028137,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
121278,TPH2,tryptophan hydroxylase 2,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7200,TRH,thyrotropin-releasing hormone,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRH,HGNC:12298,thyrotropin releasing hormone,7200,ENSG00000170893,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7276,TTR,transthyretin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TTR,HGNC:12405,transthyretin,7276,ENSG00000118271,TTR,Transthyretin,Secreted,TTHY_HUMAN,5.92,Kd,CHEMBL
7349,UCN,urocortin,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UCN,HGNC:12516,urocortin,7349,ENSG00000163794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7422,VEGFA,vascular endothelial growth factor A,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
7425,VGF,VGF nerve growth factor inducible,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VGF,HGNC:12684,VGF nerve growth factor inducible,7425,ENSG00000128564,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7466,WFS1,Wolfram syndrome 1 (wolframin),C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WFS1,HGNC:12762,wolframin ER transmembrane glycoprotein,7466,ENSG00000109501,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23286,WWC1,WW and C2 domain containing 1,C0011581,depressive disorder,Depressive disorders,C0011581,Depressive disorder,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WWC1,HGNC:29435,WW and C2 domain containing 1,23286,ENSG00000113645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0013415,dysthymic disorder,Depressive disorders,C0013415,Dysthymic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2596,GAP43,growth associated protein 43,C0013415,dysthymic disorder,Depressive disorders,C0013415,Dysthymic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3557,IL1RN,interleukin 1 receptor antagonist,C0013415,dysthymic disorder,Depressive disorders,C0013415,Dysthymic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1RN,HGNC:6000,interleukin 1 receptor antagonist,3557,ENSG00000136689,IL1RN,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,11.21467018,Kd,DRUG LABEL
4128,MAOA,monoamine oxidase A,C0013415,dysthymic disorder,Depressive disorders,C0013415,Dysthymic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0013415,dysthymic disorder,Depressive disorders,C0013415,Dysthymic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0013415,dysthymic disorder,Depressive disorders,C0013415,Dysthymic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
23394,ADNP,activity-dependent neuroprotector homeobox,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,ADNP,HGNC:15766,activity dependent neuroprotector homeobox,23394,ENSG00000101126,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
596,BCL2,B-cell CLL/lymphoma 2,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,BCL2,HGNC:990,BCL2 apoptosis regulator,596,ENSG00000171791,BCL2,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,4.22,Kd,CHEMBL
10752,CHL1,cell adhesion molecule L1-like,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,CHL1,HGNC:1939,cell adhesion molecule L1 like,10752,ENSG00000134121,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54821,ERCC6L,excision repair cross-complementation group 6-like,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,ERCC6L,HGNC:20794,"ERCC excision repair 6 like, spindle assembly checkpoint helicase",54821,ENSG00000186871,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2551,GABPA,"GA binding protein transcription factor, alpha subunit 60kDa",C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,GABPA,HGNC:4071,GA binding protein transcription factor subunit alpha,2551,ENSG00000154727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57502,NLGN4X,"neuroligin 4, X-linked",C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,NLGN4X,HGNC:14287,neuroligin 4 X-linked,57502,ENSG00000146938,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4842,NOS1,nitric oxide synthase 1 (neuronal),C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,NOS1,HGNC:7872,nitric oxide synthase 1,4842,ENSG00000089250,NOS1,"Nitric oxide synthase, brain",Enzyme,NOS1_HUMAN,4.3,IC50,CHEMBL
5015,OTX2,orthodenticle homeobox 2,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,OTX2,HGNC:8522,orthodenticle homeobox 2,5015,ENSG00000165588,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,PDGFRA,HGNC:8803,platelet derived growth factor receptor alpha,5156,ENSG00000134853,PDGFRA,Platelet-derived growth factor receptor alpha,Kinase,PGFRA_HUMAN,9.33,Kd,CHEMBL
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,PIK3CA,HGNC:8975,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",5290,ENSG00000121879,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,PK3CA_HUMAN,4.42,IC50,CHEMBL
5978,REST,RE1-silencing transcription factor,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,REST,HGNC:9966,RE1 silencing transcription factor,5978,ENSG00000084093,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6469,SHH,sonic hedgehog,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,SHH,HGNC:10848,sonic hedgehog signaling molecule,6469,ENSG00000164690,SHH,Sonic hedgehog protein,Enzyme,SHH_HUMAN,7.82,IC50,CHEMBL
84631,SLITRK2,"SLIT and NTRK-like family, member 2",C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,SLITRK2,HGNC:13449,SLIT and NTRK like family member 2,84631,ENSG00000185985,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6722,SRF,serum response factor (c-fos serum response element-binding transcription factor),C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,SRF,HGNC:11291,serum response factor,6722,ENSG00000112658,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7432,VIP,vasoactive intestinal peptide,C0015923,fetal alcohol syndrome,Alcohol use disorders,C0015923,Fetal Alcohol Syndrome,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23627,PRND,prion protein 2 (dublet),C0022107,irritable mood,Depressive disorders,C0022107,Irritable Mood,phenotype,F01,Behavior and Behavior Mechanisms,0,0,0,0,T033,Finding,PRND,HGNC:15748,prion like protein doppel,23627,ENSG00000171864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56267,CCBL2,cysteine conjugate-beta lyase 2,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1813,DRD2,dopamine receptor D2,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
3303,HSPA1A,heat shock 70kDa protein 1A,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1A,HGNC:5232,heat shock protein family A (Hsp70) member 1A,3303,ENSG00000204389,HSPA1A,Heat shock 70 kDa protein 1A,Unclassified,HS71A_HUMAN,5.46999979,IC50,CHEMBL
3304,HSPA1B,heat shock 70kDa protein 1B,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1B,HGNC:5233,heat shock protein family A (Hsp70) member 1B,3304,ENSG00000204388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3305,HSPA1L,heat shock 70kDa protein 1-like,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1L,HGNC:5234,heat shock protein family A (Hsp70) member 1 like,3305,ENSG00000204390,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
6281,S100A10,S100 calcium binding protein A10,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C0024517,single major depressive episode,Depressive disorders,C0024517,"Major depression, single episode",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",C0024713,manic disorder,Bipolar disorders and related disorders,C0024713,Manic Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ME2,HGNC:6984,malic enzyme 2,4200,ENSG00000082212,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
1133,CHRM5,"cholinergic receptor, muscarinic 5",C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM5,HGNC:1954,cholinergic receptor muscarinic 5,1133,ENSG00000184984,CHRM5,Muscarinic acetylcholine receptor M5,GPCR,ACM5_HUMAN,6.1,EC50,CHEMBL
1269,CNR2,cannabinoid receptor 2 (macrophage),C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1312,COMT,catechol-O-methyltransferase,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2A6,HGNC:2610,cytochrome P450 family 2 subfamily A member 6,1548,ENSG00000255974,CYP2A6,Cytochrome P450 2A6,Enzyme,CP2A6_HUMAN,5.3565,IC50,WOMBAT-PK
1813,DRD2,dopamine receptor D2,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1815,DRD4,dopamine receptor D4,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
1956,EGFR,epidermal growth factor receptor,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGFR,HGNC:3236,epidermal growth factor receptor,1956,ENSG00000146648,EGFR,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,5.217742426,IC50,DRUG MATRIX
2099,ESR1,estrogen receptor 1,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
2166,FAAH,fatty acid amide hydrolase,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
51083,GAL,galanin/GMAP prepropeptide,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3060,HCRT,hypocretin (orexin) neuropeptide precursor,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRT,HGNC:4847,hypocretin neuropeptide precursor,3060,ENSG00000161610,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3553,IL1B,"interleukin 1, beta",C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
1432,MAPK14,mitogen-activated protein kinase 14,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK14,HGNC:6876,mitogen-activated protein kinase 14,1432,ENSG00000112062,MAPK14,Mitogen-activated protein kinase 14,Kinase,MK14_HUMAN,5.908333042,IC50,DRUG MATRIX
4684,NCAM1,neural cell adhesion molecule 1,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3084,NRG1,neuregulin 1,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG1,HGNC:7997,neuregulin 1,3084,ENSG00000157168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5179,PENK,proenkephalin,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PENK,HGNC:8831,proenkephalin,5179,ENSG00000181195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
26575,RGS17,regulator of G-protein signaling 17,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS17,HGNC:14088,regulator of G protein signaling 17,26575,ENSG00000091844,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8601,RGS20,regulator of G-protein signaling 20,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS20,HGNC:14600,regulator of G protein signaling 20,8601,ENSG00000147509,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
7157,TP53,tumor protein p53,C0024809,marijuana abuse,Cannabis use disorders,C0024809,Marijuana Abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TP53,HGNC:11998,tumor protein p53,7157,ENSG00000141510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0025193,melancholia,Depressive disorders,C0025193,Melancholia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0027609,neonatal abstinence syndrome,Alcohol use disorders,C0027609,Neonatal Abstinence Syndrome,disease,C16;F03;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders; Substance-Related Disorders",0,0,DOID:150,disease of mental health,T047,Disease or Syndrome,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
811,CALR,calreticulin,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1808,DPYSL2,dihydropyrimidinase-like 2,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DPYSL2,HGNC:3014,dihydropyrimidinase like 2,1808,ENSG00000092964,DPYSL2,Dihydropyrimidinase-related protein 2,Unclassified,DPYL2_HUMAN,0,0,WOMBAT-PK
1812,DRD1,dopamine receptor D1,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD1,HGNC:3020,dopamine receptor D1,1812,ENSG00000184845,DRD1,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,5.339988779,Ki,DRUG MATRIX
84062,DTNBP1,dystrobrevin binding protein 1,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2730,GCLM,"glutamate-cysteine ligase, modifier subunit",C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCLM,HGNC:4312,glutamate-cysteine ligase modifier subunit,2730,ENSG00000023909,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27306,HPGDS,hematopoietic prostaglandin D synthase,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPGDS,HGNC:17890,hematopoietic prostaglandin D synthase,27306,ENSG00000163106,HPGDS,Hematopoietic prostaglandin D synthase,Enzyme,HPGDS_HUMAN,4.57,IC50,CHEMBL
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3084,NRG1,neuregulin 1,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG1,HGNC:7997,neuregulin 1,3084,ENSG00000157168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23411,SIRT1,sirtuin 1,C0033937,"psychoses, drug",Drug-induced psychosis,C0033937,"Psychoses, Drug",disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT1,HGNC:14929,sirtuin 1,23411,ENSG00000096717,SIRT1,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,4.3,IC50,CHEMBL
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
23305,ACSL6,acyl-CoA synthetase long-chain family member 6,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSL6,HGNC:16496,acyl-CoA synthetase long chain family member 6,23305,ENSG00000164398,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
104,ADARB1,"adenosine deaminase, RNA-specific, B1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADARB1,HGNC:226,adenosine deaminase RNA specific B1,104,ENSG00000197381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH1B,HGNC:250,"alcohol dehydrogenase 1B (class I), beta polypeptide",125,ENSG00000196616,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANK3,HGNC:494,ankyrin 3,288,ENSG00000151150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
200315,APOBEC3A,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOBEC3A,HGNC:17343,apolipoprotein B mRNA editing enzyme catalytic subunit 3A,200315,ENSG00000128383,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27350,APOBEC3C,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOBEC3C,HGNC:17353,apolipoprotein B mRNA editing enzyme catalytic subunit 3C,27350,ENSG00000244509,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23092,ARHGAP26,Rho GTPase activating protein 26,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGAP26,HGNC:17073,Rho GTPase activating protein 26,23092,ENSG00000145819,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
607,BCL9,B-cell CLL/lymphoma 9,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL9,HGNC:1008,BCL9 transcription coactivator,607,ENSG00000116128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
203228,C9orf72,chromosome 9 open reading frame 72,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C9orf72,HGNC:28337,C9orf72-SMCR8 complex subunit,203228,ENSG00000147894,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
811,CALR,calreticulin,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9607,CARTPT,CART prepropeptide,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
886,CCKAR,cholecystokinin A receptor,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
947,CD34,CD34 molecule,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD34,HGNC:1662,CD34 molecule,947,ENSG00000174059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1015,CDH17,"cadherin 17, LI cadherin (liver-intestine)",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH17,HGNC:1756,cadherin 17,1015,ENSG00000079112,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1267,CNP,"2',3'-cyclic nucleotide 3' phosphodiesterase",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNP,HGNC:2158,"2',3'-cyclic nucleotide 3' phosphodiesterase",1267,ENSG00000173786,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1269,CNR2,cannabinoid receptor 2 (macrophage),C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1394,CRHR1,corticotropin releasing hormone receptor 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1439,CSF2RB,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSF2RB,HGNC:2436,colony stimulating factor 2 receptor subunit beta,1439,ENSG00000100368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1454,CSNK1E,"casein kinase 1, epsilon",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1E,HGNC:2453,casein kinase 1 epsilon,1454,ENSG00000213923,CSNK1E,Casein kinase I isoform epsilon,Kinase,KC1E_HUMAN,5.82,Kd,CHEMBL
1594,CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP27B1,HGNC:2606,cytochrome P450 family 27 subfamily B member 1,1594,ENSG00000111012,CYP27B1,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,CP27B_HUMAN,0,0,WOMBAT-PK
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2B6,HGNC:2615,cytochrome P450 family 2 subfamily B member 6,1555,ENSG00000197408,CYP2B6,Cytochrome P450 2B6,Enzyme,CP2B6_HUMAN,6.3,Ki,WOMBAT-PK
1622,DBI,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBI,HGNC:2690,"diazepam binding inhibitor, acyl-CoA binding protein",1622,ENSG00000155368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
54487,DGCR8,DGCR8 microprocessor complex subunit,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGCR8,HGNC:2847,DGCR8 microprocessor complex subunit,54487,ENSG00000128191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1745,DLX1,distal-less homeobox 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLX1,HGNC:2914,distal-less homeobox 1,1745,ENSG00000144355,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2166,FAAH,fatty acid amide hydrolase,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
9638,FEZ1,fasciculation and elongation protein zeta 1 (zygin I),C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEZ1,HGNC:3659,fasciculation and elongation protein zeta 1,9638,ENSG00000149557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2263,FGFR2,fibroblast growth factor receptor 2,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR2,HGNC:3689,fibroblast growth factor receptor 2,2263,ENSG00000066468,FGFR2,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,5.85,Kd,CHEMBL
2289,FKBP5,FK506 binding protein 5,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2512,FTL,"ferritin, light polypeptide",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FTL,HGNC:3999,ferritin light chain,2512,ENSG00000087086,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7976,FZD3,frizzled class receptor 3,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FZD3,HGNC:4041,frizzled class receptor 3,7976,ENSG00000104290,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4616,GADD45B,"growth arrest and DNA-damage-inducible, beta",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GADD45B,HGNC:4096,growth arrest and DNA damage inducible beta,4616,ENSG00000099860,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2752,GLUL,glutamate-ammonia ligase,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
2768,GNA12,guanine nucleotide binding protein (G protein) alpha 12,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNA12,HGNC:4380,G protein subunit alpha 12,2768,ENSG00000146535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54584,GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB1L,HGNC:4397,G protein subunit beta 1 like,54584,ENSG00000185838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9293,GPR52,G protein-coupled receptor 52,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR52,HGNC:4508,G protein-coupled receptor 52,9293,ENSG00000203737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
2938,GSTA1,glutathione S-transferase alpha 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTA1,HGNC:4626,glutathione S-transferase alpha 1,2938,ENSG00000243955,GSTA1,Glutathione S-transferase A1,Enzyme,GSTA1_HUMAN,5.3,IC50,CHEMBL
2950,GSTP1,glutathione S-transferase pi 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTP1,HGNC:4638,glutathione S-transferase pi 1,2950,ENSG00000084207,GSTP1,Glutathione S-transferase P,Enzyme,GSTP1_HUMAN,0,0,WOMBAT-PK
3066,HDAC2,histone deacetylase 2,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC2,HGNC:4853,histone deacetylase 2,3066,ENSG00000196591,HDAC2,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,4.19,IC50,CHEMBL
3106,HLA-B,"major histocompatibility complex, class I, B",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-B,HGNC:4932,"major histocompatibility complex, class I, B",3106,ENSG00000234745,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3133,HLA-E,"major histocompatibility complex, class I, E",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-E,HGNC:4962,"major histocompatibility complex, class I, E",3133,ENSG00000204592,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27306,HPGDS,hematopoietic prostaglandin D synthase,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPGDS,HGNC:17890,hematopoietic prostaglandin D synthase,27306,ENSG00000163106,HPGDS,Hematopoietic prostaglandin D synthase,Enzyme,HPGDS_HUMAN,4.57,IC50,CHEMBL
3361,HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR5A,HGNC:5300,5-hydroxytryptamine receptor 5A,3361,ENSG00000157219,HTR5A,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,5.906403065,Ki,PDSP
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNH2,HGNC:6251,potassium voltage-gated channel subfamily H member 2,3757,ENSG00000055118,KCNH2,Potassium voltage-gated channel subfamily H member 2,Ion channel,KCNH2_HUMAN,4.89,IC50,CHEMBL
81033,KCNH6,"potassium channel, voltage gated eag related subfamily H, member 6",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNH6,HGNC:18862,potassium voltage-gated channel subfamily H member 6,81033,ENSG00000173826,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3952,LEP,leptin,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
442721,LMOD2,leiomodin 2 (cardiac),C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LMOD2,HGNC:6648,leiomodin 2,442721,ENSG00000170807,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ME2,HGNC:6984,malic enzyme 2,4200,ENSG00000082212,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4205,MEF2A,myocyte enhancer factor 2A,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MEF2A,HGNC:6993,myocyte enhancer factor 2A,4205,ENSG00000068305,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54820,NDE1,nudE neurodevelopment protein 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDE1,HGNC:17619,nudE neurodevelopment protein 1,54820,ENSG00000072864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
81565,NDEL1,nudE neurodevelopment protein 1-like 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDEL1,HGNC:17620,nudE neurodevelopment protein 1 like 1,81565,ENSG00000166579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4861,NPAS1,neuronal PAS domain protein 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS1,HGNC:7894,neuronal PAS domain protein 1,4861,ENSG00000130751,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64067,NPAS3,neuronal PAS domain protein 3,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS3,HGNC:19311,neuronal PAS domain protein 3,64067,ENSG00000151322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4886,NPY1R,neuropeptide Y receptor Y1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY1R,HGNC:7956,neuropeptide Y receptor Y1,4886,ENSG00000164128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO2,HGNC:7856,N-ribosyldihydronicotinamide:quinone reductase 2,4835,ENSG00000124588,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,NQO2_HUMAN,0,0,WOMBAT-PK
10215,OLIG2,oligodendrocyte lineage transcription factor 2,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OLIG2,HGNC:9398,oligodendrocyte transcription factor 2,10215,ENSG00000205927,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4985,OPRD1,"opioid receptor, delta 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRD1,HGNC:8153,opioid receptor delta 1,4985,ENSG00000116329,OPRD1,Delta-type opioid receptor,GPCR,OPRD_HUMAN,7.92,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
5053,PAH,phenylalanine hydroxylase,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAH,HGNC:8582,phenylalanine hydroxylase,5053,ENSG00000171759,PAH,Phenylalanine-4-hydroxylase,Enzyme,PH4H_HUMAN,5.400000095,Ki,IUPHAR
57144,PAK7,p21 protein (Cdc42/Rac)-activated kinase 7,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55193,PBRM1,polybromo 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PBRM1,HGNC:30064,polybromo 1,55193,ENSG00000163939,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
83259,PCDH11Y,protocadherin 11 Y-linked,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCDH11Y,HGNC:15813,protocadherin 11 Y-linked,83259,ENSG00000099715,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5116,PCNT,pericentrin,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCNT,HGNC:16068,pericentrin,5116,ENSG00000160299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10846,PDE10A,phosphodiesterase 10A,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE10A,HGNC:8772,phosphodiesterase 10A,10846,ENSG00000112541,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_HUMAN,6,Ki,CHEMBL
5297,PI4KA,"phosphatidylinositol 4-kinase, catalytic, alpha",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PI4KA,HGNC:8983,phosphatidylinositol 4-kinase alpha,5297,ENSG00000241973,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9463,PICK1,protein interacting with PRKCA 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PICK1,HGNC:9394,protein interacting with PRKCA 1,9463,ENSG00000100151,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G6,HGNC:9039,phospholipase A2 group VI,8398,ENSG00000184381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5327,PLAT,"plasminogen activator, tissue",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLAT,HGNC:9051,"plasminogen activator, tissue type",5327,ENSG00000104368,PLAT,Tissue-type plasminogen activator,Enzyme,TPA_HUMAN,0,0,DRUGBANK
5533,PPP3CC,"protein phosphatase 3, catalytic subunit, gamma isozyme",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP3CC,HGNC:9316,protein phosphatase 3 catalytic subunit gamma,5533,ENSG00000120910,PPP3CC,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,0,0,WOMBAT-PK
5578,PRKCA,"protein kinase C, alpha",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCA,HGNC:9393,protein kinase C alpha,5578,ENSG00000154229,PRKCA,Protein kinase C alpha type,Kinase,KPCA_HUMAN,5.22,Kd,CHEMBL
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPRC,HGNC:9666,protein tyrosine phosphatase receptor type C,5788,ENSG00000081237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPGEF5,HGNC:16862,Rap guanine nucleotide exchange factor 5,9771,ENSG00000136237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
12,SERPINA3,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINA3,HGNC:16,serpin family A member 3,12,ENSG00000196136,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHANK1,HGNC:15474,SH3 and multiple ankyrin repeat domains 1,50944,ENSG00000161681,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6474,SHOX2,short stature homeobox 2,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHOX2,HGNC:10854,short stature homeobox 2,6474,ENSG00000168779,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23408,SIRT5,sirtuin 5,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT5,HGNC:14933,sirtuin 5,23408,ENSG00000124523,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,SIR5_HUMAN,4.33,IC50,CHEMBL
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC12A2,HGNC:10911,solute carrier family 12 member 2,6558,ENSG00000064651,SLC12A2,Solute carrier family 12 member 2,Transporter,S12A2_HUMAN,5.599999905,IC50,IUPHAR
29985,SLC39A3,"solute carrier family 39 (zinc transporter), member 3",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC39A3,HGNC:17128,solute carrier family 39 member 3,29985,ENSG00000141873,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6536,SLC6A9,"solute carrier family 6 (neurotransmitter transporter, glycine), member 9",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A9,HGNC:11056,solute carrier family 6 member 9,6536,ENSG00000196517,SLC6A9,Sodium- and chloride-dependent glycine transporter 1,Transporter,SC6A9_HUMAN,4.5,IC50,CHEMBL
55084,SOBP,sine oculis binding protein homolog (Drosophila),C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOBP,HGNC:29256,sine oculis binding protein homolog,55084,ENSG00000112320,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6667,SP1,Sp1 transcription factor,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP1,HGNC:11205,Sp1 transcription factor,6667,ENSG00000185591,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6670,SP3,Sp3 transcription factor,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP3,HGNC:11208,Sp3 transcription factor,6670,ENSG00000172845,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
221833,SP8,Sp8 transcription factor,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP8,HGNC:19196,Sp8 transcription factor,221833,ENSG00000164651,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6482,ST3GAL1,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST3GAL1,HGNC:10862,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",6482,ENSG00000008513,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55808,ST6GALNAC1,"ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST6GALNAC1,HGNC:23614,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",55808,ENSG00000070526,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6899,TBX1,T-box 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX1,HGNC:11592,T-box transcription factor 1,6899,ENSG00000184058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6925,TCF4,transcription factor 4,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF4,HGNC:11634,transcription factor 4,6925,ENSG00000196628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6999,TDO2,"tryptophan 2,3-dioxygenase",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26011,TENM4,teneurin transmembrane protein 4,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TENM4,HGNC:29945,teneurin transmembrane protein 4,26011,ENSG00000149256,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80312,TET1,tet methylcytosine dioxygenase 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TET1,HGNC:29484,tet methylcytosine dioxygenase 1,80312,ENSG00000138336,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10452,TOMM40,translocase of outer mitochondrial membrane 40 homolog (yeast),C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TOMM40,HGNC:18001,translocase of outer mitochondrial membrane 40,10452,ENSG00000130204,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
121278,TPH2,tryptophan hydroxylase 2,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7226,TRPM2,"transient receptor potential cation channel, subfamily M, member 2",C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRPM2,HGNC:12339,transient receptor potential cation channel subfamily M member 2,7226,ENSG00000142185,TRPM2,Transient receptor potential cation channel subfamily M member 2,Ion channel,TRPM2_HUMAN,4.15,IC50,CHEMBL
7257,TSNAX,translin-associated factor X,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX,HGNC:12380,translin associated factor X,7257,ENSG00000116918,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7299,TYR,tyrosinase,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TYR,HGNC:12442,tyrosinase,7299,ENSG00000077498,TYR,Tyrosinase,Enzyme,TYRO_HUMAN,6.25,IC50,CHEMBL
23286,WWC1,WW and C2 domain containing 1,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WWC1,HGNC:29435,WW and C2 domain containing 1,23286,ENSG00000113645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64288,ZSCAN31,zinc finger and SCAN domain containing 31,C0033975,psychotic disorders,Schizophrenia spectrum and other psychotic disorders,C0033975,Psychotic Disorders,group,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZSCAN31,HGNC:14097,zinc finger and SCAN domain containing 31,64288,ENSG00000235109,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23305,ACSL6,acyl-CoA synthetase long-chain family member 6,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSL6,HGNC:16496,acyl-CoA synthetase long chain family member 6,23305,ENSG00000164398,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
203228,C9orf72,chromosome 9 open reading frame 72,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C9orf72,HGNC:28337,C9orf72-SMCR8 complex subunit,203228,ENSG00000147894,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
811,CALR,calreticulin,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100616496,ERVW-4,"endogenous retrovirus group W, member 4",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERVW-4,HGNC:39043,endogenous retrovirus group W member 4,100616496,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9638,FEZ1,fasciculation and elongation protein zeta 1 (zygin I),C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEZ1,HGNC:3659,fasciculation and elongation protein zeta 1,9638,ENSG00000149557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA1,HGNC:4571,glutamate ionotropic receptor AMPA type subunit 1,2890,ENSG00000155511,GRIA1,Glutamate receptor 1,Ion channel,GRIA1_HUMAN,5.7,EC50,CHEMBL
3077,HFE,hemochromatosis,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HFE,HGNC:4886,homeostatic iron regulator,3077,ENSG00000010704,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51586,MED15,mediator complex subunit 15,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED15,HGNC:14248,mediator complex subunit 15,51586,ENSG00000099917,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4762,NEUROG1,neurogenin 1,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEUROG1,HGNC:7764,neurogenin 1,4762,ENSG00000181965,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4862,NPAS2,neuronal PAS domain protein 2,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS2,HGNC:7895,neuronal PAS domain protein 2,4862,ENSG00000170485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
83259,PCDH11Y,protocadherin 11 Y-linked,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCDH11Y,HGNC:15813,protocadherin 11 Y-linked,83259,ENSG00000099715,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5159,PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDGFRB,HGNC:8804,platelet derived growth factor receptor beta,5159,ENSG00000113721,PDGFRB,Platelet-derived growth factor receptor beta,Kinase,PGFRB_HUMAN,9.2,Kd,CHEMBL
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G4A,HGNC:9035,phospholipase A2 group IVA,5321,ENSG00000116711,PLA2G4A,Cytosolic phospholipase A2,Enzyme,PA24A_HUMAN,0,0,WOMBAT-PK
5578,PRKCA,"protein kinase C, alpha",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCA,HGNC:9393,protein kinase C alpha,5578,ENSG00000154229,PRKCA,Protein kinase C alpha type,Kinase,KPCA_HUMAN,5.22,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
23408,SIRT5,sirtuin 5,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT5,HGNC:14933,sirtuin 5,23408,ENSG00000124523,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,SIR5_HUMAN,4.33,IC50,CHEMBL
6750,SST,somatostatin,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SST,HGNC:11329,somatostatin,6750,ENSG00000157005,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
25830,SULT4A1,"sulfotransferase family 4A, member 1",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SULT4A1,HGNC:14903,sulfotransferase family 4A member 1,25830,ENSG00000130540,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF7L2,HGNC:11641,transcription factor 7 like 2,6934,ENSG00000148737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7018,TF,transferrin,C0036337,schizoaffective disorder,Schizophrenia spectrum and other psychotic disorders,C0036337,Schizoaffective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TF,HGNC:11740,transferrin,7018,ENSG00000091513,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCA1,HGNC:29,ATP binding cassette subfamily A member 1,19,ENSG00000165029,ABCA1,ATP-binding cassette sub-family A member 1,Transporter,ABCA1_HUMAN,0,0,CHEMBL
154664,ABCA13,"ATP-binding cassette, sub-family A (ABC1), member 13",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCA13,HGNC:14638,ATP binding cassette subfamily A member 13,154664,ENSG00000179869,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
1636,ACE,angiotensin I converting enzyme,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
43,ACHE,acetylcholinesterase (Yt blood group),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACHE,HGNC:108,acetylcholinesterase (Cartwright blood group),43,ENSG00000087085,ACHE,Acetylcholinesterase,Enzyme,ACES_HUMAN,6.12,IC50,CHEMBL
52,ACP1,"acid phosphatase 1, soluble",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACP1,HGNC:122,acid phosphatase 1,52,ENSG00000143727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSL4,HGNC:3571,acyl-CoA synthetase long chain family member 4,2182,ENSG00000068366,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23305,ACSL6,acyl-CoA synthetase long-chain family member 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSL6,HGNC:16496,acyl-CoA synthetase long chain family member 6,23305,ENSG00000164398,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116285,ACSM1,acyl-CoA synthetase medium-chain family member 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSM1,HGNC:18049,acyl-CoA synthetase medium chain family member 1,116285,ENSG00000166743,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
60,ACTB,"actin, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACTB,HGNC:132,actin beta,60,ENSG00000075624,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10097,ACTR2,ARP2 actin-related protein 2 homolog (yeast),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACTR2,HGNC:169,actin related protein 2,10097,ENSG00000138071,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8038,ADAM12,ADAM metallopeptidase domain 12,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADAM12,HGNC:190,ADAM metallopeptidase domain 12,8038,ENSG00000148848,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
81792,ADAMTS12,"ADAM metallopeptidase with thrombospondin type 1 motif, 12",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADAMTS12,HGNC:14605,ADAM metallopeptidase with thrombospondin type 1 motif 12,81792,ENSG00000151388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57188,ADAMTSL3,ADAMTS-like 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADAMTSL3,HGNC:14633,ADAMTS like 3,57188,ENSG00000156218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
104,ADARB1,"adenosine deaminase, RNA-specific, B1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADARB1,HGNC:226,adenosine deaminase RNA specific B1,104,ENSG00000197381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1,HGNC:241,adenylate cyclase activating polypeptide 1,116,ENSG00000141433,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
117,ADCYAP1R1,adenylate cyclase activating polypeptide 1 (pituitary) receptor type I,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCYAP1R1,HGNC:242,ADCYAP receptor type I,117,ENSG00000078549,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
132,ADK,adenosine kinase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADK,HGNC:257,adenosine kinase,132,ENSG00000156110,ADK,Adenosine kinase,Kinase,ADK_HUMAN,6,IC50,WOMBAT-PK
133,ADM,adrenomedullin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADM,HGNC:259,adrenomedullin,133,ENSG00000148926,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23394,ADNP,activity-dependent neuroprotector homeobox,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADNP,HGNC:15766,activity dependent neuroprotector homeobox,23394,ENSG00000101126,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
22850,ADNP2,ADNP homeobox 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADNP2,HGNC:23803,ADNP homeobox 2,22850,ENSG00000101544,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
134,ADORA1,adenosine A1 receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADORA1,HGNC:262,adenosine A1 receptor,134,ENSG00000163485,ADORA1,Adenosine receptor A1,GPCR,AA1R_HUMAN,6.5086,EC50,WOMBAT-PK
135,ADORA2A,adenosine A2a receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADORA2A,HGNC:263,adenosine A2a receptor,135,ENSG00000128271,ADORA2A,Adenosine receptor A2a,GPCR,AA2AR_HUMAN,6.1549,EC50,WOMBAT-PK
148,ADRA1A,adrenoceptor alpha 1A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
150,ADRA2A,adrenoceptor alpha 2A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2A,HGNC:281,adrenoceptor alpha 2A,150,ENSG00000150594,ADRA2A,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,6.3,IC50,WOMBAT-PK
155,ADRB3,adrenoceptor beta 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB3,HGNC:288,adrenoceptor beta 3,155,ENSG00000188778,ADRB3,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,6.86,Kd,CHEMBL
157,ADRBK2,"adrenergic, beta, receptor kinase 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
159,ADSS,adenylosuccinate synthase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
175,AGA,aspartylglucosaminidase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGA,HGNC:318,aspartylglucosaminidase,175,ENSG00000038002,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
177,AGER,advanced glycosylation end product-specific receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGER,HGNC:320,advanced glycosylation end-product specific receptor,177,ENSG00000204305,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64902,AGXT2,alanine--glyoxylate aminotransferase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AGXT2,HGNC:14412,alanine--glyoxylate aminotransferase 2,64902,ENSG00000113492,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9495,AKAP5,A kinase (PRKA) anchor protein 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKAP5,HGNC:375,A-kinase anchoring protein 5,9495,ENSG00000179841,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10327,AKR1A1,"aldo-keto reductase family 1, member A1 (aldehyde reductase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1A1,HGNC:380,aldo-keto reductase family 1 member A1,10327,ENSG00000117448,AKR1A1,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_HUMAN,5.59,IC50,CHEMBL
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH1A1,HGNC:402,aldehyde dehydrogenase 1 family member A1,216,ENSG00000165092,ALDH1A1,Retinal dehydrogenase 1,Enzyme,AL1A1_HUMAN,0,0,WOMBAT-PK
8854,ALDH1A2,"aldehyde dehydrogenase 1 family, member A2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH1A2,HGNC:15472,aldehyde dehydrogenase 1 family member A2,8854,ENSG00000128918,ALDH1A2,Retinal dehydrogenase 2,Enzyme,AL1A2_HUMAN,0,0,WOMBAT-PK
218,ALDH3A1,"aldehyde dehydrogenase 3 family, member A1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH3A1,HGNC:405,aldehyde dehydrogenase 3 family member A1,218,ENSG00000108602,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
221,ALDH3B1,"aldehyde dehydrogenase 3 family, member B1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH3B1,HGNC:410,aldehyde dehydrogenase 3 family member B1,221,ENSG00000006534,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
238,ALK,anaplastic lymphoma receptor tyrosine kinase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALK,HGNC:427,ALK receptor tyrosine kinase,238,ENSG00000171094,ALK,ALK tyrosine kinase receptor,Kinase,ALK_HUMAN,5.92,Kd,CHEMBL
239,ALOX12,arachidonate 12-lipoxygenase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALOX12,HGNC:429,"arachidonate 12-lipoxygenase, 12S type",239,ENSG00000108839,ALOX12,"Arachidonate 12-lipoxygenase, 12S-type",Enzyme,LOX12_HUMAN,5.72,IC50,CHEMBL
23600,AMACR,alpha-methylacyl-CoA racemase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AMACR,HGNC:451,alpha-methylacyl-CoA racemase,23600,ENSG00000242110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55626,AMBRA1,autophagy/beclin-1 regulator 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AMBRA1,HGNC:25990,autophagy and beclin 1 regulator 1,55626,ENSG00000110497,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANK3,HGNC:494,ankyrin 3,288,ENSG00000151150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
26985,AP3M1,"adaptor-related protein complex 3, mu 1 subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AP3M1,HGNC:569,adaptor related protein complex 3 subunit mu 1,26985,ENSG00000185009,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
321,APBA2,"amyloid beta (A4) precursor protein-binding, family A, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APBA2,HGNC:579,amyloid beta precursor protein binding family A member 2,321,ENSG00000034053,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
324,APC,adenomatous polyposis coli,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APC,HGNC:583,APC regulator of WNT signaling pathway,324,ENSG00000134982,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
347,APOD,apolipoprotein D,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOD,HGNC:612,apolipoprotein D,347,ENSG00000189058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
350,APOH,apolipoprotein H (beta-2-glycoprotein I),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOH,HGNC:616,apolipoprotein H,350,ENSG00000091583,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
361,AQP4,aquaporin 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AQP4,HGNC:637,aquaporin 4,361,ENSG00000171885,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
367,AR,androgen receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
23237,ARC,activity-regulated cytoskeleton-associated protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARC,HGNC:648,activity regulated cytoskeleton associated protein,23237,ENSG00000198576,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
392,ARHGAP1,Rho GTPase activating protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGAP1,HGNC:673,Rho GTPase activating protein 1,392,ENSG00000175220,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
93663,ARHGAP18,Rho GTPase activating protein 18,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGAP18,HGNC:21035,Rho GTPase activating protein 18,93663,ENSG00000146376,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9743,ARHGAP32,Rho GTPase activating protein 32,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGAP32,HGNC:17399,Rho GTPase activating protein 32,9743,ENSG00000134909,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9826,ARHGEF11,Rho guanine nucleotide exchange factor (GEF) 11,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARHGEF11,HGNC:14580,Rho guanine nucleotide exchange factor 11,9826,ENSG00000132694,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
409,ARRB2,"arrestin, beta 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB2,HGNC:712,arrestin beta 2,409,ENSG00000141480,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
421,ARVCF,armadillo repeat gene deleted in velocardiofacial syndrome,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARVCF,HGNC:728,ARVCF delta catenin family member,421,ENSG00000099889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
427,ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASAH1,HGNC:735,N-acylsphingosine amidohydrolase 1,427,ENSG00000104763,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23245,ASTN2,astrotactin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASTN2,HGNC:17021,astrotactin 2,23245,ENSG00000148219,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
468,ATF4,activating transcription factor 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATF4,HGNC:786,activating transcription factor 4,468,ENSG00000128272,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
472,ATM,ATM serine/threonine kinase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATM,HGNC:795,ATM serine/threonine kinase,472,ENSG00000149311,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP2A2,HGNC:812,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,488,ENSG00000174437,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4508,ATP6,ATP synthase F0 subunit 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6311,ATXN2,ataxin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATXN2,HGNC:10555,ataxin 2,6311,ENSG00000204842,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26053,AUTS2,autism susceptibility candidate 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AUTS2,HGNC:14262,activator of transcription and developmental regulator AUTS2,26053,ENSG00000158321,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
552,AVPR1A,arginine vasopressin receptor 1A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVPR1A,HGNC:895,arginine vasopressin receptor 1A,552,ENSG00000166148,AVPR1A,Vasopressin V1a receptor,GPCR,V1AR_HUMAN,7.389999866,EC50,CHEMBL
567,B2M,beta-2-microglobulin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,B2M,HGNC:914,beta-2-microglobulin,567,ENSG00000166710,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27087,B3GAT1,"beta-1,3-glucuronyltransferase 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,B3GAT1,HGNC:921,"beta-1,3-glucuronyltransferase 1",27087,ENSG00000109956,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
135152,B3GAT2,"beta-1,3-glucuronyltransferase 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,B3GAT2,HGNC:922,"beta-1,3-glucuronyltransferase 2",135152,ENSG00000112309,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10678,B3GNT2,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,B3GNT2,HGNC:15629,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2",10678,ENSG00000170340,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23621,BACE1,beta-site APP-cleaving enzyme 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BACE1,HGNC:933,beta-secretase 1,23621,ENSG00000186318,BACE1,Beta-secretase 1,Enzyme,BACE1_HUMAN,4.519999981,IC50,CHEMBL
573,BAG1,BCL2-associated athanogene,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BAG1,HGNC:937,BAG cochaperone 1,573,ENSG00000107262,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
53335,BCL11A,B-cell CLL/lymphoma 11A (zinc finger protein),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL11A,HGNC:13221,BAF chromatin remodeling complex subunit BCL11A,53335,ENSG00000119866,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
596,BCL2,B-cell CLL/lymphoma 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL2,HGNC:990,BCL2 apoptosis regulator,596,ENSG00000171791,BCL2,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,4.22,Kd,CHEMBL
607,BCL9,B-cell CLL/lymphoma 9,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL9,HGNC:1008,BCL9 transcription coactivator,607,ENSG00000116128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8678,BECN1,"beclin 1, autophagy related",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BECN1,HGNC:1034,beclin 1,8678,ENSG00000126581,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8553,BHLHE40,"basic helix-loop-helix family, member e40",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BHLHE40,HGNC:1046,basic helix-loop-helix family member e40,8553,ENSG00000134107,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
637,BID,BH3 interacting domain death agonist,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BID,HGNC:1050,BH3 interacting domain death agonist,637,ENSG00000015475,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
638,BIK,BCL2-interacting killer (apoptosis-inducing),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BIK,HGNC:1051,BCL2 interacting killer,638,ENSG00000100290,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2647,BLOC1S1,"biogenesis of lysosomal organelles complex-1, subunit 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BLOC1S1,HGNC:4200,biogenesis of lysosomal organelles complex 1 subunit 1,2647,ENSG00000135441,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
388552,BLOC1S3,"biogenesis of lysosomal organelles complex-1, subunit 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BLOC1S3,HGNC:20914,biogenesis of lysosomal organelles complex 1 subunit 3,388552,ENSG00000189114,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8315,BRAP,BRCA1 associated protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRAP,HGNC:1099,BRCA1 associated protein,8315,ENSG00000089234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
672,BRCA1,"breast cancer 1, early onset",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRCA1,HGNC:1100,BRCA1 DNA repair associated,672,ENSG00000012048,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
675,BRCA2,"breast cancer 2, early onset",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRCA2,HGNC:1101,BRCA2 DNA repair associated,675,ENSG00000139618,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23774,BRD1,bromodomain containing 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BRD1,HGNC:1102,bromodomain containing 1,23774,ENSG00000100425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
682,BSG,basigin (Ok blood group),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BSG,HGNC:1116,basigin (Ok blood group),682,ENSG00000172270,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114781,BTBD9,BTB (POZ) domain containing 9,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BTBD9,HGNC:21228,BTB domain containing 9,114781,ENSG00000183826,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
685,BTC,betacellulin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BTC,HGNC:1121,betacellulin,685,ENSG00000174808,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57103,C12orf5,chromosome 12 open reading frame 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
400359,C15orf53,chromosome 15 open reading frame 53,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
712,C1QA,"complement component 1, q subcomponent, A chain",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C1QA,HGNC:1241,complement C1q A chain,712,ENSG00000173372,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
713,C1QB,"complement component 1, q subcomponent, B chain",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C1QB,HGNC:1242,complement C1q B chain,713,ENSG00000173369,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114899,C1QTNF3,C1q and tumor necrosis factor related protein 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C1QTNF3,HGNC:14326,C1q and TNF related 3,114899,ENSG00000082196,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
722,C4BPA,"complement component 4 binding protein, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C4BPA,HGNC:1325,complement component 4 binding protein alpha,722,ENSG00000123838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
725,C4BPB,"complement component 4 binding protein, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C4BPB,HGNC:1328,complement component 4 binding protein beta,725,ENSG00000123843,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
203228,C9orf72,chromosome 9 open reading frame 72,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,C9orf72,HGNC:28337,C9orf72-SMCR8 complex subunit,203228,ENSG00000147894,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23523,CABIN1,calcineurin binding protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CABIN1,HGNC:24187,calcineurin binding protein 1,23523,ENSG00000099991,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
774,CACNA1B,"calcium channel, voltage-dependent, N type, alpha 1B subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1B,HGNC:1389,calcium voltage-gated channel subunit alpha1 B,774,ENSG00000148408,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,CAC1B_HUMAN,5.78,IC50,CHEMBL
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
778,CACNA1F,"calcium channel, voltage-dependent, L type, alpha 1F subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1F,HGNC:1393,calcium voltage-gated channel subunit alpha1 F,778,ENSG00000102001,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,CAC1F_HUMAN,6,IC50,IUPHAR
783,CACNB2,"calcium channel, voltage-dependent, beta 2 subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNB2,HGNC:1402,calcium voltage-gated channel auxiliary subunit beta 2,783,ENSG00000165995,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10369,CACNG2,"calcium channel, voltage-dependent, gamma subunit 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNG2,HGNC:1406,calcium voltage-gated channel auxiliary subunit gamma 2,10369,ENSG00000166862,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27091,CACNG5,"calcium channel, voltage-dependent, gamma subunit 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNG5,HGNC:1409,calcium voltage-gated channel auxiliary subunit gamma 5,27091,ENSG00000075429,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
59283,CACNG8,"calcium channel, voltage-dependent, gamma subunit 8",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNG8,HGNC:13628,calcium voltage-gated channel auxiliary subunit gamma 8,59283,ENSG00000142408,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
93664,CADPS2,Ca++-dependent secretion activator 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CADPS2,HGNC:16018,calcium dependent secretion activator 2,93664,ENSG00000081803,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
793,CALB1,"calbindin 1, 28kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALB1,HGNC:1434,calbindin 1,793,ENSG00000104327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALM1,HGNC:1442,calmodulin 1,801,ENSG00000198668,CALM1,Calmodulin,Cytosolic other,CALM_HUMAN,4.7447,ID50,WOMBAT-PK
50632,CALY,calcyon neuron-specific vesicular protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALY,HGNC:17938,calcyon neuron specific vesicular protein,50632,ENSG00000130643,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10645,CAMKK2,"calcium/calmodulin-dependent protein kinase kinase 2, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMKK2,HGNC:1470,calcium/calmodulin dependent protein kinase kinase 2,10645,ENSG00000110931,CAMKK2,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,KKCC2_HUMAN,5.82,Kd,CHEMBL
9607,CARTPT,CART prepropeptide,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CASP3,HGNC:1504,caspase 3,836,ENSG00000164305,CASP3,Caspase-3,Enzyme,CASP3_HUMAN,5.099999905,EC50,CHEMBL
857,CAV1,"caveolin 1, caveolae protein, 22kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAV1,HGNC:1527,caveolin 1,857,ENSG00000105974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
875,CBS,cystathionine-beta-synthase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CBS,HGNC:1550,cystathionine beta-synthase,875,ENSG00000160200,CBS,Cystathionine beta-synthase,Enzyme,CBS_HUMAN,0,0,WOMBAT-PK
80323,CCDC68,coiled-coil domain containing 68,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCDC68,HGNC:24350,coiled-coil domain containing 68,80323,ENSG00000166510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79080,CCDC86,coiled-coil domain containing 86,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCDC86,HGNC:28359,coiled-coil domain containing 86,79080,ENSG00000110104,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
885,CCK,cholecystokinin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCK,HGNC:1569,cholecystokinin,885,ENSG00000187094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
886,CCKAR,cholecystokinin A receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
890,CCNA2,cyclin A2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCNA2,HGNC:1578,cyclin A2,890,ENSG00000145386,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
595,CCND1,cyclin D1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCND1,HGNC:1582,cyclin D1,595,ENSG00000110092,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
894,CCND2,cyclin D2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCND2,HGNC:1583,cyclin D2,894,ENSG00000118971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1234,CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCR5,HGNC:1606,C-C motif chemokine receptor 5,1234,ENSG00000160791,CCR5,C-C chemokine receptor type 5,GPCR,CCR5_HUMAN,4.737928787,Ki,DRUG MATRIX
929,CD14,CD14 molecule,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD14,HGNC:1628,CD14 molecule,929,ENSG00000170458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9332,CD163,CD163 molecule,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD163,HGNC:1631,CD163 molecule,9332,ENSG00000177575,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
962,CD48,CD48 molecule,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD48,HGNC:1683,CD48 molecule,962,ENSG00000117091,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4267,CD99,CD99 molecule,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD99,HGNC:7082,CD99 molecule (Xg blood group),4267,ENSG00000002586,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
995,CDC25C,cell division cycle 25C,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDC25C,HGNC:1727,cell division cycle 25C,995,ENSG00000158402,CDC25C,Dual specificity phosphatase Cdc25C,Enzyme,MPIP3_HUMAN,4.73,IC50,CHEMBL
998,CDC42,cell division cycle 42,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDC42,HGNC:1736,cell division cycle 42,998,ENSG00000070831,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10602,CDC42EP3,CDC42 effector protein (Rho GTPase binding) 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDC42EP3,HGNC:16943,CDC42 effector protein 3,10602,ENSG00000163171,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56990,CDC42SE2,CDC42 small effector 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDC42SE2,HGNC:18547,CDC42 small effector 2,56990,ENSG00000158985,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5127,CDK16,cyclin-dependent kinase 16,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDK16,HGNC:8749,cyclin dependent kinase 16,5127,ENSG00000102225,CDK16,Cyclin-dependent kinase 16,Kinase,CDK16_HUMAN,6.89,Kd,CHEMBL
1020,CDK5,cyclin-dependent kinase 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDK5,HGNC:1774,cyclin dependent kinase 5,1020,ENSG00000164885,CDK5,Cyclin-dependent-like kinase 5,Kinase,CDK5_HUMAN,5.21,Kd,CHEMBL
8851,CDK5R1,"cyclin-dependent kinase 5, regulatory subunit 1 (p35)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDK5R1,HGNC:1775,cyclin dependent kinase 5 regulatory subunit 1,8851,ENSG00000176749,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDKN1C,HGNC:1786,cyclin dependent kinase inhibitor 1C,1028,ENSG00000129757,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
90273,CEACAM21,carcinoembryonic antigen-related cell adhesion molecule 21,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CEACAM21,HGNC:28834,CEA cell adhesion molecule 21,90273,ENSG00000007129,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9620,CELSR1,"cadherin, EGF LAG seven-pass G-type receptor 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CELSR1,HGNC:1850,cadherin EGF LAG seven-pass G-type receptor 1,9620,ENSG00000075275,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1068,CETN1,"centrin, EF-hand protein, 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CETN1,HGNC:1866,centrin 1,1068,ENSG00000177143,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84952,CGNL1,cingulin-like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CGNL1,HGNC:25931,cingulin like 1,84952,ENSG00000128849,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1103,CHAT,choline O-acetyltransferase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHAT,HGNC:1912,choline O-acetyltransferase,1103,ENSG00000070748,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1111,CHEK1,checkpoint kinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHEK1,HGNC:1925,checkpoint kinase 1,1111,ENSG00000149554,CHEK1,Serine/threonine-protein kinase Chk1,Kinase,CHK1_HUMAN,6.52,Kd,CHEMBL
1113,CHGA,chromogranin A (parathyroid secretory protein 1),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHGA,HGNC:1929,chromogranin A,1113,ENSG00000100604,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1114,CHGB,chromogranin B (secretogranin 1),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHGB,HGNC:1930,chromogranin B,1114,ENSG00000089199,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
89832,CHRFAM7A,"CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRFAM7A,HGNC:15781,CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion,89832,ENSG00000166664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1128,CHRM1,"cholinergic receptor, muscarinic 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM1,HGNC:1950,cholinergic receptor muscarinic 1,1128,ENSG00000168539,CHRM1,Muscarinic acetylcholine receptor M1,GPCR,ACM1_HUMAN,6.11,EC50,CHEMBL
1129,CHRM2,"cholinergic receptor, muscarinic 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM2,HGNC:1951,cholinergic receptor muscarinic 2,1129,ENSG00000181072,CHRM2,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,5.900000095,Ki,IUPHAR
1132,CHRM4,"cholinergic receptor, muscarinic 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM4,HGNC:1953,cholinergic receptor muscarinic 4,1132,ENSG00000180720,CHRM4,Muscarinic acetylcholine receptor M4,GPCR,ACM4_HUMAN,5.050000191,Ki,IUPHAR
1133,CHRM5,"cholinergic receptor, muscarinic 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM5,HGNC:1954,cholinergic receptor muscarinic 5,1133,ENSG00000184984,CHRM5,Muscarinic acetylcholine receptor M5,GPCR,ACM5_HUMAN,6.1,EC50,CHEMBL
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA3,HGNC:1957,cholinergic receptor nicotinic alpha 3 subunit,1136,ENSG00000080644,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_HUMAN,4.17,Ki,CHEMBL
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA4,HGNC:1958,cholinergic receptor nicotinic alpha 4 subunit,1137,ENSG00000101204,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,4.039999962,IC50,IUPHAR
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA5,HGNC:1959,cholinergic receptor nicotinic alpha 5 subunit,1138,ENSG00000169684,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA7,HGNC:1960,cholinergic receptor nicotinic alpha 7 subunit,1139,ENSG00000175344,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_HUMAN,5.1,Ki,CHEMBL
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB2,HGNC:1962,cholinergic receptor nicotinic beta 2 subunit,1141,ENSG00000160716,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1152,CKB,"creatine kinase, brain",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CKB,HGNC:1991,creatine kinase B,1152,ENSG00000166165,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5010,CLDN11,claudin 11,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLDN11,HGNC:8514,claudin 11,5010,ENSG00000013297,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7122,CLDN5,claudin 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLDN5,HGNC:2047,claudin 5,7122,ENSG00000184113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1191,CLU,clusterin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLU,HGNC:2095,clusterin,1191,ENSG00000120885,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
134829,CLVS2,clavesin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLVS2,HGNC:23046,clavesin 2,134829,ENSG00000146352,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
202333,CMYA5,cardiomyopathy associated 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CMYA5,HGNC:14305,cardiomyopathy associated 5,202333,ENSG00000164309,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
149111,CNIH3,cornichon family AMPA receptor auxiliary protein 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNIH3,HGNC:26802,cornichon family AMPA receptor auxiliary protein 3,149111,ENSG00000143786,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29097,CNIH4,cornichon family AMPA receptor auxiliary protein 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNIH4,HGNC:25013,cornichon family AMPA receptor auxiliary protein 4,29097,ENSG00000143771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54805,CNNM2,cyclin and CBS domain divalent metal cation transport mediator 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNNM2,HGNC:103,cyclin and CBS domain divalent metal cation transport mediator 2,54805,ENSG00000148842,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1267,CNP,"2',3'-cyclic nucleotide 3' phosphodiesterase",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNP,HGNC:2158,"2',3'-cyclic nucleotide 3' phosphodiesterase",1267,ENSG00000173786,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27013,CNPPD1,cyclin Pas1/PHO80 domain containing 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNPPD1,HGNC:25220,cyclin Pas1/PHO80 domain containing 1,27013,ENSG00000115649,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1269,CNR2,cannabinoid receptor 2 (macrophage),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1270,CNTF,ciliary neurotrophic factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTF,HGNC:2169,ciliary neurotrophic factor,1270,ENSG00000242689,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1385,CREB1,cAMP responsive element binding protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1387,CREBBP,CREB binding protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREBBP,HGNC:2348,CREB binding protein,1387,ENSG00000005339,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1390,CREM,cAMP responsive element modulator,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREM,HGNC:2352,cAMP responsive element modulator,1390,ENSG00000095794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1400,CRMP1,collapsin response mediator protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRMP1,HGNC:2365,collapsin response mediator protein 1,1400,ENSG00000072832,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1401,CRP,"C-reactive protein, pentraxin-related",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRP,HGNC:2367,C-reactive protein,1401,ENSG00000132693,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1429,CRYZ,"crystallin, zeta (quinone reductase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRYZ,HGNC:2419,crystallin zeta,1429,ENSG00000116791,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSF2,HGNC:2434,colony stimulating factor 2,1437,ENSG00000164400,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1438,CSF2RA,"colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSF2RA,HGNC:2435,colony stimulating factor 2 receptor subunit alpha,1438,ENSG00000198223,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1439,CSF2RB,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSF2RB,HGNC:2436,colony stimulating factor 2 receptor subunit beta,1439,ENSG00000100368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64478,CSMD1,CUB and Sushi multiple domains 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSMD1,HGNC:14026,CUB and Sushi multiple domains 1,64478,ENSG00000183117,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114784,CSMD2,CUB and Sushi multiple domains 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSMD2,HGNC:19290,CUB and Sushi multiple domains 2,114784,ENSG00000121904,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1453,CSNK1D,"casein kinase 1, delta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1D,HGNC:2452,casein kinase 1 delta,1453,ENSG00000141551,CSNK1D,Casein kinase I isoform delta,Kinase,KC1D_HUMAN,5.46,Kd,CHEMBL
1454,CSNK1E,"casein kinase 1, epsilon",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1E,HGNC:2453,casein kinase 1 epsilon,1454,ENSG00000213923,CSNK1E,Casein kinase I isoform epsilon,Kinase,KC1E_HUMAN,5.82,Kd,CHEMBL
10675,CSPG5,chondroitin sulfate proteoglycan 5 (neuroglycan C),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSPG5,HGNC:2467,chondroitin sulfate proteoglycan 5,10675,ENSG00000114646,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10664,CTCF,CCCTC-binding factor (zinc finger protein),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTCF,HGNC:13723,CCCTC-binding factor,10664,ENSG00000102974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTLA4,HGNC:2505,cytotoxic T-lymphocyte associated protein 4,1493,ENSG00000163599,CTLA4,Cytotoxic T-lymphocyte protein 4,Surface antigen,CTLA4_HUMAN,0,0,DRUG LABEL
1496,CTNNA2,"catenin (cadherin-associated protein), alpha 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNNA2,HGNC:2510,catenin alpha 2,1496,ENSG00000066032,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNNB1,HGNC:2514,catenin beta 1,1499,ENSG00000168036,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNND2,HGNC:2516,catenin delta 2,1501,ENSG00000169862,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1506,CTRL,chymotrypsin-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTRL,HGNC:2524,chymotrypsin like,1506,ENSG00000141086,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1513,CTSK,cathepsin K,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTSK,HGNC:2536,cathepsin K,1513,ENSG00000143387,CTSK,Cathepsin K,Enzyme,CATK_HUMAN,7.4,IC50,CHEMBL
613212,CTXN3,cortexin 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTXN3,HGNC:31110,cortexin 3,613212,ENSG00000205279,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23191,CYFIP1,cytoplasmic FMR1 interacting protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYFIP1,HGNC:13759,cytoplasmic FMR1 interacting protein 1,23191,ENSG00000273749,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP1A2,HGNC:2596,cytochrome P450 family 1 subfamily A member 2,1544,ENSG00000140505,CYP1A2,Cytochrome P450 1A2,Enzyme,CP1A2_HUMAN,7.397940009,IC50,DRUG MATRIX
56603,CYP26B1,"cytochrome P450, family 26, subfamily B, polypeptide 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP26B1,HGNC:20581,cytochrome P450 family 26 subfamily B member 1,56603,ENSG00000003137,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
340665,CYP26C1,"cytochrome P450, family 26, subfamily C, polypeptide 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP26C1,HGNC:20577,cytochrome P450 family 26 subfamily C member 1,340665,ENSG00000187553,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2E1,HGNC:2631,cytochrome P450 family 2 subfamily E member 1,1571,ENSG00000130649,CYP2E1,Cytochrome P450 2E1,Enzyme,CP2E1_HUMAN,4.958607315,IC50,DRUG MATRIX
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP3A4,HGNC:2637,cytochrome P450 family 3 subfamily A member 4,1576,ENSG00000160868,CYP3A4,Cytochrome P450 3A4,Enzyme,CP3A4_HUMAN,4.61,Km,WOMBAT-PK
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP3A5,HGNC:2638,cytochrome P450 family 3 subfamily A member 5,1577,ENSG00000106258,CYP3A5,Cytochrome P450 3A5,Enzyme,CP3A5_HUMAN,5.11,IC50,WOMBAT-PK
23500,DAAM2,dishevelled associated activator of morphogenesis 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAAM2,HGNC:18143,dishevelled associated activator of morphogenesis 2,23500,ENSG00000146122,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
282706,DAOA-AS1,DAOA antisense RNA 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA-AS1,HGNC:30243,DAOA antisense RNA 1,282706,ENSG00000232307,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26528,DAZAP1,DAZ associated protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAZAP1,HGNC:2683,DAZ associated protein 1,26528,ENSG00000071626,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1622,DBI,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBI,HGNC:2690,"diazepam binding inhibitor, acyl-CoA binding protein",1622,ENSG00000155368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1627,DBN1,drebrin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBN1,HGNC:2695,drebrin 1,1627,ENSG00000113758,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1630,DCC,DCC netrin 1 receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCC,HGNC:2701,DCC netrin 1 receptor,1630,ENSG00000187323,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51473,DCDC2,doublecortin domain containing 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCDC2,HGNC:18141,doublecortin domain containing 2,51473,ENSG00000146038,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9201,DCLK1,doublecortin-like kinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCLK1,HGNC:2700,doublecortin like kinase 1,9201,ENSG00000133083,DCLK1,Serine/threonine-protein kinase DCLK1,Kinase,DCLK1_HUMAN,6.43,Kd,CHEMBL
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
8528,DDO,D-aspartate oxidase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDO,HGNC:2727,D-aspartate oxidase,8528,ENSG00000203797,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
780,DDR1,discoidin domain receptor tyrosine kinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDR1,HGNC:2730,discoidin domain receptor tyrosine kinase 1,780,ENSG00000204580,DDR1,Epithelial discoidin domain-containing receptor 1,Kinase,DDR1_HUMAN,9.16,Kd,CHEMBL
100188856,DEL22Q11.2,"Chromosome 22q11.2 deletion syndrome, distal",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
449489,DFNB47,"deafness, autosomal recessive 47",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DFNB47,HGNC:31086,"deafness, autosomal recessive 47",0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8220,DGCR14,DiGeorge syndrome critical region gene 14,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8214,DGCR6,DiGeorge syndrome critical region gene 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGCR6,HGNC:2846,DiGeorge syndrome critical region gene 6,8214,ENSG00000183628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54487,DGCR8,DGCR8 microprocessor complex subunit,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGCR8,HGNC:2847,DGCR8 microprocessor complex subunit,54487,ENSG00000128191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
160851,DGKH,"diacylglycerol kinase, eta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGKH,HGNC:2854,diacylglycerol kinase eta,160851,ENSG00000102780,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23405,DICER1,"dicer 1, ribonuclease type III",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DICER1,HGNC:17098,"dicer 1, ribonuclease III",23405,ENSG00000100697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1735,DIO3,"deiodinase, iodothyronine, type III",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DIO3,HGNC:2885,iodothyronine deiodinase 3,1735,ENSG00000197406,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27122,DKK3,dickkopf WNT signaling pathway inhibitor 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DKK3,HGNC:2893,dickkopf WNT signaling pathway inhibitor 3,27122,ENSG00000050165,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27121,DKK4,dickkopf WNT signaling pathway inhibitor 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DKK4,HGNC:2894,dickkopf WNT signaling pathway inhibitor 4,27121,ENSG00000104371,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1740,DLG2,"discs, large homolog 2 (Drosophila)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG2,HGNC:2901,discs large MAGUK scaffold protein 2,1740,ENSG00000150672,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100302690,DLG2-AS1,DLG2 antisense RNA 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG2-AS1,HGNC:37132,DLG2 antisense RNA 1,100302690,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1741,DLG3,"discs, large homolog 3 (Drosophila)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG3,HGNC:2902,discs large MAGUK scaffold protein 3,1741,ENSG00000082458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9229,DLGAP1,"discs, large (Drosophila) homolog-associated protein 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLGAP1,HGNC:2905,DLG associated protein 1,9229,ENSG00000170579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9228,DLGAP2,"discs, large (Drosophila) homolog-associated protein 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLGAP2,HGNC:2906,DLG associated protein 2,9228,ENSG00000198010,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54567,DLL4,delta-like 4 (Drosophila),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLL4,HGNC:2910,delta like canonical Notch ligand 4,54567,ENSG00000128917,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1745,DLX1,distal-less homeobox 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLX1,HGNC:2914,distal-less homeobox 1,1745,ENSG00000144355,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1759,DNM1,dynamin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNM1,HGNC:2972,dynamin 1,1759,ENSG00000106976,DNM1,Dynamin-1,Structural,DYN1_HUMAN,5.36,IC50,CHEMBL
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNMT1,HGNC:2976,DNA methyltransferase 1,1786,ENSG00000130816,DNMT1,DNA (cytosine-5)-methyltransferase 1,Enzyme,DNMT1_HUMAN,0,0,DRUGBANK
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNMT3B,HGNC:2979,DNA methyltransferase 3 beta,1789,ENSG00000088305,DNMT3B,DNA (cytosine-5)-methyltransferase 3B,Enzyme,DNM3B_HUMAN,0,0,WOMBAT-PK
29947,DNMT3L,DNA (cytosine-5-)-methyltransferase 3-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNMT3L,HGNC:2980,DNA methyltransferase 3 like,29947,ENSG00000142182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9732,DOCK4,dedicator of cytokinesis 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DOCK4,HGNC:19192,dedicator of cytokinesis 4,9732,ENSG00000128512,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29102,DROSHA,"drosha, ribonuclease type III",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DROSHA,HGNC:17904,drosha ribonuclease III,29102,ENSG00000113360,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1848,DUSP6,dual specificity phosphatase 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP6,HGNC:3072,dual specificity phosphatase 6,1848,ENSG00000139318,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54808,DYM,dymeclin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DYM,HGNC:21317,dymeclin,54808,ENSG00000141627,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
90141,EFCAB11,EF-hand calcium binding domain 11,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EFCAB11,HGNC:20357,EF-hand calcium binding domain 11,90141,ENSG00000140025,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1948,EFNB2,ephrin-B2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EFNB2,HGNC:3227,ephrin B2,1948,ENSG00000125266,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1950,EGF,epidermal growth factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGF,HGNC:3229,epidermal growth factor,1950,ENSG00000138798,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1958,EGR1,early growth response 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR1,HGNC:3238,early growth response 1,1958,ENSG00000120738,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1959,EGR2,early growth response 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR2,HGNC:3239,early growth response 2,1959,ENSG00000122877,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1960,EGR3,early growth response 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR3,HGNC:3240,early growth response 3,1960,ENSG00000179388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1961,EGR4,early growth response 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR4,HGNC:3241,early growth response 4,1961,ENSG00000135625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EIF2S1,HGNC:3265,eukaryotic translation initiation factor 2 subunit alpha,1965,ENSG00000134001,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1993,ELAVL2,ELAV like neuron-specific RNA binding protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ELAVL2,HGNC:3313,ELAV like RNA binding protein 2,1993,ENSG00000107105,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
60481,ELOVL5,ELOVL fatty acid elongase 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ELOVL5,HGNC:21308,ELOVL fatty acid elongase 5,60481,ENSG00000012660,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
161436,EML5,echinoderm microtubule associated protein like 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EML5,HGNC:18197,EMAP like 5,161436,ENSG00000165521,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2018,EMX2,empty spiracles homeobox 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EMX2,HGNC:3341,empty spiracles homeobox 2,2018,ENSG00000170370,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2019,EN1,engrailed homeobox 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EN1,HGNC:3342,engrailed homeobox 1,2019,ENSG00000163064,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2020,EN2,engrailed homeobox 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EN2,HGNC:3343,engrailed homeobox 2,2020,ENSG00000164778,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2023,ENO1,"enolase 1, (alpha)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ENO1,HGNC:3350,enolase 1,2023,ENSG00000074800,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2026,ENO2,"enolase 2 (gamma, neuronal)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ENO2,HGNC:3353,enolase 2,2026,ENSG00000111674,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9583,ENTPD4,ectonucleoside triphosphate diphosphohydrolase 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ENTPD4,HGNC:14573,ectonucleoside triphosphate diphosphohydrolase 4,9583,ENSG00000197217,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB3,HGNC:3431,erb-b2 receptor tyrosine kinase 3,2065,ENSG00000065361,ERBB3,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,7.74,Kd,CHEMBL
2066,ERBB4,erb-b2 receptor tyrosine kinase 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB4,HGNC:3432,erb-b2 receptor tyrosine kinase 4,2066,ENSG00000178568,ERBB4,Receptor tyrosine-protein kinase erbB-4,Kinase,ERBB4_HUMAN,7.26,Kd,CHEMBL
9030,ERDA1,"expanded repeat domain, CAG/CTG 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERDA1,HGNC:3442,"expanded repeat domain, CAG/CTG 1",9030,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100775105,ERVK-18,"endogenous retrovirus group K, member 18",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERVK-18,HGNC:39025,endogenous retrovirus group K member 18,100775105,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
619465,ERVK-8,"endogenous retrovirus group K, member 8",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERVK-8,HGNC:32302,"endogenous retrovirus group K member 8, envelope",619465,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
30816,ERVW-1,"endogenous retrovirus group W, member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERVW-1,HGNC:13525,"endogenous retrovirus group W member 1, envelope",30816,ENSG00000242950,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100616496,ERVW-4,"endogenous retrovirus group W, member 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERVW-4,HGNC:39043,endogenous retrovirus group W member 4,100616496,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2099,ESR1,estrogen receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
2100,ESR2,estrogen receptor 2 (ER beta),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR2,HGNC:3468,estrogen receptor 2,2100,ENSG00000140009,ESR2,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,8,IC50,CHEMBL
64850,ETNPPL,ethanolamine-phosphate phospho-lyase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ETNPPL,HGNC:14404,ethanolamine-phosphate phospho-lyase,64850,ENSG00000164089,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2166,FAAH,fatty acid amide hydrolase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
2170,FABP3,"fatty acid binding protein 3, muscle and heart",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FABP3,HGNC:3557,fatty acid binding protein 3,2170,ENSG00000121769,FABP3,"Fatty acid-binding protein, heart",Cytosolic other,FABPH_HUMAN,9.7,Kd,CHEMBL
2171,FABP5,fatty acid binding protein 5 (psoriasis-associated),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FABP5,HGNC:3560,fatty acid binding protein 5,2171,ENSG00000164687,FABP5,"Fatty acid-binding protein, epidermal",Cytosolic other,FABP5_HUMAN,6.61,Ki,CHEMBL
2173,FABP7,"fatty acid binding protein 7, brain",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FABP7,HGNC:3562,fatty acid binding protein 7,2173,ENSG00000164434,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3992,FADS1,fatty acid desaturase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FADS1,HGNC:3574,fatty acid desaturase 1,3992,ENSG00000149485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9415,FADS2,fatty acid desaturase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FADS2,HGNC:3575,fatty acid desaturase 2,9415,ENSG00000134824,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79137,FAM134A,"family with sequence similarity 134, member A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
355,FAS,Fas cell surface death receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAS,HGNC:11920,Fas cell surface death receptor,355,ENSG00000026103,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2203,FBP1,"fructose-1,6-bisphosphatase 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FBP1,HGNC:3606,fructose-bisphosphatase 1,2203,ENSG00000165140,FBP1,"Fructose-1,6-bisphosphatase 1",Enzyme,F16P1_HUMAN,6.85,IC50,CHEMBL
26223,FBXL21,F-box and leucine-rich repeat protein 21 (gene/pseudogene),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
200933,FBXO45,F-box protein 45,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FBXO45,HGNC:29148,F-box protein 45,200933,ENSG00000174013,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FCGR2A,HGNC:3616,Fc fragment of IgG receptor IIa,2212,ENSG00000143226,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9638,FEZ1,fasciculation and elongation protein zeta 1 (zygin I),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEZ1,HGNC:3659,fasciculation and elongation protein zeta 1,9638,ENSG00000149557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2247,FGF2,fibroblast growth factor 2 (basic),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF2,HGNC:3676,fibroblast growth factor 2,2247,ENSG00000138685,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2263,FGFR2,fibroblast growth factor receptor 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR2,HGNC:3689,fibroblast growth factor receptor 2,2263,ENSG00000066468,FGFR2,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,5.85,Kd,CHEMBL
2272,FHIT,fragile histidine triad,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FHIT,HGNC:3701,fragile histidine triad diadenosine triphosphatase,2272,ENSG00000189283,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2317,FLNB,"filamin B, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FLNB,HGNC:3755,filamin B,2317,ENSG00000136068,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2332,FMR1,fragile X mental retardation 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2335,FN1,fibronectin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FN1,HGNC:3778,fibronectin 1,2335,ENSG00000115414,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2346,FOLH1,folate hydrolase (prostate-specific membrane antigen) 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOLH1,HGNC:3788,folate hydrolase 1,2346,ENSG00000086205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
93986,FOXP2,forkhead box P2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXP2,HGNC:13875,forkhead box P2,93986,ENSG00000128573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2414,FRA7G,"fragile site, aphidicolin type, common, fra(7)(q31.2)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FRA7G,HGNC:3925,"fragile site, aphidicolin type, common, fra(7)(q31.2)",2414,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11167,FSTL1,follistatin-like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FSTL1,HGNC:3972,follistatin like 1,11167,ENSG00000163430,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2530,FUT8,"fucosyltransferase 8 (alpha (1,6) fucosyltransferase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FUT8,HGNC:4019,fucosyltransferase 8,2530,ENSG00000033170,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5348,FXYD1,FXYD domain containing ion transport regulator 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FXYD1,HGNC:4025,FXYD domain containing ion transport regulator 1,5348,ENSG00000266964,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
53826,FXYD6,FXYD domain containing ion transport regulator 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FXYD6,HGNC:4030,FXYD domain containing ion transport regulator 6,53826,ENSG00000137726,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FYN,HGNC:4037,"FYN proto-oncogene, Src family tyrosine kinase",2534,ENSG00000010810,FYN,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,6.087777943,IC50,DRUG MATRIX
7976,FZD3,frizzled class receptor 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FZD3,HGNC:4041,frizzled class receptor 3,7976,ENSG00000104290,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11337,GABARAP,GABA(A) receptor-associated protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABARAP,HGNC:4067,GABA type A receptor-associated protein,11337,ENSG00000170296,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2550,GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABBR1,HGNC:4070,gamma-aminobutyric acid type B receptor subunit 1,2550,ENSG00000204681,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA1,HGNC:4075,gamma-aminobutyric acid type A receptor subunit alpha1,2554,ENSG00000022355,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,7.300000191,Ki,CHEMBL
2557,GABRA4,"gamma-aminobutyric acid (GABA) A receptor, alpha 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA4,HGNC:4078,gamma-aminobutyric acid type A receptor subunit alpha4,2557,ENSG00000109158,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,GBRA4_HUMAN,6.99,Ki,CHEMBL
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA5,HGNC:4079,gamma-aminobutyric acid type A receptor subunit alpha5,2558,ENSG00000186297,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_HUMAN,7.639999866,Kd,CHEMBL
2560,GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB1,HGNC:4081,gamma-aminobutyric acid type A receptor subunit beta1,2560,ENSG00000163288,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB3,HGNC:4083,gamma-aminobutyric acid type A receptor subunit beta3,2562,ENSG00000166206,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,9.05,IC50,CHEMBL
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRG2,HGNC:4087,gamma-aminobutyric acid type A receptor subunit gamma2,2566,ENSG00000113327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2569,GABRR1,"gamma-aminobutyric acid (GABA) A receptor, rho 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRR1,HGNC:4090,gamma-aminobutyric acid type A receptor subunit rho1,2569,ENSG00000146276,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,Ion channel,GBRR1_HUMAN,6.570000172,EC50,CHEMBL
2596,GAP43,growth associated protein 43,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10634,GAS2L1,growth arrest-specific 2 like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAS2L1,HGNC:16955,growth arrest specific 2 like 1,10634,ENSG00000185340,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCLC,HGNC:4311,glutamate-cysteine ligase catalytic subunit,2729,ENSG00000001084,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2730,GCLM,"glutamate-cysteine ligase, modifier subunit",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCLM,HGNC:4312,glutamate-cysteine ligase modifier subunit,2730,ENSG00000023909,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2668,GDNF,glial cell derived neurotrophic factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50628,GEMIN4,gem (nuclear organelle) associated protein 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GEMIN4,HGNC:15717,gem nuclear organelle associated protein 4,50628,ENSG00000179409,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2674,GFRA1,GDNF family receptor alpha 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFRA1,HGNC:4243,GDNF family receptor alpha 1,2674,ENSG00000151892,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2675,GFRA2,GDNF family receptor alpha 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFRA2,HGNC:4244,GDNF family receptor alpha 2,2675,ENSG00000168546,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2676,GFRA3,GDNF family receptor alpha 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFRA3,HGNC:4245,GDNF family receptor alpha 3,2676,ENSG00000146013,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51738,GHRL,ghrelin/obestatin prepropeptide,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GHRL,HGNC:18129,ghrelin and obestatin prepropeptide,51738,ENSG00000157017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2702,GJA5,"gap junction protein, alpha 5, 40kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GJA5,HGNC:4279,gap junction protein alpha 5,2702,ENSG00000265107,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2703,GJA8,"gap junction protein, alpha 8, 50kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GJA8,HGNC:4281,gap junction protein alpha 8,2703,ENSG00000121634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57369,GJD2,"gap junction protein, delta 2, 36kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GJD2,HGNC:19154,gap junction protein delta 2,57369,ENSG00000159248,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2739,GLO1,glyoxalase I,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLO1,HGNC:4323,glyoxalase I,2739,ENSG00000124767,GLO1,Lactoylglutathione lyase,Enzyme,LGUL_HUMAN,4.89,Ki,CHEMBL
2742,GLRA2,"glycine receptor, alpha 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLRA2,HGNC:4327,glycine receptor alpha 2,2742,ENSG00000101958,GLRA2,Glycine receptor subunit alpha-2,Ion channel,GLRA2_HUMAN,4.1938,IC50,WOMBAT-PK
2744,GLS,glutaminase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLS,HGNC:4331,glutaminase,2744,ENSG00000115419,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27165,GLS2,"glutaminase 2 (liver, mitochondrial)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLS2,HGNC:29570,glutaminase 2,27165,ENSG00000135423,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2752,GLUL,glutamate-ammonia ligase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
2774,GNAL,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNAL,HGNC:4388,G protein subunit alpha L,2774,ENSG00000141404,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2775,GNAO1,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNAO1,HGNC:4389,G protein subunit alpha o1,2775,ENSG00000087258,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2778,GNAS,GNAS complex locus,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNAS,HGNC:4392,GNAS complex locus,2778,ENSG00000087460,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54584,GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB1L,HGNC:4397,G protein subunit beta 1 like,54584,ENSG00000185838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8443,GNPAT,glyceronephosphate O-acyltransferase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNPAT,HGNC:4416,glyceronephosphate O-acyltransferase,8443,ENSG00000116906,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2823,GPM6A,glycoprotein M6A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPM6A,HGNC:4460,glycoprotein M6A,2823,ENSG00000150625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9248,GPR50,G protein-coupled receptor 50,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR50,HGNC:4506,G protein-coupled receptor 50,9248,ENSG00000102195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27201,GPR78,G protein-coupled receptor 78,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR78,HGNC:4528,G protein-coupled receptor 78,27201,ENSG00000155269,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2873,GPS1,G protein pathway suppressor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPS1,HGNC:4549,G protein pathway suppressor 1,2873,ENSG00000169727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2876,GPX1,glutathione peroxidase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPX1,HGNC:4553,glutathione peroxidase 1,2876,ENSG00000233276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2887,GRB10,growth factor receptor-bound protein 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRB10,HGNC:4564,growth factor receptor bound protein 10,2887,ENSG00000106070,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2885,GRB2,growth factor receptor-bound protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRB2,HGNC:4566,growth factor receptor bound protein 2,2885,ENSG00000177885,GRB2,Growth factor receptor-bound protein 2,Cytosolic other,GRB2_HUMAN,5.3,IC50,CHEMBL
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA1,HGNC:4571,glutamate ionotropic receptor AMPA type subunit 1,2890,ENSG00000155511,GRIA1,Glutamate receptor 1,Ion channel,GRIA1_HUMAN,5.7,EC50,CHEMBL
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA2,HGNC:4572,glutamate ionotropic receptor AMPA type subunit 2,2891,ENSG00000120251,GRIA2,Glutamate receptor 2,Ion channel,GRIA2_HUMAN,5.65,EC50,CHEMBL
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA3,HGNC:4573,glutamate ionotropic receptor AMPA type subunit 3,2892,ENSG00000125675,GRIA3,Glutamate receptor 3,Ion channel,GRIA3_HUMAN,4.860000134,EC50,IUPHAR
2893,GRIA4,"glutamate receptor, ionotropic, AMPA 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA4,HGNC:4574,glutamate ionotropic receptor AMPA type subunit 4,2893,ENSG00000152578,GRIA4,Glutamate receptor 4,Ion channel,GRIA4_HUMAN,5.409999847,EC50,IUPHAR
2894,GRID1,"glutamate receptor, ionotropic, delta 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRID1,HGNC:4575,glutamate ionotropic receptor delta type subunit 1,2894,ENSG00000182771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2A,HGNC:4585,glutamate ionotropic receptor NMDA type subunit 2A,2903,ENSG00000183454,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,5.64,IC50,WOMBAT-PK
2905,GRIN2C,"glutamate receptor, ionotropic, N-methyl D-aspartate 2C",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2C,HGNC:4587,glutamate ionotropic receptor NMDA type subunit 2C,2905,ENSG00000161509,GRIN2C,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,NMDE3_HUMAN,5.34,IC50,WOMBAT-PK
116443,GRIN3A,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN3A,HGNC:16767,glutamate ionotropic receptor NMDA type subunit 3A,116443,ENSG00000198785,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,NMD3A_HUMAN,5.64,IC50,WOMBAT-PK
23426,GRIP1,glutamate receptor interacting protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIP1,HGNC:18708,glutamate receptor interacting protein 1,23426,ENSG00000155974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2870,GRK6,G protein-coupled receptor kinase 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRK6,HGNC:4545,G protein-coupled receptor kinase 6,2870,ENSG00000198055,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2911,GRM1,"glutamate receptor, metabotropic 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM1,HGNC:4593,glutamate metabotropic receptor 1,2911,ENSG00000152822,GRM1,Metabotropic glutamate receptor 1,GPCR,GRM1_HUMAN,6.05,Ki,WOMBAT-PK
2914,GRM4,"glutamate receptor, metabotropic 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM4,HGNC:4596,glutamate metabotropic receptor 4,2914,ENSG00000124493,GRM4,Metabotropic glutamate receptor 4,GPCR,GRM4_HUMAN,5.849999905,Ki,CHEMBL
2915,GRM5,"glutamate receptor, metabotropic 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM5,HGNC:4597,glutamate metabotropic receptor 5,2915,ENSG00000168959,GRM5,Metabotropic glutamate receptor 5,GPCR,GRM5_HUMAN,5.41,Ki,WOMBAT-PK
2917,GRM7,"glutamate receptor, metabotropic 7",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
2918,GRM8,"glutamate receptor, metabotropic 8",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM8,HGNC:4600,glutamate metabotropic receptor 8,2918,ENSG00000179603,GRM8,Metabotropic glutamate receptor 8,GPCR,GRM8_HUMAN,5.349999905,IC50,IUPHAR
2896,GRN,granulin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRN,HGNC:4601,granulin precursor,2896,ENSG00000030582,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2934,GSN,gelsolin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSN,HGNC:4620,gelsolin,2934,ENSG00000148180,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2937,GSS,glutathione synthetase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSS,HGNC:4624,glutathione synthetase,2937,ENSG00000100983,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2938,GSTA1,glutathione S-transferase alpha 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTA1,HGNC:4626,glutathione S-transferase alpha 1,2938,ENSG00000243955,GSTA1,Glutathione S-transferase A1,Enzyme,GSTA1_HUMAN,5.3,IC50,CHEMBL
2944,GSTM1,glutathione S-transferase mu 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTM1,HGNC:4632,glutathione S-transferase mu 1,2944,ENSG00000134184,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2946,GSTM2,glutathione S-transferase mu 2 (muscle),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTM2,HGNC:4634,glutathione S-transferase mu 2,2946,ENSG00000213366,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2950,GSTP1,glutathione S-transferase pi 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTP1,HGNC:4638,glutathione S-transferase pi 1,2950,ENSG00000084207,GSTP1,Glutathione S-transferase P,Enzyme,GSTP1_HUMAN,0,0,WOMBAT-PK
2952,GSTT1,glutathione S-transferase theta 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTT1,HGNC:4641,glutathione S-transferase theta 1,2952,ENSG00000277656,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2953,GSTT2,glutathione S-transferase theta 2 (gene/pseudogene),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTT2,HGNC:4642,glutathione S-transferase theta 2 (gene/pseudogene),2953,ENSG00000099984,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3014,H2AFX,"H2A histone family, member X",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3029,HAGH,hydroxyacylglutathione hydrolase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HAGH,HGNC:4805,hydroxyacylglutathione hydrolase,3029,ENSG00000063854,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
145864,HAPLN3,hyaluronan and proteoglycan link protein 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HAPLN3,HGNC:21446,hyaluronan and proteoglycan link protein 3,145864,ENSG00000140511,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8843,HCAR3,hydroxycarboxylic acid receptor 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCAR3,HGNC:16824,hydroxycarboxylic acid receptor 3,8843,ENSG00000255398,HCAR3,Hydroxycarboxylic acid receptor 3,GPCR,HCAR3_HUMAN,6.53,IC50,WOMBAT-PK
3061,HCRTR1,hypocretin (orexin) receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRTR1,HGNC:4848,hypocretin receptor 1,3061,ENSG00000121764,HCRTR1,Orexin receptor type 1,GPCR,OX1R_HUMAN,9.259636879,Ki,SCIENTIFIC LITERATURE
3065,HDAC1,histone deacetylase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC1,HGNC:4852,histone deacetylase 1,3065,ENSG00000116478,HDAC1,Histone deacetylase 1,Enzyme,HDAC1_HUMAN,4.19,IC50,CHEMBL
3066,HDAC2,histone deacetylase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC2,HGNC:4853,histone deacetylase 2,3066,ENSG00000196591,HDAC2,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,4.19,IC50,CHEMBL
8841,HDAC3,histone deacetylase 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC3,HGNC:4854,histone deacetylase 3,8841,ENSG00000171720,HDAC3,Histone deacetylase 3,Enzyme,HDAC3_HUMAN,7.6,IC50,CHEMBL
9759,HDAC4,histone deacetylase 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC4,HGNC:14063,histone deacetylase 4,9759,ENSG00000068024,HDAC4,Histone deacetylase 4,Enzyme,HDAC4_HUMAN,6.2924,IC50,WOMBAT-PK
9734,HDAC9,histone deacetylase 9,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC9,HGNC:14065,histone deacetylase 9,9734,ENSG00000048052,HDAC9,Histone deacetylase 9,Enzyme,HDAC9_HUMAN,5.960000038,Ki,IUPHAR
8924,HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HERC2,HGNC:4868,HECT and RLD domain containing E3 ubiquitin protein ligase 2,8924,ENSG00000128731,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3077,HFE,hemochromatosis,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HFE,HGNC:4886,homeostatic iron regulator,3077,ENSG00000010704,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55733,HHAT,hedgehog acyltransferase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HHAT,HGNC:18270,hedgehog acyltransferase,55733,ENSG00000054392,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3009,HIST1H1B,"histone cluster 1, H1b",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3008,HIST1H1E,"histone cluster 1, H1e",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8970,HIST1H2BJ,"histone cluster 1, H2bj",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3098,HK1,hexokinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HK1,HGNC:4922,hexokinase 1,3098,ENSG00000156515,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3105,HLA-A,"major histocompatibility complex, class I, A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-A,HGNC:4931,"major histocompatibility complex, class I, A",3105,ENSG00000206503,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3106,HLA-B,"major histocompatibility complex, class I, B",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-B,HGNC:4932,"major histocompatibility complex, class I, B",3106,ENSG00000234745,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3107,HLA-C,"major histocompatibility complex, class I, C",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-C,HGNC:4933,"major histocompatibility complex, class I, C",3107,ENSG00000204525,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DPB1,HGNC:4940,"major histocompatibility complex, class II, DP beta 1",3115,ENSG00000223865,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DQB1,HGNC:4944,"major histocompatibility complex, class II, DQ beta 1",3119,ENSG00000179344,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3126,HLA-DRB4,"major histocompatibility complex, class II, DR beta 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DRB4,HGNC:4952,"major histocompatibility complex, class II, DR beta 4",3126,ENSG00000227357,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3133,HLA-E,"major histocompatibility complex, class I, E",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-E,HGNC:4962,"major histocompatibility complex, class I, E",3133,ENSG00000204592,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3137,HLA-J,"major histocompatibility complex, class I, J (pseudogene)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-J,HGNC:4967,"major histocompatibility complex, class I, J (pseudogene)",3137,ENSG00000204622,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3159,HMGA1,high mobility group AT-hook 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HMGA1,HGNC:5010,high mobility group AT-hook 1,3159,ENSG00000137309,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3162,HMOX1,heme oxygenase (decycling) 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HMOX1,HGNC:5013,heme oxygenase 1,3162,ENSG00000100292,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10151,HNRNPA3P1,heterogeneous nuclear ribonucleoprotein A3 pseudogene 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HNRNPA3P1,HGNC:13729,heterogeneous nuclear ribonucleoprotein A3 pseudogene 1,10151,ENSG00000226790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9456,HOMER1,homer homolog 1 (Drosophila),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9455,HOMER2,homer homolog 2 (Drosophila),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER2,HGNC:17513,homer scaffold protein 2,9455,ENSG00000103942,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27306,HPGDS,hematopoietic prostaglandin D synthase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPGDS,HGNC:17890,hematopoietic prostaglandin D synthase,27306,ENSG00000163106,HPGDS,Hematopoietic prostaglandin D synthase,Enzyme,HPGDS_HUMAN,4.57,IC50,CHEMBL
89781,HPS4,Hermansky-Pudlak syndrome 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPS4,HGNC:15844,HPS4 biogenesis of lysosomal organelles complex 3 subunit 2,89781,ENSG00000100099,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3274,HRH2,histamine receptor H2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HRH2,HGNC:5183,histamine receptor H2,3274,ENSG00000113749,HRH2,Histamine H2 receptor,GPCR,HRH2_HUMAN,4.983844488,Ki,DRUG MATRIX
259217,HSPA12A,heat shock 70kDa protein 12A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA12A,HGNC:19022,heat shock protein family A (Hsp70) member 12A,259217,ENSG00000165868,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3303,HSPA1A,heat shock 70kDa protein 1A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1A,HGNC:5232,heat shock protein family A (Hsp70) member 1A,3303,ENSG00000204389,HSPA1A,Heat shock 70 kDa protein 1A,Unclassified,HS71A_HUMAN,5.46999979,IC50,CHEMBL
3304,HSPA1B,heat shock 70kDa protein 1B,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1B,HGNC:5233,heat shock protein family A (Hsp70) member 1B,3304,ENSG00000204388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3305,HSPA1L,heat shock 70kDa protein 1-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1L,HGNC:5234,heat shock protein family A (Hsp70) member 1 like,3305,ENSG00000204390,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA9,HGNC:5244,heat shock protein family A (Hsp70) member 9,3313,ENSG00000113013,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3342,HTC2,"hypertrichosis 2 (generalized, congenital)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTC2,HGNC:5278,"hypertrichosis 2 (generalized, congenital)",0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3352,HTR1D,"5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1D,HGNC:5289,5-hydroxytryptamine receptor 1D,3352,ENSG00000179546,HTR1D,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_HUMAN,7.5,Ki,WOMBAT-PK
3355,HTR1F,"5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1F,HGNC:5292,5-hydroxytryptamine receptor 1F,3355,ENSG00000179097,HTR1F,5-hydroxytryptamine receptor 1F,GPCR,5HT1F_HUMAN,7.2,Ki,WOMBAT-PK
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
200909,HTR3D,"5-hydroxytryptamine (serotonin) receptor 3D, ionotropic",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3D,HGNC:24004,5-hydroxytryptamine receptor 3D,200909,ENSG00000186090,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
285242,HTR3E,"5-hydroxytryptamine (serotonin) receptor 3E, ionotropic",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3E,HGNC:24005,5-hydroxytryptamine receptor 3E,285242,ENSG00000186038,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
3361,HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR5A,HGNC:5300,5-hydroxytryptamine receptor 5A,3361,ENSG00000157219,HTR5A,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,5.906403065,Ki,PDSP
3383,ICAM1,intercellular adhesion molecule 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ICAM1,HGNC:5344,intercellular adhesion molecule 1,3383,ENSG00000090339,ICAM1,Intercellular adhesion molecule 1,Unclassified,ICAM1_HUMAN,8.53,IC50,CHEMBL
3416,IDE,insulin-degrading enzyme,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IDE,HGNC:5381,insulin degrading enzyme,3416,ENSG00000119912,IDE,Insulin-degrading enzyme,Enzyme,IDE_HUMAN,5.599999905,EC50,CHEMBL
3458,IFNG,"interferon, gamma",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
282617,IFNL3,"interferon, lambda 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNL3,HGNC:18365,interferon lambda 3,282617,ENSG00000197110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3481,IGF2,insulin-like growth factor 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF2,HGNC:5466,insulin like growth factor 2,3481,ENSG00000167244,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10644,IGF2BP2,insulin-like growth factor 2 mRNA binding protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF2BP2,HGNC:28867,insulin like growth factor 2 mRNA binding protein 2,10644,ENSG00000073792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3586,IL10,interleukin 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL10,HGNC:5962,interleukin 10,3586,ENSG00000136634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3587,IL10RA,"interleukin 10 receptor, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL10RA,HGNC:5964,interleukin 10 receptor subunit alpha,3587,ENSG00000110324,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3593,IL12B,interleukin 12B,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL12B,HGNC:5970,interleukin 12B,3593,ENSG00000113302,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27189,IL17C,interleukin 17C,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL17C,HGNC:5983,interleukin 17C,27189,ENSG00000124391,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3606,IL18,interleukin 18,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL18,HGNC:5986,interleukin 18,3606,ENSG00000150782,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8809,IL18R1,interleukin 18 receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL18R1,HGNC:5988,interleukin 18 receptor 1,8809,ENSG00000115604,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29949,IL19,interleukin 19,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL19,HGNC:5990,interleukin 19,29949,ENSG00000142224,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3552,IL1A,"interleukin 1, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1A,HGNC:5991,interleukin 1 alpha,3552,ENSG00000115008,IL1A,Interleukin-1 alpha,Cytokine,IL1A_HUMAN,11.8538723,Kd,DRUG LABEL
3558,IL2,interleukin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL2,HGNC:6001,interleukin 2,3558,ENSG00000109471,IL2,Interleukin-2,Cytokine,IL2_HUMAN,0,0,WOMBAT-PK
3561,IL2RG,"interleukin 2 receptor, gamma",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL2RG,HGNC:6010,interleukin 2 receptor subunit gamma,3561,ENSG00000147168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3562,IL3,interleukin 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL3,HGNC:6011,interleukin 3,3562,ENSG00000164399,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3563,IL3RA,"interleukin 3 receptor, alpha (low affinity)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL3RA,HGNC:6012,interleukin 3 receptor subunit alpha,3563,ENSG00000185291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3565,IL4,interleukin 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL4,HGNC:6014,interleukin 4,3565,ENSG00000113520,IL4,Interleukin-4,Cytokine,IL4_HUMAN,8.33,IC50,WOMBAT-PK
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPA2,HGNC:6051,inositol monophosphatase 2,3613,ENSG00000141401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3843,IPO5,importin 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IPO5,HGNC:6402,importin 5,3843,ENSG00000065150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8516,ITGA8,"integrin, alpha 8",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITGA8,HGNC:6144,integrin subunit alpha 8,8516,ENSG00000077943,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITGAM,HGNC:6149,integrin subunit alpha M,3684,ENSG00000169896,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITGB3,HGNC:6156,integrin subunit beta 3,3690,ENSG00000259207,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3697,ITIH1,inter-alpha-trypsin inhibitor heavy chain 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH1,HGNC:6166,inter-alpha-trypsin inhibitor heavy chain 1,3697,ENSG00000055957,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3699,ITIH3,inter-alpha-trypsin inhibitor heavy chain 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH3,HGNC:6168,inter-alpha-trypsin inhibitor heavy chain 3,3699,ENSG00000162267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
182,JAG1,jagged 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,JAG1,HGNC:6188,jagged canonical Notch ligand 1,182,ENSG00000101384,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3714,JAG2,jagged 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,JAG2,HGNC:6189,jagged canonical Notch ligand 2,3714,ENSG00000184916,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3720,JARID2,"jumonji, AT rich interactive domain 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,JARID2,HGNC:6196,jumonji and AT-rich interaction domain containing 2,3720,ENSG00000008083,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3725,JUN,jun proto-oncogene,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,JUN,HGNC:6204,"Jun proto-oncogene, AP-1 transcription factor subunit",3725,ENSG00000177606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84148,KAT8,K(lysine) acetyltransferase 8,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KAT8,HGNC:17933,lysine acetyltransferase 8,84148,ENSG00000103510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3756,KCNH1,"potassium channel, voltage gated eag related subfamily H, member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNH1,HGNC:6250,potassium voltage-gated channel subfamily H member 1,3756,ENSG00000143473,KCNH1,Potassium voltage-gated channel subfamily H member 1,Ion channel,KCNH1_HUMAN,6.699999809,IC50,IUPHAR
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNH2,HGNC:6251,potassium voltage-gated channel subfamily H member 2,3757,ENSG00000055118,KCNH2,Potassium voltage-gated channel subfamily H member 2,Ion channel,KCNH2_HUMAN,4.89,IC50,CHEMBL
81033,KCNH6,"potassium channel, voltage gated eag related subfamily H, member 6",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNH6,HGNC:18862,potassium voltage-gated channel subfamily H member 6,81033,ENSG00000173826,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3766,KCNJ10,"potassium channel, inwardly rectifying subfamily J, member 10",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNJ10,HGNC:6256,potassium inwardly rectifying channel subfamily J member 10,3766,ENSG00000177807,KCNJ10,ATP-sensitive inward rectifier potassium channel 10,Ion channel,KCJ10_HUMAN,4.795879841,IC50,SCIENTIFIC LITERATURE
3760,KCNJ3,"potassium channel, inwardly rectifying subfamily J, member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNJ3,HGNC:6264,potassium inwardly rectifying channel subfamily J member 3,3760,ENSG00000162989,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3782,KCNN3,"potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNN3,HGNC:6292,potassium calcium-activated channel subfamily N member 3,3782,ENSG00000143603,KCNN3,Small conductance calcium-activated potassium channel protein 3,Ion channel,KCNN3_HUMAN,0,0,IUPHAR
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNQ2,HGNC:6296,potassium voltage-gated channel subfamily Q member 2,3785,ENSG00000075043,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,KCNQ2_HUMAN,5,EC50,IUPHAR
3786,KCNQ3,"potassium channel, voltage gated KQT-like subfamily Q, member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNQ3,HGNC:6297,potassium voltage-gated channel subfamily Q member 3,3786,ENSG00000184156,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,KCNQ3_HUMAN,0,0,WOMBAT-PK
3790,KCNS3,"potassium voltage-gated channel, modifier subfamily S, member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNS3,HGNC:6302,potassium voltage-gated channel modifier subfamily S member 3,3790,ENSG00000170745,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
115207,KCTD12,potassium channel tetramerization domain containing 12,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCTD12,HGNC:14678,potassium channel tetramerization domain containing 12,115207,ENSG00000178695,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57576,KIF17,kinesin family member 17,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KIF17,HGNC:19167,kinesin family member 17,57576,ENSG00000117245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3796,KIF2A,kinesin heavy chain member 2A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KIF2A,HGNC:6318,kinesin family member 2A,3796,ENSG00000068796,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
688,KLF5,Kruppel-like factor 5 (intestinal),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KLF5,HGNC:6349,Kruppel like factor 5,688,ENSG00000102554,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11202,KLK8,kallikrein-related peptidase 8,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KLK8,HGNC:6369,kallikrein related peptidase 8,11202,ENSG00000129455,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8564,KMO,kynurenine 3-monooxygenase (kynurenine 3-hydroxylase),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KMO,HGNC:6381,kynurenine 3-monooxygenase,8564,ENSG00000117009,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4297,KMT2A,lysine (K)-specific methyltransferase 2A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KMT2A,HGNC:7132,lysine methyltransferase 2A,4297,ENSG00000118058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3839,KPNA3,karyopherin alpha 3 (importin alpha 4),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KPNA3,HGNC:6396,karyopherin subunit alpha 3,3839,ENSG00000102753,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
83999,KREMEN1,kringle containing transmembrane protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KREMEN1,HGNC:17550,kringle containing transmembrane protein 1,83999,ENSG00000183762,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23395,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LARS2,HGNC:17095,"leucyl-tRNA synthetase 2, mitochondrial",23395,ENSG00000011376,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3927,LASP1,LIM and SH3 protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LASP1,HGNC:6513,LIM and SH3 protein 1,3927,ENSG00000002834,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3934,LCN2,lipocalin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LCN2,HGNC:6526,lipocalin 2,3934,ENSG00000148346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3952,LEP,leptin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26468,LHX6,LIM homeobox 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LHX6,HGNC:21735,LIM homeobox 6,26468,ENSG00000106852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3977,LIFR,leukemia inhibitory factor receptor alpha,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LIFR,HGNC:6597,LIF receptor subunit alpha,3977,ENSG00000113594,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10859,LILRB1,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LILRB1,HGNC:6605,leukocyte immunoglobulin like receptor B1,10859,ENSG00000104972,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100131814,LINC00271,long intergenic non-protein coding RNA 271,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LINC00271,HGNC:32526,long intergenic non-protein coding RNA 271,100131814,ENSG00000231028,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
81562,LMAN2L,"lectin, mannose-binding 2-like",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LMAN2L,HGNC:19263,"lectin, mannose binding 2 like",81562,ENSG00000114988,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
442721,LMOD2,leiomodin 2 (cardiac),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LMOD2,HGNC:6648,leiomodin 2,442721,ENSG00000170807,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4009,LMX1A,"LIM homeobox transcription factor 1, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LMX1A,HGNC:6653,LIM homeobox transcription factor 1 alpha,4009,ENSG00000162761,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4010,LMX1B,"LIM homeobox transcription factor 1, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LMX1B,HGNC:6654,LIM homeobox transcription factor 1 beta,4010,ENSG00000136944,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1902,LPAR1,lysophosphatidic acid receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LPAR1,HGNC:3166,lysophosphatidic acid receptor 1,1902,ENSG00000198121,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4023,LPL,lipoprotein lipase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LPL,HGNC:6677,lipoprotein lipase,4023,ENSG00000175445,LPL,Lipoprotein lipase,Enzyme,LIPL_HUMAN,0,0,WOMBAT-PK
4036,LRP2,low density lipoprotein receptor-related protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP2,HGNC:6694,LDL receptor related protein 2,4036,ENSG00000081479,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7804,LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP8,HGNC:6700,LDL receptor related protein 8,7804,ENSG00000157193,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
120892,LRRK2,leucine-rich repeat kinase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRRK2,HGNC:18618,leucine rich repeat kinase 2,120892,ENSG00000188906,LRRK2,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,LRRK2_HUMAN,5.54,Kd,CHEMBL
347730,LRRTM1,leucine rich repeat transmembrane neuronal 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRRTM1,HGNC:19408,leucine rich repeat transmembrane neuronal 1,347730,ENSG00000162951,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4045,LSAMP,limbic system-associated membrane protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LSAMP,HGNC:6705,limbic system associated membrane protein,4045,ENSG00000185565,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4049,LTA,lymphotoxin alpha,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LTA,HGNC:6709,lymphotoxin alpha,4049,ENSG00000226979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57128,LYRM4,LYR motif containing 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LYRM4,HGNC:21365,LYR motif containing 4,57128,ENSG00000214113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8379,MAD1L1,MAD1 mitotic arrest deficient-like 1 (yeast),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAD1L1,HGNC:6762,mitotic arrest deficient 1 like 1,8379,ENSG00000002822,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4099,MAG,myelin associated glycoprotein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAG,HGNC:6783,myelin associated glycoprotein,4099,ENSG00000105695,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54551,MAGEL2,melanoma antigen family L2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAGEL2,HGNC:6814,MAGE family member L2,54551,ENSG00000254585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9223,MAGI1,"membrane associated guanylate kinase, WW and PDZ domain containing 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAGI1,HGNC:946,"membrane associated guanylate kinase, WW and PDZ domain containing 1",9223,ENSG00000151276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9863,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAGI2,HGNC:18957,"membrane associated guanylate kinase, WW and PDZ domain containing 2",9863,ENSG00000187391,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4133,MAP2,microtubule-associated protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2,HGNC:6839,microtubule associated protein 2,4133,ENSG00000078018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5609,MAP2K7,mitogen-activated protein kinase kinase 7,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2K7,HGNC:6847,mitogen-activated protein kinase kinase 7,5609,ENSG00000076984,MAP2K7,Dual specificity mitogen-activated protein kinase kinase 7,Kinase,MP2K7_HUMAN,5.36,Kd,CHEMBL
4135,MAP6,microtubule-associated protein 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP6,HGNC:6868,microtubule associated protein 6,4135,ENSG00000171533,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5594,MAPK1,mitogen-activated protein kinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK1,HGNC:6871,mitogen-activated protein kinase 1,5594,ENSG00000100030,MAPK1,Mitogen-activated protein kinase 1,Kinase,MK01_HUMAN,5.227165073,IC50,DRUG MATRIX
1432,MAPK14,mitogen-activated protein kinase 14,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK14,HGNC:6876,mitogen-activated protein kinase 14,1432,ENSG00000112062,MAPK14,Mitogen-activated protein kinase 14,Kinase,MK14_HUMAN,5.908333042,IC50,DRUG MATRIX
5595,MAPK3,mitogen-activated protein kinase 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK3,HGNC:6877,mitogen-activated protein kinase 3,5595,ENSG00000102882,MAPK3,Mitogen-activated protein kinase 3,Kinase,MK03_HUMAN,5.213177621,IC50,DRUG MATRIX
5599,MAPK8,mitogen-activated protein kinase 8,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAPK8,HGNC:6881,mitogen-activated protein kinase 8,5599,ENSG00000107643,MAPK8,Mitogen-activated protein kinase 8,Kinase,MK08_HUMAN,5.49,Kd,CHEMBL
2011,MARK2,MAP/microtubule affinity-regulating kinase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MARK2,HGNC:3332,microtubule affinity regulating kinase 2,2011,ENSG00000072518,MARK2,Serine/threonine-protein kinase MARK2,Kinase,MARK2_HUMAN,6.51,Kd,CHEMBL
8932,MBD2,methyl-CpG binding domain protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MBD2,HGNC:6917,methyl-CpG binding domain protein 2,8932,ENSG00000134046,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4154,MBNL1,muscleblind-like splicing regulator 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MBNL1,HGNC:6923,muscleblind like splicing regulator 1,4154,ENSG00000152601,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4155,MBP,myelin basic protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MBP,HGNC:6925,myelin basic protein,4155,ENSG00000197971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4161,MC5R,melanocortin 5 receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC5R,HGNC:6933,melanocortin 5 receptor,4161,ENSG00000176136,MC5R,Melanocortin receptor 5,GPCR,MC5R_HUMAN,5.050171041,Ki,DRUG MATRIX
27349,MCAT,malonyl CoA:ACP acyltransferase (mitochondrial),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCAT,HGNC:29622,malonyl-CoA-acyl carrier protein transacylase,27349,ENSG00000100294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2847,MCHR1,melanin-concentrating hormone receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR1,HGNC:4479,melanin concentrating hormone receptor 1,2847,ENSG00000128285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84539,MCHR2,melanin-concentrating hormone receptor 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR2,HGNC:20867,melanin concentrating hormone receptor 2,84539,ENSG00000152034,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55784,MCTP2,"multiple C2 domains, transmembrane 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCTP2,HGNC:25636,multiple C2 and transmembrane domain containing 2,55784,ENSG00000140563,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266727,MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDGA1,HGNC:19267,MAM domain containing glycosylphosphatidylinositol anchor 1,266727,ENSG00000112139,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4190,MDH1,"malate dehydrogenase 1, NAD (soluble)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDH1,HGNC:6970,malate dehydrogenase 1,4190,ENSG00000014641,MDH1,Malate dehydrogenase cytoplasmic ,Enzyme,MDHC_HUMAN,4.46,IC50,CHEMBL
4192,MDK,midkine (neurite growth-promoting factor 2),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDK,HGNC:6972,midkine,4192,ENSG00000110492,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ME2,HGNC:6984,malic enzyme 2,4200,ENSG00000082212,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51586,MED15,mediator complex subunit 15,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED15,HGNC:14248,mediator complex subunit 15,51586,ENSG00000099917,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84466,MEGF10,multiple EGF-like-domains 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MEGF10,HGNC:29634,multiple EGF like domains 10,84466,ENSG00000145794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4277,MICB,MHC class I polypeptide-related sequence B,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MICB,HGNC:7091,MHC class I polypeptide-related sequence B,4277,ENSG00000204516,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIF,HGNC:7097,macrophage migration inhibitory factor,4282,ENSG00000240972,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406901,MIR107,microRNA 107,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR107,HGNC:31496,microRNA 107,406901,ENSG00000198997,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406920,MIR130B,microRNA 130b,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR130B,HGNC:31515,microRNA 130b,406920,ENSG00000283871,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
400765,MIR137HG,MIR137 host gene (non-protein coding),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR137HG,HGNC:42871,MIR137 host gene,400765,ENSG00000225206,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406952,MIR17,microRNA 17,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR17,HGNC:31547,microRNA 17,406952,ENSG00000284536,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406961,MIR185,microRNA 185,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR185,HGNC:31556,microRNA 185,406961,ENSG00000208023,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406989,MIR206,microRNA 206,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR206,HGNC:31584,microRNA 206,406989,ENSG00000207604,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
407003,MIR219A2,microRNA 219a-2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR219A2,HGNC:31598,microRNA 219a-2,407003,ENSG00000284185,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100616452,MIR2682,microRNA 2682,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR2682,HGNC:41688,microRNA 2682,100616452,ENSG00000284247,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
407034,MIR30E,microRNA 30e,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR30E,HGNC:31629,microRNA 30e,407034,ENSG00000198974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
442900,MIR326,microRNA 326,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR326,HGNC:31769,microRNA 326,442900,ENSG00000199090,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
442901,MIR328,microRNA 328,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR328,HGNC:31770,microRNA 328,442901,ENSG00000207948,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
442911,MIR346,microRNA 346,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR346,HGNC:31780,microRNA 346,442911,ENSG00000199104,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
494331,MIR382,microRNA 382,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR382,HGNC:31875,microRNA 382,494331,ENSG00000283170,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
574451,MIR432,microRNA 432,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR432,HGNC:32083,microRNA 432,574451,ENSG00000272458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
574456,MIR497,microRNA 497,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR497,HGNC:32088,microRNA 497,574456,ENSG00000284027,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MLC1,HGNC:17082,modulator of VRAC current 1,23209,ENSG00000100427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP3,HGNC:7173,matrix metallopeptidase 3,4314,ENSG00000149968,MMP3,Stromelysin-1,Enzyme,MMP3_HUMAN,4.6,IC50,CHEMBL
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP9,HGNC:7176,matrix metallopeptidase 9,4318,ENSG00000100985,MMP9,Matrix metalloproteinase-9,Enzyme,MMP9_HUMAN,4,IC50,CHEMBL
4336,MOBP,myelin-associated oligodendrocyte basic protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MOBP,HGNC:7189,myelin associated oligodendrocyte basic protein,4336,ENSG00000168314,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4340,MOG,myelin oligodendrocyte glycoprotein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MOG,HGNC:7197,myelin oligodendrocyte glycoprotein,4340,ENSG00000204655,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
25874,MPC2,mitochondrial pyruvate carrier 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MPC2,HGNC:24515,mitochondrial pyruvate carrier 2,25874,ENSG00000143158,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9019,MPZL1,myelin protein zero-like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MPZL1,HGNC:7226,myelin protein zero like 1,9019,ENSG00000197965,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4482,MSRA,methionine sulfoxide reductase A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MSRA,HGNC:7377,methionine sulfoxide reductase A,4482,ENSG00000175806,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51734,MSRB1,methionine sulfoxide reductase B1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MSRB1,HGNC:14133,methionine sulfoxide reductase B1,51734,ENSG00000198736,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
118490,MSS51,MSS51 mitochondrial translational activator,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MSS51,HGNC:21000,MSS51 mitochondrial translational activator,118490,ENSG00000166343,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4522,MTHFD1,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFD1,HGNC:7432,"methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1",4522,ENSG00000100714,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4543,MTNR1A,melatonin receptor 1A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTNR1A,HGNC:7463,melatonin receptor 1A,4543,ENSG00000168412,MTNR1A,Melatonin receptor type 1A,GPCR,MTR1A_HUMAN,10.22,Ki,CHEMBL
4544,MTNR1B,melatonin receptor 1B,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTNR1B,HGNC:7464,melatonin receptor 1B,4544,ENSG00000134640,MTNR1B,Melatonin receptor type 1B,GPCR,MTR1B_HUMAN,10,Ki,CHEMBL
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTR,HGNC:7468,5-methyltetrahydrofolate-homocysteine methyltransferase,4548,ENSG00000116984,MTR,Methionine synthase,Enzyme,METH_HUMAN,0,0,WOMBAT-PK
4627,MYH9,"myosin, heavy chain 9, non-muscle",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYH9,HGNC:7579,myosin heavy chain 9,4627,ENSG00000100345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23026,MYO16,myosin XVI,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYO16,HGNC:29822,myosin XVI,23026,ENSG00000041515,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4645,MYO5B,myosin VB,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYO5B,HGNC:7603,myosin VB,4645,ENSG00000167306,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4650,MYO9B,myosin IXB,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYO9B,HGNC:7609,myosin IXB,4650,ENSG00000099331,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23040,MYT1L,myelin transcription factor 1-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYT1L,HGNC:7623,myelin transcription factor 1 like,23040,ENSG00000186487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
259232,NALCN,"sodium leak channel, non selective",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NALCN,HGNC:19082,"sodium leak channel, non-selective",259232,ENSG00000102452,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
89796,NAV1,neuron navigator 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NAV1,HGNC:15989,neuron navigator 1,89796,ENSG00000134369,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
89797,NAV2,neuron navigator 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NAV2,HGNC:15997,neuron navigator 2,89797,ENSG00000166833,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4684,NCAM1,neural cell adhesion molecule 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1463,NCAN,neurocan,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAN,HGNC:2465,neurocan,1463,ENSG00000130287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23413,NCS1,neuronal calcium sensor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCS1,HGNC:3953,neuronal calcium sensor 1,23413,ENSG00000107130,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54820,NDE1,nudE neurodevelopment protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDE1,HGNC:17619,nudE neurodevelopment protein 1,54820,ENSG00000072864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
81565,NDEL1,nudE neurodevelopment protein 1-like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDEL1,HGNC:17620,nudE neurodevelopment protein 1 like 1,81565,ENSG00000166579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4693,NDP,Norrie disease (pseudoglioma),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDP,HGNC:7678,norrin cystine knot growth factor NDP,4693,ENSG00000124479,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9348,NDST3,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDST3,HGNC:7682,N-deacetylase and N-sulfotransferase 3,9348,ENSG00000164100,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4719,NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFS1,HGNC:7707,NADH:ubiquinone oxidoreductase core subunit S1,4719,ENSG00000023228,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
374291,NDUFS7,"NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFS7,HGNC:7714,NADH:ubiquinone oxidoreductase core subunit S7,374291,ENSG00000115286,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV1,HGNC:7716,NADH:ubiquinone oxidoreductase core subunit V1,4723,ENSG00000167792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4747,NEFL,"neurofilament, light polypeptide",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFL,HGNC:7739,neurofilament light,4747,ENSG00000277586,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4762,NEUROG1,neurogenin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEUROG1,HGNC:7764,neurogenin 1,4762,ENSG00000181965,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23114,NFASC,neurofascin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NFASC,HGNC:29866,neurofascin,23114,ENSG00000163531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4804,NGFR,nerve growth factor receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NGFR,HGNC:7809,nerve growth factor receptor,4804,ENSG00000064300,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
22871,NLGN1,neuroligin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NLGN1,HGNC:14291,neuroligin 1,22871,ENSG00000169760,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57555,NLGN2,neuroligin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NLGN2,HGNC:14290,neuroligin 2,57555,ENSG00000169992,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4837,NNMT,nicotinamide N-methyltransferase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NNMT,HGNC:7861,nicotinamide N-methyltransferase,4837,ENSG00000166741,NNMT,Nicotinamide N-methyltransferase,Enzyme,NNMT_HUMAN,0,0,WOMBAT-PK
9722,NOS1AP,nitric oxide synthase 1 (neuronal) adaptor protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOS1AP,HGNC:16859,nitric oxide synthase 1 adaptor protein,9722,ENSG00000198929,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4855,NOTCH4,notch 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NOTCH4,HGNC:7884,notch receptor 4,4855,ENSG00000204301,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4861,NPAS1,neuronal PAS domain protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS1,HGNC:7894,neuronal PAS domain protein 1,4861,ENSG00000130751,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4862,NPAS2,neuronal PAS domain protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS2,HGNC:7895,neuronal PAS domain protein 2,4862,ENSG00000170485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64067,NPAS3,neuronal PAS domain protein 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS3,HGNC:19311,neuronal PAS domain protein 3,64067,ENSG00000151322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266743,NPAS4,neuronal PAS domain protein 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS4,HGNC:18983,neuronal PAS domain protein 4,266743,ENSG00000174576,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
594857,NPS,neuropeptide S,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPS,HGNC:33940,neuropeptide S,594857,ENSG00000214285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
387129,NPSR1,neuropeptide S receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPSR1,HGNC:23631,neuropeptide S receptor 1,387129,ENSG00000187258,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27020,NPTN,neuroplastin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPTN,HGNC:17867,neuroplastin,27020,ENSG00000156642,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4886,NPY1R,neuropeptide Y receptor Y1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY1R,HGNC:7956,neuropeptide Y receptor Y1,4886,ENSG00000164128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO1,HGNC:2874,NAD(P)H quinone dehydrogenase 1,1728,ENSG00000181019,NQO1,NAD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_HUMAN,4.6,IC50,CHEMBL
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO2,HGNC:7856,N-ribosyldihydronicotinamide:quinone reductase 2,4835,ENSG00000124588,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,NQO2_HUMAN,0,0,WOMBAT-PK
7101,NR2E1,"nuclear receptor subfamily 2, group E, member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR2E1,HGNC:7973,nuclear receptor subfamily 2 group E member 1,7101,ENSG00000112333,NR2E1,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,NR2E1_HUMAN,4.560667515,Kd,SCIENTIFIC LITERATURE
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR4A2,HGNC:7981,nuclear receptor subfamily 4 group A member 2,4929,ENSG00000153234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51299,NRN1,neuritin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRN1,HGNC:17972,neuritin 1,51299,ENSG00000124785,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9379,NRXN2,neurexin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN2,HGNC:8009,neurexin 2,9379,ENSG00000110076,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9369,NRXN3,neurexin 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN3,HGNC:8010,neurexin 3,9369,ENSG00000021645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4905,NSF,N-ethylmaleimide-sensitive factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NSF,HGNC:8016,"N-ethylmaleimide sensitive factor, vesicle fusing ATPase",4905,ENSG00000073969,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK3,HGNC:8033,neurotrophic receptor tyrosine kinase 3,4916,ENSG00000140538,NTRK3,NT-3 growth factor receptor,Kinase,NTRK3_HUMAN,6.22,Kd,CHEMBL
4922,NTS,neurotensin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTS,HGNC:8038,neurotensin,4922,ENSG00000133636,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57532,NUFIP2,nuclear fragile X mental retardation protein interacting protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NUFIP2,HGNC:17634,nuclear FMR1 interacting protein 2,57532,ENSG00000108256,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9253,NUMBL,numb homolog (Drosophila)-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NUMBL,HGNC:8061,NUMB like endocytic adaptor protein,9253,ENSG00000105245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266553,OFCC1,orofacial cleft 1 candidate 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OFCC1,HGNC:21017,orofacial cleft 1 candidate 1,266553,ENSG00000181355,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10215,OLIG2,oligodendrocyte lineage transcription factor 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OLIG2,HGNC:9398,oligodendrocyte transcription factor 2,10215,ENSG00000205927,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4976,OPA1,optic atrophy 1 (autosomal dominant),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPA1,HGNC:8140,OPA1 mitochondrial dynamin like GTPase,4976,ENSG00000198836,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4978,OPCML,opioid binding protein/cell adhesion molecule-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPCML,HGNC:8143,opioid binding protein/cell adhesion molecule like,4978,ENSG00000183715,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4986,OPRK1,"opioid receptor, kappa 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
5015,OTX2,orthodenticle homeobox 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OTX2,HGNC:8522,orthodenticle homeobox 2,5015,ENSG00000165588,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9943,OXSR1,oxidative stress responsive 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXSR1,HGNC:8508,oxidative stress responsive kinase 1,9943,ENSG00000172939,OXSR1,Serine/threonine-protein kinase OSR1,Kinase,OXSR1_HUMAN,6.28,Kd,CHEMBL
5020,OXT,oxytocin/neurophysin I prepropeptide,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
11240,PADI2,"peptidyl arginine deiminase, type II",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PADI2,HGNC:18341,peptidyl arginine deiminase 2,11240,ENSG00000117115,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23569,PADI4,"peptidyl arginine deiminase, type IV",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PADI4,HGNC:18368,peptidyl arginine deiminase 4,23569,ENSG00000159339,PADI4,Protein-arginine deiminase type-4,Enzyme,PADI4_HUMAN,4,IC50,CHEMBL
5048,PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAFAH1B1,HGNC:8574,platelet activating factor acetylhydrolase 1b regulatory subunit 1,5048,ENSG00000007168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5053,PAH,phenylalanine hydroxylase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAH,HGNC:8582,phenylalanine hydroxylase,5053,ENSG00000171759,PAH,Phenylalanine-4-hydroxylase,Enzyme,PH4H_HUMAN,5.400000095,Ki,IUPHAR
79728,PALB2,partner and localizer of BRCA2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PALB2,HGNC:26144,partner and localizer of BRCA2,79728,ENSG00000083093,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80025,PANK2,pantothenate kinase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PANK2,HGNC:15894,pantothenate kinase 2,80025,ENSG00000125779,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56666,PANX2,pannexin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PANX2,HGNC:8600,pannexin 2,56666,ENSG00000073150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55486,PARL,"presenilin associated, rhomboid-like",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PARL,HGNC:18253,presenilin associated rhomboid like,55486,ENSG00000175193,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5080,PAX6,paired box 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAX6,HGNC:8620,paired box 6,5080,ENSG00000007372,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55193,PBRM1,polybromo 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PBRM1,HGNC:30064,polybromo 1,55193,ENSG00000163939,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27253,PCDH17,protocadherin 17,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCDH17,HGNC:14267,protocadherin 17,27253,ENSG00000118946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5100,PCDH8,protocadherin 8,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCDH8,HGNC:8660,protocadherin 8,5100,ENSG00000136099,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5105,PCK1,phosphoenolpyruvate carboxykinase 1 (soluble),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCK1,HGNC:8724,phosphoenolpyruvate carboxykinase 1,5105,ENSG00000124253,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5116,PCNT,pericentrin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCNT,HGNC:16068,pericentrin,5116,ENSG00000160299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5141,PDE4A,"phosphodiesterase 4A, cAMP-specific",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4A,HGNC:8780,phosphodiesterase 4A,5141,ENSG00000065989,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,5.976336082,IC50,DRUG MATRIX
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4D,HGNC:8783,phosphodiesterase 4D,5144,ENSG00000113448,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,PDE4D_HUMAN,6.78,IC50,CHEMBL
27115,PDE7B,phosphodiesterase 7B,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE7B,HGNC:8792,phosphodiesterase 7B,27115,ENSG00000171408,PDE7B,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",Enzyme,PDE7B_HUMAN,6,IC50,CHEMBL
5159,PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDGFRB,HGNC:8804,platelet derived growth factor receptor beta,5159,ENSG00000113721,PDGFRB,Platelet-derived growth factor receptor beta,Kinase,PGFRB_HUMAN,9.2,Kd,CHEMBL
149420,PDIK1L,PDLIM1 interacting kinase 1 like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDIK1L,HGNC:18981,PDLIM1 interacting kinase 1 like,149420,ENSG00000175087,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10611,PDLIM5,PDZ and LIM domain 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDLIM5,HGNC:17468,PDZ and LIM domain 5,10611,ENSG00000163110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5174,PDZK1,PDZ domain containing 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDZK1,HGNC:8821,PDZ domain containing 1,5174,ENSG00000174827,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8682,PEA15,phosphoprotein enriched in astrocytes 15,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEA15,HGNC:8822,proliferation and apoptosis adaptor protein 15,8682,ENSG00000162734,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10400,PEMT,phosphatidylethanolamine N-methyltransferase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEMT,HGNC:8830,phosphatidylethanolamine N-methyltransferase,10400,ENSG00000133027,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8863,PER3,period circadian clock 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER3,HGNC:8847,period circadian regulator 3,8863,ENSG00000049246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5824,PEX19,peroxisomal biogenesis factor 19,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEX19,HGNC:9713,peroxisomal biogenesis factor 19,5824,ENSG00000162735,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8929,PHOX2B,paired-like homeobox 2b,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PHOX2B,HGNC:9143,paired like homeobox 2B,8929,ENSG00000109132,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55300,PI4K2B,phosphatidylinositol 4-kinase type 2 beta,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PI4K2B,HGNC:18215,phosphatidylinositol 4-kinase type 2 beta,55300,ENSG00000038210,PI4K2B,Phosphatidylinositol 4-kinase type 2-beta,Kinase,P4K2B_HUMAN,4.75,IC50,IUPHAR
5297,PI4KA,"phosphatidylinositol 4-kinase, catalytic, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PI4KA,HGNC:8983,phosphatidylinositol 4-kinase alpha,5297,ENSG00000241973,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9463,PICK1,protein interacting with PRKCA 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PICK1,HGNC:9394,protein interacting with PRKCA 1,9463,ENSG00000100151,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5289,PIK3C3,"phosphatidylinositol 3-kinase, catalytic subunit type 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIK3C3,HGNC:8974,phosphatidylinositol 3-kinase catalytic subunit type 3,5289,ENSG00000078142,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIK3CA,HGNC:8975,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",5290,ENSG00000121879,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,PK3CA_HUMAN,4.42,IC50,CHEMBL
65018,PINK1,PTEN induced putative kinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PINK1,HGNC:14581,PTEN induced kinase 1,65018,ENSG00000158828,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5305,PIP4K2A,"phosphatidylinositol-5-phosphate 4-kinase, type II, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIP4K2A,HGNC:8997,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,5305,ENSG00000150867,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79837,PIP4K2C,"phosphatidylinositol-5-phosphate 4-kinase, type II, gamma",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PIP4K2C,HGNC:23786,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,79837,ENSG00000166908,PIP4K2C,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,PI42C_HUMAN,6,Kd,CHEMBL
5309,PITX3,paired-like homeodomain 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PITX3,HGNC:9006,paired like homeodomain 3,5309,ENSG00000107859,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
63876,PKNOX2,PBX/knotted 1 homeobox 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PKNOX2,HGNC:16714,PBX/knotted 1 homeobox 2,63876,ENSG00000165495,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5319,PLA2G1B,"phospholipase A2, group IB (pancreas)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G1B,HGNC:9030,phospholipase A2 group IB,5319,ENSG00000170890,PLA2G1B,Phospholipase A2,Enzyme,PA21B_HUMAN,5.7,IC50,CHEMBL
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G4A,HGNC:9035,phospholipase A2 group IVA,5321,ENSG00000116711,PLA2G4A,Cytosolic phospholipase A2,Enzyme,PA24A_HUMAN,0,0,WOMBAT-PK
100137049,PLA2G4B,"phospholipase A2, group IVB (cytosolic)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G4B,HGNC:9036,phospholipase A2 group IVB,100137049,ENSG00000243708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8605,PLA2G4C,"phospholipase A2, group IVC (cytosolic, calcium-independent)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G4C,HGNC:9037,phospholipase A2 group IVC,8605,ENSG00000105499,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
283748,PLA2G4D,"phospholipase A2, group IVD (cytosolic)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G4D,HGNC:30038,phospholipase A2 group IVD,283748,ENSG00000159337,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G6,HGNC:9039,phospholipase A2 group VI,8398,ENSG00000184381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G7,HGNC:9040,phospholipase A2 group VII,7941,ENSG00000146070,PLA2G7,Platelet-activating factor acetylhydrolase,Enzyme,PAFA_HUMAN,7.3,IC50,CHEMBL
9373,PLAA,phospholipase A2-activating protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLAA,HGNC:9043,phospholipase A2 activating protein,9373,ENSG00000137055,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5327,PLAT,"plasminogen activator, tissue",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLAT,HGNC:9051,"plasminogen activator, tissue type",5327,ENSG00000104368,PLAT,Tissue-type plasminogen activator,Enzyme,TPA_HUMAN,0,0,DRUGBANK
22874,PLEKHA6,"pleckstrin homology domain containing, family A member 6",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLEKHA6,HGNC:17053,pleckstrin homology domain containing A6,22874,ENSG00000143850,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5340,PLG,plasminogen,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLG,HGNC:9071,plasminogen,5340,ENSG00000122194,PLG,Plasminogen,Enzyme,PLMN_HUMAN,4.4,IC50,CHEMBL
51090,PLLP,plasmolipin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLLP,HGNC:18553,plasmolipin,51090,ENSG00000102934,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5354,PLP1,proteolipid protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLP1,HGNC:9086,proteolipid protein 1,5354,ENSG00000123560,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57088,PLSCR4,phospholipid scramblase 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLSCR4,HGNC:16497,phospholipid scramblase 4,57088,ENSG00000114698,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5375,PMP2,peripheral myelin protein 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PMP2,HGNC:9117,peripheral myelin protein 2,5375,ENSG00000147588,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5368,PNOC,prepronociceptin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PNOC,HGNC:9163,prepronociceptin,5368,ENSG00000168081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55163,PNPO,pyridoxamine 5'-phosphate oxidase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PNPO,HGNC:30260,pyridoxamine 5'-phosphate oxidase,55163,ENSG00000108439,PNPO,Pyridoxine-5'-phosphate oxidase,Enzyme,PNPO_HUMAN,0,0,WOMBAT-PK
5444,PON1,paraoxonase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PON1,HGNC:9204,paraoxonase 1,5444,ENSG00000005421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5465,PPARA,peroxisome proliferator-activated receptor alpha,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPARA,HGNC:9232,peroxisome proliferator activated receptor alpha,5465,ENSG00000186951,PPARA,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,PPARA_HUMAN,4.300000191,EC50,IUPHAR
5468,PPARG,peroxisome proliferator-activated receptor gamma,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPARG,HGNC:9236,peroxisome proliferator activated receptor gamma,5468,ENSG00000132170,PPARG,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,PPARG_HUMAN,0,0,CHEMBL
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPARGC1A,HGNC:9237,PPARG coactivator 1 alpha,10891,ENSG00000109819,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPIA,HGNC:9253,peptidylprolyl isomerase A,5478,ENSG00000196262,PPIA,Peptidyl-prolyl cis-trans isomerase A,Enzyme,PPIA_HUMAN,8.0458,IC50,WOMBAT-PK
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP1R1B,HGNC:9287,protein phosphatase 1 regulatory inhibitor subunit 1B,84152,ENSG00000131771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84687,PPP1R9B,"protein phosphatase 1, regulatory subunit 9B",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP1R9B,HGNC:9298,protein phosphatase 1 regulatory subunit 9B,84687,ENSG00000108819,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5521,PPP2R2B,"protein phosphatase 2, regulatory subunit B, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP2R2B,HGNC:9305,protein phosphatase 2 regulatory subunit Bbeta,5521,ENSG00000156475,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5533,PPP3CC,"protein phosphatase 3, catalytic subunit, gamma isozyme",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP3CC,HGNC:9316,protein phosphatase 3 catalytic subunit gamma,5533,ENSG00000120910,PPP3CC,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,0,0,WOMBAT-PK
5534,PPP3R1,"protein phosphatase 3, regulatory subunit B, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPP3R1,HGNC:9317,"protein phosphatase 3 regulatory subunit B, alpha",5534,ENSG00000221823,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9588,PRDX6,peroxiredoxin 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRDX6,HGNC:16753,peroxiredoxin 6,9588,ENSG00000117592,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5578,PRKCA,"protein kinase C, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCA,HGNC:9393,protein kinase C alpha,5578,ENSG00000154229,PRKCA,Protein kinase C alpha type,Kinase,KPCA_HUMAN,5.22,Kd,CHEMBL
5617,PRL,prolactin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRL,HGNC:9445,prolactin,5617,ENSG00000172179,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
58510,PRODH2,proline dehydrogenase (oxidase) 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRODH2,HGNC:17325,proline dehydrogenase 2,58510,ENSG00000250799,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10279,PRSS16,"protease, serine, 16 (thymus)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRSS16,HGNC:9480,serine protease 16,10279,ENSG00000112812,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29968,PSAT1,phosphoserine aminotransferase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSAT1,HGNC:19129,phosphoserine aminotransferase 1,29968,ENSG00000135069,PSAT1,Phosphoserine aminotransferase,Enzyme,SERC_HUMAN,0,0,WOMBAT-PK
5662,PSD,pleckstrin and Sec7 domain containing,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSD,HGNC:9507,pleckstrin and Sec7 domain containing,5662,ENSG00000059915,PSD,PH and SEC7 domain-containing protein 1,Unclassified,PSD1_HUMAN,7.7447,Ki,WOMBAT-PK
23362,PSD3,pleckstrin and Sec7 domain containing 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSD3,HGNC:19093,pleckstrin and Sec7 domain containing 3,23362,ENSG00000156011,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5664,PSEN2,presenilin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSEN2,HGNC:9509,presenilin 2,5664,ENSG00000143801,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5730,PTGDS,prostaglandin D2 synthase 21kDa (brain),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGDS,HGNC:9592,prostaglandin D2 synthase,5730,ENSG00000107317,PTGDS,Prostaglandin-H2 D-isomerase,Enzyme,PTGDS_HUMAN,6.3,IC50,WOMBAT-PK
5733,PTGER3,prostaglandin E receptor 3 (subtype EP3),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGER3,HGNC:9595,prostaglandin E receptor 3,5733,ENSG00000050628,PTGER3,Prostaglandin E2 receptor EP3 subtype,GPCR,PE2R3_HUMAN,9,EC50,WOMBAT-PK
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS1,HGNC:9604,prostaglandin-endoperoxide synthase 1,5742,ENSG00000095303,PTGS1,Prostaglandin G/H synthase 1,Enzyme,PGH1_HUMAN,0,0,KEGG DRUG
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
5770,PTPN1,"protein tyrosine phosphatase, non-receptor type 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPN1,HGNC:9642,protein tyrosine phosphatase non-receptor type 1,5770,ENSG00000196396,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,PTN1_HUMAN,0,0,WOMBAT-PK
11099,PTPN21,"protein tyrosine phosphatase, non-receptor type 21",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPN21,HGNC:9651,protein tyrosine phosphatase non-receptor type 21,11099,ENSG00000070778,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84867,PTPN5,"protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPN5,HGNC:9657,protein tyrosine phosphatase non-receptor type 5,84867,ENSG00000110786,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5777,PTPN6,"protein tyrosine phosphatase, non-receptor type 6",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPN6,HGNC:9658,protein tyrosine phosphatase non-receptor type 6,5777,ENSG00000111679,PTPN6,Protein-tyrosine phosphatase 1C,Enzyme,PTN6_HUMAN,4.68,IC50,CHEMBL
5786,PTPRA,"protein tyrosine phosphatase, receptor type, A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPRA,HGNC:9664,protein tyrosine phosphatase receptor type A,5786,ENSG00000132670,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5803,PTPRZ1,"protein tyrosine phosphatase, receptor-type, Z polypeptide 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPRZ1,HGNC:9685,protein tyrosine phosphatase receptor type Z1,5803,ENSG00000106278,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9444,QKI,"QKI, KH domain containing, RNA binding",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,QKI,HGNC:21100,"QKI, KH domain containing RNA binding",9444,ENSG00000112531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
140902,R3HDML,R3H domain containing-like,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,R3HDML,HGNC:16249,R3H domain containing like,140902,ENSG00000101074,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10743,RAI1,retinoic acid induced 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAI1,HGNC:9834,retinoic acid induced 1,10743,ENSG00000108557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5902,RANBP1,RAN binding protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RANBP1,HGNC:9847,RAN binding protein 1,5902,ENSG00000099901,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10048,RANBP9,RAN binding protein 9,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RANBP9,HGNC:13727,RAN binding protein 9,10048,ENSG00000010017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPGEF5,HGNC:16862,Rap guanine nucleotide exchange factor 5,9771,ENSG00000136237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51735,RAPGEF6,Rap guanine nucleotide exchange factor (GEF) 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPGEF6,HGNC:20655,Rap guanine nucleotide exchange factor 6,51735,ENSG00000158987,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5914,RARA,"retinoic acid receptor, alpha",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RARA,HGNC:9864,retinoic acid receptor alpha,5914,ENSG00000131759,RARA,Retinoic acid receptor alpha,Nuclear hormone receptor,RARA_HUMAN,0,0,WOMBAT-PK
23551,RASD2,"RASD family, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RASD2,HGNC:18229,RASD family member 2,23551,ENSG00000100302,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5947,RBP1,"retinol binding protein 1, cellular",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RBP1,HGNC:9919,retinol binding protein 1,5947,ENSG00000114115,RBP1,Retinol-binding protein 1,Cytosolic other,RET1_HUMAN,0,0,WOMBAT-PK
55213,RCBTB1,regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RCBTB1,HGNC:18243,RCC1 and BTB domain containing protein 1,55213,ENSG00000136144,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELA,HGNC:9955,"RELA proto-oncogene, NF-kB subunit",5970,ENSG00000173039,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5978,REST,RE1-silencing transcription factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REST,HGNC:9966,RE1 silencing transcription factor,5978,ENSG00000084093,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6001,RGS10,regulator of G-protein signaling 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS10,HGNC:9992,regulator of G protein signaling 10,6001,ENSG00000148908,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5997,RGS2,regulator of G-protein signaling 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS2,HGNC:9998,regulator of G protein signaling 2,5997,ENSG00000116741,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8490,RGS5,regulator of G-protein signaling 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS5,HGNC:10001,regulator of G protein signaling 5,8490,ENSG00000143248,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6007,RHD,"Rh blood group, D antigen",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RHD,HGNC:10009,Rh blood group D antigen,6007,ENSG00000187010,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9699,RIMS2,regulating synaptic membrane exocytosis 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RIMS2,HGNC:17283,regulating synaptic membrane exocytosis 2,9699,ENSG00000176406,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9783,RIMS3,regulating synaptic membrane exocytosis 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RIMS3,HGNC:21292,regulating synaptic membrane exocytosis 3,9783,ENSG00000117016,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54719,RNANC,"Retinal nonattachment, nonsyndromic congenital",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4550,RNR2,l-rRNA,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNR2,HGNC:10083,"RNA, ribosomal 45S cluster 2",6053,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
219790,RTKN2,rhotekin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RTKN2,HGNC:19364,rhotekin 2,219790,ENSG00000182010,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6280,S100A9,S100 calcium binding protein A9,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A9,HGNC:10499,S100 calcium binding protein A9,6280,ENSG00000163220,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
22904,SBNO2,strawberry notch homolog 2 (Drosophila),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SBNO2,HGNC:29158,strawberry notch homolog 2,22904,ENSG00000064932,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7356,SCGB1A1,"secretoglobin, family 1A, member 1 (uteroglobin)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SCGB1A1,HGNC:12523,secretoglobin family 1A member 1,7356,ENSG00000149021,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10806,SDCCAG8,serologically defined colon cancer antigen 8,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SDCCAG8,HGNC:10671,SHH signaling and ciliogenesis regulator SDCCAG8,10806,ENSG00000054282,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SDHA,HGNC:10680,succinate dehydrogenase complex flavoprotein subunit A,6389,ENSG00000073578,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10371,SEMA3A,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEMA3A,HGNC:10723,semaphorin 3A,10371,ENSG00000075213,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
223117,SEMA3D,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEMA3D,HGNC:10726,semaphorin 3D,223117,ENSG00000153993,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5274,SERPINI1,"serpin peptidase inhibitor, clade I (neuroserpin), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINI1,HGNC:8943,serpin family I member 1,5274,ENSG00000163536,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9739,SETD1A,SET domain containing 1A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SETD1A,HGNC:29010,"SET domain containing 1A, histone lysine methyltransferase",9739,ENSG00000099381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9869,SETDB1,"SET domain, bifurcated 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SETDB1,HGNC:10761,SET domain bifurcated histone lysine methyltransferase 1,9869,ENSG00000143379,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9644,SH3PXD2A,SH3 and PX domains 2A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SH3PXD2A,HGNC:23664,SH3 and PX domains 2A,9644,ENSG00000107957,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHANK1,HGNC:15474,SH3 and multiple ankyrin repeat domains 1,50944,ENSG00000161681,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6470,SHMT1,serine hydroxymethyltransferase 1 (soluble),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHMT1,HGNC:10850,serine hydroxymethyltransferase 1,6470,ENSG00000176974,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Enzyme,GLYC_HUMAN,0,0,WOMBAT-PK
6474,SHOX2,short stature homeobox 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHOX2,HGNC:10854,short stature homeobox 2,6474,ENSG00000168779,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIGMAR1,HGNC:8157,sigma non-opioid intracellular receptor 1,10280,ENSG00000147955,SIGMAR1,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_HUMAN,7.69,Ki,CHEMBL
10326,SIRPB1,signal-regulatory protein beta 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRPB1,HGNC:15928,signal regulatory protein beta 1,10326,ENSG00000101307,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23411,SIRT1,sirtuin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT1,HGNC:14929,sirtuin 1,23411,ENSG00000096717,SIRT1,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,4.3,IC50,CHEMBL
23408,SIRT5,sirtuin 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT5,HGNC:14933,sirtuin 5,23408,ENSG00000124523,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,SIR5_HUMAN,4.33,IC50,CHEMBL
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC12A2,HGNC:10911,solute carrier family 12 member 2,6558,ENSG00000064651,SLC12A2,Solute carrier family 12 member 2,Transporter,S12A2_HUMAN,5.599999905,IC50,IUPHAR
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC12A5,HGNC:13818,solute carrier family 12 member 5,57468,ENSG00000124140,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57084,SLC17A6,"solute carrier family 17 (vesicular glutamate transporter), member 6",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A6,HGNC:16703,solute carrier family 17 member 6,57084,ENSG00000091664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57030,SLC17A7,"solute carrier family 17 (vesicular glutamate transporter), member 7",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A7,HGNC:16704,solute carrier family 17 member 7,57030,ENSG00000104888,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6570,SLC18A1,"solute carrier family 18 (vesicular monoamine transporter), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A1,HGNC:10934,solute carrier family 18 member A1,6570,ENSG00000036565,SLC18A1,Chromaffin granule amine transporter,Transporter,VMAT1_HUMAN,5.8,Ki,IUPHAR
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A2,HGNC:10940,solute carrier family 1 member 2,6506,ENSG00000110436,SLC1A2,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,4.210000038,Ki,CHEMBL
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A3,HGNC:10941,solute carrier family 1 member 3,6507,ENSG00000079215,SLC1A3,Excitatory amino acid transporter 1,Transporter,EAA1_HUMAN,4.460000038,Ki,CHEMBL
6509,SLC1A4,"solute carrier family 1 (glutamate/neutral amino acid transporter), member 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A4,HGNC:10942,solute carrier family 1 member 4,6509,ENSG00000115902,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6510,SLC1A5,"solute carrier family 1 (neutral amino acid transporter), member 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A5,HGNC:10943,solute carrier family 1 member 5,6510,ENSG00000105281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6511,SLC1A6,"solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A6,HGNC:10944,solute carrier family 1 member 6,6511,ENSG00000105143,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
151295,SLC23A3,"solute carrier family 23, member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC23A3,HGNC:20601,solute carrier family 23 member 3,151295,ENSG00000213901,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6576,SLC25A1,"solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC25A1,HGNC:10979,solute carrier family 25 member 1,6576,ENSG00000100075,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8604,SLC25A12,"solute carrier family 25 (aspartate/glutamate carrier), member 12",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC25A12,HGNC:10982,solute carrier family 25 member 12,8604,ENSG00000115840,SLC25A12,Calcium-binding mitochondrial carrier protein Aralar1,Unclassified,CMC1_HUMAN,0,0,WOMBAT-PK
9481,SLC25A27,"solute carrier family 25, member 27",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC25A27,HGNC:21065,solute carrier family 25 member 27,9481,ENSG00000153291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7781,SLC30A3,"solute carrier family 30 (zinc transporter), member 3",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC30A3,HGNC:11014,solute carrier family 30 member 3,7781,ENSG00000115194,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
169026,SLC30A8,"solute carrier family 30 (zinc transporter), member 8",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC30A8,HGNC:20303,solute carrier family 30 member 8,169026,ENSG00000164756,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
140679,SLC32A1,"solute carrier family 32 (GABA vesicular transporter), member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC32A1,HGNC:11018,solute carrier family 32 member 1,140679,ENSG00000101438,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54407,SLC38A2,"solute carrier family 38, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC38A2,HGNC:13448,solute carrier family 38 member 2,54407,ENSG00000134294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6538,SLC6A11,"solute carrier family 6 (neurotransmitter transporter), member 11",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A11,HGNC:11044,solute carrier family 6 member 11,6538,ENSG00000132164,SLC6A11,Sodium- and chloride-dependent GABA transporter 3,Transporter,S6A11_HUMAN,5.150000095,IC50,CHEMBL
6539,SLC6A12,"solute carrier family 6 (neurotransmitter transporter), member 12",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A12,HGNC:11045,solute carrier family 6 member 12,6539,ENSG00000111181,SLC6A12,Sodium- and chloride-dependent betaine transporter,Transporter,S6A12_HUMAN,4.440000057,IC50,CHEMBL
6540,SLC6A13,"solute carrier family 6 (neurotransmitter transporter), member 13",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A13,HGNC:11046,solute carrier family 6 member 13,6540,ENSG00000010379,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
9152,SLC6A5,"solute carrier family 6 (neurotransmitter transporter), member 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A5,HGNC:11051,solute carrier family 6 member 5,9152,ENSG00000165970,SLC6A5,Sodium- and chloride-dependent glycine transporter 2,Transporter,SC6A5_HUMAN,4.0362,IC50,WOMBAT-PK
6536,SLC6A9,"solute carrier family 6 (neurotransmitter transporter, glycine), member 9",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A9,HGNC:11056,solute carrier family 6 member 9,6536,ENSG00000196517,SLC6A9,Sodium- and chloride-dependent glycine transporter 1,Transporter,SC6A9_HUMAN,4.5,IC50,CHEMBL
56301,SLC7A10,"solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC7A10,HGNC:11058,solute carrier family 7 member 10,56301,ENSG00000130876,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6586,SLIT3,slit homolog 3 (Drosophila),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLIT3,HGNC:11087,slit guidance ligand 3,6586,ENSG00000184347,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4090,SMAD5,SMAD family member 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SMAD5,HGNC:6771,SMAD family member 5,4090,ENSG00000113658,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6595,SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SMARCA2,HGNC:11098,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",6595,ENSG00000080503,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9342,SNAP29,"synaptosomal-associated protein, 29kDa",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNAP29,HGNC:11133,synaptosome associated protein 29,9342,ENSG00000099940,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6620,SNCB,"synuclein, beta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNCB,HGNC:11140,synuclein beta,6620,ENSG00000074317,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
692200,SNORD85,"small nucleolar RNA, C/D box 85",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
169166,SNX31,sorting nexin 31,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNX31,HGNC:28605,sorting nexin 31,169166,ENSG00000174226,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8835,SOCS2,suppressor of cytokine signaling 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOCS2,HGNC:19382,suppressor of cytokine signaling 2,8835,ENSG00000120833,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6647,SOD1,"superoxide dismutase 1, soluble",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD1,HGNC:11179,superoxide dismutase 1,6647,ENSG00000142168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6648,SOD2,"superoxide dismutase 2, mitochondrial",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOD2,HGNC:11180,superoxide dismutase 2,6648,ENSG00000112096,SOD2,"Superoxide dismutase [Mn], mitochondrial",Enzyme,SODM_HUMAN,0,0,WOMBAT-PK
6663,SOX10,SRY (sex determining region Y)-box 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOX10,HGNC:11190,SRY-box transcription factor 10,6663,ENSG00000100146,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6660,SOX5,SRY (sex determining region Y)-box 5,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOX5,HGNC:11201,SRY-box transcription factor 5,6660,ENSG00000134532,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55553,SOX6,SRY (sex determining region Y)-box 6,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOX6,HGNC:16421,SRY-box transcription factor 6,55553,ENSG00000110693,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6667,SP1,Sp1 transcription factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP1,HGNC:11205,Sp1 transcription factor,6667,ENSG00000185591,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6670,SP3,Sp3 transcription factor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SP3,HGNC:11208,Sp3 transcription factor,6670,ENSG00000172845,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6712,SPTBN2,"spectrin, beta, non-erythrocytic 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SPTBN2,HGNC:11276,"spectrin beta, non-erythrocytic 2",6712,ENSG00000173898,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A2,HGNC:11285,steroid 5 alpha-reductase 2,6716,ENSG00000277893,SRD5A2,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,S5A2_HUMAN,0,0,WOMBAT-PK
6720,SREBF1,sterol regulatory element binding transcription factor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SREBF1,HGNC:11289,sterol regulatory element binding transcription factor 1,6720,ENSG00000072310,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6721,SREBF2,sterol regulatory element binding transcription factor 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SREBF2,HGNC:11290,sterol regulatory element binding transcription factor 2,6721,ENSG00000198911,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9901,SRGAP3,SLIT-ROBO Rho GTPase activating protein 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRGAP3,HGNC:19744,SLIT-ROBO Rho GTPase activating protein 3,9901,ENSG00000196220,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
63826,SRR,serine racemase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRR,HGNC:14398,serine racemase,63826,ENSG00000167720,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10772,SRSF10,serine/arginine-rich splicing factor 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRSF10,HGNC:16713,serine and arginine rich splicing factor 10,10772,ENSG00000188529,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6750,SST,somatostatin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SST,HGNC:11329,somatostatin,6750,ENSG00000157005,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6482,ST3GAL1,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST3GAL1,HGNC:10862,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",6482,ENSG00000008513,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55808,ST6GALNAC1,"ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST6GALNAC1,HGNC:23614,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",55808,ENSG00000070526,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8128,ST8SIA2,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST8SIA2,HGNC:10870,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",8128,ENSG00000140557,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7903,ST8SIA4,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ST8SIA4,HGNC:10871,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4",7903,ENSG00000113532,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
246744,STH,saitohin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STH,HGNC:18839,saitohin,246744,ENSG00000256762,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
85439,STON2,stonin 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STON2,HGNC:30652,stonin 2,85439,ENSG00000140022,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6804,STX1A,syntaxin 1A (brain),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STX1A,HGNC:11433,syntaxin 1A,6804,ENSG00000106089,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6812,STXBP1,syntaxin binding protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STXBP1,HGNC:11444,syntaxin binding protein 1,6812,ENSG00000136854,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
25830,SULT4A1,"sulfotransferase family 4A, member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SULT4A1,HGNC:14903,sulfotransferase family 4A member 1,25830,ENSG00000130540,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9900,SV2A,synaptic vesicle glycoprotein 2A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SV2A,HGNC:20566,synaptic vesicle glycoprotein 2A,9900,ENSG00000159164,SV2A,Synaptic vesicle glycoprotein 2A,Transporter,SV2A_HUMAN,6.099999905,Ki,CHEMBL
6853,SYN1,synapsin I,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYN1,HGNC:11494,synapsin I,6853,ENSG00000008056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8224,SYN3,synapsin III,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYN3,HGNC:11496,synapsin III,8224,ENSG00000185666,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8831,SYNGAP1,synaptic Ras GTPase activating protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYNGAP1,HGNC:11497,synaptic Ras GTPase activating protein 1,8831,ENSG00000197283,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9145,SYNGR1,synaptogyrin 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYNGR1,HGNC:11498,synaptogyrin 1,9145,ENSG00000100321,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23208,SYT11,synaptotagmin XI,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYT11,HGNC:19239,synaptotagmin 11,23208,ENSG00000132718,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
134864,TAAR1,trace amine associated receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAAR1,HGNC:17734,trace amine associated receptor 1,134864,ENSG00000146399,TAAR1,Trace amine-associated receptor 1,GPCR,TAAR1_HUMAN,6.221848965,EC50,SCIENTIFIC LITERATURE
6869,TACR1,tachykinin receptor 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR1,HGNC:11526,tachykinin receptor 1,6869,ENSG00000115353,TACR1,Substance-P receptor,GPCR,NK1R_HUMAN,10.7,Ki,CHEMBL
6870,TACR3,tachykinin receptor 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR3,HGNC:11528,tachykinin receptor 3,6870,ENSG00000169836,TACR3,Neuromedin-K receptor,GPCR,NK3R_HUMAN,6.34,Ki,CHEMBL
6890,TAP1,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAP1,HGNC:43,"transporter 1, ATP binding cassette subfamily B member",6890,ENSG00000168394,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6891,TAP2,"transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAP2,HGNC:44,"transporter 2, ATP binding cassette subfamily B member",6891,ENSG00000204267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6892,TAPBP,TAP binding protein (tapasin),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAPBP,HGNC:11566,TAP binding protein,6892,ENSG00000231925,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6908,TBP,TATA box binding protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBP,HGNC:11588,TATA-box binding protein,6908,ENSG00000112592,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6899,TBX1,T-box 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX1,HGNC:11592,T-box transcription factor 1,6899,ENSG00000184058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6925,TCF4,transcription factor 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF4,HGNC:11634,transcription factor 4,6925,ENSG00000196628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF7L2,HGNC:11641,transcription factor 7 like 2,6934,ENSG00000148737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6950,TCP1,t-complex 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCP1,HGNC:11655,t-complex 1,6950,ENSG00000120438,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6999,TDO2,"tryptophan 2,3-dioxygenase",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26011,TENM4,teneurin transmembrane protein 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TENM4,HGNC:29945,teneurin transmembrane protein 4,26011,ENSG00000149256,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80312,TET1,tet methylcytosine dioxygenase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TET1,HGNC:29484,tet methylcytosine dioxygenase 1,80312,ENSG00000138336,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7018,TF,transferrin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TF,HGNC:11740,transferrin,7018,ENSG00000091513,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TFAP2A,HGNC:11742,transcription factor AP-2 alpha,7020,ENSG00000137203,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGFBR2,HGNC:11773,transforming growth factor beta receptor 2,7048,ENSG00000163513,TGFBR2,TGF-beta receptor type-2,Kinase,TGFR2_HUMAN,5.54,Kd,CHEMBL
7052,TGM2,transglutaminase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGM2,HGNC:11778,transglutaminase 2,7052,ENSG00000198959,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7079,TIMP4,TIMP metallopeptidase inhibitor 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TIMP4,HGNC:11823,TIMP metallopeptidase inhibitor 4,7079,ENSG00000157150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7092,TLL1,tolloid-like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLL1,HGNC:11843,tolloid like 1,7092,ENSG00000038295,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7097,TLR2,toll-like receptor 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR2,HGNC:11848,toll like receptor 2,7097,ENSG00000137462,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7098,TLR3,toll-like receptor 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR3,HGNC:11849,toll like receptor 3,7098,ENSG00000164342,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7099,TLR4,toll-like receptor 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR4,HGNC:11850,toll like receptor 4,7099,ENSG00000136869,TLR4,Toll-like receptor 4,Membrane receptor,TLR4_HUMAN,0,0,WOMBAT-PK
23731,TMEM245,transmembrane protein 245,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TMEM245,HGNC:1363,transmembrane protein 245,23731,ENSG00000106771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9168,TMSB10,thymosin beta 10,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TMSB10,HGNC:11879,thymosin beta 10,9168,ENSG00000034510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1A,HGNC:11916,TNF receptor superfamily member 1A,7132,ENSG00000067182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1B,HGNC:11917,TNF receptor superfamily member 1B,7133,ENSG00000028137,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8741,TNFSF13,"tumor necrosis factor (ligand) superfamily, member 13",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFSF13,HGNC:11928,TNF superfamily member 13,8741,ENSG00000161955,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23043,TNIK,TRAF2 and NCK interacting kinase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNIK,HGNC:30765,TRAF2 and NCK interacting kinase,23043,ENSG00000154310,TNIK,TRAF2 and NCK-interacting protein kinase,Kinase,TNIK_HUMAN,5.7,Kd,CHEMBL
7148,TNXB,tenascin XB,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNXB,HGNC:11976,tenascin XB,7148,ENSG00000168477,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8940,TOP3B,topoisomerase (DNA) III beta,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TOP3B,HGNC:11993,DNA topoisomerase III beta,8940,ENSG00000100038,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
121278,TPH2,tryptophan hydroxylase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7167,TPI1,triosephosphate isomerase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPI1,HGNC:12009,triosephosphate isomerase 1,7167,ENSG00000111669,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7178,TPT1,"tumor protein, translationally-controlled 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPT1,HGNC:12022,"tumor protein, translationally-controlled 1",7178,ENSG00000133112,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54210,TREM1,triggering receptor expressed on myeloid cells 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TREM1,HGNC:17760,triggering receptor expressed on myeloid cells 1,54210,ENSG00000124731,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27037,TRMT2A,tRNA methyltransferase 2 homolog A (S. cerevisiae),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRMT2A,HGNC:24974,tRNA methyltransferase 2 homolog A,27037,ENSG00000099899,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4308,TRPM1,"transient receptor potential cation channel, subfamily M, member 1",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRPM1,HGNC:7146,transient receptor potential cation channel subfamily M member 1,4308,ENSG00000134160,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
203062,TSNARE1,t-SNARE domain containing 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNARE1,HGNC:26437,t-SNARE domain containing 1,203062,ENSG00000171045,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7257,TSNAX,translin-associated factor X,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX,HGNC:12380,translin associated factor X,7257,ENSG00000116918,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100303453,TSNAX-DISC1,TSNAX-DISC1 readthrough (NMD candidate),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX-DISC1,HGNC:49177,TSNAX-DISC1 readthrough (NMD candidate),100303453,ENSG00000270106,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7103,TSPAN8,tetraspanin 8,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSPAN8,HGNC:11855,tetraspanin 8,7103,ENSG00000127324,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7276,TTR,transthyretin,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TTR,HGNC:12405,transthyretin,7276,ENSG00000118271,TTR,Transthyretin,Secreted,TTHY_HUMAN,5.92,Kd,CHEMBL
81567,TXNDC5,thioredoxin domain containing 5 (endoplasmic reticulum),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TXNDC5,HGNC:21073,thioredoxin domain containing 5,81567,ENSG00000239264,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7299,TYR,tyrosinase,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TYR,HGNC:12442,tyrosinase,7299,ENSG00000077498,TYR,Tyrosinase,Enzyme,TYRO_HUMAN,6.25,IC50,CHEMBL
7305,TYROBP,TYRO protein tyrosine kinase binding protein,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TYROBP,HGNC:12449,transmembrane immune signaling adaptor TYROBP,7305,ENSG00000011600,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UCP2,HGNC:12518,uncoupling protein 2,7351,ENSG00000175567,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7353,UFD1L,ubiquitin fusion degradation 1 like (yeast),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
127933,UHMK1,U2AF homology motif (UHM) kinase 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UHMK1,HGNC:19683,U2AF homology motif kinase 1,127933,ENSG00000152332,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54986,ULK4,unc-51 like kinase 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ULK4,HGNC:15784,unc-51 like kinase 4,54986,ENSG00000168038,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8633,UNC5C,unc-5 homolog C (C. elegans),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UNC5C,HGNC:12569,unc-5 netrin receptor C,8633,ENSG00000182168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64854,USP46,ubiquitin specific peptidase 46,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,USP46,HGNC:20075,ubiquitin specific peptidase 46,64854,ENSG00000109189,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6843,VAMP1,vesicle-associated membrane protein 1 (synaptobrevin 1),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP1,HGNC:12642,vesicle associated membrane protein 1,6843,ENSG00000139190,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6844,VAMP2,vesicle-associated membrane protein 2 (synaptobrevin 2),C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP2,HGNC:12643,vesicle associated membrane protein 2,6844,ENSG00000220205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6845,VAMP7,vesicle-associated membrane protein 7,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP7,HGNC:11486,vesicle associated membrane protein 7,6845,ENSG00000124333,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VDR,HGNC:12679,vitamin D receptor,7421,ENSG00000111424,VDR,Vitamin D3 receptor,Nuclear hormone receptor,VDR_HUMAN,0,0,WOMBAT-PK
7422,VEGFA,vascular endothelial growth factor A,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
7425,VGF,VGF nerve growth factor inducible,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VGF,HGNC:12684,VGF nerve growth factor inducible,7425,ENSG00000128564,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7432,VIP,vasoactive intestinal peptide,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7436,VLDLR,very low density lipoprotein receptor,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VLDLR,HGNC:12698,very low density lipoprotein receptor,7436,ENSG00000147852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7444,VRK2,vaccinia related kinase 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VRK2,HGNC:12719,VRK serine/threonine kinase 2,7444,ENSG00000028116,VRK2,Serine/threonine-protein kinase VRK2,Kinase,VRK2_HUMAN,5.49,Kd,CHEMBL
7447,VSNL1,visinin-like 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VSNL1,HGNC:12722,visinin like 1,7447,ENSG00000163032,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
65267,WNK3,WNK lysine deficient protein kinase 3,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WNK3,HGNC:14543,WNK lysine deficient protein kinase 3,65267,ENSG00000196632,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
65266,WNK4,WNK lysine deficient protein kinase 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WNK4,HGNC:14544,WNK lysine deficient protein kinase 4,65266,ENSG00000126562,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7472,WNT2,wingless-type MMTV integration site family member 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WNT2,HGNC:12780,Wnt family member 2,7472,ENSG00000105989,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7494,XBP1,X-box binding protein 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,XBP1,HGNC:12801,X-box binding protein 1,7494,ENSG00000100219,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,XRCC1,HGNC:12828,X-ray repair cross complementing 1,7515,ENSG00000073050,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7518,XRCC4,X-ray repair complementing defective repair in Chinese hamster cells 4,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,XRCC4,HGNC:12831,X-ray repair cross complementing 4,7518,ENSG00000152422,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7531,YWHAE,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAE,HGNC:12851,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,7531,ENSG00000108953,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7533,YWHAH,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAH,HGNC:12853,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta,7533,ENSG00000128245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
86123,YWHAZP5,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta pseudogene 5",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAZP5,HGNC:30564,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta pseudogene 5,86123,ENSG00000213260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29801,ZDHHC8,"zinc finger, DHHC-type containing 8",C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZDHHC8,HGNC:18474,zinc finger DHHC-type palmitoyltransferase 8,29801,ENSG00000099904,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7546,ZIC2,Zic family member 2,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZIC2,HGNC:12873,Zic family member 2,7546,ENSG00000043355,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7625,ZNF74,zinc finger protein 74,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZNF74,HGNC:13144,zinc finger protein 74,7625,ENSG00000185252,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64288,ZSCAN31,zinc finger and SCAN domain containing 31,C0036341,schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036341,Schizophrenia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZSCAN31,HGNC:14097,zinc finger and SCAN domain containing 31,64288,ENSG00000235109,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9620,CELSR1,"cadherin, EGF LAG seven-pass G-type receptor 1",C0036344,"schizophrenia, catatonic",Schizophrenia spectrum and other psychotic disorders,C0036344,"Schizophrenia, Catatonic",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,CELSR1,HGNC:1850,cadherin EGF LAG seven-pass G-type receptor 1,9620,ENSG00000075275,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57369,GJD2,"gap junction protein, delta 2, 36kDa",C0036344,"schizophrenia, catatonic",Schizophrenia spectrum and other psychotic disorders,C0036344,"Schizophrenia, Catatonic",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,GJD2,HGNC:19154,gap junction protein delta 2,57369,ENSG00000159248,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,C0036344,"schizophrenia, catatonic",Schizophrenia spectrum and other psychotic disorders,C0036344,"Schizophrenia, Catatonic",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MLC1,HGNC:17082,modulator of VRAC current 1,23209,ENSG00000100427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7782,SLC30A4,"solute carrier family 30 (zinc transporter), member 4",C0036344,"schizophrenia, catatonic",Schizophrenia spectrum and other psychotic disorders,C0036344,"Schizophrenia, Catatonic",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC30A4,HGNC:11015,solute carrier family 30 member 4,7782,ENSG00000104154,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23040,MYT1L,myelin transcription factor 1-like,C0036346,"schizophrenia, childhood",Schizophrenia spectrum and other psychotic disorders,C0036346,"Schizophrenia, Childhood",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MYT1L,HGNC:7623,myelin transcription factor 1 like,23040,ENSG00000186487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
221,ALDH3B1,"aldehyde dehydrogenase 3 family, member B1",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH3B1,HGNC:410,aldehyde dehydrogenase 3 family member B1,221,ENSG00000006534,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
811,CALR,calreticulin,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
886,CCKAR,cholecystokinin A receptor,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2B6,HGNC:2615,cytochrome P450 family 2 subfamily B member 6,1555,ENSG00000197408,CYP2B6,Cytochrome P450 2B6,Enzyme,CP2B6_HUMAN,6.3,Ki,WOMBAT-PK
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
3105,HLA-A,"major histocompatibility complex, class I, A",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-A,HGNC:4931,"major histocompatibility complex, class I, A",3105,ENSG00000206503,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3126,HLA-DRB4,"major histocompatibility complex, class II, DR beta 4",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DRB4,HGNC:4952,"major histocompatibility complex, class II, DR beta 4",3126,ENSG00000227357,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3303,HSPA1A,heat shock 70kDa protein 1A,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1A,HGNC:5232,heat shock protein family A (Hsp70) member 1A,3303,ENSG00000204389,HSPA1A,Heat shock 70 kDa protein 1A,Unclassified,HS71A_HUMAN,5.46999979,IC50,CHEMBL
3305,HSPA1L,heat shock 70kDa protein 1-like,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1L,HGNC:5234,heat shock protein family A (Hsp70) member 1 like,3305,ENSG00000204390,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
3558,IL2,interleukin 2,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL2,HGNC:6001,interleukin 2,3558,ENSG00000109471,IL2,Interleukin-2,Cytokine,IL2_HUMAN,0,0,WOMBAT-PK
3565,IL4,interleukin 4,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL4,HGNC:6014,interleukin 4,3565,ENSG00000113520,IL4,Interleukin-4,Cytokine,IL4_HUMAN,8.33,IC50,WOMBAT-PK
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFRSF1B,HGNC:11917,TNF receptor superfamily member 1B,7133,ENSG00000028137,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
121278,TPH2,tryptophan hydroxylase 2,C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",C0036349,paranoid schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036349,Paranoid Schizophrenia,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,YWHAZ,HGNC:12855,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,7534,ENSG00000164924,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2730,GCLM,"glutamate-cysteine ligase, modifier subunit",C0036351,residual schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036351,Residual schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GCLM,HGNC:4312,glutamate-cysteine ligase modifier subunit,2730,ENSG00000023909,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2876,GPX1,glutathione peroxidase 1,C0036351,residual schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0036351,Residual schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GPX1,HGNC:4553,glutathione peroxidase 1,2876,ENSG00000233276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
811,CALR,calreticulin,C0036939,shared paranoid disorder,Schizophrenia spectrum and other psychotic disorders,C0036939,Shared Paranoid Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2099,ESR1,estrogen receptor 1,C0036939,shared paranoid disorder,Schizophrenia spectrum and other psychotic disorders,C0036939,Shared Paranoid Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
2730,GCLM,"glutamate-cysteine ligase, modifier subunit",C0036939,shared paranoid disorder,Schizophrenia spectrum and other psychotic disorders,C0036939,Shared Paranoid Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCLM,HGNC:4312,glutamate-cysteine ligase modifier subunit,2730,ENSG00000023909,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2950,GSTP1,glutathione S-transferase pi 1,C0036939,shared paranoid disorder,Schizophrenia spectrum and other psychotic disorders,C0036939,Shared Paranoid Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTP1,HGNC:4638,glutathione S-transferase pi 1,2950,ENSG00000084207,GSTP1,Glutathione S-transferase P,Enzyme,GSTP1_HUMAN,0,0,WOMBAT-PK
23411,SIRT1,sirtuin 1,C0036939,shared paranoid disorder,Schizophrenia spectrum and other psychotic disorders,C0036939,Shared Paranoid Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT1,HGNC:14929,sirtuin 1,23411,ENSG00000096717,SIRT1,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,4.3,IC50,CHEMBL
121278,TPH2,tryptophan hydroxylase 2,C0038586,substance use disorders,Alcohol use disorders,C0038586,Substance Use Disorders,group,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
25890,ABI3BP,"ABI family, member 3 (NESH) binding protein",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABI3BP,HGNC:17265,ABI family member 3 binding protein,25890,ENSG00000154175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
52,ACP1,"acid phosphatase 1, soluble",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACP1,HGNC:122,acid phosphatase 1,52,ENSG00000143727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116285,ACSM1,acyl-CoA synthetase medium-chain family member 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSM1,HGNC:18049,acyl-CoA synthetase medium chain family member 1,116285,ENSG00000166743,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
111,ADCY5,adenylate cyclase 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY5,HGNC:236,adenylate cyclase 5,111,ENSG00000173175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
113,ADCY7,adenylate cyclase 7,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY7,HGNC:238,adenylate cyclase 7,113,ENSG00000121281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
148,ADRA1A,adrenoceptor alpha 1A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
155,ADRB3,adrenoceptor beta 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB3,HGNC:288,adrenoceptor beta 3,155,ENSG00000188778,ADRB3,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,6.86,Kd,CHEMBL
10270,AKAP8,A kinase (PRKA) anchor protein 8,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKAP8,HGNC:378,A-kinase anchoring protein 8,10270,ENSG00000105127,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
290,ANPEP,alanyl (membrane) aminopeptidase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANPEP,HGNC:500,"alanyl aminopeptidase, membrane",290,ENSG00000166825,ANPEP,Aminopeptidase N,Enzyme,AMPN_HUMAN,5.62,IC50,CHEMBL
317,APAF1,apoptotic peptidase activating factor 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APAF1,HGNC:576,apoptotic peptidase activating factor 1,317,ENSG00000120868,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
353,APRT,adenine phosphoribosyltransferase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APRT,HGNC:626,adenine phosphoribosyltransferase,353,ENSG00000198931,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
408,ARRB1,"arrestin, beta 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB1,HGNC:711,arrestin beta 1,408,ENSG00000137486,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
410,ARSA,arylsulfatase A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARSA,HGNC:713,arylsulfatase A,410,ENSG00000100299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9048,ARTN,artemin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARTN,HGNC:727,artemin,9048,ENSG00000117407,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP7B,HGNC:870,ATPase copper transporting beta,540,ENSG00000123191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
551,AVP,arginine vasopressin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
607,BCL9,B-cell CLL/lymphoma 9,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL9,HGNC:1008,BCL9 transcription coactivator,607,ENSG00000116128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
613,BCR,breakpoint cluster region,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCR,HGNC:1014,BCR activator of RhoGEF and GTPase,613,ENSG00000186716,BCR,Breakpoint cluster region protein,Kinase,BCR_HUMAN,0,0,WOMBAT-PK
624,BDKRB2,bradykinin receptor B2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDKRB2,HGNC:1030,bradykinin receptor B2,624,ENSG00000168398,BDKRB2,B2 bradykinin receptor,GPCR,BKRB2_HUMAN,5.114978205,Ki,DRUG MATRIX
627,BDNF,brain-derived neurotrophic factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
655,BMP7,bone morphogenetic protein 7,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BMP7,HGNC:1074,bone morphogenetic protein 7,655,ENSG00000101144,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK2A,HGNC:1460,calcium/calmodulin dependent protein kinase II alpha,815,ENSG00000070808,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,7.1,Kd,CHEMBL
847,CAT,catalase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAT,HGNC:1516,catalase,847,ENSG00000121691,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54862,CC2D1A,coiled-coil and C2 domain containing 1A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CC2D1A,HGNC:30237,coiled-coil and C2 domain containing 1A,54862,ENSG00000132024,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
883,CCBL1,"cysteine conjugate-beta lyase, cytoplasmic",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56267,CCBL2,cysteine conjugate-beta lyase 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
886,CCKAR,cholecystokinin A receptor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
6347,CCL2,chemokine (C-C motif) ligand 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL2,HGNC:10618,C-C motif chemokine ligand 2,6347,ENSG00000108691,CCL2,C-C motif chemokine 2,Cytokine,CCL2_HUMAN,5.16,IC50,CHEMBL
6369,CCL24,chemokine (C-C motif) ligand 24,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL24,HGNC:10623,C-C motif chemokine ligand 24,6369,ENSG00000106178,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
595,CCND1,cyclin D1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCND1,HGNC:1582,cyclin D1,595,ENSG00000110092,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
947,CD34,CD34 molecule,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD34,HGNC:1662,CD34 molecule,947,ENSG00000174059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1005,CDH7,"cadherin 7, type 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH7,HGNC:1766,cadherin 7,1005,ENSG00000081138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDKN2A,HGNC:1787,cyclin dependent kinase inhibitor 2A,1029,ENSG00000147889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1131,CHRM3,"cholinergic receptor, muscarinic 3",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM3,HGNC:1952,cholinergic receptor muscarinic 3,1131,ENSG00000133019,CHRM3,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,6.66,EC50,CHEMBL
9575,CLOCK,clock circadian regulator,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
202333,CMYA5,cardiomyopathy associated 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CMYA5,HGNC:14305,cardiomyopathy associated 5,202333,ENSG00000164309,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1267,CNP,"2',3'-cyclic nucleotide 3' phosphodiesterase",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNP,HGNC:2158,"2',3'-cyclic nucleotide 3' phosphodiesterase",1267,ENSG00000173786,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
26047,CNTNAP2,contactin associated protein-like 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTNAP2,HGNC:13830,contactin associated protein 2,26047,ENSG00000174469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1385,CREB1,cAMP responsive element binding protein 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1390,CREM,cAMP responsive element modulator,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREM,HGNC:2352,cAMP responsive element modulator,1390,ENSG00000095794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1401,CRP,"C-reactive protein, pentraxin-related",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRP,HGNC:2367,C-reactive protein,1401,ENSG00000132693,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1429,CRYZ,"crystallin, zeta (quinone reductase)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRYZ,HGNC:2419,crystallin zeta,1429,ENSG00000116791,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1439,CSF2RB,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSF2RB,HGNC:2436,colony stimulating factor 2 receptor subunit beta,1439,ENSG00000100368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1453,CSNK1D,"casein kinase 1, delta",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1D,HGNC:2452,casein kinase 1 delta,1453,ENSG00000141551,CSNK1D,Casein kinase I isoform delta,Kinase,KC1D_HUMAN,5.46,Kd,CHEMBL
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTLA4,HGNC:2505,cytotoxic T-lymphocyte associated protein 4,1493,ENSG00000163599,CTLA4,Cytotoxic T-lymphocyte protein 4,Surface antigen,CTLA4_HUMAN,0,0,DRUG LABEL
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNND2,HGNC:2516,catenin delta 2,1501,ENSG00000169862,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1523,CUX1,cut-like homeobox 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CUX1,HGNC:2557,cut like homeobox 1,1523,ENSG00000257923,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3627,CXCL10,chemokine (C-X-C motif) ligand 10,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL10,HGNC:10637,C-X-C motif chemokine ligand 10,3627,ENSG00000169245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C19,HGNC:2621,cytochrome P450 family 2 subfamily C member 19,1557,ENSG00000165841,CYP2C19,Cytochrome P450 2C19,Enzyme,CP2CJ_HUMAN,6,IC50,CHEMBL
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C9,HGNC:2623,cytochrome P450 family 2 subfamily C member 9,1559,ENSG00000138109,CYP2C9,Cytochrome P450 2C9,Enzyme,CP2C9_HUMAN,7.3979,EC50,WOMBAT-PK
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
267012,DAOA,D-amino acid oxidase activator,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
140947,DCANP1,dendritic cell-associated nuclear protein,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCANP1,HGNC:24459,dendritic cell associated nuclear protein,140947,ENSG00000251380,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
54541,DDIT4,DNA-damage-inducible transcript 4,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDIT4,HGNC:24944,DNA damage inducible transcript 4,54541,ENSG00000168209,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10522,DEAF1,DEAF1 transcription factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DEAF1,HGNC:14677,DEAF1 transcription factor,10522,ENSG00000177030,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
160851,DGKH,"diacylglycerol kinase, eta",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DGKH,HGNC:2854,diacylglycerol kinase eta,160851,ENSG00000102780,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27185,DISC1,disrupted in schizophrenia 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27184,DISC2,disrupted in schizophrenia 2 (non-protein coding),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC2,HGNC:2889,disrupted in schizophrenia 2,27184,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1740,DLG2,"discs, large homolog 2 (Drosophila)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG2,HGNC:2901,discs large MAGUK scaffold protein 2,1740,ENSG00000150672,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1741,DLG3,"discs, large homolog 3 (Drosophila)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG3,HGNC:2902,discs large MAGUK scaffold protein 3,1741,ENSG00000082458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1813,DRD2,dopamine receptor D2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
84062,DTNBP1,dystrobrevin binding protein 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9695,EDEM1,"ER degradation enhancer, mannosidase alpha-like 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EDEM1,HGNC:18967,ER degradation enhancing alpha-mannosidase like protein 1,9695,ENSG00000134109,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1906,EDN1,endothelin 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EDN1,HGNC:3176,endothelin 1,1906,ENSG00000078401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1950,EGF,epidermal growth factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGF,HGNC:3229,epidermal growth factor,1950,ENSG00000138798,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1956,EGFR,epidermal growth factor receptor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGFR,HGNC:3236,epidermal growth factor receptor,1956,ENSG00000146648,EGFR,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,5.217742426,IC50,DRUG MATRIX
30845,EHD3,EH-domain containing 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EHD3,HGNC:3244,EH domain containing 3,30845,ENSG00000013016,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1975,EIF4B,eukaryotic translation initiation factor 4B,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EIF4B,HGNC:3285,eukaryotic translation initiation factor 4B,1975,ENSG00000063046,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2012,EMP1,epithelial membrane protein 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EMP1,HGNC:3333,epithelial membrane protein 1,2012,ENSG00000134531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2028,ENPEP,glutamyl aminopeptidase (aminopeptidase A),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ENPEP,HGNC:3355,glutamyl aminopeptidase,2028,ENSG00000138792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB3,HGNC:3431,erb-b2 receptor tyrosine kinase 3,2065,ENSG00000065361,ERBB3,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,7.74,Kd,CHEMBL
2100,ESR2,estrogen receptor 2 (ER beta),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR2,HGNC:3468,estrogen receptor 2,2100,ENSG00000140009,ESR2,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,8,IC50,CHEMBL
2166,FAAH,fatty acid amide hydrolase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
2260,FGFR1,fibroblast growth factor receptor 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR1,HGNC:3688,fibroblast growth factor receptor 1,2260,ENSG00000077782,FGFR1,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,5.43,Kd,CHEMBL
2288,FKBP4,"FK506 binding protein 4, 59kDa",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP4,HGNC:3720,FKBP prolyl isomerase 4,2288,ENSG00000004478,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Enzyme,FKBP4_HUMAN,7.8,IC50,CHEMBL
2289,FKBP5,FK506 binding protein 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2332,FMR1,fragile X mental retardation 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOS,HGNC:3796,"Fos proto-oncogene, AP-1 transcription factor subunit",2353,ENSG00000170345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27022,FOXD3,forkhead box D3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXD3,HGNC:3804,forkhead box D3,27022,ENSG00000187140,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
93986,FOXP2,forkhead box P2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXP2,HGNC:13875,forkhead box P2,93986,ENSG00000128573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
166752,FREM3,FRAS1 related extracellular matrix 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FREM3,HGNC:25172,FRAS1 related extracellular matrix 3,166752,ENSG00000183090,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9568,GABBR2,"gamma-aminobutyric acid (GABA) B receptor, 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABBR2,HGNC:4507,gamma-aminobutyric acid type B receptor subunit 2,9568,ENSG00000136928,GABBR2,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,GABR2_HUMAN,8.027,IC50,WOMBAT-PK
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8811,GALR2,galanin receptor 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR2,HGNC:4133,galanin receptor 2,8811,ENSG00000182687,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51573,GDE1,glycerophosphodiester phosphodiesterase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GDE1,HGNC:29644,glycerophosphodiester phosphodiesterase 1,51573,ENSG00000006007,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2668,GDNF,glial cell derived neurotrophic factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2697,GJA1,"gap junction protein, alpha 1, 43kDa",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GJA1,HGNC:4274,gap junction protein alpha 1,2697,ENSG00000152661,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55830,GLT8D1,glycosyltransferase 8 domain containing 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLT8D1,HGNC:24870,glycosyltransferase 8 domain containing 1,55830,ENSG00000016864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51291,GMIP,GEM interacting protein,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GMIP,HGNC:24852,GEM interacting protein,51291,ENSG00000089639,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54584,GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB1L,HGNC:4397,G protein subunit beta 1 like,54584,ENSG00000185838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55507,GPRC5D,"G protein-coupled receptor, class C, group 5, member D",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPRC5D,HGNC:13310,G protein-coupled receptor class C group 5 member D,55507,ENSG00000111291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA2,HGNC:4572,glutamate ionotropic receptor AMPA type subunit 2,2891,ENSG00000120251,GRIA2,Glutamate receptor 2,Ion channel,GRIA2_HUMAN,5.65,EC50,CHEMBL
2893,GRIA4,"glutamate receptor, ionotropic, AMPA 4",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA4,HGNC:4574,glutamate ionotropic receptor AMPA type subunit 4,2893,ENSG00000152578,GRIA4,Glutamate receptor 4,Ion channel,GRIA4_HUMAN,5.409999847,EC50,IUPHAR
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
2869,GRK5,G protein-coupled receptor kinase 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRK5,HGNC:4544,G protein-coupled receptor kinase 5,2869,ENSG00000198873,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2911,GRM1,"glutamate receptor, metabotropic 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM1,HGNC:4593,glutamate metabotropic receptor 1,2911,ENSG00000152822,GRM1,Metabotropic glutamate receptor 1,GPCR,GRM1_HUMAN,6.05,Ki,WOMBAT-PK
2915,GRM5,"glutamate receptor, metabotropic 5",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM5,HGNC:4597,glutamate metabotropic receptor 5,2915,ENSG00000168959,GRM5,Metabotropic glutamate receptor 5,GPCR,GRM5_HUMAN,5.41,Ki,WOMBAT-PK
2917,GRM7,"glutamate receptor, metabotropic 7",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
10014,HDAC5,histone deacetylase 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC5,HGNC:14068,histone deacetylase 5,10014,ENSG00000108840,HDAC5,Histone deacetylase 5,Enzyme,HDAC5_HUMAN,6.260000229,Ki,IUPHAR
9734,HDAC9,histone deacetylase 9,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC9,HGNC:14065,histone deacetylase 9,9734,ENSG00000048052,HDAC9,Histone deacetylase 9,Enzyme,HDAC9_HUMAN,5.960000038,Ki,IUPHAR
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HIF1A,HGNC:4910,hypoxia inducible factor 1 subunit alpha,3091,ENSG00000100644,HIF1A,Hypoxia-inducible factor 1-alpha,Transcription factor,HIF1A_HUMAN,4.75,EC50,CHEMBL
3131,HLF,hepatic leukemia factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLF,HGNC:4977,"HLF transcription factor, PAR bZIP family member",3131,ENSG00000108924,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9456,HOMER1,homer homolog 1 (Drosophila),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3240,HP,haptoglobin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP,HGNC:5141,haptoglobin,3240,ENSG00000257017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10855,HPSE,heparanase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPSE,HGNC:5164,heparanase,10855,ENSG00000173083,HPSE,Heparanase,Enzyme,HPSE_HUMAN,4.28,Kd,CHEMBL
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSP90AA1,HGNC:5253,heat shock protein 90 alpha family class A member 1,3320,ENSG00000080824,HSP90AA1,Heat shock protein HSP 90-alpha,Cytosolic other,HS90A_HUMAN,5.3036,IC50,WOMBAT-PK
259217,HSPA12A,heat shock 70kDa protein 12A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA12A,HGNC:19022,heat shock protein family A (Hsp70) member 12A,259217,ENSG00000165868,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3303,HSPA1A,heat shock 70kDa protein 1A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1A,HGNC:5232,heat shock protein family A (Hsp70) member 1A,3303,ENSG00000204389,HSPA1A,Heat shock 70 kDa protein 1A,Unclassified,HS71A_HUMAN,5.46999979,IC50,CHEMBL
3304,HSPA1B,heat shock 70kDa protein 1B,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1B,HGNC:5233,heat shock protein family A (Hsp70) member 1B,3304,ENSG00000204388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3305,HSPA1L,heat shock 70kDa protein 1-like,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1L,HGNC:5234,heat shock protein family A (Hsp70) member 1 like,3305,ENSG00000204390,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3308,HSPA4,heat shock 70kDa protein 4,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
3439,IFNA1,"interferon, alpha 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNA1,HGNC:5417,interferon alpha 1,3439,ENSG00000197919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
282617,IFNL3,"interferon, lambda 3",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNL3,HGNC:18365,interferon lambda 3,282617,ENSG00000197110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9641,IKBKE,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IKBKE,HGNC:14552,inhibitor of nuclear factor kappa B kinase subunit epsilon,9641,ENSG00000263528,IKBKE,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,IKKE_HUMAN,6.21,Kd,CHEMBL
3586,IL10,interleukin 10,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL10,HGNC:5962,interleukin 10,3586,ENSG00000136634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3589,IL11,interleukin 11,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL11,HGNC:5966,interleukin 11,3589,ENSG00000095752,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29949,IL19,interleukin 19,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL19,HGNC:5990,interleukin 19,29949,ENSG00000142224,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3553,IL1B,"interleukin 1, beta",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
50604,IL20,interleukin 20,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL20,HGNC:6002,interleukin 20,50604,ENSG00000162891,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11009,IL24,interleukin 24,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL24,HGNC:11346,interleukin 24,11009,ENSG00000162892,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3559,IL2RA,"interleukin 2 receptor, alpha",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL2RA,HGNC:6008,interleukin 2 receptor subunit alpha,3559,ENSG00000134460,IL2RA,Interleukin-2 receptor subunit alpha,Membrane receptor,IL2RA_HUMAN,10,Kd,DRUG LABEL
3569,IL6,interleukin 6,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
3630,INS,insulin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,INS,HGNC:6081,insulin,3630,ENSG00000254647,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3665,IRF7,interferon regulatory factor 7,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IRF7,HGNC:6122,interferon regulatory factor 7,3665,ENSG00000185507,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3697,ITIH1,inter-alpha-trypsin inhibitor heavy chain 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH1,HGNC:6166,inter-alpha-trypsin inhibitor heavy chain 1,3697,ENSG00000055957,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8997,KALRN,"kalirin, RhoGEF kinase",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KALRN,HGNC:4814,kalirin RhoGEF kinase,8997,ENSG00000160145,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3791,KDR,kinase insert domain receptor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KDR,HGNC:6307,kinase insert domain receptor,3791,ENSG00000128052,KDR,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_HUMAN,5.54,Kd,CHEMBL
8564,KMO,kynurenine 3-monooxygenase (kynurenine 3-hydroxylase),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KMO,HGNC:6381,kynurenine 3-monooxygenase,8564,ENSG00000117009,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3839,KPNA3,karyopherin alpha 3 (importin alpha 4),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KPNA3,HGNC:6396,karyopherin subunit alpha 3,3839,ENSG00000102753,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8942,KYNU,kynureninase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KYNU,HGNC:6469,kynureninase,8942,ENSG00000115919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3939,LDHA,lactate dehydrogenase A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LDHA,HGNC:6535,lactate dehydrogenase A,3939,ENSG00000134333,LDHA,L-lactate dehydrogenase A chain,Enzyme,LDHA_HUMAN,3.19,Kd,CHEMBL
64077,LHPP,phospholysine phosphohistidine inorganic pyrophosphate phosphatase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LHPP,HGNC:30042,phospholysine phosphohistidine inorganic pyrophosphate phosphatase,64077,ENSG00000107902,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4035,LRP1,low density lipoprotein receptor-related protein 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP1,HGNC:6692,LDL receptor related protein 1,4035,ENSG00000123384,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7804,LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP8,HGNC:6700,LDL receptor related protein 8,7804,ENSG00000157193,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4045,LSAMP,limbic system-associated membrane protein,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LSAMP,HGNC:6705,limbic system associated membrane protein,4045,ENSG00000185565,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4049,LTA,lymphotoxin alpha,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LTA,HGNC:6709,lymphotoxin alpha,4049,ENSG00000226979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4074,M6PR,mannose-6-phosphate receptor (cation dependent),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,M6PR,HGNC:6752,"mannose-6-phosphate receptor, cation dependent",4074,ENSG00000003056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
4133,MAP2,microtubule-associated protein 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2,HGNC:6839,microtubule associated protein 2,4133,ENSG00000078018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5604,MAP2K1,mitogen-activated protein kinase kinase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2K1,HGNC:6840,mitogen-activated protein kinase kinase 1,5604,ENSG00000169032,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,MP2K1_HUMAN,6,Kd,CHEMBL
55784,MCTP2,"multiple C2 domains, transmembrane 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCTP2,HGNC:25636,multiple C2 and transmembrane domain containing 2,55784,ENSG00000140563,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266727,MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDGA1,HGNC:19267,MAM domain containing glycosylphosphatidylinositol anchor 1,266727,ENSG00000112139,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4194,MDM4,"MDM4, p53 regulator",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDM4,HGNC:6974,MDM4 regulator of p53,4194,ENSG00000198625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100302259,MIR1202,microRNA 1202,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR1202,HGNC:35268,microRNA 1202,100302259,ENSG00000221456,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
407034,MIR30E,microRNA 30e,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR30E,HGNC:31629,microRNA 30e,407034,ENSG00000198974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4317,MMP8,matrix metallopeptidase 8 (neutrophil collagenase),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP8,HGNC:7175,matrix metallopeptidase 8,4317,ENSG00000118113,MMP8,Neutrophil collagenase,Enzyme,MMP8_HUMAN,4.599999905,IC50,IUPHAR
27136,MORC1,MORC family CW-type zinc finger 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MORC1,HGNC:7198,MORC family CW-type zinc finger 1,27136,ENSG00000114487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTOR,HGNC:3942,mechanistic target of rapamycin kinase,2475,ENSG00000198793,MTOR,Serine/threonine-protein kinase mTOR,Kinase,MTOR_HUMAN,4.46,IC50,CHEMBL
23040,MYT1L,myelin transcription factor 1-like,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYT1L,HGNC:7623,myelin transcription factor 1 like,23040,ENSG00000186487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4684,NCAM1,neural cell adhesion molecule 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV1,HGNC:7716,NADH:ubiquinone oxidoreductase core subunit V1,4723,ENSG00000167792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV2,HGNC:7717,NADH:ubiquinone oxidoreductase core subunit V2,4729,ENSG00000178127,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4747,NEFL,"neurofilament, light polypeptide",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFL,HGNC:7739,neurofilament light,4747,ENSG00000277586,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4745,NELL1,NEL-like 1 (chicken),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NELL1,HGNC:7750,neural EGFL like 1,4745,ENSG00000165973,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64067,NPAS3,neuronal PAS domain protein 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS3,HGNC:19311,neuronal PAS domain protein 3,64067,ENSG00000151322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR4A2,HGNC:7981,nuclear receptor subfamily 4 group A member 2,4929,ENSG00000153234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4908,NTF3,neurotrophin 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTF3,HGNC:8023,neurotrophin 3,4908,ENSG00000185652,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50863,NTM,neurotrimin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTM,HGNC:17941,neurotrimin,50863,ENSG00000182667,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK3,HGNC:8033,neurotrophic receptor tyrosine kinase 3,4916,ENSG00000140538,NTRK3,NT-3 growth factor receptor,Kinase,NTRK3_HUMAN,6.22,Kd,CHEMBL
4939,OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OAS2,HGNC:8087,2'-5'-oligoadenylate synthetase 2,4939,ENSG00000111335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5020,OXT,oxytocin/neurophysin I prepropeptide,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
5021,OXTR,oxytocin receptor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXTR,HGNC:8529,oxytocin receptor,5021,ENSG00000180914,OXTR,Oxytocin receptor,GPCR,OXYR_HUMAN,8.148741722,Ki,SCIENTIFIC LITERATURE
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27445,PCLO,piccolo presynaptic cytomatrix protein,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCLO,HGNC:13406,piccolo presynaptic cytomatrix protein,27445,ENSG00000186472,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5116,PCNT,pericentrin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCNT,HGNC:16068,pericentrin,5116,ENSG00000160299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50940,PDE11A,phosphodiesterase 11A,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE11A,HGNC:8773,phosphodiesterase 11A,50940,ENSG00000128655,PDE11A,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,PDE11_HUMAN,6.4,Ki,CHEMBL
10611,PDLIM5,PDZ and LIM domain 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDLIM5,HGNC:17468,PDZ and LIM domain 5,10611,ENSG00000163110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8682,PEA15,phosphoprotein enriched in astrocytes 15,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEA15,HGNC:8822,proliferation and apoptosis adaptor protein 15,8682,ENSG00000162734,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5824,PEX19,peroxisomal biogenesis factor 19,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEX19,HGNC:9713,peroxisomal biogenesis factor 19,5824,ENSG00000162735,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKFB3,HGNC:8874,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",5209,ENSG00000170525,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
65018,PINK1,PTEN induced putative kinase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PINK1,HGNC:14581,PTEN induced kinase 1,65018,ENSG00000158828,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLCB1,HGNC:15917,phospholipase C beta 1,23236,ENSG00000182621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5340,PLG,plasminogen,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLG,HGNC:9071,plasminogen,5340,ENSG00000122194,PLG,Plasminogen,Enzyme,PLMN_HUMAN,4.4,IC50,CHEMBL
5453,POU3F1,POU class 3 homeobox 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POU3F1,HGNC:9214,POU class 3 homeobox 1,5453,ENSG00000185668,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
145270,PRIMA1,proline rich membrane anchor 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRIMA1,HGNC:18319,proline rich membrane anchor 1,145270,ENSG00000175785,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5579,PRKCB,"protein kinase C, beta",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCB,HGNC:9395,protein kinase C beta,5579,ENSG00000166501,PRKCB,Protein kinase C beta type,Kinase,KPCB_HUMAN,8.33,IC50,CHEMBL
60675,PROK2,prokineticin 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROK2,HGNC:18455,prokineticin 2,60675,ENSG00000163421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8842,PROM1,prominin 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROM1,HGNC:9454,prominin 1,8842,ENSG00000007062,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5692,PSMB4,"proteasome (prosome, macropain) subunit, beta type, 4",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSMB4,HGNC:9541,proteasome 20S subunit beta 4,5692,ENSG00000159377,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
5801,PTPRR,"protein tyrosine phosphatase, receptor type, R",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPRR,HGNC:9680,protein tyrosine phosphatase receptor type R,5801,ENSG00000153233,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5806,PTX3,"pentraxin 3, long",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTX3,HGNC:9692,pentraxin 3,5806,ENSG00000163661,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9444,QKI,"QKI, KH domain containing, RNA binding",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,QKI,HGNC:21100,"QKI, KH domain containing RNA binding",9444,ENSG00000112531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPGEF5,HGNC:16862,Rap guanine nucleotide exchange factor 5,9771,ENSG00000136237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
65059,RAPH1,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPH1,HGNC:14436,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,65059,ENSG00000173166,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7905,REEP5,receptor accessory protein 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REEP5,HGNC:30077,receptor accessory protein 5,7905,ENSG00000129625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5649,RELN,reelin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELN,HGNC:9957,reelin,5649,ENSG00000189056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5972,REN,renin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REN,HGNC:9958,renin,5972,ENSG00000143839,REN,Renin,Enzyme,RENI_HUMAN,9.22,IC50,WOMBAT-PK
10193,RNF41,"ring finger protein 41, E3 ubiquitin protein ligase",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNF41,HGNC:18401,ring finger protein 41,10193,ENSG00000181852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6281,S100A10,S100 calcium binding protein A10,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
9632,SEC24C,SEC24 family member C,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEC24C,HGNC:10705,"SEC24 homolog C, COPII coat complex component",9632,ENSG00000176986,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINE1,HGNC:8583,serpin family E member 1,5054,ENSG00000106366,SERPINE1,Plasminogen activator inhibitor 1,Secreted,PAI1_HUMAN,0,0,WOMBAT-PK
6446,SGK1,serum/glucocorticoid regulated kinase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SGK1,HGNC:10810,serum/glucocorticoid regulated kinase 1,6446,ENSG00000118515,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57084,SLC17A6,"solute carrier family 17 (vesicular glutamate transporter), member 6",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A6,HGNC:16703,solute carrier family 17 member 6,57084,ENSG00000091664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6511,SLC1A6,"solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A6,HGNC:10944,solute carrier family 1 member 6,6511,ENSG00000105143,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
60482,SLC5A7,"solute carrier family 5 (sodium/choline cotransporter), member 7",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC5A7,HGNC:14025,solute carrier family 5 member 7,60482,ENSG00000115665,SLC5A7,High affinity choline transporter 1,Transporter,SC5A7_HUMAN,4.24,IC50,WOMBAT-PK
6540,SLC6A13,"solute carrier family 6 (neurotransmitter transporter), member 13",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A13,HGNC:11046,solute carrier family 6 member 13,6540,ENSG00000010379,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55117,SLC6A15,"solute carrier family 6 (neutral amino acid transporter), member 15",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A15,HGNC:13621,solute carrier family 6 member 15,55117,ENSG00000072041,SLC6A15,Sodium-dependent neutral amino acid transporter B(0)AT2,Transporter,S6A15_HUMAN,5.400000095,IC50,CHEMBL
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
6586,SLIT3,slit homolog 3 (Drosophila),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLIT3,HGNC:11087,slit guidance ligand 3,6586,ENSG00000184347,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6662,SOX9,SRY (sex determining region Y)-box 9,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOX9,HGNC:11204,SRY-box transcription factor 9,6662,ENSG00000125398,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51593,SRRT,"serrate, RNA effector molecule",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRRT,HGNC:24101,"serrate, RNA effector molecule",51593,ENSG00000087087,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6750,SST,somatostatin,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SST,HGNC:11329,somatostatin,6750,ENSG00000157005,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6755,SSTR5,somatostatin receptor 5,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SSTR5,HGNC:11334,somatostatin receptor 5,6755,ENSG00000162009,SSTR5,Somatostatin receptor type 5,GPCR,SSR5_HUMAN,5.39,Ki,CHEMBL
30009,TBX21,T-box 21,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX21,HGNC:11599,T-box transcription factor 21,30009,ENSG00000073861,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6999,TDO2,"tryptophan 2,3-dioxygenase",C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7008,TEF,thyrotrophic embryonic factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TEF,HGNC:11722,"TEF transcription factor, PAR bZIP family member",7008,ENSG00000167074,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7015,TERT,telomerase reverse transcriptase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TERT,HGNC:11730,telomerase reverse transcriptase,7015,ENSG00000164362,TERT,Telomerase reverse transcriptase,Enzyme,TERT_HUMAN,4.14,IC50,CHEMBL
7024,TFCP2,transcription factor CP2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TFCP2,HGNC:11748,transcription factor CP2,7024,ENSG00000135457,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
51284,TLR7,toll-like receptor 7,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR7,HGNC:15631,toll like receptor 7,51284,ENSG00000196664,TLR7,Toll-like receptor 7,Membrane receptor,TLR7_HUMAN,5.559999943,IC50,IUPHAR
7124,TNF,tumor necrosis factor,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNF,HGNC:11892,tumor necrosis factor,7124,ENSG00000232810,TNF,Tumor necrosis factor,Cytokine,TNFA_HUMAN,8,IC50,WOMBAT-PK
10452,TOMM40,translocase of outer mitochondrial membrane 40 homolog (yeast),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TOMM40,HGNC:18001,translocase of outer mitochondrial membrane 40,10452,ENSG00000130204,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
121278,TPH2,tryptophan hydroxylase 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7200,TRH,thyrotropin-releasing hormone,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRH,HGNC:12298,thyrotropin releasing hormone,7200,ENSG00000170893,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100303453,TSNAX-DISC1,TSNAX-DISC1 readthrough (NMD candidate),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX-DISC1,HGNC:49177,TSNAX-DISC1 readthrough (NMD candidate),100303453,ENSG00000270106,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7297,TYK2,tyrosine kinase 2,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TYK2,HGNC:12440,tyrosine kinase 2,7297,ENSG00000105397,TYK2,Non-receptor tyrosine-protein kinase TYK2,Kinase,TYK2_HUMAN,6.96,Kd,CHEMBL
114131,UCN3,urocortin 3,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UCN3,HGNC:17781,urocortin 3,114131,ENSG00000178473,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6844,VAMP2,vesicle-associated membrane protein 2 (synaptobrevin 2),C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP2,HGNC:12643,vesicle associated membrane protein 2,6844,ENSG00000220205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7432,VIP,vasoactive intestinal peptide,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7704,ZBTB16,zinc finger and BTB domain containing 16,C0041696,unipolar depression,Depressive disorders,C0041696,Unipolar Depression,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZBTB16,HGNC:12930,zinc finger and BTB domain containing 16,7704,ENSG00000109906,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL,HGNC:701,aryl hydrocarbon receptor nuclear translocator like,406,ENSG00000133794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1407,CRY1,cryptochrome circadian clock 1,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY1,HGNC:2384,cryptochrome circadian regulator 1,1407,ENSG00000008405,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1408,CRY2,cryptochrome circadian clock 2,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRY2,HGNC:2385,cryptochrome circadian regulator 2,1408,ENSG00000121671,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1815,DRD4,dopamine receptor D4,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
9248,GPR50,G protein-coupled receptor 50,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR50,HGNC:4506,G protein-coupled receptor 50,9248,ENSG00000102195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
4862,NPAS2,neuronal PAS domain protein 2,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS2,HGNC:7895,neuronal PAS domain protein 2,4862,ENSG00000170485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9572,NR1D1,"nuclear receptor subfamily 1, group D, member 1",C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR1D1,HGNC:7962,nuclear receptor subfamily 1 group D member 1,9572,ENSG00000126368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
94233,OPN4,opsin 4,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPN4,HGNC:14449,opsin 4,94233,ENSG00000122375,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5141,PDE4A,"phosphodiesterase 4A, cAMP-specific",C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE4A,HGNC:8780,phosphodiesterase 4A,5141,ENSG00000065989,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,5.976336082,IC50,DRUG MATRIX
8863,PER3,period circadian clock 3,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER3,HGNC:8847,period circadian regulator 3,8863,ENSG00000049246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6095,RORA,RAR-related orphan receptor A,C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RORA,HGNC:10258,RAR related orphan receptor A,6095,ENSG00000069667,RORA,Nuclear receptor ROR-alpha,Nuclear hormone receptor,RORA_HUMAN,9,EC50,WOMBAT-PK
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0085159,seasonal affective disorder,Depressive disorders,C0085159,Seasonal Affective Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C0085633,mood swings,Depressive disorders,C0085633,Mood swings,disease,0,0,HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
4135,MAP6,microtubule-associated protein 6,C0085633,mood swings,Depressive disorders,C0085633,Mood swings,disease,0,0,HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,MAP6,HGNC:6868,microtubule associated protein 6,4135,ENSG00000171533,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABO,HGNC:79,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",28,ENSG00000175164,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH1B,HGNC:250,"alcohol dehydrogenase 1B (class I), beta polypeptide",125,ENSG00000196616,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH1C,HGNC:251,"alcohol dehydrogenase 1C (class I), gamma polypeptide",126,ENSG00000248144,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
127,ADH4,"alcohol dehydrogenase 4 (class II), pi polypeptide",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADH4,HGNC:252,"alcohol dehydrogenase 4 (class II), pi polypeptide",127,ENSG00000198099,ADH4,Alcohol dehydrogenase 4,Enzyme,ADH4_HUMAN,5.523,Ki,WOMBAT-PK
10327,AKR1A1,"aldo-keto reductase family 1, member A1 (aldehyde reductase)",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1A1,HGNC:380,aldo-keto reductase family 1 member A1,10327,ENSG00000117448,AKR1A1,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_HUMAN,5.59,IC50,CHEMBL
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH1A1,HGNC:402,aldehyde dehydrogenase 1 family member A1,216,ENSG00000165092,ALDH1A1,Retinal dehydrogenase 1,Enzyme,AL1A1_HUMAN,0,0,WOMBAT-PK
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
348,APOE,apolipoprotein E,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APOE,HGNC:613,apolipoprotein E,348,ENSG00000130203,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56938,ARNTL2,aryl hydrocarbon receptor nuclear translocator-like 2,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL2,HGNC:18984,aryl hydrocarbon receptor nuclear translocator like 2,56938,ENSG00000029153,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
627,BDNF,brain-derived neurotrophic factor,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1269,CNR2,cannabinoid receptor 2 (macrophage),C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1392,CRH,corticotropin releasing hormone,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2E1,HGNC:2631,cytochrome P450 family 2 subfamily E member 1,1571,ENSG00000130649,CYP2E1,Cytochrome P450 2E1,Enzyme,CP2E1_HUMAN,4.958607315,IC50,DRUG MATRIX
1813,DRD2,dopamine receptor D2,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
1956,EGFR,epidermal growth factor receptor,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGFR,HGNC:3236,epidermal growth factor receptor,1956,ENSG00000146648,EGFR,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,5.217742426,IC50,DRUG MATRIX
2147,F2,coagulation factor II (thrombin),C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,F2,HGNC:3535,"coagulation factor II, thrombin",2147,ENSG00000180210,F2,Prothrombin,Enzyme,THRB_HUMAN,7.39794,Ki,WOMBAT-PK
2335,FN1,fibronectin 1,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FN1,HGNC:3778,fibronectin 1,2335,ENSG00000115414,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FYN,HGNC:4037,"FYN proto-oncogene, Src family tyrosine kinase",2534,ENSG00000010810,FYN,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,6.087777943,IC50,DRUG MATRIX
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA1,HGNC:4075,gamma-aminobutyric acid type A receptor subunit alpha1,2554,ENSG00000022355,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,7.300000191,Ki,CHEMBL
51083,GAL,galanin/GMAP prepropeptide,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2587,GALR1,galanin receptor 1,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR1,HGNC:4132,galanin receptor 1,2587,ENSG00000166573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8811,GALR2,galanin receptor 2,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR2,HGNC:4133,galanin receptor 2,8811,ENSG00000182687,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8484,GALR3,galanin receptor 3,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR3,HGNC:4134,galanin receptor 3,8484,ENSG00000128310,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3077,HFE,hemochromatosis,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HFE,HGNC:4886,homeostatic iron regulator,3077,ENSG00000010704,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3479,IGF1,insulin-like growth factor 1 (somatomedin C),C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IGF1,HGNC:5464,insulin like growth factor 1,3479,ENSG00000017427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3605,IL17A,interleukin 17A,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL17A,HGNC:5981,interleukin 17A,3605,ENSG00000112115,IL17A,Interleukin-17A,Cytokine,IL17_HUMAN,0,0,SCIENTIFIC LITERATURE
3949,LDLR,low density lipoprotein receptor,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LDLR,HGNC:6547,low density lipoprotein receptor,3949,ENSG00000130164,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP2,HGNC:7166,matrix metallopeptidase 2,4313,ENSG00000087245,MMP2,72 kDa type IV collagenase,Enzyme,MMP2_HUMAN,5,IC50,CHEMBL
8777,MPDZ,multiple PDZ domain protein,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MPDZ,HGNC:7208,multiple PDZ domain crumbs cell polarity complex component,8777,ENSG00000107186,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4889,NPY5R,neuropeptide Y receptor Y5,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY5R,HGNC:7958,neuropeptide Y receptor Y5,4889,ENSG00000164129,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4988,OPRM1,"opioid receptor, mu 1",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
5443,POMC,proopiomelanocortin,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POMC,HGNC:9201,proopiomelanocortin,5443,ENSG00000115138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23411,SIRT1,sirtuin 1,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT1,HGNC:14929,sirtuin 1,23411,ENSG00000096717,SIRT1,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,4.3,IC50,CHEMBL
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
7097,TLR2,toll-like receptor 2,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR2,HGNC:11848,toll like receptor 2,7097,ENSG00000137462,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7099,TLR4,toll-like receptor 4,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR4,HGNC:11850,toll like receptor 4,7099,ENSG00000136869,TLR4,Toll-like receptor 4,Membrane receptor,TLR4_HUMAN,0,0,WOMBAT-PK
121278,TPH2,tryptophan hydroxylase 2,C0085762,alcohol abuse,Alcohol use disorders,C0085762,Alcohol abuse,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10060,ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,ABCC9,HGNC:60,ATP binding cassette subfamily C member 9,10060,ENSG00000069431,ABCC9,ATP-binding cassette sub-family C member 9,Ion channel,ABCC9_HUMAN,5.45,EC50,CHEMBL
1636,ACE,angiotensin I converting enzyme,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
163,AP2B1,"adaptor-related protein complex 2, beta 1 subunit",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,AP2B1,HGNC:563,adaptor related protein complex 2 subunit beta 1,163,ENSG00000006125,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
551,AVP,arginine vasopressin,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,CYP19A1,HGNC:2594,cytochrome P450 family 19 subfamily A member 1,1588,ENSG00000137869,CYP19A1,Aromatase,Enzyme,CP19A_HUMAN,5.11,IC50,WOMBAT-PK
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,CYP1A1,HGNC:2595,cytochrome P450 family 1 subfamily A member 1,1543,ENSG00000140465,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,CYP1B1,HGNC:2597,cytochrome P450 family 1 subfamily B member 1,1545,ENSG00000138061,CYP1B1,Cytochrome P450 1B1,Enzyme,CP1B1_HUMAN,6.29,IC50,CHEMBL
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,CYP3A4,HGNC:2637,cytochrome P450 family 3 subfamily A member 4,1576,ENSG00000160868,CYP3A4,Cytochrome P450 3A4,Enzyme,CP3A4_HUMAN,4.61,Km,WOMBAT-PK
1610,DAO,D-amino-acid oxidase,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,DAO,HGNC:2671,D-amino acid oxidase,1610,ENSG00000110887,DAO,D-amino-acid oxidase,Enzyme,OXDA_HUMAN,5,IC50,CHEMBL
2194,FASN,fatty acid synthase,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,FASN,HGNC:3594,fatty acid synthase,2194,ENSG00000169710,FASN,Fatty acid synthase,Enzyme,FAS_HUMAN,5.24,IC50,CHEMBL
2332,FMR1,fragile X mental retardation 1,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3439,IFNA1,"interferon, alpha 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,IFNA1,HGNC:5417,interferon alpha 1,3439,ENSG00000197919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3454,IFNAR1,"interferon (alpha, beta and omega) receptor 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,IFNAR1,HGNC:5432,interferon alpha and beta receptor subunit 1,3454,ENSG00000142166,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3586,IL10,interleukin 10,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,IL10,HGNC:5962,interleukin 10,3586,ENSG00000136634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3787,KCNS1,"potassium voltage-gated channel, modifier subfamily S, member 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,KCNS1,HGNC:6300,potassium voltage-gated channel modifier subfamily S member 1,3787,ENSG00000124134,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
120892,LRRK2,leucine-rich repeat kinase 2,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,LRRK2,HGNC:18618,leucine rich repeat kinase 2,120892,ENSG00000188906,LRRK2,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,LRRK2_HUMAN,5.54,Kd,CHEMBL
1432,MAPK14,mitogen-activated protein kinase 14,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,MAPK14,HGNC:6876,mitogen-activated protein kinase 14,1432,ENSG00000112062,MAPK14,Mitogen-activated protein kinase 14,Kinase,MK14_HUMAN,5.908333042,IC50,DRUG MATRIX
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,MMP9,HGNC:7176,matrix metallopeptidase 9,4318,ENSG00000100985,MMP9,Matrix metalloproteinase-9,Enzyme,MMP9_HUMAN,4,IC50,CHEMBL
4397,MS,multiple sclerosis,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,MS,HGNC:7314,multiple sclerosis,0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
344148,NCKAP5,NCK-associated protein 5,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,NCKAP5,HGNC:29847,NCK associated protein 5,344148,ENSG00000176771,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
140902,R3HDML,R3H domain containing-like,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,R3HDML,HGNC:16249,R3H domain containing like,140902,ENSG00000101074,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,SERPINE1,HGNC:8583,serpin family E member 1,5054,ENSG00000106366,SERPINE1,Plasminogen activator inhibitor 1,Secreted,PAI1_HUMAN,0,0,WOMBAT-PK
60482,SLC5A7,"solute carrier family 5 (sodium/choline cotransporter), member 7",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,SLC5A7,HGNC:14025,solute carrier family 5 member 7,60482,ENSG00000115665,SLC5A7,High affinity choline transporter 1,Transporter,SC5A7_HUMAN,4.24,IC50,WOMBAT-PK
6817,SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,SULT1A1,HGNC:11453,sulfotransferase family 1A member 1,6817,ENSG00000196502,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79953,SYNDIG1,synapse differentiation inducing 1,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,SYNDIG1,HGNC:15885,synapse differentiation inducing 1,79953,ENSG00000101463,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8871,SYNJ2,synaptojanin 2,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,SYNJ2,HGNC:11504,synaptojanin 2,8871,ENSG00000078269,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7076,TIMP1,TIMP metallopeptidase inhibitor 1,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,TIMP1,HGNC:11820,TIMP metallopeptidase inhibitor 1,7076,ENSG00000102265,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10587,TXNRD2,thioredoxin reductase 2,C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,TXNRD2,HGNC:18155,thioredoxin reductase 2,10587,ENSG00000184470,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",C0086132,depressive symptoms,Depressive disorders,C0086132,Depressive Symptoms,phenotype,F01,Behavior and Behavior Mechanisms,0,0,DOID:150,disease of mental health,T184,Sign or Symptom,VDR,HGNC:12679,vitamin D receptor,7421,ENSG00000111424,VDR,Vitamin D3 receptor,Nuclear hormone receptor,VDR_HUMAN,0,0,WOMBAT-PK
1312,COMT,catechol-O-methyltransferase,C0086133,depressive syndrome,Depressive disorders,C0086133,Depressive Syndrome,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
290,ANPEP,alanyl (membrane) aminopeptidase,C0149821,acute alcohol withdrawal,Alcohol use disorders,C0149821,ACUTE ALCOHOL WITHDRAWAL,disease,0,0,0,0,0,0,T047,Disease or Syndrome,ANPEP,HGNC:500,"alanyl aminopeptidase, membrane",290,ENSG00000166825,ANPEP,Aminopeptidase N,Enzyme,AMPN_HUMAN,5.62,IC50,CHEMBL
8777,MPDZ,multiple PDZ domain protein,C0149821,acute alcohol withdrawal,Alcohol use disorders,C0149821,ACUTE ALCOHOL WITHDRAWAL,disease,0,0,0,0,0,0,T047,Disease or Syndrome,MPDZ,HGNC:7208,multiple PDZ domain crumbs cell polarity complex component,8777,ENSG00000107186,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",C0154409,recurrent major depressive episodes,Depressive disorders,C0154409,Recurrent major depressive episodes,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SYNE1,HGNC:17089,spectrin repeat containing nuclear envelope protein 1,23345,ENSG00000131018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,ANK3,HGNC:494,ankyrin 3,288,ENSG00000151150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,ATP1A3,HGNC:801,ATPase Na+/K+ transporting subunit alpha 3,478,ENSG00000105409,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
551,AVP,arginine vasopressin,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
1235,CCR6,chemokine (C-C motif) receptor 6,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,CCR6,HGNC:1607,C-C motif chemokine receptor 6,1235,ENSG00000112486,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1236,CCR7,chemokine (C-C motif) receptor 7,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,CCR7,HGNC:1608,C-C motif chemokine receptor 7,1236,ENSG00000126353,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1392,CRH,corticotropin releasing hormone,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1395,CRHR2,corticotropin releasing hormone receptor 2,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,CRHR2,HGNC:2358,corticotropin releasing hormone receptor 2,1395,ENSG00000106113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27185,DISC1,disrupted in schizophrenia 1,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1813,DRD2,dopamine receptor D2,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
2697,GJA1,"gap junction protein, alpha 1, 43kDa",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,GJA1,HGNC:4274,gap junction protein alpha 1,2697,ENSG00000152661,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,GRIN2B,HGNC:4586,glutamate ionotropic receptor NMDA type subunit 2B,2904,ENSG00000273079,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,5.64,IC50,WOMBAT-PK
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3620,IDO1,"indoleamine 2,3-dioxygenase 1",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,IDO1,HGNC:6059,"indoleamine 2,3-dioxygenase 1",3620,ENSG00000131203,IDO1,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_HUMAN,4.639999866,IC50,CHEMBL
3776,KCNK2,"potassium channel, two pore domain subfamily K, member 2",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,KCNK2,HGNC:6277,potassium two pore domain channel subfamily K member 2,3776,ENSG00000082482,KCNK2,Potassium channel subfamily K member 2,Ion channel,KCNK2_HUMAN,6.4,IC50,CHEMBL
5594,MAPK1,mitogen-activated protein kinase 1,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,MAPK1,HGNC:6871,mitogen-activated protein kinase 1,5594,ENSG00000100030,MAPK1,Mitogen-activated protein kinase 1,Kinase,MK01_HUMAN,5.227165073,IC50,DRUG MATRIX
4160,MC4R,melanocortin 4 receptor,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,MC4R,HGNC:6932,melanocortin 4 receptor,4160,ENSG00000166603,MC4R,Melanocortin receptor 4,GPCR,MC4R_HUMAN,4.878571482,Ki,DRUG MATRIX
4986,OPRK1,"opioid receptor, kappa 1",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
5173,PDYN,prodynorphin,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5309,PITX3,paired-like homeodomain 3,C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,PITX3,HGNC:9006,paired like homeodomain 3,5309,ENSG00000107859,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9869,SETDB1,"SET domain, bifurcated 1",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,SETDB1,HGNC:10761,SET domain bifurcated histone lysine methyltransferase 1,9869,ENSG00000143379,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57030,SLC17A7,"solute carrier family 17 (vesicular glutamate transporter), member 7",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,SLC17A7,HGNC:16704,solute carrier family 17 member 7,57030,ENSG00000104888,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,SLC1A3,HGNC:10941,solute carrier family 1 member 3,6507,ENSG00000079215,SLC1A3,Excitatory amino acid transporter 1,Transporter,EAA1_HUMAN,4.460000038,Ki,CHEMBL
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0178417,anhedonia,Depressive disorders,C0178417,Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",HP:0000707,Abnormality of the nervous system,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
6999,TDO2,"tryptophan 2,3-dioxygenase",C0220702,schizophrenia 1 (disorder),Schizophrenia spectrum and other psychotic disorders,C0220702,SCHIZOPHRENIA 1 (disorder),disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100303453,TSNAX-DISC1,TSNAX-DISC1 readthrough (NMD candidate),C0220702,schizophrenia 1 (disorder),Schizophrenia spectrum and other psychotic disorders,C0220702,SCHIZOPHRENIA 1 (disorder),disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX-DISC1,HGNC:49177,TSNAX-DISC1 readthrough (NMD candidate),100303453,ENSG00000270106,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50809,HP1BP3,"heterochromatin protein 1, binding protein 3",C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP1BP3,HGNC:24973,heterochromatin protein 1 binding protein 3,50809,ENSG00000127483,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4988,OPRM1,"opioid receptor, mu 1",C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
8864,PER2,period circadian clock 2,C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
148014,TTC9B,tetratricopeptide repeat domain 9B,C0221074,"depression, postpartum",Depressive disorders,C0221074,"Depression, Postpartum",disease,C13;F03,Female Urogenital Diseases and Pregnancy Complications; Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TTC9B,HGNC:26395,tetratricopeptide repeat domain 9B,148014,ENSG00000174521,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1812,DRD1,dopamine receptor D1,C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD1,HGNC:3020,dopamine receptor D1,1812,ENSG00000184845,DRD1,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,5.339988779,Ki,DRUG MATRIX
1813,DRD2,dopamine receptor D2,C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
6285,S100B,S100 calcium binding protein B,C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
60482,SLC5A7,"solute carrier family 5 (sodium/choline cotransporter), member 7",C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC5A7,HGNC:14025,solute carrier family 5 member 7,60482,ENSG00000115665,SLC5A7,High affinity choline transporter 1,Transporter,SC5A7_HUMAN,4.24,IC50,WOMBAT-PK
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
7054,TH,tyrosine hydroxylase,C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
1861,TOR1A,"torsin family 1, member A (torsin A)",C0221480,recurrent depression,Depressive disorders,C0221480,Recurrent depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TOR1A,HGNC:3098,torsin family 1 member A,1861,ENSG00000136827,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
427,ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ASAH1,HGNC:735,N-acylsphingosine amidohydrolase 1,427,ENSG00000104763,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1114,CHGB,chromogranin B (secretogranin 1),C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CHGB,HGNC:1930,chromogranin B,1114,ENSG00000089199,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1128,CHRM1,"cholinergic receptor, muscarinic 1",C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CHRM1,HGNC:1950,cholinergic receptor muscarinic 1,1128,ENSG00000168539,CHRM1,Muscarinic acetylcholine receptor M1,GPCR,ACM1_HUMAN,6.11,EC50,CHEMBL
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CYP3A4,HGNC:2637,cytochrome P450 family 3 subfamily A member 4,1576,ENSG00000160868,CYP3A4,Cytochrome P450 3A4,Enzyme,CP3A4_HUMAN,4.61,Km,WOMBAT-PK
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HSPA9,HGNC:5244,heat shock protein family A (Hsp70) member 9,3313,ENSG00000113013,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10644,IGF2BP2,insulin-like growth factor 2 mRNA binding protein 2,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IGF2BP2,HGNC:28867,insulin like growth factor 2 mRNA binding protein 2,10644,ENSG00000073792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3561,IL2RG,"interleukin 2 receptor, gamma",C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IL2RG,HGNC:6010,interleukin 2 receptor subunit gamma,3561,ENSG00000147168,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3952,LEP,leptin,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MLC1,HGNC:17082,modulator of VRAC current 1,23209,ENSG00000100427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10611,PDLIM5,PDZ and LIM domain 5,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PDLIM5,HGNC:17468,PDZ and LIM domain 5,10611,ENSG00000163110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6667,SP1,Sp1 transcription factor,C0221765,chronic schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0221765,Chronic schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SP1,HGNC:11205,Sp1 transcription factor,6667,ENSG00000185591,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1395,CRHR2,corticotropin releasing hormone receptor 2,C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CRHR2,HGNC:2358,corticotropin releasing hormone receptor 2,1395,ENSG00000106113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1815,DRD4,dopamine receptor D4,C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
1432,MAPK14,mitogen-activated protein kinase 14,C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MAPK14,HGNC:6876,mitogen-activated protein kinase 14,1432,ENSG00000112062,MAPK14,Mitogen-activated protein kinase 14,Kinase,MK14_HUMAN,5.908333042,IC50,DRUG MATRIX
4988,OPRM1,"opioid receptor, mu 1",C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
5173,PDYN,prodynorphin,C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0233477,dysphoric mood,Depressive disorders,C0233477,Dysphoric mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
367,AR,androgen receptor,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
885,CCK,cholecystokinin,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,CCK,HGNC:1569,cholecystokinin,885,ENSG00000187094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,CYP19A1,HGNC:2594,cytochrome P450 family 19 subfamily A member 1,1588,ENSG00000137869,CYP19A1,Aromatase,Enzyme,CP19A_HUMAN,5.11,IC50,WOMBAT-PK
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,GAD2,HGNC:4093,glutamate decarboxylase 2,2572,ENSG00000136750,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2752,GLUL,glutamate-ammonia ligase,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
2944,GSTM1,glutathione S-transferase mu 1,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,GSTM1,HGNC:4632,glutathione S-transferase mu 1,2944,ENSG00000134184,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23081,KDM4C,lysine (K)-specific demethylase 4C,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,KDM4C,HGNC:17071,lysine demethylase 4C,23081,ENSG00000107077,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3952,LEP,leptin,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
378938,MALAT1,metastasis associated lung adenocarcinoma transcript 1 (non-protein coding),C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,MALAT1,HGNC:29665,metastasis associated lung adenocarcinoma transcript 1,378938,ENSG00000251562,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8777,MPDZ,multiple PDZ domain protein,C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,MPDZ,HGNC:7208,multiple PDZ domain crumbs cell polarity complex component,8777,ENSG00000107186,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4803,NGF,nerve growth factor (beta polypeptide),C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,NGF,HGNC:7808,nerve growth factor,4803,ENSG00000134259,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",C0236663,alcohol withdrawal syndrome,Alcohol use disorders,C0236663,Alcohol withdrawal syndrome,disease,0,0,0,0,DOID:0014667,disease of metabolism,T047,Disease or Syndrome,NQO1,HGNC:2874,NAD(P)H quinone dehydrogenase 1,1728,ENSG00000181019,NQO1,NAD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_HUMAN,4.6,IC50,CHEMBL
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0236664,alcohol-related disorders,Alcohol use disorders,C0236664,Alcohol-Related Disorders,group,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",C0236664,alcohol-related disorders,Alcohol use disorders,C0236664,Alcohol-Related Disorders,group,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2E1,HGNC:2631,cytochrome P450 family 2 subfamily E member 1,1571,ENSG00000130649,CYP2E1,Cytochrome P450 2E1,Enzyme,CP2E1_HUMAN,4.958607315,IC50,DRUG MATRIX
4881,NPR1,natriuretic peptide receptor 1,C0236664,alcohol-related disorders,Alcohol use disorders,C0236664,Alcohol-Related Disorders,group,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPR1,HGNC:7943,natriuretic peptide receptor 1,4881,ENSG00000169418,NPR1,Atrial natriuretic peptide receptor 1,Enzyme,ANPRA_HUMAN,0,0,WOMBAT-PK
4852,NPY,neuropeptide Y,C0236664,alcohol-related disorders,Alcohol use disorders,C0236664,Alcohol-Related Disorders,group,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0236701,cocaine-induced mood disorder,Substance/drug induced depressive disorder,C0236701,Cocaine-induced mood disorder,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6611,SMS,spermine synthase,C0236788,bipolar ii disorder,Bipolar disorders and related disorders,C0236788,Bipolar II disorder,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SMS,HGNC:11123,spermine synthase,6611,ENSG00000102172,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9456,HOMER1,homer homolog 1 (Drosophila),C0237123,alcohol or other drugs use,Alcohol use disorders,C0237123,Alcohol or Other Drugs use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
84062,DTNBP1,dystrobrevin binding protein 1,C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FOS,HGNC:3796,"Fos proto-oncogene, AP-1 transcription factor subunit",2353,ENSG00000170345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
4128,MAOA,monoamine oxidase A,C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
7166,TPH1,tryptophan hydroxylase 1,C0270458,severe major depression with psychotic features,Depressive disorders,C0270458,Severe major depression with psychotic features,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
2557,GABRA4,"gamma-aminobutyric acid (GABA) A receptor, alpha 4",C0270496,"schizoaffective disorder, bipolar type",Schizophrenia spectrum and other psychotic disorders,C0270496,"Schizoaffective disorder, bipolar type",disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GABRA4,HGNC:4078,gamma-aminobutyric acid type A receptor subunit alpha4,2557,ENSG00000109158,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,GBRA4_HUMAN,6.99,Ki,CHEMBL
2560,GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",C0270496,"schizoaffective disorder, bipolar type",Schizophrenia spectrum and other psychotic disorders,C0270496,"Schizoaffective disorder, bipolar type",disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GABRB1,HGNC:4081,gamma-aminobutyric acid type A receptor subunit beta1,2560,ENSG00000163288,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6480,ST6GAL1,"ST6 beta-galactosamide alpha-2,6-sialyltranferase 1",C0337677,moderate drinker,Alcohol use disorders,C0337677,Moderate drinker,phenotype,0,0,0,0,0,0,T033,Finding,ST6GAL1,HGNC:10860,"ST6 beta-galactoside alpha-2,6-sialyltransferase 1",6480,ENSG00000073849,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
361,AQP4,aquaporin 4,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,AQP4,HGNC:637,aquaporin 4,361,ENSG00000171885,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
627,BDNF,brain-derived neurotrophic factor,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
875,CBS,cystathionine-beta-synthase,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CBS,HGNC:1550,cystathionine beta-synthase,875,ENSG00000160200,CBS,Cystathionine beta-synthase,Enzyme,CBS_HUMAN,0,0,WOMBAT-PK
51083,GAL,galanin/GMAP prepropeptide,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3060,HCRT,hypocretin (orexin) neuropeptide precursor,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HCRT,HGNC:4847,hypocretin neuropeptide precursor,3060,ENSG00000161610,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3620,IDO1,"indoleamine 2,3-dioxygenase 1",C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IDO1,HGNC:6059,"indoleamine 2,3-dioxygenase 1",3620,ENSG00000131203,IDO1,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_HUMAN,4.639999866,IC50,CHEMBL
3454,IFNAR1,"interferon (alpha, beta and omega) receptor 1",C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IFNAR1,HGNC:5432,interferon alpha and beta receptor subunit 1,3454,ENSG00000142166,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
3569,IL6,interleukin 6,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
1432,MAPK14,mitogen-activated protein kinase 14,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MAPK14,HGNC:6876,mitogen-activated protein kinase 14,1432,ENSG00000112062,MAPK14,Mitogen-activated protein kinase 14,Kinase,MK14_HUMAN,5.908333042,IC50,DRUG MATRIX
4939,OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,OAS2,HGNC:8087,2'-5'-oligoadenylate synthetase 2,4939,ENSG00000111335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5319,PLA2G1B,"phospholipase A2, group IB (pancreas)",C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PLA2G1B,HGNC:9030,phospholipase A2 group IB,5319,ENSG00000170890,PLA2G1B,Phospholipase A2,Enzyme,PA21B_HUMAN,5.7,IC50,CHEMBL
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
121278,TPH2,tryptophan hydroxylase 2,C0338715,drug-induced depressive state,Substance/drug induced depressive disorder,C0338715,Drug-induced depressive state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
8644,AKR1C3,"aldo-keto reductase family 1, member C3",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKR1C3,HGNC:386,aldo-keto reductase family 1 member C3,8644,ENSG00000196139,AKR1C3,Aldo-keto reductase family 1 member C3,Enzyme,AK1C3_HUMAN,5.59,IC50,CHEMBL
885,CCK,cholecystokinin,C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCK,HGNC:1569,cholecystokinin,885,ENSG00000187094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6347,CCL2,chemokine (C-C motif) ligand 2,C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL2,HGNC:10618,C-C motif chemokine ligand 2,6347,ENSG00000108691,CCL2,C-C motif chemokine 2,Cytokine,CCL2_HUMAN,5.16,IC50,CHEMBL
1769,DNAH8,"dynein, axonemal, heavy chain 8",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNAH8,HGNC:2952,dynein axonemal heavy chain 8,1769,ENSG00000124721,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3308,HSPA4,heat shock 70kDa protein 4,C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ME2,HGNC:6984,malic enzyme 2,4200,ENSG00000082212,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP9,HGNC:7176,matrix metallopeptidase 9,4318,ENSG00000100985,MMP9,Matrix metalloproteinase-9,Enzyme,MMP9_HUMAN,4,IC50,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
5550,PREP,prolyl endopeptidase,C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PREP,HGNC:9358,prolyl endopeptidase,5550,ENSG00000085377,PREP,Prolyl endopeptidase,Enzyme,PPCE_HUMAN,4.89,IC50,CHEMBL
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SHANK3,HGNC:14294,SH3 and multiple ankyrin repeat domains 3,85358,ENSG00000251322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRD5A1,HGNC:11284,steroid 5 alpha-reductase 1,6715,ENSG00000145545,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,8.49,IC50,WOMBAT-PK
23166,STAB1,stabilin 1,C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,STAB1,HGNC:18628,stabilin 1,23166,ENSG00000010327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
25830,SULT4A1,"sulfotransferase family 4A, member 1",C0338831,manic,Bipolar disorders and related disorders,C0338831,Manic,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SULT4A1,HGNC:14903,sulfotransferase family 4A member 1,25830,ENSG00000130540,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2332,FMR1,fragile X mental retardation 1,C0338908,mixed anxiety and depressive disorder,Depressive disorders,C0338908,Mixed anxiety and depressive disorder,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5362,PLXNA2,plexin A2,C0338908,mixed anxiety and depressive disorder,Depressive disorders,C0338908,Mixed anxiety and depressive disorder,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PLXNA2,HGNC:9100,plexin A2,5362,ENSG00000076356,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
551,AVP,arginine vasopressin,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
796,CALCA,calcitonin-related polypeptide alpha,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,CALCA,HGNC:1437,calcitonin related polypeptide alpha,796,ENSG00000110680,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
883,CCBL1,"cysteine conjugate-beta lyase, cytoplasmic",C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,CHRNA4,HGNC:1958,cholinergic receptor nicotinic alpha 4 subunit,1137,ENSG00000101204,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,4.039999962,IC50,IUPHAR
1401,CRP,"C-reactive protein, pentraxin-related",C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,CRP,HGNC:2367,C-reactive protein,1401,ENSG00000132693,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3576,CXCL8,chemokine (C-X-C motif) ligand 8,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,CXCL8,HGNC:6025,C-X-C motif chemokine ligand 8,3576,ENSG00000169429,CXCL8,Interleukin-8,Cytokine,IL8_HUMAN,8.1,IC50,CHEMBL
8942,KYNU,kynureninase,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,KYNU,HGNC:6469,kynureninase,8942,ENSG00000115919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4615,MYD88,myeloid differentiation primary response 88,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,MYD88,HGNC:7562,MYD88 innate immune signal transduction adaptor,4615,ENSG00000172936,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5004,ORM1,orosomucoid 1,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,ORM1,HGNC:8498,orosomucoid 1,5004,ENSG00000229314,ORM1,Alpha-1-acid glycoprotein 1,Secreted,A1AG1_HUMAN,0,0,WOMBAT-PK
5806,PTX3,"pentraxin 3, long",C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,PTX3,HGNC:9692,pentraxin 3,5806,ENSG00000163661,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6281,S100A10,S100 calcium binding protein A10,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,SELP,HGNC:10721,selectin P,6403,ENSG00000174175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
140691,TRIM69,tripartite motif containing 69,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,TRIM69,HGNC:17857,tripartite motif containing 69,140691,ENSG00000185880,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7297,TYK2,tyrosine kinase 2,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,TYK2,HGNC:12440,tyrosine kinase 2,7297,ENSG00000105397,TYK2,Non-receptor tyrosine-protein kinase TYK2,Kinase,TYK2_HUMAN,6.96,Kd,CHEMBL
7432,VIP,vasoactive intestinal peptide,C0344315,depressed mood,Depressive disorders,C0344315,Depressed mood,phenotype,0,0,0,0,DOID:150,disease of mental health,T033,Finding,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ANK3,HGNC:494,ankyrin 3,288,ENSG00000151150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
200315,APOBEC3A,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,APOBEC3A,HGNC:17343,apolipoprotein B mRNA editing enzyme catalytic subunit 3A,200315,ENSG00000128383,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27350,APOBEC3C,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,APOBEC3C,HGNC:17353,apolipoprotein B mRNA editing enzyme catalytic subunit 3C,27350,ENSG00000244509,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
203228,C9orf72,chromosome 9 open reading frame 72,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,C9orf72,HGNC:28337,C9orf72-SMCR8 complex subunit,203228,ENSG00000147894,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
811,CALR,calreticulin,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CALR,HGNC:1455,calreticulin,811,ENSG00000179218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9607,CARTPT,CART prepropeptide,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CARTPT,HGNC:24323,CART prepropeptide,9607,ENSG00000164326,CARTPT,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,0,0,WOMBAT-PK
947,CD34,CD34 molecule,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CD34,HGNC:1662,CD34 molecule,947,ENSG00000174059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1015,CDH17,"cadherin 17, LI cadherin (liver-intestine)",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CDH17,HGNC:1756,cadherin 17,1015,ENSG00000079112,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1454,CSNK1E,"casein kinase 1, epsilon",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CSNK1E,HGNC:2453,casein kinase 1 epsilon,1454,ENSG00000213923,CSNK1E,Casein kinase I isoform epsilon,Kinase,KC1E_HUMAN,5.82,Kd,CHEMBL
1594,CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CYP27B1,HGNC:2606,cytochrome P450 family 27 subfamily B member 1,1594,ENSG00000111012,CYP27B1,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,CP27B_HUMAN,0,0,WOMBAT-PK
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CYP2B6,HGNC:2615,cytochrome P450 family 2 subfamily B member 6,1555,ENSG00000197408,CYP2B6,Cytochrome P450 2B6,Enzyme,CP2B6_HUMAN,6.3,Ki,WOMBAT-PK
54487,DGCR8,DGCR8 microprocessor complex subunit,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DGCR8,HGNC:2847,DGCR8 microprocessor complex subunit,54487,ENSG00000128191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1745,DLX1,distal-less homeobox 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DLX1,HGNC:2914,distal-less homeobox 1,1745,ENSG00000144355,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2166,FAAH,fatty acid amide hydrolase,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
2263,FGFR2,fibroblast growth factor receptor 2,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FGFR2,HGNC:3689,fibroblast growth factor receptor 2,2263,ENSG00000066468,FGFR2,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,5.85,Kd,CHEMBL
2289,FKBP5,FK506 binding protein 5,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2512,FTL,"ferritin, light polypeptide",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FTL,HGNC:3999,ferritin light chain,2512,ENSG00000087086,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7976,FZD3,frizzled class receptor 3,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FZD3,HGNC:4041,frizzled class receptor 3,7976,ENSG00000104290,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4616,GADD45B,"growth arrest and DNA-damage-inducible, beta",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GADD45B,HGNC:4096,growth arrest and DNA damage inducible beta,4616,ENSG00000099860,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2768,GNA12,guanine nucleotide binding protein (G protein) alpha 12,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GNA12,HGNC:4380,G protein subunit alpha 12,2768,ENSG00000146535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54584,GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GNB1L,HGNC:4397,G protein subunit beta 1 like,54584,ENSG00000185838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9293,GPR52,G protein-coupled receptor 52,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GPR52,HGNC:4508,G protein-coupled receptor 52,9293,ENSG00000203737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
2950,GSTP1,glutathione S-transferase pi 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GSTP1,HGNC:4638,glutathione S-transferase pi 1,2950,ENSG00000084207,GSTP1,Glutathione S-transferase P,Enzyme,GSTP1_HUMAN,0,0,WOMBAT-PK
3066,HDAC2,histone deacetylase 2,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HDAC2,HGNC:4853,histone deacetylase 2,3066,ENSG00000196591,HDAC2,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,4.19,IC50,CHEMBL
3133,HLA-E,"major histocompatibility complex, class I, E",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HLA-E,HGNC:4962,"major histocompatibility complex, class I, E",3133,ENSG00000204592,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3361,HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HTR5A,HGNC:5300,5-hydroxytryptamine receptor 5A,3361,ENSG00000157219,HTR5A,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,5.906403065,Ki,PDSP
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,KCNH2,HGNC:6251,potassium voltage-gated channel subfamily H member 2,3757,ENSG00000055118,KCNH2,Potassium voltage-gated channel subfamily H member 2,Ion channel,KCNH2_HUMAN,4.89,IC50,CHEMBL
81033,KCNH6,"potassium channel, voltage gated eag related subfamily H, member 6",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,KCNH6,HGNC:18862,potassium voltage-gated channel subfamily H member 6,81033,ENSG00000173826,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3952,LEP,leptin,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
442721,LMOD2,leiomodin 2 (cardiac),C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,LMOD2,HGNC:6648,leiomodin 2,442721,ENSG00000170807,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ME2,HGNC:6984,malic enzyme 2,4200,ENSG00000082212,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4205,MEF2A,myocyte enhancer factor 2A,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MEF2A,HGNC:6993,myocyte enhancer factor 2A,4205,ENSG00000068305,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54820,NDE1,nudE neurodevelopment protein 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NDE1,HGNC:17619,nudE neurodevelopment protein 1,54820,ENSG00000072864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
81565,NDEL1,nudE neurodevelopment protein 1-like 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NDEL1,HGNC:17620,nudE neurodevelopment protein 1 like 1,81565,ENSG00000166579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4861,NPAS1,neuronal PAS domain protein 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NPAS1,HGNC:7894,neuronal PAS domain protein 1,4861,ENSG00000130751,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64067,NPAS3,neuronal PAS domain protein 3,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NPAS3,HGNC:19311,neuronal PAS domain protein 3,64067,ENSG00000151322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4886,NPY1R,neuropeptide Y receptor Y1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NPY1R,HGNC:7956,neuropeptide Y receptor Y1,4886,ENSG00000164128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NQO2,HGNC:7856,N-ribosyldihydronicotinamide:quinone reductase 2,4835,ENSG00000124588,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,NQO2_HUMAN,0,0,WOMBAT-PK
10215,OLIG2,oligodendrocyte lineage transcription factor 2,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,OLIG2,HGNC:9398,oligodendrocyte transcription factor 2,10215,ENSG00000205927,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4985,OPRD1,"opioid receptor, delta 1",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,OPRD1,HGNC:8153,opioid receptor delta 1,4985,ENSG00000116329,OPRD1,Delta-type opioid receptor,GPCR,OPRD_HUMAN,7.92,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
57144,PAK7,p21 protein (Cdc42/Rac)-activated kinase 7,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55193,PBRM1,polybromo 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PBRM1,HGNC:30064,polybromo 1,55193,ENSG00000163939,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
83259,PCDH11Y,protocadherin 11 Y-linked,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PCDH11Y,HGNC:15813,protocadherin 11 Y-linked,83259,ENSG00000099715,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5116,PCNT,pericentrin,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PCNT,HGNC:16068,pericentrin,5116,ENSG00000160299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10846,PDE10A,phosphodiesterase 10A,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PDE10A,HGNC:8772,phosphodiesterase 10A,10846,ENSG00000112541,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_HUMAN,6,Ki,CHEMBL
5297,PI4KA,"phosphatidylinositol 4-kinase, catalytic, alpha",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PI4KA,HGNC:8983,phosphatidylinositol 4-kinase alpha,5297,ENSG00000241973,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9463,PICK1,protein interacting with PRKCA 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PICK1,HGNC:9394,protein interacting with PRKCA 1,9463,ENSG00000100151,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PLA2G6,HGNC:9039,phospholipase A2 group VI,8398,ENSG00000184381,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5327,PLAT,"plasminogen activator, tissue",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PLAT,HGNC:9051,"plasminogen activator, tissue type",5327,ENSG00000104368,PLAT,Tissue-type plasminogen activator,Enzyme,TPA_HUMAN,0,0,DRUGBANK
5533,PPP3CC,"protein phosphatase 3, catalytic subunit, gamma isozyme",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PPP3CC,HGNC:9316,protein phosphatase 3 catalytic subunit gamma,5533,ENSG00000120910,PPP3CC,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,0,0,WOMBAT-PK
5578,PRKCA,"protein kinase C, alpha",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PRKCA,HGNC:9393,protein kinase C alpha,5578,ENSG00000154229,PRKCA,Protein kinase C alpha type,Kinase,KPCA_HUMAN,5.22,Kd,CHEMBL
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PTPRC,HGNC:9666,protein tyrosine phosphatase receptor type C,5788,ENSG00000081237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,RAPGEF5,HGNC:16862,Rap guanine nucleotide exchange factor 5,9771,ENSG00000136237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
12,SERPINA3,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SERPINA3,HGNC:16,serpin family A member 3,12,ENSG00000196136,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SHANK1,HGNC:15474,SH3 and multiple ankyrin repeat domains 1,50944,ENSG00000161681,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6474,SHOX2,short stature homeobox 2,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SHOX2,HGNC:10854,short stature homeobox 2,6474,ENSG00000168779,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29985,SLC39A3,"solute carrier family 39 (zinc transporter), member 3",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC39A3,HGNC:17128,solute carrier family 39 member 3,29985,ENSG00000141873,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6536,SLC6A9,"solute carrier family 6 (neurotransmitter transporter, glycine), member 9",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A9,HGNC:11056,solute carrier family 6 member 9,6536,ENSG00000196517,SLC6A9,Sodium- and chloride-dependent glycine transporter 1,Transporter,SC6A9_HUMAN,4.5,IC50,CHEMBL
55084,SOBP,sine oculis binding protein homolog (Drosophila),C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SOBP,HGNC:29256,sine oculis binding protein homolog,55084,ENSG00000112320,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6667,SP1,Sp1 transcription factor,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SP1,HGNC:11205,Sp1 transcription factor,6667,ENSG00000185591,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6670,SP3,Sp3 transcription factor,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SP3,HGNC:11208,Sp3 transcription factor,6670,ENSG00000172845,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
221833,SP8,Sp8 transcription factor,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SP8,HGNC:19196,Sp8 transcription factor,221833,ENSG00000164651,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6482,ST3GAL1,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ST3GAL1,HGNC:10862,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",6482,ENSG00000008513,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55808,ST6GALNAC1,"ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ST6GALNAC1,HGNC:23614,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1",55808,ENSG00000070526,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6899,TBX1,T-box 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TBX1,HGNC:11592,T-box transcription factor 1,6899,ENSG00000184058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6925,TCF4,transcription factor 4,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TCF4,HGNC:11634,transcription factor 4,6925,ENSG00000196628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6999,TDO2,"tryptophan 2,3-dioxygenase",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26011,TENM4,teneurin transmembrane protein 4,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TENM4,HGNC:29945,teneurin transmembrane protein 4,26011,ENSG00000149256,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
80312,TET1,tet methylcytosine dioxygenase 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TET1,HGNC:29484,tet methylcytosine dioxygenase 1,80312,ENSG00000138336,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10452,TOMM40,translocase of outer mitochondrial membrane 40 homolog (yeast),C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TOMM40,HGNC:18001,translocase of outer mitochondrial membrane 40,10452,ENSG00000130204,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7226,TRPM2,"transient receptor potential cation channel, subfamily M, member 2",C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TRPM2,HGNC:12339,transient receptor potential cation channel subfamily M member 2,7226,ENSG00000142185,TRPM2,Transient receptor potential cation channel subfamily M member 2,Ion channel,TRPM2_HUMAN,4.15,IC50,CHEMBL
7257,TSNAX,translin-associated factor X,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TSNAX,HGNC:12380,translin associated factor X,7257,ENSG00000116918,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7299,TYR,tyrosinase,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TYR,HGNC:12442,tyrosinase,7299,ENSG00000077498,TYR,Tyrosinase,Enzyme,TYRO_HUMAN,6.25,IC50,CHEMBL
23286,WWC1,WW and C2 domain containing 1,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,WWC1,HGNC:29435,WW and C2 domain containing 1,23286,ENSG00000113645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64288,ZSCAN31,zinc finger and SCAN domain containing 31,C0349204,nonorganic psychosis,Schizophrenia spectrum and other psychotic disorders,C0349204,Nonorganic psychosis,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ZSCAN31,HGNC:14097,zinc finger and SCAN domain containing 31,64288,ENSG00000235109,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10855,HPSE,heparanase,C0349217,"depressive episode, unspecified",Depressive disorders,C0349217,"Depressive episode, unspecified",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPSE,HGNC:5164,heparanase,10855,ENSG00000173083,HPSE,Heparanase,Enzyme,HPSE_HUMAN,4.28,Kd,CHEMBL
6281,S100A10,S100 calcium binding protein A10,C0349217,"depressive episode, unspecified",Depressive disorders,C0349217,"Depressive episode, unspecified",disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4502,MT2A,metallothionein 2A,C0349218,"recurrent depressive disorder, unspecified",Depressive disorders,C0349218,Recurrent depressive disorder,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MT2A,HGNC:7406,metallothionein 2A,4502,ENSG00000125148,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",C0349218,"recurrent depressive disorder, unspecified",Depressive disorders,C0349218,Recurrent depressive disorder,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PLA2G2A,HGNC:9031,phospholipase A2 group IIA,5320,ENSG00000188257,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3977,LIFR,leukemia inhibitory factor receptor alpha,C0349398,paranoid delusion,Schizophrenia spectrum and other psychotic disorders,C0349398,Paranoid delusion,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,LIFR,HGNC:6597,LIF receptor subunit alpha,3977,ENSG00000113594,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",C0349464,wernicke-korsakoff syndrome,Drug-induced psychosis,C0349464,Wernicke-Korsakoff Syndrome,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",0,0,DOID:0014667,disease of metabolism,T048,Mental or Behavioral Dysfunction,ADH1B,HGNC:250,"alcohol dehydrogenase 1B (class I), beta polypeptide",125,ENSG00000196616,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0349464,wernicke-korsakoff syndrome,Drug-induced psychosis,C0349464,Wernicke-Korsakoff Syndrome,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",0,0,DOID:0014667,disease of metabolism,T048,Mental or Behavioral Dysfunction,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
1743,DLST,dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex),C0349464,wernicke-korsakoff syndrome,Drug-induced psychosis,C0349464,Wernicke-Korsakoff Syndrome,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",0,0,DOID:0014667,disease of metabolism,T048,Mental or Behavioral Dysfunction,DLST,HGNC:2911,dihydrolipoamide S-succinyltransferase,1743,ENSG00000119689,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",C0393756,hangover from alcohol,Alcohol use disorders,C0393756,Hangover from alcohol,phenotype,0,0,0,0,0,0,T184,Sign or Symptom,ADH1B,HGNC:250,"alcohol dehydrogenase 1B (class I), beta polypeptide",125,ENSG00000196616,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),C0393756,hangover from alcohol,Alcohol use disorders,C0393756,Hangover from alcohol,phenotype,0,0,0,0,0,0,T184,Sign or Symptom,ALDH2,HGNC:404,aldehyde dehydrogenase 2 family member,217,ENSG00000111275,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,0,0,WOMBAT-PK
1974,EIF4A2,eukaryotic translation initiation factor 4A2,C0394996,acute alcoholic intoxication,Alcohol use disorders,C0394996,Acute alcoholic intoxication,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,EIF4A2,HGNC:3284,eukaryotic translation initiation factor 4A2,1974,ENSG00000156976,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5726,TAS2R38,"taste receptor, type 2, member 38",C0455383,fh: depression,Depressive disorders,C0455383,FH: Depression,phenotype,0,0,0,0,0,0,T033,Finding,TAS2R38,HGNC:9584,taste 2 receptor member 38,5726,ENSG00000257138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C0455503,h/o: depression,Depressive disorders,C0455503,H/O: depression,phenotype,0,0,0,0,0,0,T033,Finding,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
7040,TGFB1,"transforming growth factor, beta 1",C0455503,h/o: depression,Depressive disorders,C0455503,H/O: depression,phenotype,0,0,0,0,0,0,T033,Finding,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9619,ABCG1,"ATP-binding cassette, sub-family G (WHITE), member 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCG1,HGNC:73,ATP binding cassette subfamily G member 1,9619,ENSG00000160179,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABO,HGNC:79,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",28,ENSG00000175164,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
109,ADCY3,adenylate cyclase 3,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY3,HGNC:234,adenylate cyclase 3,109,ENSG00000138031,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
113,ADCY7,adenylate cyclase 7,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY7,HGNC:238,adenylate cyclase 7,113,ENSG00000121281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
114,ADCY8,adenylate cyclase 8 (brain),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY8,HGNC:239,adenylate cyclase 8,114,ENSG00000155897,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
135,ADORA2A,adenosine A2a receptor,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADORA2A,HGNC:263,adenosine A2a receptor,135,ENSG00000128271,ADORA2A,Adenosine receptor A2a,GPCR,AA2AR_HUMAN,6.1549,EC50,WOMBAT-PK
147,ADRA1B,adrenoceptor alpha 1B,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1B,HGNC:278,adrenoceptor alpha 1B,147,ENSG00000170214,ADRA1B,Alpha-1B adrenergic receptor,GPCR,ADA1B_HUMAN,8.55,Ki,CHEMBL
150,ADRA2A,adrenoceptor alpha 2A,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2A,HGNC:281,adrenoceptor alpha 2A,150,ENSG00000150594,ADRA2A,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,6.3,IC50,WOMBAT-PK
152,ADRA2C,adrenoceptor alpha 2C,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA2C,HGNC:283,adrenoceptor alpha 2C,152,ENSG00000184160,ADRA2C,Alpha-2C adrenergic receptor,GPCR,ADA2C_HUMAN,7,Ki,WOMBAT-PK
153,ADRB1,adrenoceptor beta 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB1,HGNC:285,adrenoceptor beta 1,153,ENSG00000043591,ADRB1,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,0,0,DRUGBANK
155,ADRB3,adrenoceptor beta 3,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB3,HGNC:288,adrenoceptor beta 3,155,ENSG00000188778,ADRB3,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,6.86,Kd,CHEMBL
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKT1,HGNC:391,AKT serine/threonine kinase 1,207,ENSG00000142208,AKT1,RAC-alpha serine/threonine-protein kinase,Kinase,AKT1_HUMAN,5.02,IC50,CHEMBL
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANK3,HGNC:494,ankyrin 3,288,ENSG00000151150,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
367,AR,androgen receptor,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARNTL,HGNC:701,aryl hydrocarbon receptor nuclear translocator like,406,ENSG00000133794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
409,ARRB2,"arrestin, beta 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB2,HGNC:712,arrestin beta 2,409,ENSG00000141480,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP2A2,HGNC:812,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,488,ENSG00000174437,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
553,AVPR1B,arginine vasopressin receptor 1B,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVPR1B,HGNC:896,arginine vasopressin receptor 1B,553,ENSG00000198049,AVPR1B,Vasopressin V1b receptor,GPCR,V1BR_HUMAN,9.43,Ki,CHEMBL
627,BDNF,brain-derived neurotrophic factor,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
26580,BSCL2,Berardinelli-Seip congenital lipodystrophy 2 (seipin),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BSCL2,HGNC:15832,"BSCL2 lipid droplet biogenesis associated, seipin",26580,ENSG00000168000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
776,CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1D,HGNC:1391,calcium voltage-gated channel subunit alpha1 D,776,ENSG00000157388,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_HUMAN,8.399999619,IC50,IUPHAR
1129,CHRM2,"cholinergic receptor, muscarinic 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM2,HGNC:1951,cholinergic receptor muscarinic 2,1129,ENSG00000181072,CHRM2,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,5.900000095,Ki,IUPHAR
1131,CHRM3,"cholinergic receptor, muscarinic 3",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM3,HGNC:1952,cholinergic receptor muscarinic 3,1131,ENSG00000133019,CHRM3,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,6.66,EC50,CHEMBL
9575,CLOCK,clock circadian regulator,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1385,CREB1,cAMP responsive element binding protein 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1395,CRHR2,corticotropin releasing hormone receptor 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR2,HGNC:2358,corticotropin releasing hormone receptor 2,1395,ENSG00000106113,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23373,CRTC1,CREB regulated transcription coactivator 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRTC1,HGNC:16062,CREB regulated transcription coactivator 1,23373,ENSG00000105662,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1429,CRYZ,"crystallin, zeta (quinone reductase)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRYZ,HGNC:2419,crystallin zeta,1429,ENSG00000116791,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1523,CUX1,cut-like homeobox 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CUX1,HGNC:2557,cut like homeobox 1,1523,ENSG00000257923,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
1610,DAO,D-amino-acid oxidase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAO,HGNC:2671,D-amino acid oxidase,1610,ENSG00000110887,DAO,D-amino-acid oxidase,Enzyme,OXDA_HUMAN,5,IC50,CHEMBL
267012,DAOA,D-amino acid oxidase activator,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
27185,DISC1,disrupted in schizophrenia 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27184,DISC2,disrupted in schizophrenia 2 (non-protein coding),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC2,HGNC:2889,disrupted in schizophrenia 2,27184,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1741,DLG3,"discs, large homolog 3 (Drosophila)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG3,HGNC:2902,discs large MAGUK scaffold protein 3,1741,ENSG00000082458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNMT1,HGNC:2976,DNA methyltransferase 1,1786,ENSG00000130816,DNMT1,DNA (cytosine-5)-methyltransferase 1,Enzyme,DNMT1_HUMAN,0,0,DRUGBANK
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DNMT3B,HGNC:2979,DNA methyltransferase 3 beta,1789,ENSG00000088305,DNMT3B,DNA (cytosine-5)-methyltransferase 3B,Enzyme,DNM3B_HUMAN,0,0,WOMBAT-PK
1813,DRD2,dopamine receptor D2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
84062,DTNBP1,dystrobrevin binding protein 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1848,DUSP6,dual specificity phosphatase 6,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DUSP6,HGNC:3072,dual specificity phosphatase 6,1848,ENSG00000139318,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1906,EDN1,endothelin 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EDN1,HGNC:3176,endothelin 1,1906,ENSG00000078401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9030,ERDA1,"expanded repeat domain, CAG/CTG 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERDA1,HGNC:3442,"expanded repeat domain, CAG/CTG 1",9030,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2099,ESR1,estrogen receptor 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR1,HGNC:3467,estrogen receptor 1,2099,ENSG00000091831,ESR1,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,6.74,IC50,CHEMBL
2166,FAAH,fatty acid amide hydrolase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
54738,FEV,FEV (ETS oncogene family),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FEV,HGNC:18562,"FEV transcription factor, ETS family member",54738,ENSG00000163497,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2247,FGF2,fibroblast growth factor 2 (basic),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGF2,HGNC:3676,fibroblast growth factor 2,2247,ENSG00000138685,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2289,FKBP5,FK506 binding protein 5,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2332,FMR1,fragile X mental retardation 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2354,FOSB,FBJ murine osteosarcoma viral oncogene homolog B,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOSB,HGNC:3797,"FosB proto-oncogene, AP-1 transcription factor subunit",2354,ENSG00000125740,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79068,FTO,fat mass and obesity associated,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FTO,HGNC:24678,FTO alpha-ketoglutarate dependent dioxygenase,79068,ENSG00000140718,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7976,FZD3,frizzled class receptor 3,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FZD3,HGNC:4041,frizzled class receptor 3,7976,ENSG00000104290,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA1,HGNC:4075,gamma-aminobutyric acid type A receptor subunit alpha1,2554,ENSG00000022355,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,7.300000191,Ki,CHEMBL
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA5,HGNC:4079,gamma-aminobutyric acid type A receptor subunit alpha5,2558,ENSG00000186297,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_HUMAN,7.639999866,Kd,CHEMBL
2559,GABRA6,"gamma-aminobutyric acid (GABA) A receptor, alpha 6",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA6,HGNC:4080,gamma-aminobutyric acid type A receptor subunit alpha6,2559,ENSG00000145863,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,GBRA6_HUMAN,6.29,IC50,WOMBAT-PK
2561,GABRB2,"gamma-aminobutyric acid (GABA) A receptor, beta 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRB2,HGNC:4082,gamma-aminobutyric acid type A receptor subunit beta2,2561,ENSG00000145864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2563,GABRD,"gamma-aminobutyric acid (GABA) A receptor, delta",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRD,HGNC:4084,gamma-aminobutyric acid type A receptor subunit delta,2563,ENSG00000187730,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD2,HGNC:4093,glutamate decarboxylase 2,2572,ENSG00000136750,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51083,GAL,galanin/GMAP prepropeptide,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAL,HGNC:4114,galanin and GMAP prepropeptide,51083,ENSG00000069482,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2596,GAP43,growth associated protein 43,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAP43,HGNC:4140,growth associated protein 43,2596,ENSG00000172020,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2752,GLUL,glutamate-ammonia ligase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLUL,HGNC:4341,glutamate-ammonia ligase,2752,ENSG00000135821,GLUL,Glutamine synthetase,Enzyme,GLNA_HUMAN,7.49,EC50,CHEMBL
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9248,GPR50,G protein-coupled receptor 50,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPR50,HGNC:4506,G protein-coupled receptor 50,9248,ENSG00000102195,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55507,GPRC5D,"G protein-coupled receptor, class C, group 5, member D",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPRC5D,HGNC:13310,G protein-coupled receptor class C group 5 member D,55507,ENSG00000111291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK2,HGNC:4580,glutamate ionotropic receptor kainate type subunit 2,2898,ENSG00000164418,GRIK2,"Glutamate receptor ionotropic, kainate 2",Ion channel,GRIK2_HUMAN,5.960000038,Ki,CHEMBL
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIN2A,HGNC:4585,glutamate ionotropic receptor NMDA type subunit 2A,2903,ENSG00000183454,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,5.64,IC50,WOMBAT-PK
2912,GRM2,"glutamate receptor, metabotropic 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM2,HGNC:4594,glutamate metabotropic receptor 2,2912,ENSG00000164082,GRM2,Metabotropic glutamate receptor 2,GPCR,GRM2_HUMAN,6.539999962,EC50,CHEMBL
2913,GRM3,"glutamate receptor, metabotropic 3",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM3,HGNC:4595,glutamate metabotropic receptor 3,2913,ENSG00000198822,GRM3,Metabotropic glutamate receptor 3,GPCR,GRM3_HUMAN,6.900000095,Ki,IUPHAR
2932,GSK3B,glycogen synthase kinase 3 beta,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSK3B,HGNC:4617,glycogen synthase kinase 3 beta,2932,ENSG00000082701,GSK3B,Glycogen synthase kinase-3 beta,Kinase,GSK3B_HUMAN,4.57,IC50,CHEMBL
10021,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCN4,HGNC:16882,hyperpolarization activated cyclic nucleotide gated potassium channel 4,10021,ENSG00000138622,HCN4,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,HCN4_HUMAN,5.3468,IC50,WOMBAT-PK
3061,HCRTR1,hypocretin (orexin) receptor 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HCRTR1,HGNC:4848,hypocretin receptor 1,3061,ENSG00000121764,HCRTR1,Orexin receptor type 1,GPCR,OX1R_HUMAN,9.259636879,Ki,SCIENTIFIC LITERATURE
3065,HDAC1,histone deacetylase 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC1,HGNC:4852,histone deacetylase 1,3065,ENSG00000116478,HDAC1,Histone deacetylase 1,Enzyme,HDAC1_HUMAN,4.19,IC50,CHEMBL
3066,HDAC2,histone deacetylase 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC2,HGNC:4853,histone deacetylase 2,3066,ENSG00000196591,HDAC2,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,4.19,IC50,CHEMBL
9759,HDAC4,histone deacetylase 4,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC4,HGNC:14063,histone deacetylase 4,9759,ENSG00000068024,HDAC4,Histone deacetylase 4,Enzyme,HDAC4_HUMAN,6.2924,IC50,WOMBAT-PK
55502,HES6,hes family bHLH transcription factor 6,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HES6,HGNC:18254,hes family bHLH transcription factor 6,55502,ENSG00000144485,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HIF1A,HGNC:4910,hypoxia inducible factor 1 subunit alpha,3091,ENSG00000100644,HIF1A,Hypoxia-inducible factor 1-alpha,Transcription factor,HIF1A_HUMAN,4.75,EC50,CHEMBL
3240,HP,haptoglobin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP,HGNC:5141,haptoglobin,3240,ENSG00000257017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27306,HPGDS,hematopoietic prostaglandin D synthase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPGDS,HGNC:17890,hematopoietic prostaglandin D synthase,27306,ENSG00000163106,HPGDS,Hematopoietic prostaglandin D synthase,Enzyme,HPGDS_HUMAN,4.57,IC50,CHEMBL
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSP90AA1,HGNC:5253,heat shock protein 90 alpha family class A member 1,3320,ENSG00000080824,HSP90AA1,Heat shock protein HSP 90-alpha,Cytosolic other,HS90A_HUMAN,5.3036,IC50,WOMBAT-PK
3308,HSPA4,heat shock 70kDa protein 4,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
3361,HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR5A,HGNC:5300,5-hydroxytryptamine receptor 5A,3361,ENSG00000157219,HTR5A,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,5.906403065,Ki,PDSP
3362,HTR6,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR6,HGNC:5301,5-hydroxytryptamine receptor 6,3362,ENSG00000158748,HTR6,5-hydroxytryptamine receptor 6,GPCR,5HT6R_HUMAN,5.044504671,Ki,DRUG MATRIX
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR7,HGNC:5302,5-hydroxytryptamine receptor 7,3363,ENSG00000148680,HTR7,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,7.93930216,Ki,PDSP
3064,HTT,huntingtin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTT,HGNC:4851,huntingtin,3064,ENSG00000197386,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3557,IL1RN,interleukin 1 receptor antagonist,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1RN,HGNC:6000,interleukin 1 receptor antagonist,3557,ENSG00000136689,IL1RN,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,11.21467018,Kd,DRUG LABEL
3581,IL9R,interleukin 9 receptor,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL9R,HGNC:6030,interleukin 9 receptor,3581,ENSG00000124334,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IMPA2,HGNC:6051,inositol monophosphatase 2,3613,ENSG00000141401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8850,KAT2B,K(lysine) acetyltransferase 2B,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KAT2B,HGNC:8638,lysine acetyltransferase 2B,8850,ENSG00000114166,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51305,KCNK9,"potassium channel, two pore domain subfamily K, member 9",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCNK9,HGNC:6283,potassium two pore domain channel subfamily K member 9,51305,ENSG00000169427,KCNK9,Potassium channel subfamily K member 9,Ion channel,KCNK9_HUMAN,0,0,CHEMBL
115207,KCTD12,potassium channel tetramerization domain containing 12,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KCTD12,HGNC:14678,potassium channel tetramerization domain containing 12,115207,ENSG00000178695,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3939,LDHA,lactate dehydrogenase A,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LDHA,HGNC:6535,lactate dehydrogenase A,3939,ENSG00000134333,LDHA,L-lactate dehydrogenase A chain,Enzyme,LDHA_HUMAN,3.19,Kd,CHEMBL
54551,MAGEL2,melanoma antigen family L2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAGEL2,HGNC:6814,MAGE family member L2,54551,ENSG00000254585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
4133,MAP2,microtubule-associated protein 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2,HGNC:6839,microtubule associated protein 2,4133,ENSG00000078018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2847,MCHR1,melanin-concentrating hormone receptor 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCHR1,HGNC:4479,melanin concentrating hormone receptor 1,2847,ENSG00000128285,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4645,MYO5B,myosin VB,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYO5B,HGNC:7603,myosin VB,4645,ENSG00000167306,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4684,NCAM1,neural cell adhesion molecule 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NFKB1,HGNC:7794,nuclear factor kappa B subunit 1,4790,ENSG00000109320,NFKB1,Nuclear factor NF-kappa-B p105 subunit,Cytosolic other,NFKB1_HUMAN,5.6,IC50,CHEMBL
4852,NPY,neuropeptide Y,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4887,NPY2R,neuropeptide Y receptor Y2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY2R,HGNC:7957,neuropeptide Y receptor Y2,4887,ENSG00000185149,NPY2R,Neuropeptide Y receptor type 2,GPCR,NPY2R_HUMAN,4.959081349,Ki,DRUG MATRIX
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO1,HGNC:2874,NAD(P)H quinone dehydrogenase 1,1728,ENSG00000181019,NQO1,NAD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_HUMAN,4.6,IC50,CHEMBL
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4908,NTF3,neurotrophin 3,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTF3,HGNC:8023,neurotrophin 3,4908,ENSG00000185652,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK3,HGNC:8033,neurotrophic receptor tyrosine kinase 3,4916,ENSG00000140538,NTRK3,NT-3 growth factor receptor,Kinase,NTRK3_HUMAN,6.22,Kd,CHEMBL
4922,NTS,neurotensin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTS,HGNC:8038,neurotensin,4922,ENSG00000133636,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4923,NTSR1,neurotensin receptor 1 (high affinity),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTSR1,HGNC:8039,neurotensin receptor 1,4923,ENSG00000101188,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4986,OPRK1,"opioid receptor, kappa 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
5020,OXT,oxytocin/neurophysin I prepropeptide,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,P2RX7,HGNC:8537,purinergic receptor P2X 7,5027,ENSG00000089041,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKFB3,HGNC:8874,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",5209,ENSG00000170525,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5211,PFKL,"phosphofructokinase, liver",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKL,HGNC:8876,"phosphofructokinase, liver type",5211,ENSG00000141959,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5319,PLA2G1B,"phospholipase A2, group IB (pancreas)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLA2G1B,HGNC:9030,phospholipase A2 group IB,5319,ENSG00000170890,PLA2G1B,Phospholipase A2,Enzyme,PA21B_HUMAN,5.7,IC50,CHEMBL
5367,PMCH,pro-melanin-concentrating hormone,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PMCH,HGNC:9109,pro-melanin concentrating hormone,5367,ENSG00000183395,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5368,PNOC,prepronociceptin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PNOC,HGNC:9163,prepronociceptin,5368,ENSG00000168081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5428,POLG,"polymerase (DNA directed), gamma",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POLG,HGNC:9179,"DNA polymerase gamma, catalytic subunit",5428,ENSG00000140521,POLG,DNA polymerase subunit gamma-1,Enzyme,DPOG1_HUMAN,0,0,WOMBAT-PK
5468,PPARG,peroxisome proliferator-activated receptor gamma,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PPARG,HGNC:9236,peroxisome proliferator activated receptor gamma,5468,ENSG00000132170,PPARG,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,PPARG_HUMAN,0,0,CHEMBL
5617,PRL,prolactin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRL,HGNC:9445,prolactin,5617,ENSG00000172179,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5621,PRNP,prion protein,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRNP,HGNC:9449,prion protein,5621,ENSG00000171867,PRNP,Major prion protein,Surface antigen,PRIO_HUMAN,5.3,EC50,CHEMBL
60675,PROK2,prokineticin 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROK2,HGNC:18455,prokineticin 2,60675,ENSG00000163421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
128674,PROKR2,prokineticin receptor 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROKR2,HGNC:15836,prokineticin receptor 2,128674,ENSG00000101292,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
5914,RARA,"retinoic acid receptor, alpha",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RARA,HGNC:9864,retinoic acid receptor alpha,5914,ENSG00000131759,RARA,Retinoic acid receptor alpha,Nuclear hormone receptor,RARA_HUMAN,0,0,WOMBAT-PK
5649,RELN,reelin,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELN,HGNC:9957,reelin,5649,ENSG00000189056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9628,RGS6,regulator of G-protein signaling 6,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RGS6,HGNC:10002,regulator of G protein signaling 6,9628,ENSG00000182732,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10921,RNPS1,"RNA binding protein S1, serine-rich domain",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNPS1,HGNC:10080,RNA binding protein with serine rich domain 1,10921,ENSG00000205937,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6281,S100A10,S100 calcium binding protein A10,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINA1,HGNC:8941,serpin family A member 1,5265,ENSG00000197249,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29950,SERTAD1,SERTA domain containing 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERTAD1,HGNC:17932,SERTA domain containing 1,29950,ENSG00000197019,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIGMAR1,HGNC:8157,sigma non-opioid intracellular receptor 1,10280,ENSG00000147955,SIGMAR1,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_HUMAN,7.69,Ki,CHEMBL
23411,SIRT1,sirtuin 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT1,HGNC:14929,sirtuin 1,23411,ENSG00000096717,SIRT1,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,4.3,IC50,CHEMBL
22933,SIRT2,sirtuin 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SIRT2,HGNC:10886,sirtuin 2,22933,ENSG00000068903,SIRT2,NAD-dependent protein deacetylase sirtuin-2,Enzyme,SIR2_HUMAN,5.92,IC50,CHEMBL
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC12A5,HGNC:13818,solute carrier family 12 member 5,57468,ENSG00000124140,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A2,HGNC:10940,solute carrier family 1 member 2,6506,ENSG00000110436,SLC1A2,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,4.210000038,Ki,CHEMBL
60482,SLC5A7,"solute carrier family 5 (sodium/choline cotransporter), member 7",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC5A7,HGNC:14025,solute carrier family 5 member 7,60482,ENSG00000115665,SLC5A7,High affinity choline transporter 1,Transporter,SC5A7_HUMAN,4.24,IC50,WOMBAT-PK
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
54498,SMOX,spermine oxidase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SMOX,HGNC:15862,spermine oxidase,54498,ENSG00000088826,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6611,SMS,spermine synthase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SMS,HGNC:11123,spermine synthase,6611,ENSG00000102172,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6697,SPR,"sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SPR,HGNC:11257,sepiapterin reductase,6697,ENSG00000116096,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6753,SSTR3,somatostatin receptor 3,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SSTR3,HGNC:11332,somatostatin receptor 3,6753,ENSG00000278195,SSTR3,Somatostatin receptor type 3,GPCR,SSR3_HUMAN,7.6,Ki,IUPHAR
6863,TAC1,"tachykinin, precursor 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAC1,HGNC:11517,tachykinin precursor 1,6863,ENSG00000006128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6869,TACR1,tachykinin receptor 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TACR1,HGNC:11526,tachykinin receptor 1,6869,ENSG00000115353,TACR1,Substance-P receptor,GPCR,NK1R_HUMAN,10.7,Ki,CHEMBL
4943,TBC1D25,"TBC1 domain family, member 25",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBC1D25,HGNC:8092,TBC1 domain family member 25,4943,ENSG00000068354,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6899,TBX1,T-box 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX1,HGNC:11592,T-box transcription factor 1,6899,ENSG00000184058,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7040,TGFB1,"transforming growth factor, beta 1",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGFB1,HGNC:11766,transforming growth factor beta 1,7040,ENSG00000105329,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10618,TGOLN2,trans-golgi network protein 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TGOLN2,HGNC:15450,trans-golgi network protein 2,10618,ENSG00000152291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
8914,TIMELESS,timeless circadian clock,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TIMELESS,HGNC:11813,timeless circadian regulator,8914,ENSG00000111602,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7124,TNF,tumor necrosis factor,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNF,HGNC:11892,tumor necrosis factor,7124,ENSG00000232810,TNF,Tumor necrosis factor,Cytokine,TNFA_HUMAN,8,IC50,WOMBAT-PK
10673,TNFSF13B,"tumor necrosis factor (ligand) superfamily, member 13b",C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNFSF13B,HGNC:11929,TNF superfamily member 13b,10673,ENSG00000102524,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Cytokine,TN13B_HUMAN,0,0,DRUG LABEL
7166,TPH1,tryptophan hydroxylase 1,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
121278,TPH2,tryptophan hydroxylase 2,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7257,TSNAX,translin-associated factor X,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX,HGNC:12380,translin associated factor X,7257,ENSG00000116918,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100303453,TSNAX-DISC1,TSNAX-DISC1 readthrough (NMD candidate),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX-DISC1,HGNC:49177,TSNAX-DISC1 readthrough (NMD candidate),100303453,ENSG00000270106,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7103,TSPAN8,tetraspanin 8,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSPAN8,HGNC:11855,tetraspanin 8,7103,ENSG00000127324,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7422,VEGFA,vascular endothelial growth factor A,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
7425,VGF,VGF nerve growth factor inducible,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VGF,HGNC:12684,VGF nerve growth factor inducible,7425,ENSG00000128564,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7432,VIP,vasoactive intestinal peptide,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23230,VPS13A,vacuolar protein sorting 13 homolog A (S. cerevisiae),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VPS13A,HGNC:1908,vacuolar protein sorting 13 homolog A,23230,ENSG00000197969,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7466,WFS1,Wolfram syndrome 1 (wolframin),C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,WFS1,HGNC:12762,wolframin ER transmembrane glycoprotein,7466,ENSG00000109501,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
91752,ZNF804A,zinc finger protein 804A,C0525045,mood disorders,Depressive disorders,C0525045,Mood Disorders,group,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZNF804A,HGNC:21711,zinc finger protein 804A,91752,ENSG00000170396,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
948,CD36,CD36 molecule (thrombospondin receptor),C0556303,drinking habits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,CD36,HGNC:1663,CD36 molecule,948,ENSG00000135218,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2067,ERCC1,excision repair cross-complementation group 1,C0556303,drinking habits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,ERCC1,HGNC:3433,"ERCC excision repair 1, endonuclease non-catalytic subunit",2067,ENSG00000012061,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406935,MIR143,microRNA 143,C0556303,drinking habits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,MIR143,HGNC:31530,microRNA 143,406935,ENSG00000284182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406986,MIR203A,microRNA 203a,C0556303,drinking habits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,MIR203A,HGNC:31581,microRNA 203a,406986,ENSG00000207568,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2668,GDNF,glial cell derived neurotrophic factor,C0556344,drinking session,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0556347,drinking day,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0556347,drinking day,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
367,AR,androgen receptor,C0556385,craving for alcohol,Alcohol use disorders,C0556385,Craving for alcohol,phenotype,0,0,0,0,0,0,T033,Finding,AR,HGNC:644,androgen receptor,367,ENSG00000169083,AR,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,0,0,WOMBAT-PK
3952,LEP,leptin,C0556385,craving for alcohol,Alcohol use disorders,C0556385,Craving for alcohol,phenotype,0,0,0,0,0,0,T033,Finding,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6863,TAC1,"tachykinin, precursor 1",C0556385,craving for alcohol,Alcohol use disorders,C0556385,Craving for alcohol,phenotype,0,0,0,0,0,0,T033,Finding,TAC1,HGNC:11517,tachykinin precursor 1,6863,ENSG00000006128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
361,AQP4,aquaporin 4,C0560219,alcohol intake above recommended sensible limits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,AQP4,HGNC:637,aquaporin 4,361,ENSG00000171885,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
22943,DKK1,dickkopf WNT signaling pathway inhibitor 1,C0560219,alcohol intake above recommended sensible limits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,DKK1,HGNC:2891,dickkopf WNT signaling pathway inhibitor 1,22943,ENSG00000107984,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2668,GDNF,glial cell derived neurotrophic factor,C0560219,alcohol intake above recommended sensible limits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406935,MIR143,microRNA 143,C0560219,alcohol intake above recommended sensible limits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,MIR143,HGNC:31530,microRNA 143,406935,ENSG00000284182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406986,MIR203A,microRNA 203a,C0560219,alcohol intake above recommended sensible limits,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,MIR203A,HGNC:31581,microRNA 203a,406986,ENSG00000207568,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8644,AKR1C3,"aldo-keto reductase family 1, member C3",C0564408,manic mood,Bipolar disorders and related disorders,C0564408,Manic mood,phenotype,0,0,0,0,0,0,T033,Finding,AKR1C3,HGNC:386,aldo-keto reductase family 1 member C3,8644,ENSG00000196139,AKR1C3,Aldo-keto reductase family 1 member C3,Enzyme,AK1C3_HUMAN,5.59,IC50,CHEMBL
885,CCK,cholecystokinin,C0564408,manic mood,Bipolar disorders and related disorders,C0564408,Manic mood,phenotype,0,0,0,0,0,0,T033,Finding,CCK,HGNC:1569,cholecystokinin,885,ENSG00000187094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3308,HSPA4,heat shock 70kDa protein 4,C0564408,manic mood,Bipolar disorders and related disorders,C0564408,Manic mood,phenotype,0,0,0,0,0,0,T033,Finding,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,C0564408,manic mood,Bipolar disorders and related disorders,C0564408,Manic mood,phenotype,0,0,0,0,0,0,T033,Finding,SHANK3,HGNC:14294,SH3 and multiple ankyrin repeat domains 3,85358,ENSG00000251322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",C0564408,manic mood,Bipolar disorders and related disorders,C0564408,Manic mood,phenotype,0,0,0,0,0,0,T033,Finding,SRD5A1,HGNC:11284,steroid 5 alpha-reductase 1,6715,ENSG00000145545,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,8.49,IC50,WOMBAT-PK
23166,STAB1,stabilin 1,C0564408,manic mood,Bipolar disorders and related disorders,C0564408,Manic mood,phenotype,0,0,0,0,0,0,T033,Finding,STAB1,HGNC:18628,stabilin 1,23166,ENSG00000010327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0573196,overdose of cocaine,Cocaine use disorders,C0573196,Overdose of cocaine,disease,0,0,0,0,0,0,T037,Injury or Poisoning,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
3620,IDO1,"indoleamine 2,3-dioxygenase 1",C0581391,chronic depression,Depressive disorders,C0581391,Chronic depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IDO1,HGNC:6059,"indoleamine 2,3-dioxygenase 1",3620,ENSG00000131203,IDO1,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_HUMAN,4.639999866,IC50,CHEMBL
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0581391,chronic depression,Depressive disorders,C0581391,Chronic depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
8777,MPDZ,multiple PDZ domain protein,C0586323,alcohol withdrawal seizures,Alcohol use disorders,C0586323,Alcohol Withdrawal Seizures,disease,C23;C10;C25,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Substance-Related Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,MPDZ,HGNC:7208,multiple PDZ domain crumbs cell polarity complex component,8777,ENSG00000107186,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),C0588006,mild depression,Depressive disorders,C0588006,Mild depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MTOR,HGNC:3942,mechanistic target of rapamycin kinase,2475,ENSG00000198793,MTOR,Serine/threonine-protein kinase mTOR,Kinase,MTOR_HUMAN,4.46,IC50,CHEMBL
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",C0588008,severe depression,Depressive disorders,C0588008,Severe depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CALM2,HGNC:1445,calmodulin 2,805,ENSG00000143933,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1813,DRD2,dopamine receptor D2,C0588008,severe depression,Depressive disorders,C0588008,Severe depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
2100,ESR2,estrogen receptor 2 (ER beta),C0588008,severe depression,Depressive disorders,C0588008,Severe depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ESR2,HGNC:3468,estrogen receptor 2,2100,ENSG00000140009,ESR2,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,8,IC50,CHEMBL
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C0588008,severe depression,Depressive disorders,C0588008,Severe depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,C0588008,severe depression,Depressive disorders,C0588008,Severe depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MTR,HGNC:7468,5-methyltetrahydrofolate-homocysteine methyltransferase,4548,ENSG00000116984,MTR,Methionine synthase,Enzyme,METH_HUMAN,0,0,WOMBAT-PK
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0588008,severe depression,Depressive disorders,C0588008,Severe depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
148,ADRA1A,adrenoceptor alpha 1A,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
157,ADRBK2,"adrenergic, beta, receptor kinase 2",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
255239,ANKK1,ankyrin repeat and kinase domain containing 1,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANKK1,HGNC:21027,ankyrin repeat and kinase domain containing 1,255239,ENSG00000170209,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,6.51,Kd,CHEMBL
409,ARRB2,"arrestin, beta 2",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB2,HGNC:712,arrestin beta 2,409,ENSG00000141480,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
551,AVP,arginine vasopressin,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50632,CALY,calcyon neuron-specific vesicular protein,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CALY,HGNC:17938,calcyon neuron specific vesicular protein,50632,ENSG00000130643,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
814,CAMK4,calcium/calmodulin-dependent protein kinase IV,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK4,HGNC:1464,calcium/calmodulin dependent protein kinase IV,814,ENSG00000152495,CAMK4,Calcium/calmodulin-dependent protein kinase type IV,Kinase,KCC4_HUMAN,6.05,Kd,CHEMBL
11126,CD160,CD160 molecule,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD160,HGNC:17013,CD160 molecule,11126,ENSG00000117281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1020,CDK5,cyclin-dependent kinase 5,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDK5,HGNC:1774,cyclin dependent kinase 5,1020,ENSG00000164885,CDK5,Cyclin-dependent-like kinase 5,Kinase,CDK5_HUMAN,5.21,Kd,CHEMBL
441549,CDNF,cerebral dopamine neurotrophic factor,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDNF,HGNC:24913,cerebral dopamine neurotrophic factor,441549,ENSG00000185267,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA3,HGNC:1957,cholinergic receptor nicotinic alpha 3 subunit,1136,ENSG00000080644,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_HUMAN,4.17,Ki,CHEMBL
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNA5,HGNC:1959,cholinergic receptor nicotinic alpha 5 subunit,1138,ENSG00000169684,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB3,HGNC:1963,cholinergic receptor nicotinic beta 3 subunit,1142,ENSG00000147432,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1143,CHRNB4,"cholinergic receptor, nicotinic, beta 4 (neuronal)",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRNB4,HGNC:1964,cholinergic receptor nicotinic beta 4 subunit,1143,ENSG00000117971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
1312,COMT,catechol-O-methyltransferase,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1385,CREB1,cAMP responsive element binding protein 1,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
1813,DRD2,dopamine receptor D2,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
9679,FAM53B,"family with sequence similarity 53, member B",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAM53B,HGNC:28968,family with sequence similarity 53 member B,9679,ENSG00000189319,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABRA2,HGNC:4076,gamma-aminobutyric acid type A receptor subunit alpha2,2555,ENSG00000151834,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,6.94,Ki,CHEMBL
2587,GALR1,galanin receptor 1,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR1,HGNC:4132,galanin receptor 1,2587,ENSG00000166573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2950,GSTP1,glutathione S-transferase pi 1,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSTP1,HGNC:4638,glutathione S-transferase pi 1,2950,ENSG00000084207,GSTP1,Glutathione S-transferase P,Enzyme,GSTP1_HUMAN,0,0,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
4128,MAOA,monoamine oxidase A,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4160,MC4R,melanocortin 4 receptor,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MC4R,HGNC:6932,melanocortin 4 receptor,4160,ENSG00000166603,MC4R,Melanocortin receptor 4,GPCR,MC4R_HUMAN,4.878571482,Ki,DRUG MATRIX
23413,NCS1,neuronal calcium sensor 1,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCS1,HGNC:3953,neuronal calcium sensor 1,23413,ENSG00000107130,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4905,NSF,N-ethylmaleimide-sensitive factor,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NSF,HGNC:8016,"N-ethylmaleimide sensitive factor, vesicle fusing ATPase",4905,ENSG00000073969,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4985,OPRD1,"opioid receptor, delta 1",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRD1,HGNC:8153,opioid receptor delta 1,4985,ENSG00000116329,OPRD1,Delta-type opioid receptor,GPCR,OPRD_HUMAN,7.92,Ki,CHEMBL
4986,OPRK1,"opioid receptor, kappa 1",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRK1,HGNC:8154,opioid receptor kappa 1,4986,ENSG00000082556,OPRK1,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,7,Ki,CHEMBL
4988,OPRM1,"opioid receptor, mu 1",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5187,PER1,period circadian clock 1,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER1,HGNC:8845,period circadian regulator 1,5187,ENSG00000179094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8864,PER2,period circadian clock 2,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC18A2,HGNC:10935,solute carrier family 18 member A2,6571,ENSG00000165646,SLC18A2,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,0,0,CHEMBL
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A3,HGNC:11049,solute carrier family 6 member 3,6531,ENSG00000142319,SLC6A3,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,5.701146924,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
6079,SNORD15A,"small nucleolar RNA, C/D box 15A",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SNORD15A,HGNC:10114,"small nucleolar RNA, C/D box 15A",6079,ENSG00000206941,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6863,TAC1,"tachykinin, precursor 1",C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TAC1,HGNC:11517,tachykinin precursor 1,6863,ENSG00000006128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
121278,TPH2,tryptophan hydroxylase 2,C0600427,cocaine dependence,Cocaine use disorders,C0600427,Cocaine Dependence,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2312,FLG,filaggrin,C0678306,alcohol sensitivity,Alcohol use disorders,C0678306,alcohol sensitivity,phenotype,0,0,0,0,0,0,T033,Finding,FLG,HGNC:3748,filaggrin,2312,ENSG00000143631,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",C0678306,alcohol sensitivity,Alcohol use disorders,C0678306,alcohol sensitivity,phenotype,0,0,0,0,0,0,T033,Finding,UCP2,HGNC:12518,uncoupling protein 2,7351,ENSG00000175567,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7520,XRCC5,X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining),C0678306,alcohol sensitivity,Alcohol use disorders,C0678306,alcohol sensitivity,phenotype,0,0,0,0,0,0,T033,Finding,XRCC5,HGNC:12833,X-ray repair cross complementing 5,7520,ENSG00000079246,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
814,CAMK4,calcium/calmodulin-dependent protein kinase IV,C0678356,alcohol effect,Alcohol use disorders,C0678356,alcohol effect,phenotype,0,0,0,0,0,0,T047,Disease or Syndrome,CAMK4,HGNC:1464,calcium/calmodulin dependent protein kinase IV,814,ENSG00000152495,CAMK4,Calcium/calmodulin-dependent protein kinase type IV,Kinase,KCC4_HUMAN,6.05,Kd,CHEMBL
9421,HAND1,heart and neural crest derivatives expressed 1,C0678807,prenatal fetal exposure to alcohol,Alcohol use disorders,C0678807,prenatal alcohol exposure,phenotype,0,0,0,0,0,0,T033,Finding,HAND1,HGNC:4807,heart and neural crest derivatives expressed 1,9421,ENSG00000113196,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9464,HAND2,heart and neural crest derivatives expressed 2,C0678807,prenatal fetal exposure to alcohol,Alcohol use disorders,C0678807,prenatal alcohol exposure,phenotype,0,0,0,0,0,0,T033,Finding,HAND2,HGNC:4808,heart and neural crest derivatives expressed 2,9464,ENSG00000164107,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3481,IGF2,insulin-like growth factor 2,C0678807,prenatal fetal exposure to alcohol,Alcohol use disorders,C0678807,prenatal alcohol exposure,phenotype,0,0,0,0,0,0,T033,Finding,IGF2,HGNC:5466,insulin like growth factor 2,3481,ENSG00000167244,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C0678807,prenatal fetal exposure to alcohol,Alcohol use disorders,C0678807,prenatal alcohol exposure,phenotype,0,0,0,0,0,0,T033,Finding,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
7422,VEGFA,vascular endothelial growth factor A,C0678807,prenatal fetal exposure to alcohol,Alcohol use disorders,C0678807,prenatal alcohol exposure,phenotype,0,0,0,0,0,0,T033,Finding,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
2668,GDNF,glial cell derived neurotrophic factor,C0683357,excessive drinking,Alcohol use disorders,C0683357,Excessive drinking,phenotype,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
92086,GGTLC1,gamma-glutamyltransferase light chain 1,C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GGTLC1,HGNC:16437,gamma-glutamyltransferase light chain 1,92086,ENSG00000149435,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51738,GHRL,ghrelin/obestatin prepropeptide,C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GHRL,HGNC:18129,ghrelin and obestatin prepropeptide,51738,ENSG00000157017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
406935,MIR143,microRNA 143,C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MIR143,HGNC:31530,microRNA 143,406935,ENSG00000284182,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406986,MIR203A,microRNA 203a,C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MIR203A,HGNC:31581,microRNA 203a,406986,ENSG00000207568,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5444,PON1,paraoxonase 1,C0687132,heavy drinking,Alcohol use disorders,C0687132,heavy drinking,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PON1,HGNC:9204,paraoxonase 1,5444,ENSG00000005421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
460,ASTN1,astrotactin 1,C0740858,substance abuse problem,Alcohol use disorders,C0740858,Substance abuse problem,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ASTN1,HGNC:773,astrotactin 1,460,ENSG00000152092,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",C0740858,substance abuse problem,Alcohol use disorders,C0740858,Substance abuse problem,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C19,HGNC:2621,cytochrome P450 family 2 subfamily C member 19,1557,ENSG00000165841,CYP2C19,Cytochrome P450 2C19,Enzyme,CP2CJ_HUMAN,6,IC50,CHEMBL
11343,MGLL,monoglyceride lipase,C0740858,substance abuse problem,Alcohol use disorders,C0740858,Substance abuse problem,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MGLL,HGNC:17038,monoglyceride lipase,11343,ENSG00000074416,MGLL,Monoglyceride lipase,Enzyme,MGLL_HUMAN,5.9,IC50,CHEMBL
5327,PLAT,"plasminogen activator, tissue",C0740858,substance abuse problem,Alcohol use disorders,C0740858,Substance abuse problem,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLAT,HGNC:9051,"plasminogen activator, tissue type",5327,ENSG00000104368,PLAT,Tissue-type plasminogen activator,Enzyme,TPA_HUMAN,0,0,DRUGBANK
5340,PLG,plasminogen,C0740858,substance abuse problem,Alcohol use disorders,C0740858,Substance abuse problem,disease,F03;C25,Mental Disorders; Substance-Related Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLG,HGNC:9071,plasminogen,5340,ENSG00000122194,PLG,Plasminogen,Enzyme,PLMN_HUMAN,4.4,IC50,CHEMBL
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,C0743072,"depression, psychotic",Depressive disorders,C0743072,"Depression, psychotic",disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FOS,HGNC:3796,"Fos proto-oncogene, AP-1 transcription factor subunit",2353,ENSG00000170345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1465,CSRP1,cysteine and glycine-rich protein 1,C0746402,manic symptom,Bipolar disorders and related disorders,C0746402,manic symptom,phenotype,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CSRP1,HGNC:2469,cysteine and glycine rich protein 1,1465,ENSG00000159176,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
421,ARVCF,armadillo repeat gene deleted in velocardiofacial syndrome,C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,ARVCF,HGNC:728,ARVCF delta catenin family member,421,ENSG00000099889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,CYP1A2,HGNC:2596,cytochrome P450 family 1 subfamily A member 2,1544,ENSG00000140505,CYP1A2,Cytochrome P450 1A2,Enzyme,CP1A2_HUMAN,7.397940009,IC50,DRUG MATRIX
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,CYP3A5,HGNC:2638,cytochrome P450 family 3 subfamily A member 5,1577,ENSG00000106258,CYP3A5,Cytochrome P450 3A5,Enzyme,CP3A5_HUMAN,5.11,IC50,WOMBAT-PK
1740,DLG2,"discs, large homolog 2 (Drosophila)",C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,DLG2,HGNC:2901,discs large MAGUK scaffold protein 2,1740,ENSG00000150672,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100302690,DLG2-AS1,DLG2 antisense RNA 1,C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,DLG2-AS1,HGNC:37132,DLG2 antisense RNA 1,100302690,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2530,FUT8,"fucosyltransferase 8 (alpha (1,6) fucosyltransferase)",C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,FUT8,HGNC:4019,fucosyltransferase 8,2530,ENSG00000033170,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1,C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,IL1RAPL1,HGNC:5996,interleukin 1 receptor accessory protein like 1,11141,ENSG00000169306,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8224,SYN3,synapsin III,C0809983,schizophrenia and related disorders,Schizophrenia spectrum and other psychotic disorders,C0809983,Schizophrenia and related disorders,group,0,0,0,0,0,0,T047,Disease or Syndrome,SYN3,HGNC:11496,synapsin III,8224,ENSG00000185666,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
596,BCL2,B-cell CLL/lymphoma 2,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL2,HGNC:990,BCL2 apoptosis regulator,596,ENSG00000171791,BCL2,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,4.22,Kd,CHEMBL
6347,CCL2,chemokine (C-C motif) ligand 2,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL2,HGNC:10618,C-C motif chemokine ligand 2,6347,ENSG00000108691,CCL2,C-C motif chemokine 2,Cytokine,CCL2_HUMAN,5.16,IC50,CHEMBL
1610,DAO,D-amino-acid oxidase,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAO,HGNC:2671,D-amino acid oxidase,1610,ENSG00000110887,DAO,D-amino-acid oxidase,Enzyme,OXDA_HUMAN,5,IC50,CHEMBL
1958,EGR1,early growth response 1,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR1,HGNC:3238,early growth response 1,1958,ENSG00000120738,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1961,EGR4,early growth response 4,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGR4,HGNC:3241,early growth response 4,1961,ENSG00000135625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
339896,GADL1,glutamate decarboxylase-like 1,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GADL1,HGNC:27949,glutamate decarboxylase like 1,339896,ENSG00000144644,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK3,HGNC:4581,glutamate ionotropic receptor kainate type subunit 3,2899,ENSG00000163873,GRIK3,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,6.099999905,Ki,CHEMBL
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA5,HGNC:5238,heat shock protein family A (Hsp70) member 5,3309,ENSG00000044574,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23522,KAT6B,K(lysine) acetyltransferase 6B,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KAT6B,HGNC:17582,lysine acetyltransferase 6B,23522,ENSG00000156650,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
406989,MIR206,microRNA 206,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR206,HGNC:31584,microRNA 206,406989,ENSG00000207604,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NQO1,HGNC:2874,NAD(P)H quinone dehydrogenase 1,1728,ENSG00000181019,NQO1,NAD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_HUMAN,4.6,IC50,CHEMBL
7101,NR2E1,"nuclear receptor subfamily 2, group E, member 1",C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR2E1,HGNC:7973,nuclear receptor subfamily 2 group E member 1,7101,ENSG00000112333,NR2E1,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,NR2E1_HUMAN,4.560667515,Kd,SCIENTIFIC LITERATURE
10718,NRG3,neuregulin 3,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRG3,HGNC:7999,neuregulin 3,10718,ENSG00000185737,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9369,NRXN3,neurexin 3,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NRXN3,HGNC:8010,neurexin 3,9369,ENSG00000021645,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5444,PON1,paraoxonase 1,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PON1,HGNC:9204,paraoxonase 1,5444,ENSG00000005421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
85413,SLC22A16,"solute carrier family 22 (organic cation/carnitine transporter), member 16",C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC22A16,HGNC:20302,solute carrier family 22 member 16,85413,ENSG00000004809,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57113,TRPC7,"transient receptor potential cation channel, subfamily C, member 7",C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TRPC7,HGNC:20754,transient receptor potential cation channel subfamily C member 7,57113,ENSG00000069018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7494,XBP1,X-box binding protein 1,C0853193,bipolar i disorder,Bipolar disorders and related disorders,C0853193,Bipolar I disorder,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,XBP1,HGNC:12801,X-box binding protein 1,7494,ENSG00000100219,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,C0853206,alcohol interaction,Alcohol use disorders,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,XRCC3,HGNC:12830,X-ray repair cross complementing 3,7517,ENSG00000126215,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1152,CKB,"creatine kinase, brain",C0857501,acute schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0857501,Acute schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CKB,HGNC:1991,creatine kinase B,1152,ENSG00000166165,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C0857501,acute schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0857501,Acute schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
7167,TPI1,triosephosphate isomerase 1,C0857501,acute schizophrenia,Schizophrenia spectrum and other psychotic disorders,C0857501,Acute schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TPI1,HGNC:12009,triosephosphate isomerase 1,7167,ENSG00000111669,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2912,GRM2,"glutamate receptor, metabotropic 2",C0858355,addicted to cocaine,Cocaine use disorders,C0858355,Addicted to cocaine,phenotype,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GRM2,HGNC:4594,glutamate metabotropic receptor 2,2912,ENSG00000164082,GRM2,Metabotropic glutamate receptor 2,GPCR,GRM2_HUMAN,6.539999962,EC50,CHEMBL
2913,GRM3,"glutamate receptor, metabotropic 3",C0858355,addicted to cocaine,Cocaine use disorders,C0858355,Addicted to cocaine,phenotype,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GRM3,HGNC:4595,glutamate metabotropic receptor 3,2913,ENSG00000198822,GRM3,Metabotropic glutamate receptor 3,GPCR,GRM3_HUMAN,6.900000095,Ki,IUPHAR
8864,PER2,period circadian clock 2,C0858355,addicted to cocaine,Cocaine use disorders,C0858355,Addicted to cocaine,phenotype,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
79971,WLS,wntless Wnt ligand secretion mediator,C0858355,addicted to cocaine,Cocaine use disorders,C0858355,Addicted to cocaine,phenotype,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,WLS,HGNC:30238,Wnt ligand secretion mediator,79971,ENSG00000116729,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABCB1,HGNC:40,ATP binding cassette subfamily B member 1,5243,ENSG00000085563,ABCB1,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,0,0,WOMBAT-PK
25890,ABI3BP,"ABI family, member 3 (NESH) binding protein",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ABI3BP,HGNC:17265,ABI family member 3 binding protein,25890,ENSG00000154175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1636,ACE,angiotensin I converting enzyme,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
52,ACP1,"acid phosphatase 1, soluble",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACP1,HGNC:122,acid phosphatase 1,52,ENSG00000143727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
116285,ACSM1,acyl-CoA synthetase medium-chain family member 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ACSM1,HGNC:18049,acyl-CoA synthetase medium chain family member 1,116285,ENSG00000166743,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
111,ADCY5,adenylate cyclase 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY5,HGNC:236,adenylate cyclase 5,111,ENSG00000173175,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
113,ADCY7,adenylate cyclase 7,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADCY7,HGNC:238,adenylate cyclase 7,113,ENSG00000121281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
148,ADRA1A,adrenoceptor alpha 1A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
155,ADRB3,adrenoceptor beta 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ADRB3,HGNC:288,adrenoceptor beta 3,155,ENSG00000188778,ADRB3,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,6.86,Kd,CHEMBL
10270,AKAP8,A kinase (PRKA) anchor protein 8,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AKAP8,HGNC:378,A-kinase anchoring protein 8,10270,ENSG00000105127,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
290,ANPEP,alanyl (membrane) aminopeptidase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ANPEP,HGNC:500,"alanyl aminopeptidase, membrane",290,ENSG00000166825,ANPEP,Aminopeptidase N,Enzyme,AMPN_HUMAN,5.62,IC50,CHEMBL
317,APAF1,apoptotic peptidase activating factor 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APAF1,HGNC:576,apoptotic peptidase activating factor 1,317,ENSG00000120868,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
353,APRT,adenine phosphoribosyltransferase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,APRT,HGNC:626,adenine phosphoribosyltransferase,353,ENSG00000198931,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
408,ARRB1,"arrestin, beta 1",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARRB1,HGNC:711,arrestin beta 1,408,ENSG00000137486,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
410,ARSA,arylsulfatase A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARSA,HGNC:713,arylsulfatase A,410,ENSG00000100299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9048,ARTN,artemin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ARTN,HGNC:727,artemin,9048,ENSG00000117407,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ATP7B,HGNC:870,ATPase copper transporting beta,540,ENSG00000123191,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
551,AVP,arginine vasopressin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,AVP,HGNC:894,arginine vasopressin,551,ENSG00000101200,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
607,BCL9,B-cell CLL/lymphoma 9,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCL9,HGNC:1008,BCL9 transcription coactivator,607,ENSG00000116128,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
613,BCR,breakpoint cluster region,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BCR,HGNC:1014,BCR activator of RhoGEF and GTPase,613,ENSG00000186716,BCR,Breakpoint cluster region protein,Kinase,BCR_HUMAN,0,0,WOMBAT-PK
624,BDKRB2,bradykinin receptor B2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDKRB2,HGNC:1030,bradykinin receptor B2,624,ENSG00000168398,BDKRB2,B2 bradykinin receptor,GPCR,BKRB2_HUMAN,5.114978205,Ki,DRUG MATRIX
627,BDNF,brain-derived neurotrophic factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BDNF,HGNC:1033,brain derived neurotrophic factor,627,ENSG00000176697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
655,BMP7,bone morphogenetic protein 7,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,BMP7,HGNC:1074,bone morphogenetic protein 7,655,ENSG00000101144,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CACNA1C,HGNC:1390,calcium voltage-gated channel subunit alpha1 C,775,ENSG00000151067,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,0,0,SCIENTIFIC LITERATURE
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAMK2A,HGNC:1460,calcium/calmodulin dependent protein kinase II alpha,815,ENSG00000070808,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,7.1,Kd,CHEMBL
847,CAT,catalase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CAT,HGNC:1516,catalase,847,ENSG00000121691,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54862,CC2D1A,coiled-coil and C2 domain containing 1A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CC2D1A,HGNC:30237,coiled-coil and C2 domain containing 1A,54862,ENSG00000132024,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
883,CCBL1,"cysteine conjugate-beta lyase, cytoplasmic",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56267,CCBL2,cysteine conjugate-beta lyase 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
886,CCKAR,cholecystokinin A receptor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCKAR,HGNC:1570,cholecystokinin A receptor,886,ENSG00000163394,CCKAR,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,0,0,DRUGBANK
6347,CCL2,chemokine (C-C motif) ligand 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL2,HGNC:10618,C-C motif chemokine ligand 2,6347,ENSG00000108691,CCL2,C-C motif chemokine 2,Cytokine,CCL2_HUMAN,5.16,IC50,CHEMBL
6369,CCL24,chemokine (C-C motif) ligand 24,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCL24,HGNC:10623,C-C motif chemokine ligand 24,6369,ENSG00000106178,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
595,CCND1,cyclin D1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CCND1,HGNC:1582,cyclin D1,595,ENSG00000110092,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
947,CD34,CD34 molecule,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CD34,HGNC:1662,CD34 molecule,947,ENSG00000174059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1005,CDH7,"cadherin 7, type 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDH7,HGNC:1766,cadherin 7,1005,ENSG00000081138,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CDKN2A,HGNC:1787,cyclin dependent kinase inhibitor 2A,1029,ENSG00000147889,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1131,CHRM3,"cholinergic receptor, muscarinic 3",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CHRM3,HGNC:1952,cholinergic receptor muscarinic 3,1131,ENSG00000133019,CHRM3,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,6.66,EC50,CHEMBL
9575,CLOCK,clock circadian regulator,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
202333,CMYA5,cardiomyopathy associated 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CMYA5,HGNC:14305,cardiomyopathy associated 5,202333,ENSG00000164309,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1267,CNP,"2',3'-cyclic nucleotide 3' phosphodiesterase",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNP,HGNC:2158,"2',3'-cyclic nucleotide 3' phosphodiesterase",1267,ENSG00000173786,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1268,CNR1,cannabinoid receptor 1 (brain),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNR1,HGNC:2159,cannabinoid receptor 1,1268,ENSG00000118432,CNR1,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,0,0,WOMBAT-PK
26047,CNTNAP2,contactin associated protein-like 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CNTNAP2,HGNC:13830,contactin associated protein 2,26047,ENSG00000174469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1312,COMT,catechol-O-methyltransferase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1385,CREB1,cAMP responsive element binding protein 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREB1,HGNC:2345,cAMP responsive element binding protein 1,1385,ENSG00000118260,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1390,CREM,cAMP responsive element modulator,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CREM,HGNC:2352,cAMP responsive element modulator,1390,ENSG00000095794,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1392,CRH,corticotropin releasing hormone,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRH,HGNC:2355,corticotropin releasing hormone,1392,ENSG00000147571,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1393,CRHBP,corticotropin releasing hormone binding protein,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHBP,HGNC:2356,corticotropin releasing hormone binding protein,1393,ENSG00000145708,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1394,CRHR1,corticotropin releasing hormone receptor 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRHR1,HGNC:2357,corticotropin releasing hormone receptor 1,1394,ENSG00000120088,CRHR1,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,8.48148632,Kd,SCIENTIFIC LITERATURE
1401,CRP,"C-reactive protein, pentraxin-related",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRP,HGNC:2367,C-reactive protein,1401,ENSG00000132693,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1429,CRYZ,"crystallin, zeta (quinone reductase)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CRYZ,HGNC:2419,crystallin zeta,1429,ENSG00000116791,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1439,CSF2RB,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSF2RB,HGNC:2436,colony stimulating factor 2 receptor subunit beta,1439,ENSG00000100368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1453,CSNK1D,"casein kinase 1, delta",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CSNK1D,HGNC:2452,casein kinase 1 delta,1453,ENSG00000141551,CSNK1D,Casein kinase I isoform delta,Kinase,KC1D_HUMAN,5.46,Kd,CHEMBL
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTLA4,HGNC:2505,cytotoxic T-lymphocyte associated protein 4,1493,ENSG00000163599,CTLA4,Cytotoxic T-lymphocyte protein 4,Surface antigen,CTLA4_HUMAN,0,0,DRUG LABEL
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CTNND2,HGNC:2516,catenin delta 2,1501,ENSG00000169862,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1523,CUX1,cut-like homeobox 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CUX1,HGNC:2557,cut like homeobox 1,1523,ENSG00000257923,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3627,CXCL10,chemokine (C-X-C motif) ligand 10,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CXCL10,HGNC:10637,C-X-C motif chemokine ligand 10,3627,ENSG00000169245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C19,HGNC:2621,cytochrome P450 family 2 subfamily C member 19,1557,ENSG00000165841,CYP2C19,Cytochrome P450 2C19,Enzyme,CP2CJ_HUMAN,6,IC50,CHEMBL
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2C9,HGNC:2623,cytochrome P450 family 2 subfamily C member 9,1559,ENSG00000138109,CYP2C9,Cytochrome P450 2C9,Enzyme,CP2C9_HUMAN,7.3979,EC50,WOMBAT-PK
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,CYP2D6,HGNC:2625,cytochrome P450 family 2 subfamily D member 6,1565,ENSG00000100197,CYP2D6,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,6.706858517,IC50,DRUG MATRIX
267012,DAOA,D-amino acid oxidase activator,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DAOA,HGNC:21191,D-amino acid oxidase activator,267012,ENSG00000182346,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
140947,DCANP1,dendritic cell-associated nuclear protein,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DCANP1,HGNC:24459,dendritic cell associated nuclear protein,140947,ENSG00000251380,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
54541,DDIT4,DNA-damage-inducible transcript 4,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DDIT4,HGNC:24944,DNA damage inducible transcript 4,54541,ENSG00000168209,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10522,DEAF1,DEAF1 transcription factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DEAF1,HGNC:14677,DEAF1 transcription factor,10522,ENSG00000177030,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27185,DISC1,disrupted in schizophrenia 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DISC1,HGNC:2888,DISC1 scaffold protein,27185,ENSG00000162946,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1740,DLG2,"discs, large homolog 2 (Drosophila)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG2,HGNC:2901,discs large MAGUK scaffold protein 2,1740,ENSG00000150672,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1741,DLG3,"discs, large homolog 3 (Drosophila)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG3,HGNC:2902,discs large MAGUK scaffold protein 3,1741,ENSG00000082458,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1742,DLG4,"discs, large homolog 4 (Drosophila)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DLG4,HGNC:2903,discs large MAGUK scaffold protein 4,1742,ENSG00000132535,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1813,DRD2,dopamine receptor D2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD2,HGNC:3023,dopamine receptor D2,1813,ENSG00000149295,DRD2,D(2) dopamine receptor,GPCR,DRD2_HUMAN,0,0,DRUGBANK
1814,DRD3,dopamine receptor D3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD3,HGNC:3024,dopamine receptor D3,1814,ENSG00000151577,DRD3,D(3) dopamine receptor,GPCR,DRD3_HUMAN,6.1837587,Ki,DRUG MATRIX
1815,DRD4,dopamine receptor D4,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
84062,DTNBP1,dystrobrevin binding protein 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,DTNBP1,HGNC:17328,dystrobrevin binding protein 1,84062,ENSG00000047579,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9695,EDEM1,"ER degradation enhancer, mannosidase alpha-like 1",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EDEM1,HGNC:18967,ER degradation enhancing alpha-mannosidase like protein 1,9695,ENSG00000134109,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1906,EDN1,endothelin 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EDN1,HGNC:3176,endothelin 1,1906,ENSG00000078401,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1950,EGF,epidermal growth factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGF,HGNC:3229,epidermal growth factor,1950,ENSG00000138798,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1956,EGFR,epidermal growth factor receptor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EGFR,HGNC:3236,epidermal growth factor receptor,1956,ENSG00000146648,EGFR,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,5.217742426,IC50,DRUG MATRIX
30845,EHD3,EH-domain containing 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EHD3,HGNC:3244,EH domain containing 3,30845,ENSG00000013016,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1975,EIF4B,eukaryotic translation initiation factor 4B,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EIF4B,HGNC:3285,eukaryotic translation initiation factor 4B,1975,ENSG00000063046,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2012,EMP1,epithelial membrane protein 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,EMP1,HGNC:3333,epithelial membrane protein 1,2012,ENSG00000134531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2028,ENPEP,glutamyl aminopeptidase (aminopeptidase A),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ENPEP,HGNC:3355,glutamyl aminopeptidase,2028,ENSG00000138792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ERBB3,HGNC:3431,erb-b2 receptor tyrosine kinase 3,2065,ENSG00000065361,ERBB3,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,7.74,Kd,CHEMBL
2100,ESR2,estrogen receptor 2 (ER beta),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ESR2,HGNC:3468,estrogen receptor 2,2100,ENSG00000140009,ESR2,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,8,IC50,CHEMBL
2166,FAAH,fatty acid amide hydrolase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FAAH,HGNC:3553,fatty acid amide hydrolase,2166,ENSG00000117480,FAAH,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,6.34,IC50,CHEMBL
2260,FGFR1,fibroblast growth factor receptor 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FGFR1,HGNC:3688,fibroblast growth factor receptor 1,2260,ENSG00000077782,FGFR1,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,5.43,Kd,CHEMBL
2288,FKBP4,"FK506 binding protein 4, 59kDa",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP4,HGNC:3720,FKBP prolyl isomerase 4,2288,ENSG00000004478,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Enzyme,FKBP4_HUMAN,7.8,IC50,CHEMBL
2289,FKBP5,FK506 binding protein 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
2332,FMR1,fragile X mental retardation 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOS,HGNC:3796,"Fos proto-oncogene, AP-1 transcription factor subunit",2353,ENSG00000170345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27022,FOXD3,forkhead box D3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXD3,HGNC:3804,forkhead box D3,27022,ENSG00000187140,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
93986,FOXP2,forkhead box P2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FOXP2,HGNC:13875,forkhead box P2,93986,ENSG00000128573,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
166752,FREM3,FRAS1 related extracellular matrix 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,FREM3,HGNC:25172,FRAS1 related extracellular matrix 3,166752,ENSG00000183090,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9568,GABBR2,"gamma-aminobutyric acid (GABA) B receptor, 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GABBR2,HGNC:4507,gamma-aminobutyric acid type B receptor subunit 2,9568,ENSG00000136928,GABBR2,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,GABR2_HUMAN,8.027,IC50,WOMBAT-PK
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GAD1,HGNC:4092,glutamate decarboxylase 1,2571,ENSG00000128683,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8811,GALR2,galanin receptor 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GALR2,HGNC:4133,galanin receptor 2,8811,ENSG00000182687,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2643,GCH1,GTP cyclohydrolase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GCH1,HGNC:4193,GTP cyclohydrolase 1,2643,ENSG00000131979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51573,GDE1,glycerophosphodiester phosphodiesterase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GDE1,HGNC:29644,glycerophosphodiester phosphodiesterase 1,51573,ENSG00000006007,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2668,GDNF,glial cell derived neurotrophic factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GDNF,HGNC:4232,glial cell derived neurotrophic factor,2668,ENSG00000168621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2670,GFAP,glial fibrillary acidic protein,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GFAP,HGNC:4235,glial fibrillary acidic protein,2670,ENSG00000131095,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2697,GJA1,"gap junction protein, alpha 1, 43kDa",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GJA1,HGNC:4274,gap junction protein alpha 1,2697,ENSG00000152661,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55830,GLT8D1,glycosyltransferase 8 domain containing 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GLT8D1,HGNC:24870,glycosyltransferase 8 domain containing 1,55830,ENSG00000016864,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51291,GMIP,GEM interacting protein,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GMIP,HGNC:24852,GEM interacting protein,51291,ENSG00000089639,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
54584,GNB1L,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB1L,HGNC:4397,G protein subunit beta 1 like,54584,ENSG00000185838,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GNB3,HGNC:4400,G protein subunit beta 3,2784,ENSG00000111664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55507,GPRC5D,"G protein-coupled receptor, class C, group 5, member D",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GPRC5D,HGNC:13310,G protein-coupled receptor class C group 5 member D,55507,ENSG00000111291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA2,HGNC:4572,glutamate ionotropic receptor AMPA type subunit 2,2891,ENSG00000120251,GRIA2,Glutamate receptor 2,Ion channel,GRIA2_HUMAN,5.65,EC50,CHEMBL
2893,GRIA4,"glutamate receptor, ionotropic, AMPA 4",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIA4,HGNC:4574,glutamate ionotropic receptor AMPA type subunit 4,2893,ENSG00000152578,GRIA4,Glutamate receptor 4,Ion channel,GRIA4_HUMAN,5.409999847,EC50,IUPHAR
2900,GRIK4,"glutamate receptor, ionotropic, kainate 4",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRIK4,HGNC:4582,glutamate ionotropic receptor kainate type subunit 4,2900,ENSG00000149403,GRIK4,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,7.73754891,Ki,PDSP
2869,GRK5,G protein-coupled receptor kinase 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRK5,HGNC:4544,G protein-coupled receptor kinase 5,2869,ENSG00000198873,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2915,GRM5,"glutamate receptor, metabotropic 5",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM5,HGNC:4597,glutamate metabotropic receptor 5,2915,ENSG00000168959,GRM5,Metabotropic glutamate receptor 5,GPCR,GRM5_HUMAN,5.41,Ki,WOMBAT-PK
2917,GRM7,"glutamate receptor, metabotropic 7",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GRM7,HGNC:4599,glutamate metabotropic receptor 7,2917,ENSG00000196277,GRM7,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,0,0,WOMBAT-PK
2932,GSK3B,glycogen synthase kinase 3 beta,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,GSK3B,HGNC:4617,glycogen synthase kinase 3 beta,2932,ENSG00000082701,GSK3B,Glycogen synthase kinase-3 beta,Kinase,GSK3B_HUMAN,4.57,IC50,CHEMBL
10014,HDAC5,histone deacetylase 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HDAC5,HGNC:14068,histone deacetylase 5,10014,ENSG00000108840,HDAC5,Histone deacetylase 5,Enzyme,HDAC5_HUMAN,6.260000229,Ki,IUPHAR
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HIF1A,HGNC:4910,hypoxia inducible factor 1 subunit alpha,3091,ENSG00000100644,HIF1A,Hypoxia-inducible factor 1-alpha,Transcription factor,HIF1A_HUMAN,4.75,EC50,CHEMBL
3131,HLF,hepatic leukemia factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLF,HGNC:4977,"HLF transcription factor, PAR bZIP family member",3131,ENSG00000108924,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9456,HOMER1,homer homolog 1 (Drosophila),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HOMER1,HGNC:17512,homer scaffold protein 1,9456,ENSG00000152413,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3240,HP,haptoglobin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HP,HGNC:5141,haptoglobin,3240,ENSG00000257017,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10855,HPSE,heparanase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HPSE,HGNC:5164,heparanase,10855,ENSG00000173083,HPSE,Heparanase,Enzyme,HPSE_HUMAN,4.28,Kd,CHEMBL
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSP90AA1,HGNC:5253,heat shock protein 90 alpha family class A member 1,3320,ENSG00000080824,HSP90AA1,Heat shock protein HSP 90-alpha,Cytosolic other,HS90A_HUMAN,5.3036,IC50,WOMBAT-PK
259217,HSPA12A,heat shock 70kDa protein 12A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA12A,HGNC:19022,heat shock protein family A (Hsp70) member 12A,259217,ENSG00000165868,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3303,HSPA1A,heat shock 70kDa protein 1A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1A,HGNC:5232,heat shock protein family A (Hsp70) member 1A,3303,ENSG00000204389,HSPA1A,Heat shock 70 kDa protein 1A,Unclassified,HS71A_HUMAN,5.46999979,IC50,CHEMBL
3304,HSPA1B,heat shock 70kDa protein 1B,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1B,HGNC:5233,heat shock protein family A (Hsp70) member 1B,3304,ENSG00000204388,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3305,HSPA1L,heat shock 70kDa protein 1-like,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA1L,HGNC:5234,heat shock protein family A (Hsp70) member 1 like,3305,ENSG00000204390,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3308,HSPA4,heat shock 70kDa protein 4,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1A,HGNC:5286,5-hydroxytryptamine receptor 1A,3350,ENSG00000178394,HTR1A,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,6.7212,Ki,WOMBAT-PK
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR1B,HGNC:5287,5-hydroxytryptamine receptor 1B,3351,ENSG00000135312,HTR1B,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,8,Ki,WOMBAT-PK
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2A,HGNC:5293,5-hydroxytryptamine receptor 2A,3356,ENSG00000102468,HTR2A,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,5.400000095,Ki,IUPHAR
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR2C,HGNC:5295,5-hydroxytryptamine receptor 2C,3358,ENSG00000147246,HTR2C,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,6.199999809,Ki,IUPHAR
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3A,HGNC:5297,5-hydroxytryptamine receptor 3A,3359,ENSG00000166736,HTR3A,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,0,0,WOMBAT-PK
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HTR3B,HGNC:5298,5-hydroxytryptamine receptor 3B,9177,ENSG00000149305,HTR3B,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,8.8,Ki,CHEMBL
3439,IFNA1,"interferon, alpha 1",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNA1,HGNC:5417,interferon alpha 1,3439,ENSG00000197919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
282617,IFNL3,"interferon, lambda 3",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IFNL3,HGNC:18365,interferon lambda 3,282617,ENSG00000197110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9641,IKBKE,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IKBKE,HGNC:14552,inhibitor of nuclear factor kappa B kinase subunit epsilon,9641,ENSG00000263528,IKBKE,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,IKKE_HUMAN,6.21,Kd,CHEMBL
3586,IL10,interleukin 10,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL10,HGNC:5962,interleukin 10,3586,ENSG00000136634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3589,IL11,interleukin 11,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL11,HGNC:5966,interleukin 11,3589,ENSG00000095752,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
29949,IL19,interleukin 19,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL19,HGNC:5990,interleukin 19,29949,ENSG00000142224,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3553,IL1B,"interleukin 1, beta",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL1B,HGNC:5992,interleukin 1 beta,3553,ENSG00000125538,IL1B,Interleukin-1 beta,Cytokine,IL1B_HUMAN,0,0,DRUG LABEL
50604,IL20,interleukin 20,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL20,HGNC:6002,interleukin 20,50604,ENSG00000162891,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11009,IL24,interleukin 24,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL24,HGNC:11346,interleukin 24,11009,ENSG00000162892,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3559,IL2RA,"interleukin 2 receptor, alpha",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL2RA,HGNC:6008,interleukin 2 receptor subunit alpha,3559,ENSG00000134460,IL2RA,Interleukin-2 receptor subunit alpha,Membrane receptor,IL2RA_HUMAN,10,Kd,DRUG LABEL
3569,IL6,interleukin 6,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IL6,HGNC:6018,interleukin 6,3569,ENSG00000136244,IL6,Interleukin-6,Cytokine,IL6_HUMAN,8.38,IC50,CHEMBL
3665,IRF7,interferon regulatory factor 7,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,IRF7,HGNC:6122,interferon regulatory factor 7,3665,ENSG00000185507,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3697,ITIH1,inter-alpha-trypsin inhibitor heavy chain 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ITIH1,HGNC:6166,inter-alpha-trypsin inhibitor heavy chain 1,3697,ENSG00000055957,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8997,KALRN,"kalirin, RhoGEF kinase",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KALRN,HGNC:4814,kalirin RhoGEF kinase,8997,ENSG00000160145,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3791,KDR,kinase insert domain receptor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KDR,HGNC:6307,kinase insert domain receptor,3791,ENSG00000128052,KDR,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_HUMAN,5.54,Kd,CHEMBL
8564,KMO,kynurenine 3-monooxygenase (kynurenine 3-hydroxylase),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KMO,HGNC:6381,kynurenine 3-monooxygenase,8564,ENSG00000117009,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3839,KPNA3,karyopherin alpha 3 (importin alpha 4),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KPNA3,HGNC:6396,karyopherin subunit alpha 3,3839,ENSG00000102753,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8942,KYNU,kynureninase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,KYNU,HGNC:6469,kynureninase,8942,ENSG00000115919,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3939,LDHA,lactate dehydrogenase A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LDHA,HGNC:6535,lactate dehydrogenase A,3939,ENSG00000134333,LDHA,L-lactate dehydrogenase A chain,Enzyme,LDHA_HUMAN,3.19,Kd,CHEMBL
3952,LEP,leptin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LEP,HGNC:6553,leptin,3952,ENSG00000174697,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64077,LHPP,phospholysine phosphohistidine inorganic pyrophosphate phosphatase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LHPP,HGNC:30042,phospholysine phosphohistidine inorganic pyrophosphate phosphatase,64077,ENSG00000107902,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4035,LRP1,low density lipoprotein receptor-related protein 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP1,HGNC:6692,LDL receptor related protein 1,4035,ENSG00000123384,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7804,LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LRP8,HGNC:6700,LDL receptor related protein 8,7804,ENSG00000157193,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4045,LSAMP,limbic system-associated membrane protein,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LSAMP,HGNC:6705,limbic system associated membrane protein,4045,ENSG00000185565,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4049,LTA,lymphotoxin alpha,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,LTA,HGNC:6709,lymphotoxin alpha,4049,ENSG00000226979,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4074,M6PR,mannose-6-phosphate receptor (cation dependent),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,M6PR,HGNC:6752,"mannose-6-phosphate receptor, cation dependent",4074,ENSG00000003056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4128,MAOA,monoamine oxidase A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4129,MAOB,monoamine oxidase B,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAOB,HGNC:6834,monoamine oxidase B,4129,ENSG00000069535,MAOB,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,0,0,WOMBAT-PK
4133,MAP2,microtubule-associated protein 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2,HGNC:6839,microtubule associated protein 2,4133,ENSG00000078018,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5604,MAP2K1,mitogen-activated protein kinase kinase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MAP2K1,HGNC:6840,mitogen-activated protein kinase kinase 1,5604,ENSG00000169032,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,MP2K1_HUMAN,6,Kd,CHEMBL
55784,MCTP2,"multiple C2 domains, transmembrane 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MCTP2,HGNC:25636,multiple C2 and transmembrane domain containing 2,55784,ENSG00000140563,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
266727,MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDGA1,HGNC:19267,MAM domain containing glycosylphosphatidylinositol anchor 1,266727,ENSG00000112139,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4194,MDM4,"MDM4, p53 regulator",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MDM4,HGNC:6974,MDM4 regulator of p53,4194,ENSG00000198625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9968,MED12,mediator complex subunit 12,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MED12,HGNC:11957,mediator complex subunit 12,9968,ENSG00000184634,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100302259,MIR1202,microRNA 1202,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR1202,HGNC:35268,microRNA 1202,100302259,ENSG00000221456,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
407034,MIR30E,microRNA 30e,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MIR30E,HGNC:31629,microRNA 30e,407034,ENSG00000198974,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4317,MMP8,matrix metallopeptidase 8 (neutrophil collagenase),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MMP8,HGNC:7175,matrix metallopeptidase 8,4317,ENSG00000118113,MMP8,Neutrophil collagenase,Enzyme,MMP8_HUMAN,4.599999905,IC50,IUPHAR
27136,MORC1,MORC family CW-type zinc finger 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MORC1,HGNC:7198,MORC family CW-type zinc finger 1,27136,ENSG00000114487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTHFR,HGNC:7436,methylenetetrahydrofolate reductase,4524,ENSG00000177000,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MTOR,HGNC:3942,mechanistic target of rapamycin kinase,2475,ENSG00000198793,MTOR,Serine/threonine-protein kinase mTOR,Kinase,MTOR_HUMAN,4.46,IC50,CHEMBL
23040,MYT1L,myelin transcription factor 1-like,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,MYT1L,HGNC:7623,myelin transcription factor 1 like,23040,ENSG00000186487,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4684,NCAM1,neural cell adhesion molecule 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NCAM1,HGNC:7656,neural cell adhesion molecule 1,4684,ENSG00000149294,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV1,HGNC:7716,NADH:ubiquinone oxidoreductase core subunit V1,4723,ENSG00000167792,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NDUFV2,HGNC:7717,NADH:ubiquinone oxidoreductase core subunit V2,4729,ENSG00000178127,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4747,NEFL,"neurofilament, light polypeptide",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NEFL,HGNC:7739,neurofilament light,4747,ENSG00000277586,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4745,NELL1,NEL-like 1 (chicken),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NELL1,HGNC:7750,neural EGFL like 1,4745,ENSG00000165973,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64067,NPAS3,neuronal PAS domain protein 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPAS3,HGNC:19311,neuronal PAS domain protein 3,64067,ENSG00000151322,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4852,NPY,neuropeptide Y,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C1,HGNC:7978,nuclear receptor subfamily 3 group C member 1,2908,ENSG00000113580,NR3C1,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,0,0,CHEMBL
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR3C2,HGNC:7979,nuclear receptor subfamily 3 group C member 2,4306,ENSG00000151623,NR3C2,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,8.42,EC50,CHEMBL
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NR4A2,HGNC:7981,nuclear receptor subfamily 4 group A member 2,4929,ENSG00000153234,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4908,NTF3,neurotrophin 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTF3,HGNC:8023,neurotrophin 3,4908,ENSG00000185652,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50863,NTM,neurotrimin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTM,HGNC:17941,neurotrimin,50863,ENSG00000182667,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,NTRK3,HGNC:8033,neurotrophic receptor tyrosine kinase 3,4916,ENSG00000140538,NTRK3,NT-3 growth factor receptor,Kinase,NTRK3_HUMAN,6.22,Kd,CHEMBL
4939,OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OAS2,HGNC:8087,2'-5'-oligoadenylate synthetase 2,4939,ENSG00000111335,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5020,OXT,oxytocin/neurophysin I prepropeptide,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXT,HGNC:8528,oxytocin/neurophysin I prepropeptide,5020,ENSG00000101405,OXT,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,0,0,WOMBAT-PK
5021,OXTR,oxytocin receptor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OXTR,HGNC:8529,oxytocin receptor,5021,ENSG00000180914,OXTR,Oxytocin receptor,GPCR,OXYR_HUMAN,8.148741722,Ki,SCIENTIFIC LITERATURE
5074,PAWR,"PRKC, apoptosis, WT1, regulator",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PAWR,HGNC:8614,pro-apoptotic WT1 regulator,5074,ENSG00000177425,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
27445,PCLO,piccolo presynaptic cytomatrix protein,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCLO,HGNC:13406,piccolo presynaptic cytomatrix protein,27445,ENSG00000186472,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5116,PCNT,pericentrin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PCNT,HGNC:16068,pericentrin,5116,ENSG00000160299,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
50940,PDE11A,phosphodiesterase 11A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDE11A,HGNC:8773,phosphodiesterase 11A,50940,ENSG00000128655,PDE11A,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,PDE11_HUMAN,6.4,Ki,CHEMBL
10611,PDLIM5,PDZ and LIM domain 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDLIM5,HGNC:17468,PDZ and LIM domain 5,10611,ENSG00000163110,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5173,PDYN,prodynorphin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PDYN,HGNC:8820,prodynorphin,5173,ENSG00000101327,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8682,PEA15,phosphoprotein enriched in astrocytes 15,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEA15,HGNC:8822,proliferation and apoptosis adaptor protein 15,8682,ENSG00000162734,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5824,PEX19,peroxisomal biogenesis factor 19,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PEX19,HGNC:9713,peroxisomal biogenesis factor 19,5824,ENSG00000162735,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PFKFB3,HGNC:8874,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",5209,ENSG00000170525,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
65018,PINK1,PTEN induced putative kinase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PINK1,HGNC:14581,PTEN induced kinase 1,65018,ENSG00000158828,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLCB1,HGNC:15917,phospholipase C beta 1,23236,ENSG00000182621,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5340,PLG,plasminogen,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PLG,HGNC:9071,plasminogen,5340,ENSG00000122194,PLG,Plasminogen,Enzyme,PLMN_HUMAN,4.4,IC50,CHEMBL
5453,POU3F1,POU class 3 homeobox 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,POU3F1,HGNC:9214,POU class 3 homeobox 1,5453,ENSG00000185668,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
145270,PRIMA1,proline rich membrane anchor 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRIMA1,HGNC:18319,proline rich membrane anchor 1,145270,ENSG00000175785,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5579,PRKCB,"protein kinase C, beta",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PRKCB,HGNC:9395,protein kinase C beta,5579,ENSG00000166501,PRKCB,Protein kinase C beta type,Kinase,KPCB_HUMAN,8.33,IC50,CHEMBL
60675,PROK2,prokineticin 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROK2,HGNC:18455,prokineticin 2,60675,ENSG00000163421,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8842,PROM1,prominin 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PROM1,HGNC:9454,prominin 1,8842,ENSG00000007062,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5692,PSMB4,"proteasome (prosome, macropain) subunit, beta type, 4",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PSMB4,HGNC:9541,proteasome 20S subunit beta 4,5692,ENSG00000159377,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTGS2,HGNC:9605,prostaglandin-endoperoxide synthase 2,5743,ENSG00000073756,PTGS2,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,0,0,DRUG LABEL
5801,PTPRR,"protein tyrosine phosphatase, receptor type, R",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTPRR,HGNC:9680,protein tyrosine phosphatase receptor type R,5801,ENSG00000153233,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5806,PTX3,"pentraxin 3, long",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,PTX3,HGNC:9692,pentraxin 3,5806,ENSG00000163661,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9444,QKI,"QKI, KH domain containing, RNA binding",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,QKI,HGNC:21100,"QKI, KH domain containing RNA binding",9444,ENSG00000112531,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPGEF5,HGNC:16862,Rap guanine nucleotide exchange factor 5,9771,ENSG00000136237,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
65059,RAPH1,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RAPH1,HGNC:14436,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,65059,ENSG00000173166,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7905,REEP5,receptor accessory protein 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REEP5,HGNC:30077,receptor accessory protein 5,7905,ENSG00000129625,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5649,RELN,reelin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RELN,HGNC:9957,reelin,5649,ENSG00000189056,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5978,REST,RE1-silencing transcription factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,REST,HGNC:9966,RE1 silencing transcription factor,5978,ENSG00000084093,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10193,RNF41,"ring finger protein 41, E3 ubiquitin protein ligase",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,RNF41,HGNC:18401,ring finger protein 41,10193,ENSG00000181852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6281,S100A10,S100 calcium binding protein A10,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100A10,HGNC:10487,S100 calcium binding protein A10,6281,ENSG00000197747,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6285,S100B,S100 calcium binding protein B,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,S100B,HGNC:10500,S100 calcium binding protein B,6285,ENSG00000160307,S100B,Protein S100-B,Cytosolic other,S100B_HUMAN,6,Kd,CHEMBL
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SAT1,HGNC:10540,spermidine/spermine N1-acetyltransferase 1,6303,ENSG00000130066,SAT1,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,5.7,Ki,CHEMBL
9632,SEC24C,SEC24 family member C,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SEC24C,HGNC:10705,"SEC24 homolog C, COPII coat complex component",9632,ENSG00000176986,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SERPINE1,HGNC:8583,serpin family E member 1,5054,ENSG00000106366,SERPINE1,Plasminogen activator inhibitor 1,Secreted,PAI1_HUMAN,0,0,WOMBAT-PK
6446,SGK1,serum/glucocorticoid regulated kinase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SGK1,HGNC:10810,serum/glucocorticoid regulated kinase 1,6446,ENSG00000118515,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57084,SLC17A6,"solute carrier family 17 (vesicular glutamate transporter), member 6",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC17A6,HGNC:16703,solute carrier family 17 member 6,57084,ENSG00000091664,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6511,SLC1A6,"solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC1A6,HGNC:10944,solute carrier family 1 member 6,6511,ENSG00000105143,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
60482,SLC5A7,"solute carrier family 5 (sodium/choline cotransporter), member 7",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC5A7,HGNC:14025,solute carrier family 5 member 7,60482,ENSG00000115665,SLC5A7,High affinity choline transporter 1,Transporter,SC5A7_HUMAN,4.24,IC50,WOMBAT-PK
6540,SLC6A13,"solute carrier family 6 (neurotransmitter transporter), member 13",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A13,HGNC:11046,solute carrier family 6 member 13,6540,ENSG00000010379,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55117,SLC6A15,"solute carrier family 6 (neutral amino acid transporter), member 15",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A15,HGNC:13621,solute carrier family 6 member 15,55117,ENSG00000072041,SLC6A15,Sodium-dependent neutral amino acid transporter B(0)AT2,Transporter,S6A15_HUMAN,5.400000095,IC50,CHEMBL
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
6586,SLIT3,slit homolog 3 (Drosophila),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SLIT3,HGNC:11087,slit guidance ligand 3,6586,ENSG00000184347,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6662,SOX9,SRY (sex determining region Y)-box 9,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SOX9,HGNC:11204,SRY-box transcription factor 9,6662,ENSG00000125398,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
51593,SRRT,"serrate, RNA effector molecule",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SRRT,HGNC:24101,"serrate, RNA effector molecule",51593,ENSG00000087087,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6750,SST,somatostatin,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SST,HGNC:11329,somatostatin,6750,ENSG00000157005,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6755,SSTR5,somatostatin receptor 5,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,SSTR5,HGNC:11334,somatostatin receptor 5,6755,ENSG00000162009,SSTR5,Somatostatin receptor type 5,GPCR,SSR5_HUMAN,5.39,Ki,CHEMBL
30009,TBX21,T-box 21,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TBX21,HGNC:11599,T-box transcription factor 21,30009,ENSG00000073861,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6999,TDO2,"tryptophan 2,3-dioxygenase",C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TDO2,HGNC:11708,"tryptophan 2,3-dioxygenase",6999,ENSG00000151790,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7008,TEF,thyrotrophic embryonic factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TEF,HGNC:11722,"TEF transcription factor, PAR bZIP family member",7008,ENSG00000167074,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7015,TERT,telomerase reverse transcriptase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TERT,HGNC:11730,telomerase reverse transcriptase,7015,ENSG00000164362,TERT,Telomerase reverse transcriptase,Enzyme,TERT_HUMAN,4.14,IC50,CHEMBL
7024,TFCP2,transcription factor CP2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TFCP2,HGNC:11748,transcription factor CP2,7024,ENSG00000135457,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7054,TH,tyrosine hydroxylase,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TH,HGNC:11782,tyrosine hydroxylase,7054,ENSG00000180176,TH,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,0,0,DRUGBANK
51284,TLR7,toll-like receptor 7,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TLR7,HGNC:15631,toll like receptor 7,51284,ENSG00000196664,TLR7,Toll-like receptor 7,Membrane receptor,TLR7_HUMAN,5.559999943,IC50,IUPHAR
7124,TNF,tumor necrosis factor,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TNF,HGNC:11892,tumor necrosis factor,7124,ENSG00000232810,TNF,Tumor necrosis factor,Cytokine,TNFA_HUMAN,8,IC50,WOMBAT-PK
10452,TOMM40,translocase of outer mitochondrial membrane 40 homolog (yeast),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TOMM40,HGNC:18001,translocase of outer mitochondrial membrane 40,10452,ENSG00000130204,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7166,TPH1,tryptophan hydroxylase 1,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH1,HGNC:12008,tryptophan hydroxylase 1,7166,ENSG00000129167,TPH1,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,7.795879841,IC50,SCIENTIFIC LITERATURE
121278,TPH2,tryptophan hydroxylase 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TPH2,HGNC:20692,tryptophan hydroxylase 2,121278,ENSG00000139287,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
100303453,TSNAX-DISC1,TSNAX-DISC1 readthrough (NMD candidate),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TSNAX-DISC1,HGNC:49177,TSNAX-DISC1 readthrough (NMD candidate),100303453,ENSG00000270106,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7297,TYK2,tyrosine kinase 2,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TYK2,HGNC:12440,tyrosine kinase 2,7297,ENSG00000105397,TYK2,Non-receptor tyrosine-protein kinase TYK2,Kinase,TYK2_HUMAN,6.96,Kd,CHEMBL
114131,UCN3,urocortin 3,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,UCN3,HGNC:17781,urocortin 3,114131,ENSG00000178473,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
64854,USP46,ubiquitin specific peptidase 46,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,USP46,HGNC:20075,ubiquitin specific peptidase 46,64854,ENSG00000109189,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6844,VAMP2,vesicle-associated membrane protein 2 (synaptobrevin 2),C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VAMP2,HGNC:12643,vesicle associated membrane protein 2,6844,ENSG00000220205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7422,VEGFA,vascular endothelial growth factor A,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
7432,VIP,vasoactive intestinal peptide,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7704,ZBTB16,zinc finger and BTB domain containing 16,C1269683,major depressive disorder,Depressive disorders,C1269683,Major Depressive Disorder,disease,F03,Mental Disorders,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,ZBTB16,HGNC:12930,zinc finger and BTB domain containing 16,7704,ENSG00000109906,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
983,CDK1,cyclin-dependent kinase 1,C1306067,drug-induced paranoid state,Drug-induced psychosis,C1306067,Drug-induced paranoid state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CDK1,HGNC:1722,cyclin dependent kinase 1,983,ENSG00000170312,CDK1,Cyclin-dependent kinase 1,Kinase,CDK1_HUMAN,6.35,IC50,CHEMBL
1312,COMT,catechol-O-methyltransferase,C1306067,drug-induced paranoid state,Drug-induced psychosis,C1306067,Drug-induced paranoid state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),C1306067,drug-induced paranoid state,Drug-induced psychosis,C1306067,Drug-induced paranoid state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DBH,HGNC:2689,dopamine beta-hydroxylase,1621,ENSG00000123454,DBH,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,3,Km,WOMBAT-PK
5187,PER1,period circadian clock 1,C1306067,drug-induced paranoid state,Drug-induced psychosis,C1306067,Drug-induced paranoid state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PER1,HGNC:8845,period circadian regulator 1,5187,ENSG00000179094,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8864,PER2,period circadian clock 2,C1306067,drug-induced paranoid state,Drug-induced psychosis,C1306067,Drug-induced paranoid state,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PER2,HGNC:8846,period circadian regulator 2,8864,ENSG00000132326,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3105,HLA-A,"major histocompatibility complex, class I, A",C1456784,paranoia,Schizophrenia spectrum and other psychotic disorders,C1456784,Paranoia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-A,HGNC:4931,"major histocompatibility complex, class I, A",3105,ENSG00000206503,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3126,HLA-DRB4,"major histocompatibility complex, class II, DR beta 4",C1456784,paranoia,Schizophrenia spectrum and other psychotic disorders,C1456784,Paranoia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,HLA-DRB4,HGNC:4952,"major histocompatibility complex, class II, DR beta 4",3126,ENSG00000227357,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6925,TCF4,transcription factor 4,C1456784,paranoia,Schizophrenia spectrum and other psychotic disorders,C1456784,Paranoia,disease,F03,Mental Disorders,HP:0000707,Abnormality of the nervous system,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,TCF4,HGNC:11634,transcription factor 4,6925,ENSG00000196628,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23394,ADNP,activity-dependent neuroprotector homeobox,C1542327,fetus or newborn affected by alcohol transmitted via placenta or breast milk,Alcohol use disorders,C1542327,Fetus or newborn affected by alcohol transmitted via placenta or breast milk,disease,0,0,0,0,0,0,T033,Finding,ADNP,HGNC:15766,activity dependent neuroprotector homeobox,23394,ENSG00000101126,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7432,VIP,vasoactive intestinal peptide,C1542327,fetus or newborn affected by alcohol transmitted via placenta or breast milk,Alcohol use disorders,C1542327,Fetus or newborn affected by alcohol transmitted via placenta or breast milk,disease,0,0,0,0,0,0,T033,Finding,VIP,HGNC:12693,vasoactive intestinal peptide,7432,ENSG00000146469,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,C1656427,early onset schizophrenia,Schizophrenia spectrum and other psychotic disorders,C1656427,Early onset schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DNMT3B,HGNC:2979,DNA methyltransferase 3 beta,1789,ENSG00000088305,DNMT3B,DNA (cytosine-5)-methyltransferase 3B,Enzyme,DNM3B_HUMAN,0,0,WOMBAT-PK
4719,NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",C1656427,early onset schizophrenia,Schizophrenia spectrum and other psychotic disorders,C1656427,Early onset schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NDUFS1,HGNC:7707,NADH:ubiquinone oxidoreductase core subunit S1,4719,ENSG00000023228,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6663,SOX10,SRY (sex determining region Y)-box 10,C1656427,early onset schizophrenia,Schizophrenia spectrum and other psychotic disorders,C1656427,Early onset schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SOX10,HGNC:11190,SRY-box transcription factor 10,6663,ENSG00000100146,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4988,OPRM1,"opioid receptor, mu 1",C1837893,schizophrenia 12,Schizophrenia spectrum and other psychotic disorders,C1837893,SCHIZOPHRENIA 12,disease,0,0,0,0,DOID:150,disease of mental health,T047,Disease or Syndrome,OPRM1,HGNC:8156,opioid receptor mu 1,4988,ENSG00000112038,OPRM1,Mu-type opioid receptor,GPCR,OPRM_HUMAN,8.5,EC50,WOMBAT-PK
1636,ACE,angiotensin I converting enzyme,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,ACE,HGNC:2707,angiotensin I converting enzyme,1636,ENSG00000159640,ACE,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,6.5,IC50,CHEMBL
1015,CDH17,"cadherin 17, LI cadherin (liver-intestine)",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,CDH17,HGNC:1756,cadherin 17,1015,ENSG00000079112,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23316,CUX2,cut-like homeobox 2,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,CUX2,HGNC:19347,cut like homeobox 2,23316,ENSG00000111249,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1610,DAO,D-amino-acid oxidase,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,DAO,HGNC:2671,D-amino acid oxidase,1610,ENSG00000110887,DAO,D-amino-acid oxidase,Enzyme,OXDA_HUMAN,5,IC50,CHEMBL
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,DDC,HGNC:2719,dopa decarboxylase,1644,ENSG00000132437,DDC,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,0,0,WOMBAT-PK
144717,FAM109A,"family with sequence similarity 109, member A",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
8322,FZD4,frizzled class receptor 4,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,FZD4,HGNC:4042,frizzled class receptor 4,8322,ENSG00000174804,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55507,GPRC5D,"G protein-coupled receptor, class C, group 5, member D",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,GPRC5D,HGNC:13310,G protein-coupled receptor class C group 5 member D,55507,ENSG00000111291,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10042,HMGXB4,HMG box domain containing 4,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,HMGXB4,HGNC:5003,HMG-box containing 4,10042,ENSG00000100281,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
55364,IMPACT,impact RWD domain protein,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,IMPACT,HGNC:20387,impact RWD domain protein,55364,ENSG00000154059,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3680,ITGA9,"integrin, alpha 9",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,ITGA9,HGNC:6145,integrin subunit alpha 9,3680,ENSG00000144668,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,KCNQ2,HGNC:6296,potassium voltage-gated channel subfamily Q member 2,3785,ENSG00000075043,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,KCNQ2_HUMAN,5,EC50,IUPHAR
9223,MAGI1,"membrane associated guanylate kinase, WW and PDZ domain containing 1",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,MAGI1,HGNC:946,"membrane associated guanylate kinase, WW and PDZ domain containing 1",9223,ENSG00000151276,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9863,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,MAGI2,HGNC:18957,"membrane associated guanylate kinase, WW and PDZ domain containing 2",9863,ENSG00000187391,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,MLC1,HGNC:17082,modulator of VRAC current 1,23209,ENSG00000100427,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4391,MRX27,"mental retardation, X-linked 27",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,MRX27,HGNC:7257,"mental retardation, X-linked 27",0,0,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,PLA2G2A,HGNC:9031,phospholipase A2 group IIA,5320,ENSG00000188257,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,PLA2G4A,HGNC:9035,phospholipase A2 group IVA,5321,ENSG00000116711,PLA2G4A,Cytosolic phospholipase A2,Enzyme,PA24A_HUMAN,0,0,WOMBAT-PK
5524,PPP2R4,"protein phosphatase 2A activator, regulatory subunit 4",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5590,PRKCZ,"protein kinase C, zeta",C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,PRKCZ,HGNC:9412,protein kinase C zeta,5590,ENSG00000067606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
10043,TOM1,target of myb1 (chicken),C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,TOM1,HGNC:11982,target of myb1 membrane trafficking protein,10043,ENSG00000100284,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6844,VAMP2,vesicle-associated membrane protein 2 (synaptobrevin 2),C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,VAMP2,HGNC:12643,vesicle associated membrane protein 2,6844,ENSG00000220205,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9341,VAMP3,vesicle-associated membrane protein 3,C1839839,major affective disorder 2,Bipolar disorders and related disorders,C1839839,MAJOR AFFECTIVE DISORDER 2,disease,C16;F03,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders",0,0,0,0,T048,Mental or Behavioral Dysfunction,VAMP3,HGNC:12644,vesicle associated membrane protein 3,9341,ENSG00000049245,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
85439,STON2,stonin 2,C1842605,schizophrenia 11,Schizophrenia spectrum and other psychotic disorders,C1842605,SCHIZOPHRENIA 11,disease,0,0,0,0,DOID:150,disease of mental health,T047,Disease or Syndrome,STON2,HGNC:30652,stonin 2,85439,ENSG00000140022,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
474,ATOH1,atonal homolog 1 (Drosophila),C1879677,alcohol toxicity,Alcohol use disorders,C1879677,Alcohol Toxicity,disease,0,0,0,0,0,0,T037,Injury or Poisoning,ATOH1,HGNC:797,atonal bHLH transcription factor 1,474,ENSG00000172238,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
894,CCND2,cyclin D2,C1879677,alcohol toxicity,Alcohol use disorders,C1879677,Alcohol Toxicity,disease,0,0,0,0,0,0,T037,Injury or Poisoning,CCND2,HGNC:1583,cyclin D2,894,ENSG00000118971,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3251,HPRT1,hypoxanthine phosphoribosyltransferase 1,C1959897,alcohol consumption during pregnancy,Alcohol use disorders,C1959897,Alcohol consumption during pregnancy,phenotype,0,0,0,0,0,0,T033,Finding,HPRT1,HGNC:5157,hypoxanthine phosphoribosyltransferase 1,3251,ENSG00000165704,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,Enzyme,HPRT_HUMAN,0,0,WOMBAT-PK
4128,MAOA,monoamine oxidase A,C2063866,"depressive disorder, treatment-resistant",Depressive disorders,C2063866,"Depressive Disorder, Treatment-Resistant",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
5604,MAP2K1,mitogen-activated protein kinase kinase 1,C2063866,"depressive disorder, treatment-resistant",Depressive disorders,C2063866,"Depressive Disorder, Treatment-Resistant",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,MAP2K1,HGNC:6840,mitogen-activated protein kinase kinase 1,5604,ENSG00000169032,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,MP2K1_HUMAN,6,Kd,CHEMBL
5999,RGS4,regulator of G-protein signaling 4,C2063866,"depressive disorder, treatment-resistant",Depressive disorders,C2063866,"Depressive Disorder, Treatment-Resistant",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,RGS4,HGNC:10000,regulator of G protein signaling 4,5999,ENSG00000117152,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",C2063866,"depressive disorder, treatment-resistant",Depressive disorders,C2063866,"Depressive Disorder, Treatment-Resistant",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A2,HGNC:11048,solute carrier family 6 member 2,6530,ENSG00000103546,SLC6A2,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,6,Ki,DRUG MATRIX
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C2063866,"depressive disorder, treatment-resistant",Depressive disorders,C2063866,"Depressive Disorder, Treatment-Resistant",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
7422,VEGFA,vascular endothelial growth factor A,C2063866,"depressive disorder, treatment-resistant",Depressive disorders,C2063866,"Depressive Disorder, Treatment-Resistant",disease,F03,Mental Disorders,0,0,0,0,T048,Mental or Behavioral Dysfunction,VEGFA,HGNC:12680,vascular endothelial growth factor A,7422,ENSG00000112715,VEGFA,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,0,0,WOMBAT-PK
6310,ATXN1,ataxin 1,C2362914,clinical depression,Depressive disorders,C2362914,clinical depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ATXN1,HGNC:10548,ataxin 1,6310,ENSG00000124788,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2289,FKBP5,FK506 binding protein 5,C2362914,clinical depression,Depressive disorders,C2362914,clinical depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,FKBP5,HGNC:3721,FKBP prolyl isomerase 5,2289,ENSG00000096060,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,8.52,Ki,CHEMBL
3683,ITGAL,"integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",C2362914,clinical depression,Depressive disorders,C2362914,clinical depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ITGAL,HGNC:6148,integrin subunit alpha L,3683,ENSG00000005844,ITGAL,Leukocyte adhesion glycoprotein LFA-1 alpha,Adhesion,ITAL_HUMAN,4.89,Kd,CHEMBL
4128,MAOA,monoamine oxidase A,C2362914,clinical depression,Depressive disorders,C2362914,clinical depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,MAOA,HGNC:6833,monoamine oxidase A,4128,ENSG00000189221,MAOA,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,4.07,IC50,CHEMBL
4852,NPY,neuropeptide Y,C2362914,clinical depression,Depressive disorders,C2362914,clinical depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NPY,HGNC:7955,neuropeptide Y,4852,ENSG00000122585,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5621,PRNP,prion protein,C2362914,clinical depression,Depressive disorders,C2362914,clinical depression,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,PRNP,HGNC:9449,prion protein,5621,ENSG00000171867,PRNP,Major prion protein,Surface antigen,PRIO_HUMAN,5.3,EC50,CHEMBL
4627,MYH9,"myosin, heavy chain 9, non-muscle",C2673482,increased susceptibility to schizophrenia,Schizophrenia spectrum and other psychotic disorders,C2673482,Increased susceptibility to schizophrenia,phenotype,0,0,0,0,0,0,T033,Finding,MYH9,HGNC:7579,myosin heavy chain 9,4627,ENSG00000100345,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5354,PLP1,proteolipid protein 1,C2673482,increased susceptibility to schizophrenia,Schizophrenia spectrum and other psychotic disorders,C2673482,Increased susceptibility to schizophrenia,phenotype,0,0,0,0,0,0,T033,Finding,PLP1,HGNC:9086,proteolipid protein 1,5354,ENSG00000123560,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4135,MAP6,microtubule-associated protein 6,C2678117,schizophrenia-like symptoms (uncommon),Schizophrenia spectrum and other psychotic disorders,C2678117,Schizophrenia-like symptoms (uncommon),phenotype,0,0,0,0,0,0,T033,Finding,MAP6,HGNC:6868,microtubule associated protein 6,4135,ENSG00000171533,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
160851,DGKH,"diacylglycerol kinase, eta",C2678248,mood instability,Depressive disorders,C2678248,Mood instability,phenotype,0,0,0,0,0,0,T033,Finding,DGKH,HGNC:2854,diacylglycerol kinase eta,160851,ENSG00000102780,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2332,FMR1,fragile X mental retardation 1,C2678248,mood instability,Depressive disorders,C2678248,Mood instability,phenotype,0,0,0,0,0,0,T033,Finding,FMR1,HGNC:3775,FMRP translational regulator 1,2332,ENSG00000102081,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3458,IFNG,"interferon, gamma",C2939186,disturbance in mood,Depressive disorders,C2939186,Disturbance in mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,IFNG,HGNC:5438,interferon gamma,3458,ENSG00000111537,IFNG,Interferon gamma,Cytokine,IFNG_HUMAN,9.5,IC50,WOMBAT-PK
22933,SIRT2,sirtuin 2,C2939186,disturbance in mood,Depressive disorders,C2939186,Disturbance in mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SIRT2,HGNC:10886,sirtuin 2,22933,ENSG00000068903,SIRT2,NAD-dependent protein deacetylase sirtuin-2,Enzyme,SIR2_HUMAN,5.92,IC50,CHEMBL
7226,TRPM2,"transient receptor potential cation channel, subfamily M, member 2",C2939186,disturbance in mood,Depressive disorders,C2939186,Disturbance in mood,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TRPM2,HGNC:12339,transient receptor potential cation channel subfamily M member 2,7226,ENSG00000142185,TRPM2,Transient receptor potential cation channel subfamily M member 2,Ion channel,TRPM2_HUMAN,4.15,IC50,CHEMBL
596,BCL2,B-cell CLL/lymphoma 2,C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,BCL2,HGNC:990,BCL2 apoptosis regulator,596,ENSG00000171791,BCL2,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,4.22,Kd,CHEMBL
10752,CHL1,cell adhesion molecule L1-like,C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,CHL1,HGNC:1939,cell adhesion molecule L1 like,10752,ENSG00000134121,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2551,GABPA,"GA binding protein transcription factor, alpha subunit 60kDa",C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,GABPA,HGNC:4071,GA binding protein transcription factor subunit alpha,2551,ENSG00000154727,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
57502,NLGN4X,"neuroligin 4, X-linked",C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,NLGN4X,HGNC:14287,neuroligin 4 X-linked,57502,ENSG00000146938,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5015,OTX2,orthodenticle homeobox 2,C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,OTX2,HGNC:8522,orthodenticle homeobox 2,5015,ENSG00000165588,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,PDGFRA,HGNC:8803,platelet derived growth factor receptor alpha,5156,ENSG00000134853,PDGFRA,Platelet-derived growth factor receptor alpha,Kinase,PGFRA_HUMAN,9.33,Kd,CHEMBL
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,PIK3CA,HGNC:8975,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",5290,ENSG00000121879,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,PK3CA_HUMAN,4.42,IC50,CHEMBL
6469,SHH,sonic hedgehog,C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,SHH,HGNC:10848,sonic hedgehog signaling molecule,6469,ENSG00000164690,SHH,Sonic hedgehog protein,Enzyme,SHH_HUMAN,7.82,IC50,CHEMBL
84631,SLITRK2,"SLIT and NTRK-like family, member 2",C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,SLITRK2,HGNC:13449,SLIT and NTRK like family member 2,84631,ENSG00000185985,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6722,SRF,serum response factor (c-fos serum response element-binding transcription factor),C2985290,fetal alcohol spectrum disorders,Alcohol use disorders,C2985290,Fetal Alcohol Spectrum Disorders,group,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047;T019,Disease or Syndrome; Congenital Abnormality,SRF,HGNC:11291,serum response factor,6722,ENSG00000112658,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",C3146244,alcohol related birth defect,Alcohol use disorders,C3146244,Alcohol Related Birth Defect,disease,C16;C13;C25,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Substance-Related Disorders",0,0,0,0,T047,Disease or Syndrome,NTRK2,HGNC:8032,neurotrophic receptor tyrosine kinase 2,4915,ENSG00000148053,NTRK2,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,6.31,Kd,CHEMBL
5015,OTX2,orthodenticle homeobox 2,C3151380,schizophrenia 15,Schizophrenia spectrum and other psychotic disorders,C3151380,SCHIZOPHRENIA 15,disease,0,0,0,0,DOID:150,disease of mental health,T048,Mental or Behavioral Dysfunction,OTX2,HGNC:8522,orthodenticle homeobox 2,5015,ENSG00000165588,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1269,CNR2,cannabinoid receptor 2 (macrophage),C3160814,cannabis use,Cannabis use disorders,C3160814,Cannabis use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CNR2,HGNC:2160,cannabinoid receptor 2,1269,ENSG00000188822,CNR2,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,4.2,Ki,WOMBAT-PK
1312,COMT,catechol-O-methyltransferase,C3160814,cannabis use,Cannabis use disorders,C3160814,Cannabis use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,COMT,HGNC:2228,catechol-O-methyltransferase,1312,ENSG00000093010,COMT,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,4.85,IC50,WOMBAT-PK
1815,DRD4,dopamine receptor D4,C3160814,cannabis use,Cannabis use disorders,C3160814,Cannabis use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DRD4,HGNC:3025,dopamine receptor D4,1815,ENSG00000069696,DRD4,D(4) dopamine receptor,GPCR,DRD4_HUMAN,5.206698646,Ki,DRUG MATRIX
64123,ELTD1,"EGF, latrophilin and seven transmembrane domain containing 1",C3160814,cannabis use,Cannabis use disorders,C3160814,Cannabis use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",C3160814,cannabis use,Cannabis use disorders,C3160814,Cannabis use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GABRA2,HGNC:4076,gamma-aminobutyric acid type A receptor subunit alpha2,2555,ENSG00000151834,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,6.94,Ki,CHEMBL
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",C3160814,cannabis use,Cannabis use disorders,C3160814,Cannabis use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC6A4,HGNC:11050,solute carrier family 6 member 4,6532,ENSG00000108576,SLC6A4,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,5.744245213,Ki,DRUG MATRIX
408,ARRB1,"arrestin, beta 1",C3178803,social anhedonia,Depressive disorders,C3178803,Social Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",0,0,0,0,T048,Mental or Behavioral Dysfunction,ARRB1,HGNC:711,arrestin beta 1,408,ENSG00000137486,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1400,CRMP1,collapsin response mediator protein 1,C3178803,social anhedonia,Depressive disorders,C3178803,Social Anhedonia,disease,C23;C10;F01,"Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms",0,0,0,0,T048,Mental or Behavioral Dysfunction,CRMP1,HGNC:2365,collapsin response mediator protein 1,1400,ENSG00000072832,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
148,ADRA1A,adrenoceptor alpha 1A,C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,ADRA1A,HGNC:277,adrenoceptor alpha 1A,148,ENSG00000120907,ADRA1A,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,8.09,Ki,CHEMBL
8973,CHRNA6,"cholinergic receptor, nicotinic, alpha 6 (neuronal)",C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CHRNA6,HGNC:15963,cholinergic receptor nicotinic alpha 6 subunit,8973,ENSG00000147434,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,ACHA6_HUMAN,4.039999962,IC50,IUPHAR
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CHRNB3,HGNC:1963,cholinergic receptor nicotinic beta 3 subunit,1142,ENSG00000147432,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
9575,CLOCK,clock circadian regulator,C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CLOCK,HGNC:2082,clock circadian regulator,9575,ENSG00000134852,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,CYP11A1,HGNC:2590,cytochrome P450 family 11 subfamily A member 1,1583,ENSG00000140459,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",Enzyme,CP11A_HUMAN,0,0,CHEMBL
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,DNMT3A,HGNC:2978,DNA methyltransferase 3 alpha,1788,ENSG00000119772,DNMT3A,DNA (cytosine-5)-methyltransferase 3A,Enzyme,DNM3A_HUMAN,0,0,CHEMBL
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,GRIK1,HGNC:4579,glutamate ionotropic receptor kainate type subunit 1,2897,ENSG00000171189,GRIK1,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,6.150000095,Ki,CHEMBL
3308,HSPA4,heat shock 70kDa protein 4,C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HSPA4,HGNC:5237,heat shock protein family A (Hsp70) member 4,3308,ENSG00000170606,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SCN1A,HGNC:10585,sodium voltage-gated channel alpha subunit 1,6323,ENSG00000144285,SCN1A,Sodium channel protein type 1 subunit alpha,Ion channel,SCN1A_HUMAN,5.79,IC50,WOMBAT-PK
10948,STARD3,StAR-related lipid transfer (START) domain containing 3,C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,STARD3,HGNC:17579,StAR related lipid transfer domain containing 3,10948,ENSG00000131748,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
7022,TFAP2C,transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma),C3496069,cocaine use,Cocaine use disorders,C3496069,cocaine use,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TFAP2C,HGNC:11744,transcription factor AP-2 gamma,7022,ENSG00000087510,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",C3544321,treatment-resistant schizophrenia,Schizophrenia spectrum and other psychotic disorders,C3544321,Treatment-resistant schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,HTR4,HGNC:5299,5-hydroxytryptamine receptor 4,3360,ENSG00000164270,HTR4,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,7.54,Ki,CHEMBL
4855,NOTCH4,notch 4,C3544321,treatment-resistant schizophrenia,Schizophrenia spectrum and other psychotic disorders,C3544321,Treatment-resistant schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,NOTCH4,HGNC:7884,notch receptor 4,4855,ENSG00000204301,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
56301,SLC7A10,"solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10",C3544321,treatment-resistant schizophrenia,Schizophrenia spectrum and other psychotic disorders,C3544321,Treatment-resistant schizophrenia,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,SLC7A10,HGNC:11058,solute carrier family 7 member 10,56301,ENSG00000130876,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
11076,TPPP,tubulin polymerization promoting protein,C3826462,depression in children,Depressive disorders,C3826462,Depression in children,disease,0,0,0,0,0,0,T048,Mental or Behavioral Dysfunction,TPPP,HGNC:24164,tubulin polymerization promoting protein,11076,ENSG00000171368,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
